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Abstract 
In order to characterise the angiogenic response of human dental pulps to orthodontic 
force application, transcriptomic and proteomic changes were investigated relative to 
three early time-points of routine clinical treatment in contralateral pairs of treated and 
control teeth. It was hypothesised that varied intensities of hypoxic exposure 
(intermittent, repeated intermittent and chronic) would result in distinct angiogenic 
responses within untreated pulp tissues. It was further hypothesised that angiogenic 
responses of pulps exposed to early time-points of orthodontic treatment would 
correlate with those of tissues exposed to varied hypoxic intensities; and changes would 
be associated with known stages of clinical treatment, namely: initial, lag, acceleration 
and linear phases of orthodontic tooth movement. 
Prior to performing all experimentation, methodologies for handling of rare clinical 
samples were established. Protocols for sample storage, homogenisation, RNAtotal 
isolation, quantification, purification and amplification were optimised; a normalising 
factor created from the mean expression of reference genes RPL13A and UBC was 
found to be most appropriate for RT-qPCR analysis of human dental pulps under these 
experimental conditions. 
Orthodontic force application resulted in a potential angiogenic or putative 
inflammatory response at all treatment time-points; and altered gene expression 
associated with hypoxia is evident in pulps following 2 weeks of force application. The 
response to each defined hypoxic intensity was unique; and the associated angiogenic 
response correlated with the duration of hypoxic exposure. Reoxygenation following 
hypoxia was linked to the putative inflammatory response of pulps during orthodontic 
treatment. 
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Results showed that the experimental potential of a single clinical sample can be 
amplified significantly, dependent upon the selection of specific experimental protocols; 
thus eliminating the need for pooling samples or using cell lines which are far removed 
from true physiological conditions. Both angiogenesis and hypoxia appear to have a 
significant role in response of human dental pulps to routine orthodontic treatment. 
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 Aims of the Thesis 
The aims of this study were to: 
1. Determine appropriate protocols for sample storage, homogenisation, RNAtotal 
isolation, RNAtotal quantification, reverse-transcription, gene expression 
normalisation and data analysis in the human dental pulp; thus maximising a 
single tissue’s experimental potential in transcriptomic expression analyses. 
2. Determine the transcriptomic and proteomic expression of angiogenesis-specific 
genes in order to elucidate the angiogenic response of the human dental pulp to 
the early stages of orthodontic force application. 
3. Characterise the angiogenic response of the human dental pulp to defined 
intensities of hypoxia in order to more fully comprehend the survival mechanisms 
of this unique tissue. 
4. Contrast the angiogenic response of the human dental pulp to orthodontic force 
application with the angiogenic response of this tissue to various intensities of 
hypoxia in order to determine whether hypoxia plays a role in routine clinical 
orthodontic treatment.  
 









 Chapter I  
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Introduction 
While stem cell isolation and public health issues, such as caries, have brought the 
human dental pulp to the forefront of translational research (Farges et al. 2015, La Noce 
et al. 2014, Werle et al. 2016, Winderlich et al. 2016, Yusa et al. 2016, Zhang et al. 
2015,); little is currently understood regarding the effects of routine clinical procedures 
on the behaviour of this specialised tissue. Specifically, the current comprehension of 
the angiogenic response of the human dental pulp to orthodontic force application is 
limited, as few studies have been carried out in order to identify and determine key 
signalling processes in the tissue’s response to treatment. 
Orthodontic force application has been shown to induce a number of changes in the 
periodontium, including localised inflammation (Boyd et al. 1989, Eliasson et al. 1982, 
Yamaguchi and Kasai 2005), ischemia (Alfuriji et al. 2014, Khorsand et al. 2013, Rygh 
1974, Yamaguchi and Kasai 2005) and reduced blood flow rates in the tissue (d'Apuzzo 
et al. 2013, Patil et al. 2013, Zainal et al. 2011). It has been hypothesised that the 
alteration to periodontal blood flow could have an adverse effect on the tightly enclosed 
dental pulp. A number of studies have investigated changes to the pulpal blood flow 
rates at the onset of orthodontic treatment and have identified a decrease in flow rate as 
a direct response (Sano et al. 2002, Yamaguchi 2007). Reactive hyperaemia has also 
been shown to take place in the pulp within half an hour of forces being applied 
(McDonald and Pitt Ford 1994). 
Whether the changes to the pulpal blood flow rates are produced solely as a knock-on 
effect to the alterations in the periodontium or whether the pulp initiates its own 
survival mechanism remains unknown. However, several growth factors known to be 
associated with the angiogenic signalling cascade have been shown to be secreted from 
the pulp tissue in response to orthodontic treatment (Derringer et al. 1996,  
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Derringer and Linden 1998, Derringer and Linden 2003, Derringer and Linden 2004, 
Derringer and Linden 2007), indicating that the induced response is a reaction to a 
negative characteristic of routine force application. 
As the tooth undergoes repeated cycles of force loading during the course of orthodontic 
treatment, a progressive assault on this highly sensitive tissue may be occurring. 
Therefore it is fundamental that we further investigate the angiogenic response of the 
human dental pulp in order to: (1) elucidate the degree of assault, (2) identify the cause 
of the response and (3) assess whether clinical practices require adjustment in order to 
maintain the integrity of this tissue. 
1.1.1 Origins of the Dental Pulp – An Overview of Tooth Development 
The tooth organ is known to develop through a series of interactions between the 
ectodermal epithelium and the underlying neural-crest derived mesenchyme of the first 
branchial arch during early embryogenesis (Chai et al. 2000, Haworth et al. 2004, 
Lumsden 1988, Mina and Kollar 1987, Peters and Balling 1999). These interactions are 
tightly controlled through the expression of growth factors, transcription factors and 
morphogens alongside their respective receptors; and have been characterised in the 
murine model through a number of in vivo and in vitro experiments. 
Following the processes of mapping out the location of future teeth, and determining the 
number and type of teeth to develop along the mandibular and maxillary arches; the 
initiation of tooth development is marked by a thickening of the oral epithelium, hereon 
referred to as the dental lamina, and the formation of an ectodermal placode, which acts 
as the primary signalling centre in tooth organogenesis (Aberg et al. 2004, Cobourne et 
al. 2001, Hardcastle et al. 1998, Haworth et al. 2004, Liu et al. 2008, Mustonen et al. 
2004, Peters and Balling 1999, Pispa and Thesleff 2003, Salmivirta et al. 1996, Thesleff 
et al. 2001). 
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Reciprocal signalling between the epithelium and the mesenchyme is induced by the 
ectodermal placode, initiating the process of epithelial cell invagination of the 
underlying mesenchyme and tooth bud formation, accompanied by concurrent 
condensation of epithelial and mesenchymal cells at the tip of the bud structure 
(Cobourne et al. 2001, Hardcastle et al. 1998, Liu et al. 2008, Lumsden 1988, Pispa and 
Thesleff 2003, Salmivirta et al. 1996). Although it is considered that the tooth bud 
forms as a result of epithelial cell proliferation, the cellular mechanisms governing this 
process have yet to be fully characterised (Mustonen et al. 2004). 
The developing tooth now moves from a phase of initiation to a phase of morphogenesis 
and the signalling for subsequent odontogenesis shifts from an epithelial to a 
mesenchymal origin (Liu et al. 2008, Vaahtokari et al. 1996). This process is marked by 
the formation of the enamel knot, the second signalling centre of tooth development and 
site for induction of epithelial folding, from the condensed epithelium at the tip of the 
bud structure during the late-bud stage (Aberg et al. 2004, Pispa and Thesleff 2003, 
Thesleff et al.2001). 
Once the enamel knot has fully differentiated, the tooth germ has entered the cap stage 
of development. At this point, proximal proliferation of the epithelium in conjunction 
with proliferation of the underlying condensed mesenchyme is induced in order to form 
the structures associated with this point of morphogenesis, i.e., the dental follicle/sac, 
the enamel epithelium and the dental papilla (Gritli-Linde et al. 2002, Hardcastle et al. 
1998, Iacob and Veis 2006, Koyama et al. 2001, Lesot et al. 1996, Matalova et al. 2005, 
Tucker and Sharpe 1999). It has been shown that the size and signal activity of the 
enamel knot plays a significant role in the size of the crown and number of cusps which 
will form subsequently (Salazar-Ciudad and Jernvall 2004, Tummers and Thesleff 
2009).  
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As the tooth germ moves through the cap stage toward the bell stage, the epithelium 
which proliferates in a proximal direction to the enamel knot is folded convexly, 
enveloping the forming dental papilla. At the tip of each of these folds lies a cervical 
loop, marking the junction at which the inner and outer enamel epithelium meets (Aberg 
et al. 2004, Jernvall et al. 1994, Pispa and Thesleff 2003, Tucker and Sharpe 2004, 
Vaahtokari et al. 1996).  
At the late-cap to early-bell stage, the primary enamel knot is removed from the tooth 
germ by a process of apoptosis. In the incisor, some of the enamel knot cells are 
maintained in order to identify the site of cusp formation; while in the molars, these 
remaining primary enamel knot cells migrate proximally to the future sites of the 
metacone or metaconid cusps (Aberg et al. 2004, Gritli-Linde et al. 2002, Lesot et al. 
1996, Matalova et al. 2005, Pispa and Thesleff 2003, Thesleff et al. 2001, Tucker and 
Sharpe 1999). These cusp patterns are later fixed in place by the terminal differentiation 
of the odontoblasts and the deposition of a mineralised dentine matrix (Thesleff et al. 
2001).  
Concurrent to the removal of the primary enamel knot, differentiation of the pre-
odontoblasts and pre-ameloblasts, dental papilla cells and epithelial cells lying directly 
along the epithelio-mesenchymal interface respectively, is induced in conjunction with 
multi-layering of the epithelial cells above the pre-ameloblasts (Gritli-Linde et al. 2002, 
Iacob and Veis 2006, Thesleff et al. 2001). This multi-layered epithelium forms the 
stratum intermedium (Gritli-Linde et al. 2002, Koyama et al. 2001, Lesot et al. 1996). 
During the bell stage, the enamel organ is distinct from the dental mesenchyme and can 
be seen as four separate elements: (1) the outer enamel epithelium which is separated 
from the highly vascularised peridental connective tissue by a basal lamina; (2) the 
inner enamel epithelium which is the site of ameloblast differentiation; (3) the stratum 
intermedium which acts in conjunction with the inner enamel epithelium during 
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amelogenesis; and (4) the stellate reticulum, composed of star-shaped epithelial cells 
with wide irregular intercellular spaces, which acts to recruit nutrients from the outlying 
circulation; and to protect the tooth crown during formation (Gritli-Linde et al. 2002, 
Ida-Yonemochi et al. 2010, Matthiessen and Romert 1980, Nait Lechguer et al. 2008). 
The tooth crown is formed in the late-bell stage when tooth development shifts from a 
phase of morphogenesis to a phase of cytodifferentiation, as the odontoblasts and 
ameloblasts are terminally differentiated (D'Souza et al. 1999, Vaahtokari A, et al. 
1991). Terminal differentiation of the odontoblasts occurs at the sites corresponding to 
the future cusp tips and is marked by the withdrawal of the pre-odontoblast from the cell 
cycle, resulting in cell elongation and polarization, in conjunction with secretion of a 
predentine mix along the future dentino-enamel junction (D'Souza et al. 1999, Tucker 
and Sharpe 2004, Wang et al. 2010). The secretion of the mantle dentine layer induces 
the terminal differentiation of the ameloblasts, which are shown to elongate, change in 
cytoskeletal structure and alter in polarity of the nuclei and cell organelles (Gritli-Linde 
et al. 2002). The differentiated ameloblasts then deposit a layer of pre-enamel prisms 
also referred to as aprismatic enamel (D'Souza et al. 1999, Simmer et al. 2010). 
Concurrent to the terminal differentiation of the odonto- and amelo-blasts, blood vessels 
from the peridental mesenchyme and mandibular mesenchyme are shown to infiltrate 
the tooth bell structure. Blood vessels are observed throughout the entire dental pulp 
(formed from the remainder of the dental papilla cells directly below the odontoblast 
layer); and are identified perforating the edge of the outer enamel epithelium and 
invading the stellate reticulum (Arana-Chavez and Massa 2004, D'Souza et al. 1999, 
Wise et al.1990).  
As the tooth crown matures, a continuous process of organic matrix secretion coupled 
with secreted matrix mineralisation occurs in both the odontoblasts and the ameloblasts. 
In the odontoblasts, the odontoblastic processes secrete collagen which forms structural 
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cross-linkages with other collagen fibrils; it is within these cross-linkages that mineral 
formation occurs, leading to the foundation of a mineralisation front (Linde and 
Goldberg 1993, Smith and Lesot 2001). As the odontoblasts continue to deposit the 
organic matrix, they move in an apical direction toward the pulp cavity (Arana-Chavez 
and Massa 2004). Ameloblasts form a mineralisation front by depositing enamel 
proteins in the extracellular space along the ameloblast cell membrane; these enamel 
proteins form enamel ribbons which are lengthened in the direction of what remains of 
the outer enamel epithelium and are thickened by the deposition of amorphous calcium 
phosphate (Simmer et al. 2010, Wise et al. 1990). The thickness of these enamel 
ribbons will determine the hardness of the mature enamel as ribbons are required to 
interlock to add structural stability to the composite. The amorphous calcium phosphate 
surrounding the enamel ribbons is then converted to hydroxyapatite and maturation 
ameloblasts are shown to deposit calcium, phosphate and bicarbonate ions into the 
organic matrix. This process removes water and neutralises the acidity created in the 
conversion of calcium phosphate to hydroxyapatite, thus strengthening the structure 
further (Nait et al. 2008, Simmer et al. 2010). Carbonic anhydrase is also considered to 
play a role in neutralising the acidity of hydroxyapatite formation in the maturing 
enamel as it is known to catalyse the reversible hydration-dehydration reaction of 
carbon dioxide and bicarbonate, and is not found in the enamel epithelium at any stage 
prior to that of maturation (Wang et al. 2010).  
Formation of the tooth crown is completed postnatally and this is followed by the 
induction of tooth root formation through the apical elongation of cells of the cervical 
loop, also referred to at this stage as the cervical margin or enamel organ cuff (Fujiwara 
et al. 2008, Grando Mattuella et al. 2007, Ida-Yonemochi et al. 2005). It was originally 
hypothesised that the root forms from a bilayer of epithelium of the outer and inner 
enamel epithelium as the cervical loops mark the junction where these two epithelia 
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meet. However, it has been shown that there is a cessation of inner enamel epithelium 
proliferation prior to root development and the bilayer known most commonly as 
Hertwig’s epithelial root sheath is formed from the outer enamel epithelium only 
(Fujiwara et al. 2008). As these cells proliferate apically, the immature root apex is seen 
to be made up of four distinct zones: (1) the dental sac/follicle which gives rise to the 
tissue of the periodontium; (2) radicular dental pulp which extends from the coronal 
portion of the tooth to the apex; (3) the apical dental papilla mesenchyme which is 
attached externally at the apical diaphragm and is thought to contribute to the 
periodontium; and (4) the apical cell-rich zone which is comprised of apical dental 
papilla mesenchyme but is encased within the root sheath at the apical diaphragm 
(Gritli-Linde et al. 2002, Sonoyama et al. 2008, Thesleff et al. 2001, Thomas 1995, 
Tziafas and Kodonas 2010). The cementum which forms over the circumpulpal dentine 
of the root structure is produced in a reaction at the epithelio-mesenchyme junction, as 
in enamel formation, where the cells of the Hertwig’s epithelial root sheath differentiate 
into functional cementoblasts following odontoblast differentiation (Fong et al. 2005, 
Sonoyama et al. 2007). 
In the murine model it has been shown that root and periodontal ligament (PDL) 
formation is completed 4 weeks postnatally (Ida-Yonemochi et al. 2005). Tooth 
eruption through the gingival margin of the mandible or maxilla is then initiated by an 
infiltration of monocytes into the dental follicle. This infiltration is thought to be caused 
by the secretion of a monocytic chemoattractant from the stellate reticulum into the 
capillaries of the dental follicle, initiating monocyte migration into the follicle. 
Concurrently, there is an increase in the number of osteoclasts present in the 
surrounding alveolar bone, which facilitates in alveolar bone resorption, constructing a 
pathway for tooth eruption (Cohen 1994, Sonoyama et al. 2007). 
This overview of tooth development has been summarised in Figure 1. 
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Figure 1 Stages of tooth development 
Illustration of the five phases of tooth development: (1) Initiation [A]; (2) Bud Stage [B – Early &  
C – Late]; (3) Cap Stage [D]; (4) Bell Stage [E – Early & F – Late]; (5) Crown/Maturation [G]. 
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1.1.2 Anatomy of the Dental Pulp 
The dental pulp can most straightforwardly be described as having three functional 
modalities which are directly correlated with its specialised and well-defined 
morphology. These are: (1) Reparatory – The tissue contributes to the restoration of the 
encasing calcified tissues through the formation of secondary and tertiary dentine 
(Goldberg et al. 2004, Hosoya and Nakamura 2015, Ricucci et al. 2014, Sloan and 
Smith 2007, Stanley et al. 1966,); (2) Sensory – In response to irritation from external 
factors, e.g. extreme temperature differences (Baldissara et al. 1997, Hannig and Bott 
1999, Pohto and Scheinin 1958), or internal inflammation (Farges et al. 2013), e.g. 
response to resultant localised infection from caries, endodontal or periodontal disease, 
patterns of neural activity are induced giving rise to a pain stimulus (Gopinath and 
Anwar 2014, Jain and Gupta 2013, Narhi et al. 2016); and (3) Regulatory – Cellular 
vitality is strictly maintained through homeostasis in order to sustain tissue integrity and 
functionality (Smith 2003). 
1.1.2.1 Dental Pulp Morphology 
The dental pulp anatomically resembles a vascular loose connective tissue encased 
within rigid enamel, dentine and cementum sheaths; and is developed from the 
mesenchyme following pre-odontoblast differentiation during odontogenesis (Grando 
Mattuella et al. 2007, Linde and Goldberg 1993). Pulpal development continues 
throughout the stage of apexogenesis, forming the radicular or root pulp which is clearly 
distinguishable from that of the coronal portion, pertaining to the crown (Cohen 1994, 
Thesleff 2006). In addition to being well-defined across the horizontal plane, the pulp 
can be divided longitudinally into four distinct zones: (1) Odontoblastic zone, (2) Cell-
free zone of Weil, (3) Cell-rich zone of Hőhl, and (4) Pulp core or pulp proper  
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(Avery 2006a, Avery 2006b, Avery and Avery 2001, Berkovitz 2002, Cohen 1994, 
Nanci 2003).  
The outermost layer of the pulp, the odontoblastic zone, is comprised primarily of 
odontoblast cell bodies and lies directly beneath the predentine layer, in which the 
odontoblastic processes are embedded within the dentinal tubules (Avery 2006, 
Berkovitz and Holland 2002, Cohen 1994). Capillaries, nerve fibres and dendritic cells 
are also found within this cell layer although their numbers are few (Cohen 1994, 
Hargreaves 2002). In the coronal portion of the pulp the odontoblasts are functionally 
active and maintain a tall columnar shape, while cells within in the mid-radicular region 
are cuboidal having low-level activity. The odontoblasts located in the most apical 
portion of the root are quiescent and appear as a flattened layer at the apical foramen 
(Berkovitz and Holland 2002, Cohen 1994, Nanci 2003).  
Subjacent to the odontoblastic zone in the coronal pulp, lies a narrow region relatively 
free from cells. This cell-free zone, also referred to as Weil’s basal layer, has been 
demonstrated to be traversed with capillary vessels, unmyelinated nerve fibres and the 
cellular processes of fibroblasts of the cell-rich zone (Avery 2006, Cohen 1994, 
Hargreaves 2002, Linde and Goldberg 1993). The cell-free zone has been shown to 
disappear in pulps where the odontoblastic layer is disrupted, such as in teeth which 
have been avulsed or those treated with an orthodontic force, and is also absent from the 
maturing pulps of young teeth (Breivik 1981, Cohen 1994, Santamaria et al. 2007).  
Directly beneath the cell-free zone lies the cell-rich zone of Hőhl. This cell-rich layer is 
composed from a collection of fibroblasts, undifferentiated mesenchymal progenitor 
cells, macrophages and lymphocytes; and is most prominent in the coronal portion of 
the tissue (Cohen 1994, Hargreaves 2002, Jontell et al. 1998, Nanci 2003, Tziafas 
2010). Fibroblasts are responsible for the production and secretion of proteoglycans, 
fibronectin and other extracellular matrix components such as type I and type III 
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collagens, which are fundamental components in the support of the vasculature (Avery 
and Avery 2001, Cohen 1994). They are particularly responsible for the maintenance 
and turnover of the extracellular matrix, as they are capable of the tissue-specific 
production and degradation of collagen fibrils (Avery 2006, Avery and Avery 2001, 
Cohen 1994). 
The connective tissue of the pulp proper or pulp core makes up most of the mass of the 
dental pulp and is composed of a gelatinous extracellular matrix constituting: blood and 
lymph vessels; nerve trunks; glycoproteins; ground substance; hydrophilic 
glycosaminoglycans including heparin sulphate and hyaluronic acid; fibroblasts and 
immunocompetent cells including macrophages, B-lymphocytes and T-lymphocytes 
(Avery and Avery 2001, Berkovitz and Holland 2002). The combination of collagen, 
proteoglycans and glycoproteins within the extracellular matrix enable the pulp core to 
maintain large volumes of water, giving the non-compressible tissue added physical 
strength in its unique non-compliant environment (Harlamb and Messer 1996). 
1.1.2.2 Dental Pulp Vasculature 
Development of the vasculature of the dental pulp is initiated at the bell stage of 
odontogenesis where blood vessels from the peridental and mandibular mesenchyme 
infiltrate the structure (Arana-Chavez and Massa 2004, D'Souza et al. 1999, Wise et al. 
1990). It is known that pulpal vasculature formation coincides with the differentiation of 
odontoblasts and the formation of dentine, as odontoblasts require a rapid and sufficient 
supply of raw materials for the production and subsequent calcification of the dentine 
matrix (Yoshida and Ohshima 1996). 
Initially, the vasculature is formed from a coarse network of thick capillaries, which 
increases in density and decreases in vessel diameter at the onset of odontoblast 
differentiation (Yoshida and Ohshima 1996). At this stage of development the 
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capillaries are located within the inner region of the dental pulp and have no contact 
with the odontoblasts (Yoshida and Ohshima 1996). As predentine formation is 
induced, the vascular network increases in density and the external surface of the 
capillaries becomes undulated, while vessels begin to invade the odontoblastic layer 
(Yoshida and Ohshima 1996). Dentine formation continues as the mineralisation front 
pushes the odontoblasts apically and distally toward the pulp core, at this stage vessels 
are shown to have a flat and dense external surface; and are seen penetrating the 
predentine layer (Yoshida and Ohshima 1996). At the completion of crown formation, 
odontoblastic activity is reduced and the peripheral capillaries of the coronal pulp retreat 
from the predentine layer to the odontoblastic layer (Yoshida and Ohshima 1996). 
In the fully formed tooth, the vasculature of the dental pulp is characterised as a 
complex, isolated network of precapillary arterioles, capillaries, postcapillary venules 
and muscular venules (Digka et al. 2006, Rodd 2005). Blood and lymph vessels in 
conjunction with nerve fibre bundles enter the tooth through the apical and accessory 
foramina; and course along the radicular root axis toward the chamber of the coronal 
pulp (Berkovitz and Holland 2002, Hargreaves 2002, Rodd and Boissonade 2005, 
Vandevska-Radunovic et al. 1997). In the coronal pulp, the capillary plexus expands 
and presents as three distinct layers: (1) the terminal capillary network which lies 
parallel and in close proximity to the predentine; (2) the central capillary network which 
lies perpendicular to the pulp surface; and (3) the venular network which lies parallel to 
the odontoblastic surface and acts as a source of drainage in the tissue (Rodd 2005, 
Yoshida and Ohshima 1996, Vandevska-Radunovic et al. 1997). In order to ensure that 
sufficient oxygen reaches the fibroblasts and odontoblasts, capillary loops are formed 
within the subodontoblastic region (Avery 2006.). 
Myelinated and unmyelinated sensory and sympathetic nerve fibres within the pulp are 
thought to play a specific role in the regulation of tissue pressure and microcirculation 
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(Hargreaves 2002. Okamura et al. 1994, Rodd and Boissonade 2005, Zhang et al. 
1998). In a study investigating the pulpal response to caries, a significant increase in 
vascularity was observed within the pulpal horns; however, this increase did not pertain 
to vessel number but rather to vessel size (Rodd and Boissonade 2005). As the highest 
concentration of neural elements has been localised to the pulp horns, and terminal 
axons from unmyelinated nerves are located exclusively adjacent to the outermost cells 
of the smooth-muscle layer of arterioles; it can be concluded that vasomotor nerves 
regulate pulpal microcirculation through the contraction or relaxation of sphincter-like 
vessels (Hall and Freer 1998, Hargreaves 2002. Okamura et al. 1994, Zhang et al. 
1998). 
1.1.3 Orthodontic Tooth Movement 
Orthodontic tooth movement is characterised by the remodelling of dental and 
paradental tissues resulting in translocation and alteration of tooth position (Krishnan 
and Davidovitch 2006). Application of orthodontic force has been demonstrated to 
result in areas of tension and compression, within the supporting alveolar bone, in 
conjunction with injury to the periodontium and associated vascular network 
(Davidovitch et al. 1988, Mostafa et al. 1991). 
1.1.3.1 Mechanisms of Orthodontic Tooth Movement 
Orthodontic tooth movement has been postulated to occur by one of two processes: (1) 
pressure-tension theory (Oppenheim 2007) or (2) bone bending/bioelectric theory 
(Baumrind 1969, Davidovitch et al. 1980a, Davidovitch et al. 1980b, Zengo et al. 
1974). In both systems it has been noted that tooth movement (through the processes of 
bone, gingival and PDL remodelling) occurs in distinct phases, which from hereon will 
be referred to as the: (a) initial, (b) lag, (c) acceleration and (d) linear phases (Pilon et 
al. 1996). In the initial phase of tooth movement which can last anywhere from 24 to  
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48 hr (Krishnan and Davidovitch 2006, Meeran 2013, Zainal Ariffin et al. 2011), rapid 
displacement of the tooth in the periodontal ligament (PDL) space and tooth socket 
occurs, resulting in damage to the cells in the PDL at the “pressure” side of the tooth, in 
the direction of tooth movement (Dorow et al. 2002, Henneman et al. 2008, Mavragani 
et al. 2004, van Driel et al. 2000). The tooth then enters the lag phase, where movement 
is halted until necrotic tissues are removed by phagocytosis in a process that can last up 
to 20 days (Von Bohl et al. 2004, Zainal Ariffin et al. 2011). Movement is then 
accelerated (acceleration phase) through the alveolar bone in a continuous cycle of bone 
resorption and osteoid deposition until an internal biologically limiting rate is reached 
where the rate of movement is at a constant and is no longer dependent upon the 
magnitude of force which has been applied (Pilon et al. 1996). This is referred to as the 
linear phase of orthodontic tooth movement. 
It has been shown that during the initial and lag phases of tooth movement that a 
compression of the PDL vasculature at the “pressure” side, results in localised ischemia 
and hypoxia, leakage of blood constituents into the surrounding tissue, tissue 
hyalinization, and cell death (Kitase et al. 2009, Miyagawa et al. 2009, Ren et al. 2008). 
While at the “tension” side, in the direction opposite to tooth movement, there is an 
increase in vessel formation which has been shown to aid in the alveolar bone 
remodelling process (Ren et al. 2008). It has been postulated that the circulatory 
damage which occurs in the vasculature at the “pressure” side not only results in 
localised hypoxia in the PDL, but that this has a knock-on effect on the highly sensitive 
tissue contained within the pulp chamber of the tooth (Romer et al. 2014, Sano et al. 
2002). 
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1.1.3.2 Response of the Human Dental Pulp to Orthodontic Tooth Movement 
A number of investigations have been performed in order to determine the physiological 
and pathological response of the periodontium and dental pulp to orthodontic force 
application (Abi-Ramia et al. 2010, Grunheid et al. 2007, Han et al. 2010, Kvinnsland 
et al. 1989, Nakamura et al. 2008, Nakanishi et al. 2004, Toyono et al. 1997, 
Tripuwabhrut et al. 2010, Uematsu et al. 1996, Von Bohl et al. 2004, Von Bohl et al. 
2016). However, few of these studies have focussed on the response of these tissues 
within humans; despite the clinical application of these practises being carried out in 
humans. The small number of these studies which have been performed in the human 
draws attention to the need for further investigation into the effects of routine clinical 
treatment; it also highlights the issues surrounding standardisation of experimental 
protocols, as groups which have investigated a single issue, e.g. force intensity, will 
have to extrapolate findings from a model that often responds very differently to the 
target organism (Noda et al. 2009, Sano et al. 2002).  
It has been established within the literature, that following force application, human 
dental pulps will respond by: (a) vacuolisation (Han et al. 2013, Ramazanzadeh et al. 
2009, Stenvik and Mjor 1970), (b) nodule formation (Lazzaretti et al. 2014) or  
(c) hypoxia and alteration to the pulpal blood flow (Hamersky et al. 1980, Mostafa et al. 
1991, Sano et al. 2002). Pulpal blood flow is a topic of particular interest as hypoxia 
could result in necrosis of the tissue. Should hypoxia occur, it is anticipated that 
angiogenesis will occur in order to reoxygenate the tissue.  
Angiogenesis has been outlined as a potential response of the pulp to orthodontic force 
application as several angiogenic growth factors have been found to be secreted from 
the human dental pulp following a fortnight of treatment (Derringer et al. 1996, 
Derringer and Linden 1998, Derringer and Linden 2003, Derringer and Linden 2004, 
Derringer and Linden 2007). 
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1.1.4 Angiogenesis 
Angiogenesis is the process of new vessel formation from a pre-existing capillary 
plexus (Brown et al. 1992, Li et al. 2003, Yano et al. 2003) and is known to occur in the 
embryo during development following vasculogenesis and in the adult as a result of 
localised hypoxia, reaction to tissue damage or an imbalance of regulatory cytokines 
(Carmeliet 2000, Risau 1996, Risau 1997). This complex signalling cascade has been 
shown to occur by one process or by two processes concurrently: sprouting 
angiogenesis (Carmeliet 2000, Folkman and D'Amore 1996) and intussusceptive 
angiogenesis (Burri et al. 2004, Djonov et al. 2000); and is tightly regulated by a large 
number of cytokines, chemokines and growth factors.  
1.1.4.1 Intussusceptive Angiogenesis 
Intussusceptive angiogenesis has been defined by Burri et al. (2004) as the ‘further 
development of a capillary network through the insertion of transcapillary pillars’. 
Although originally described by Short (1950), little is known about its functional 
mechanisms as sprouting angiogenesis has remained at the forefront of current research 
investigations. It is considered that like sprouting angiogenesis, intussusception occurs 
in a series of well-defined stages and sub-stages which results in the formation of new 
vessels from the pre-existing vascular plexus; and it has been shown to play a role in 
both the embryo (following vasculogenesis) (Risau 1997) and in the adult (Burri and 
Djonov 2002) in a response to inflammation or chronic hypoxic exposure (De 
Spiegelaere et al. 2012, Styp-Rekowska et al. 2011). 
Intussusceptive angiogenesis has been determined to occur in three stages:  
(a) intussusceptive microvascular growth, (b) intussusceptive arborisation and  
(c) intussusceptive branching remodelling (Makanya et al. 2009). In the primary stage 
of intussusceptive microvascular growth, a number of well defined sub-stages have 
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been characterised. Angiogenesis is initiated when the outer wall of two proximal 
capillaries touch and form an interendothelial transluminal bridge (Burri et al. 2004, 
Djonov et al. 2000, Kurz et al. 2003). Following the formation of the bridge, the 
circumference of the contact zone is sealed by junctional complexes in order to prevent 
vascular leakage (Burri and Djonov 2002, De Spiegelaere et al. 2012). The intercellular 
junctions of the endothelial bilayer are then reorganised and a central perforation is 
formed (Djonov et al. 2000, Kurz et al. 2003). The endothelial cells of the contact zone 
expand and flatten out to form transcapillary tissue pillars, which are then invaded by 
cytoplasmic extensions of myofibroblasts, perictyes and interstitial fibers from the 
external surface of the endothelium (De Spiegelaere et al. 2012, Djonov et al. 2000, 
Kurz et al. 2003). Pillar diameter is then allowed to increase and they are stabilised 
further (Djonov et al. 2000, Kurz et al. 2003). The opposing walls at the centre of the 
perforation then meet and form a contact zone and through the process of cellular 
reorganisation, longitudinal vessels will form; and the vasculature will have the 
phenotype of a large capillary mesh (Djonov et al. 2000). 
Following initial intussusceptive microvascular growth, angiogenesis moves into the 
second stage: intussusceptive arborisation. Not much is known about the sub-stages of 
this phase of angiogenesis; but it is known that the neovessels adapt into a typical 
vascular tree pattern where arterioles, venules and capillaries are clearly identifiable 
(Djonov et al. 2000, Makanya et al. 2009). In the final stage of angiogenesis, 
intussusceptive branching remodelling, the neovessels are ‘pruned’ by the formation a 
number of occluding endothelial cell – endothelial cell contact zones in order to 
remodel the vasculature for current perfusion requirements (Makanya et al. 2009).  
Unlike sprouting angiogenesis, intussusception does not rely on increased endothelial 
cell proliferation, basement membrane degradation or on cell signalling from alternate 
tissues (Burri and Djonov 2002, De Spiegelaere et al. 2012); it is however moderated by 
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a number of angiogenic growth factors, cytokines and chemokines (De Spiegelaere et 
al. 2012, Burri and Djonov 2002, Styp-Rekowska et al. 2011). These factors are 
important to consider as their expression may act as a biomarker of the mechanism of 
angiogenesis that is occurring in the tissues. This is particularly true for the growth 
factor vascular endothelial growth factor alpha (VEGFA) which is known to be a 
leading protagonist in the sprouting angiogenic cascade but has been shown to have 
little effect or control over intussusception (Burri and Djonov 2002). 
1.1.4.2 Sprouting Angiogenesis 
Sprouting angiogenesis can be defined as the outgrowth of endothelial sprouts, 
composed of tip and stalk cells, from the existing vasculature towards an angiogenic 
stimulus (Gerhardt 2000-2013, Gerhardt et al. 2003, Heck et al. 2015). Originally 
characterised by Ausprank and Folkman (1977) in the rabbit cornea, it was established 
that neovascularisation of the eye by sprouting angiogenesis occurred in a number of 
well-defined stages. We have defined these stages according to the literature as:  
(a) Receipt of stimulus from signalling tissue or cells (Kilarski 2005), (b) Localised 
degradation of the endothelial basement membrane of the responding vasculature 
(Brooks et al. 1996, Silletti et al. 2001), (c) Reorganisation of the inter-endothelial 
junctions and concurrent selection of tip cells (Bentley et al. 2008, Jakobsson et al. 
2010), (d) Degradation of the surrounding matrix and concurrent sprout extension. 
(Brooks et al. 1996, Silletti et al. 2001), (e) Guided migration of the vascular sprout and 
simultaneous stalk cell proliferation (Gerhardt et al. 2003, Phng et al. 2013), (f) Lumen 
formation by apical membrane invagination. (Gebala et al. 2016) and (g) Anastomosis 
of the sprout with the signalling endothelium accompanied by new basement membrane 
synthesis with pericyte recruitment. (Bergers and Song 2005, Bondjers et al. 2003, Song 
et al. 2012). 
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Due to the complex nature of this angiogenic mechanism, where its stages are regulated 
by the varied expression of a vast number of cytokines, chemokines and growth factors 
at any one time, a full and comprehensive review of the signalling cascade is 
implausible. It had previously been postulated by researchers that during each stage of 
sprouting angiogenesis, there was a set regulated increase or decrease in a specific 
growth factor and that this increase or decrease was restricted to act upon a particular 
cell type. However, the new emerging model of angiogenesis is that of a bee colony, 
where individual endothelial cells hold differing roles, express differing phenotypes and 
respond to angiogenic cues in an individualistic manner; and that depending upon the 
angiogenic cues, cells may alter their role and phenotypes at any time (Chappell et al. 
2011). In conjunction with this new model of cell behaviours, it has been highlighted 
that the concept of a single increase or decrease in expression of a protein of interest 
will not fully replicate the signalling mechanisms in vivo.; and that should all factors not 
be activated in a coordinated and complementary manner, functional vessels will not 
form (Yancopoulos et al. 2000). We support these statements with the findings of a 
review of the sprouting angiogenesis protagonist, VEGFA, where it has been shown that 
during angiogenesis, extracellular VEGFA is controlled at the pre-transcriptional, 
splicing, cell surface retention, protein uptake and degradation stages; and that the 
complex regulation of this single gene will result in an extracellular gradient which 
controls proper vascular patterning (Gerhardt 2000-2013. Gerhardt et al. 2003). As 
VEGFA is only a single gene within this highly complex signalling cascade, it is clear 
to see that any alteration to the concerted up- and down- regulation of mRNA in 
conjunction with increased or decreased protein expression could result in a 
pathological phenotype. 
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1.1.5 Hypoxia and Angiogenesis 
Hypoxia has been defined as the state where oxygen concentrations within a tissue or 
cell have been reduced below physiological levels, despite the presence of adequate 
perfusion by blood (Dorland 2007). It can occur continuously or intermittently whilst 
ranging in severity from an acute to a chronic condition, depending on the physiological 
or pathological cause. Hypoxia is mediated by the stabilisation of the mRNA of the 
transcription factor hypoxia inducible factor-1, alpha (HIF1A) and is regulated 
homeostatically by oxygen dependent hydroxylation of the oxygen-dependent 
degradation (ODD) domain of the HIF1A protein by prolylhydroxylase (PHD) enzymes 
(Ivan et al. 2001, Jaakkola et al. 2001); or polyubiquitylation of the von Hippel-Lindau 
tumour suppressor (pVHL) E3 ligase complex (Jaakkola et al. 2001, Maxwell et al. 
1999, Semenza 2003). Should the HIF1A transcript become stabilised by (1) decreased 
oxygen concentration and an absence of oxygen-dependent hydroxylation, (2) 
nitrosylation of the oxygen-dependent domain of the HIF1A subunit by free radicals  
(Li et al. 2007) or (3) up-regulation of growth factors which inhibit PHD enzymes 
necessary for hydroxylation (Dengler et al. 2014, McMahon et al. 2006); angiogenesis, 
and the concordant up-regulation of angiogenesis-specific growth factor mRNA and 
increased protein transcription occurs in order to regulate oxygen tension (Krock et al. 
2011, Pugh and Ratcliffe 2003, Semenza 2001).  
Angiogenesis has been shown to be induced in a number of tissues in response to 
hypoxia (Brogi et al. 1994, Liu et al. 2013, Pham et al. 2002, Raja et al. 2014); and this 
is mediated through the hypoxic-induction of VEGFA by HIF1A binding to the HIF-
related binding site located within the 5’-flanking region of the VEGFA gene (Abraham 
et al. 2004, Flamme et al. 1997). Activated VEGFA then binds to the kinase insert 
domain receptor (a type III receptor tyrosine kinase) (KDR), a predominantly vascular 
endothelial tyrosine kinase (Millauer et al. 1993), to induce endothelial cell 
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proliferation. This proliferation is then linked to an increase in expression of growth 
factors and cytokines as the complex processes of angiogenesis are initiated. As 
previously discussed, VEGFA has been shown to have little influence on 
intussusceptive angiogenesis as this mechanism of angiogenesis is not driven by 
external signalling. Instead, VEGFA will play a significant role in the proliferation of 
the endothelial sprout during sprouting angiogenesis.  
While it is commonly accepted that hypoxia and angiogenesis work hand in hand, in a 
supply and demand relationship, this hypothesis is now being called into question, as a 
strong link has been established between inflammation and hypoxia (Moeller et al. 
2004). It is now a consideration that inflammation will induce HIF1A expression and it 
is rather inflammation that induces angiogenesis, as hypoxia alone is insufficient. 
1.1.6 Hypoxic and Angiogenic Growth Factors in the Human Dental Pulp 
The human dental pulp is a known source of regulatory cytokines, chemokines and 
growth factors and of these factors, a number are associated with both the angiogenic 
and hypoxic signalling cascades. Below are outlined a number of investigations which 
have determined the presence of factors associated with both the angiogenic and 
hypoxic signalling cascades: 
1. In an attempt to identify a pathological intervention for bone healing in 
distraction osteogenesis, Fujio et al. (2015) established that the culture media 
from human dental pulp cells which had been exposed to hypoxia contained a 
number of factors that promote bone healing; these factors include angiopoietin 1 
(ANGPT1) and VEGFA.  
2. Odontoblast differentiation was studied by Kim et al. (2010) with the view to 
induce mineralisation for reparative dentistry. They established that fibroblast 
growth factor 2 (basic) (FGF2) plays a role as both (a) an inducer of 
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odontoblastic differentiation and (b) a chemokine regulator within human dental 
pulp cells.  
3. Hypoxia was shown to induce the expression of HIF1A and VEGFA in human 
dental pulp stem cells and human dental pulp fibroblasts when cells were 
examined with respect to identifying a solution to dental trauma involving the 
luxation or avulsion of the tooth (Aranha et al. 2010).  
4. As dental pulp surface adhesion has yet to be characterised fully, so as better to 
understand the physiology of this tissue, Zhu et al. (1998) performed a number of 
experiments in order to determine the integrin expression patterns in human 
dental pulp cells cultured from third molar teeth. They established that a number 
of integrins were expressed by the tissue, some of which include integrin, alpha V 
(vitronectin receptor, alpha polypeptide, antigen CD51) (ITGAV) and integrin, 
beta 3 (platelet glycoprotein IIIa, antigen CD61) (ITGB3).  
5. In addition to establishing that VEGFA is expressed within the human dental 
pulp, it has been shown that its receptor KDR is expressed in the vasculature of 
the human dental pulps (Virtej et al. 2013).  
6. In an attempt to confirm the effectiveness of New Zealand Fetal Bovine Serum in 
comparison to Conventional Fetal Bovine Serum, in order to continue the 
promotion of the use of serum in cell culture protocols; investigators established 
that human dental pulp stem cells grown in serum expressed higher levels of 
mRNA for platelet-derived growth factor alpha polypeptide (PDGFA) and 
VEGFA under their preferred experimental conditions (Spina et al. 2016). 
7. Orthodontic traction was investigated to determine whether there would be any 
long-lasting effects on the tissue. Nitric oxide synthase 2, inducible (NOS2), a 
pro-inflammatory chemokine was found to be present in both the control and the 
treated teeth and was explained as a response to the extraction process. Matrix 
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metallopeptidase 2 (gelatinase A, 72 kDa gelatinase, 72 kDa type IV collagenase) 
(MMP2) expression was shown to significantly decrease over the duration of the 
treatment and this was interpreted to correlate with an impediment of the pulp to 
regenerate and restore proper function (Leone et al. 2009).  
8. Cell adhesion molecules in the human dental pulp endothelial cells were assessed 
in order to determine the effect of reparative crowning with adhesive on the 
pulps’ inflammatory response. It was established that a number of cell adhesion 
molecules including selectin E (SELE) were present in both the control and 
treated teeth; and that the application of a crowning adhesive resulted in pulpal 
inflammation (Bagis et al. 2007). 
9. Odontoblastic differentiation in tooth repair by mineralisation was investigated by 
Yongchaitrakul and Pavasant (2007) in order to establish the effect of 
transforming growth factor, beta 1 (TGFB1) on nerve growth factor (NGF) in 
injured dental pulps; as NGF promotes survival and repair of nervous tissues. 
They identified that TGFB in conjunction with its receptor, transforming growth 
factor, beta receptor 1 (TGFBR1) will induce NGF in human dental pulp cells, 
suggestion that TGFB1 may play a role in tooth repair following injury. 
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MATERIALS 
2.1 Human Dental Pulp Tissue 
Following informed parental and patient consent, human dental pulps were obtained 
from healthy first and second premolar teeth extracted from volunteers aged between  
12 – 16 years. All patients included in the study required extraction of a minimum of 2 
contralateral premolar teeth from a paired dental position (i.e. first upper left premolar 
and first upper right premolar), in conjunction with fixed appliance orthodontic 
treatment. Ethical approval was granted by the Research Ethics Committee at Guy’s 
Hospital and King’s College Hospital.  
 
METHODS 
2.2 Orthodontic Force Application and Dental Pulp Isolation 
In each experimental chapter, unless otherwise specified, contralateral pairs of control 
and orthodontically treated teeth were used to assess mRNA and protein expression in 
the angiogenic response of human dental pulp to orthodontic force application. Duration 
of force application to the teeth prior to extraction ranged from no treatment to 2 weeks 
of treatment and specific details are provided in the materials and methods section of the 
experimental chapters. 
In every patient, the oral cavity was divided along the mid-sagittal plane in order to 
assign a ‘control’ sample that would forego orthodontic force application; and a 
contralateral ‘treated’ sample which would experience a force in the range of 0.5 – 1 N 
for the duration of treatment. Fixed appliance straight wire orthodontic brackets (Roth 
0.022 inch, 3M Unitek, California, USA) were direct bonded (Transbond, 3M Unitek, 
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California, USA) to the upper and/or lower teeth from second premolar to second 
premolar, except the assigned ‘control’ teeth. Orthodontic bands were cemented (Ketac, 
3M ESPE, Seefeld, Germany) onto all first permanent molar teeth. Test tooth position 
was carefully assessed and brackets were bonded in a position (offset if necessary) so 
that the archwires (0.016 inch nickel-titanium, TP Orthodontics Inc., Leeds, UK) placed 
gave the required force of 0.5 – 1 N in a mesial and extrusive direction. 
Following the required period of force application, brackets were removed from the 
premolar teeth assigned as ‘treated’ teeth. The ‘control’ and contralateral ‘treated’ 
premolar teeth were extracted under local anaesthesia, placed in individual tubes 
containing 20 ml of cold sterile saline solution, and sectioned immediately with a high-
speed water-cooled diamond bur through the buccolingual aspect. Dental pulps with a 
mean mass of ± 0.05 g (n = 5) were removed from the pulp chamber with sterile blunt 
instruments. Isolated pulps were then: (a) individually placed in a sterile 1.5 ml 
centrifuge tube and snap-frozen in liquid nitrogen before transferring to -70 °C for 
permanent storage; or (b) immersed separately in 500 µl RNALater™ (Catalogue 
Number (Cat. No.) AM7021) (Ambion Inc., Warrington, UK), an RNA preservation 
solution, kept at 4 °C for 8 hr and transferred to -20 °C for permanent storage.  
All orthodontic procedures and dental pulp isolations, following tooth extraction, were 
performed by Dr K. A. Derringer, Dental Institute, King’s College London at Guy’s 
Hospital and King’s College Hospital. 
 
2.3 RNA Isolation 
Unless stated otherwise, RNAtotal was isolated from individual pulp samples using a 
modified phenol:chloroform extraction protocol that had been optimised in 
collaboration with Dr N. Silver, Dental Institute, King’s College London.  
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Pulp samples were ground in a 7 ml glass Dounce tissue homogeniser (Wheaton 
Science Products from VWR, Poole, UK) containing 600 µl of the RNA stabilisation 
solution RNA-Bee™ (Cat. No. CS-104B or CS-105B or CS-501B) (AMS 
Biotechnology, Abingdon, UK) and homogenates were transferred to sterile centrifuge 
tubes. 60 µl of chloroform (Cat. No. C7559) (Sigma-Aldrich, Poole, UK) was added to 
the homogenate and samples were centrifuged at 4 °C for 15 min at 9,000 g. 
Supernatants were collected in fresh tubes and a single volume of 70 % ethanol was 
added. Samples were inverted repeatedly and transferred to spin columns and RNAtotal 
was extracted using the RNEasy Mini Kit (Cat. No. 74104 or 74106) (Qiagen Ltd, 
Crawley, UK) according to manufacturer’s instructions. Isolated RNAtotal was 
suspended in a final volume of 30 µl nuclease-free water (Cat. No. AM9938) (Ambion 
Inc., Warrington, UK) and stored at -70 °C. 
2.4 RNA Quantification 
Unless specified otherwise, the purity and concentration (ng/µl) of RNAtotal for each 
sample was determined by calculating the A260:A280 and A260:A230 ratios using the 
NanoDrop™ 1000 spectrophotometer (Now replaced by Cat. No. ND-2000, 
NanoDrop™ 2000 spectrophotometer) (ThermoFisher Scientific, Nottingham, UK), 
according to manufacturer’s instructions. RNAtotal was then quantified by fluorescence 
with the Quant-iT™ Ribogreen® RNA Assay Kit (Cat. No. R11490) (Molecular 
Probes, Invitrogen Ltd., Paisley, UK), according to the manufacturer’s protocol.  
2.5 Reverse Transcription 
The general procedure for reverse transcription of RNAtotal to cDNA is as follows; 
details of alternate protocols are given in the materials and methods section of the 
experimental chapters. 
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50 ng RNAtotal was converted to cDNA using the WT-Ovation™ Pico RNA 
Amplification System (Now replaced by Cat. No. 3302, Ovation Pico WTA System V2) 
(NuGen Technologies, Inc., California, USA) according to the manufacturer’s protocol. 
cDNA was then purified using the DNA Clean and Concentrator 25™ kit (Cat. No. 
D4033 or D4034) (Zymo Research Corporation, California, USA) according to 
manufacturer’s instructions; and quantified with the NanoDrop™ 1000 
spectrophotometer.  
2.6 Quantitative real-time reverse-transcription Polymerase 
Chain Reaction (RT-qPCR) 
The general procedure for RT-qPCR analysis of mRNA expression is as follows; details 
of alternate protocols are given in the materials and methods section of the experimental 
chapters along with specific primer sequences, efficiencies and melting points. 
RT-qPCR was performed on 20 µl reactions set up manually in 0.1 ml strip tubes (Cat. 
No. 981103) (Qiagen Ltd., Crawley, UK): 5 µl cDNA (2 ng/µl), 1 µl forward and 
reverse primer mix (6 µM) (designed and optimised by PrimerDesign Ltd., 
Southampton, UK), 10 µl Precision Mastermix with SYBR Green (Now replaced by 
Cat. No. PrecisionPlus-SY, PrecisionPlus™ Mastermix) (PrimerDesign Ltd., 
Southampton, UK) and 4 µl RNAse/DNAse-free water (delivered in conjunction with 
the primers, no individual Cat. No.) (PrimerDesign Ltd., Southampton, UK) with the 
Corbett Rotor-Gene™ 6000 (No Cat. No. available but item is still available from 
Qiagen) (Corbett Life Science, Qiagen Ltd., Crawley, UK). Amplifications were 
performed with an initial template denaturation step at 95 °C for 10 min followed by  
50 cycles of denaturation at 95 °C for 15 sec; combined primer annealing/extension at 
60 °C for 60 sec; and data acquisition.  
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A disassociation protocol was performed from 72 °C to 95 °C at 1 °C increments in 
order to determine the presence of primer-dimer formation or other spurious binding 
products. 
2.7 Statistical Analysis of RT-qPCR Data 
RT-qPCR data captured by the Corbett Rotor-Gene™ 6000 and viewed with Corbett 
Rotor-Gene™ 6000 Application Software, version 1.7 (Build 87) was analysed using 
the paired Student’s t-Test and Relative Expression Software Tool (REST©) 2009 
Software (developed by Prof. M. Pfaffl, Technical University Munich, Germany and 
Qiagen Ltd., Crawley, UK; http://www.gene-quantification.com/rest-2009.html). 
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3.1 Introduction 
Current protocols for molecular analysis of gene expression in the human dental pulp 
are extensively varied (Buchaille et al. 2000, Huang et al. 2006, Lee et al. 2013, 
McLachlan et al. 2005, Paakkonen and Tjaderhane 2010, Park et al. 2014, Virtej et al. 
2013). Tissues are either collected after administration of experimental treatment; or are 
extracted from untreated teeth and then moved into a culture system for creating cell-
type specific cell-lines or for explant culture. RNAtotal is isolated from cell-lines or 
explants by a number of recognised methodologies, quantified and then processed for in 
situ hybridisation, suppression subtractive hybridization or microarray analysis; or 
reverse-transcribed for semi-quantitative RT-PCR or RT-qPCR analysis (Bartlett 2002, 
Buchaille et al. 2000, Felaco et al. 2000, Lee et al. 2013, Matsushita et al. 2000, 
Shimabukuro et al. 2005, Sloan et al. 2001, Staquet et al. 2006, Ueda et al. 2001, Virtej 
et al. 2013). 
RT-qPCR is a well established and highly sensitive technique for high-throughput 
analysis of gene expression profiles and quantification of mRNA; and has proven to be 
particularly useful for expression analysis of mRNA transcribed in low abundance 
(Bustin 2000, Sanders et al. 2013), in samples with small amounts (ng) of isolated 
RNAtotal (Cremer et al. 1997) and in limited clinical samples, such as laser-captured 
tumour tissue or isolated single cells etc (Glockner et al. 2000, Saliba et al. 2014). 
While the technique is widely used, there are a number of questions that have been 
raised about multiple factors, which are frequently overlooked; and their effects on the 
reliability of RT-qPCR data (Bustin 2002, Bustin 2010, Bustin and Nolan 2004, Bustin 
et al. 2009, Dheda et al. 2004). These factors may be introduced at multiple stages of 
the experimental protocol and include: poor sample preservation (Bustin and Nolan 
2004) inaccurate quantification (Huggett et al. 2005); RNA integrity (Fleige and Pfaffl 
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2006, Imbeaud et al. 2005); inefficiency in the reverse-transcription step (Bustin et al. 
2005, Dheda K, et al. 2004, Stahlberg et al. 2004); manual manipulation of reaction 
thresholds and therefore quantification points (Bustin 2004, Vandesompele et al. 2009); 
and inappropriate normalisation of gene expression data (Pfaffl 2001, Pfaffl et al. 2004, 
Vandesompele and Kubista 2009). Although it is believed that there is no absolute way 
to control for disturbances in gene expression quantification (Pfaffl et al. 2004), 
limitation of experimental variability by optimisation of preservation, extraction, 
quantification and reverse-transcription protocols followed by normalisation against the 
total amount of input RNAtotal (ng) or against a stable internal control, to limit the 
influence of sample-to-sample and run-to-run variability, is considered to be the 
paragon approach to RT-qPCR (Bustin 2002). 
For the internal control, commonly referred to as a housekeeping or reference gene, to 
be considered as stable it should be expressed constitutively and in abundance in the 
tissue of interest, showing little variation in expression between the physiological or 
control state and states induced under different experimental conditions (Bar et al. 2009, 
Coulson et al. 2000). A number of studies have been carried out in order to identify a 
single “universal” reference gene for normalising human gene expression in all tissues 
(de Kok 2005, Eisenberg and Levanon 2003, Hsiao et al. 2001, Warrington et al. 2000); 
nevertheless, attempts to date have been unsuccessful and have resulted instead in the 
compilation of three lists of human reference genes, available for public access 
(Eisenberg and Levanon 2003, Hsiao et al. 2001, Warrington et al. 2000). 
In a number of studies, generic reference genes such as glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) and beta actin (ACTB) have been shown to be susceptible to 
regulation by experimental and pathological conditions; and to vary substantially 
between the control and treated/diseased samples of a single tissue type as a result 
(Goidin et al. 2001, Huggett et al. 2005, Revillion et al. 2000, Selvey et al. 2001, 
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Sirover 1997, Suzuki et al. 2000, Thellin et al. 1999, Zhong and Simons 1999). These 
findings have been the driving force behind a recent surge of investigations attempting 
to identify an appropriate reference gene for a given experimental system; where it is 
often concluded that in a complex experiment, evaluating multiple manipulations of a 
single tissue type, no single suitable reference gene can be identified and normalisation 
against the geometric mean expression of multiple reference genes is required (Coulson 
et al. 2008, Davoren et al. 2008, Fink et al. 2008, Gubern et al. 2009, Perez et al. 2007, 
Pombo-Suarez et al. 2008, Rhinn et al. 2008, Stern-Straeter et al. 2009, Valente et al. 
2009). 
GAPDH and ACTB have previously been used for normalising data in RT-qPCR 
studies of the human dental pulp (Dissanayaka et al. 2015, Dong et al. 2013, Gronthos 
et al. 2002, Liu et al. 2007, McLachlan et al. 2005) but, as no rationale has been given 
to substantiate the use of these two generic reference genes, and in light of the findings 
that reference gene expression is prone to modification by experimental systems, it 
seems unlikely that under a range of varied experimental conditions the expression of 
these generic genes will be infinitely stable in this tissue.  
Therefore, the aim of this experimental chapter was to identify optimal procedures for 
sample collection, RNAtotal isolation, quantification and reverse-transcription; prior to 
identification of a suitable reference gene from a panel of 7 generic genes for assessing 
relative expression of angiogenesis-associated growth factor mRNA in human dental 
pulps isolated from premolar teeth treated with an orthodontic force for two weeks prior 
to extraction. 
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3.2 Aims 
1. Compare and identify appropriate protocols for sample storage and RNA 
preservation. 
2. Identify a suitable protocol for isolating RNAtotal from the human dental pulp by 
optimising homogenisation techniques and comparing standard extraction 
methods. 
3. Identify a suitable protocol for quantifying RNA isolates by comparing well-
established universal methodologies. 
4. Attempt to maximise the experimental potential of a single dental pulp for RT-
qPCR analysis. 
5. Identify a suitable reference gene for normalising gene expression data in our 
unique experimental model. 
6. Identify an appropriate method for normalising gene expression data from RT-
qPCR experiments by comparing well-established approaches. 
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3.3 Materials and Methods 
MATERIALS 
3.3.1 MG-63 Osteosarcoma Cells 
Human MG-63 osteosarcoma cells (Cat. No. CRL-1427™) (ATCC® LGC Promochem, 
Teddington, UK) were provided by Prof A. E. Grigoriadis, Dental Institute, King’s 
College London. RNAtotal extracted from the cells was used in the construction of 
standard/calibration curves for reaction efficiency calculation in RT-qPCR analysis, and 
for optimisation of experimental protocols where pulp samples were limited. 
3.3.2 Human Dental Pulps 
Following informed parental and patient consent, human dental pulps were obtained 
from healthy first and second premolar teeth extracted from volunteers aged between  
12 – 16 years. All patients included in the study required extraction of a minimum of 2 
contralateral premolar teeth in conjunction with fixed appliance orthodontic treatment. 
Ethical approval was granted by the Research Ethics Committee at Guy’s Hospital and 
King’s College Hospital. 
METHODS 
3.3.3 Cell Culture 
MG-63 osteosarcoma cells were grown under sterile conditions at 37 ° C, 5 % CO2 in 
Eagle’s Alpha Minimum Essential Medium (MEM) (Cat. No. M8042) supplemented 
with 1 % L-Glutamine (Cat. No. G6784), 1 % Pen-Strep (Cat. No. G6784) and 10 % 
heat-inactivated Fetal Calf Serum (FCS) (Cat. No. F9665). Cells at passage 5 and a 
confluence level of 90 – 100 % were trypsinised (0.25 % trypsin solution (Cat. No. 
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T4049)) and stored as 1 ml aliquots in 40 % Eagle’s Alpha MEM (Cat. No. M8042),  
50 % FCS (Cat. No. F9665) and 10 % dimethylsulphoxide (Cat. No. C6295) at – 70 °C. 
All chemicals were sourced from Sigma-Aldrich, Poole, UK 
3.3.4 Orthodontic Force Application and Dental Pulp Isolation 
In this experimental chapter, pulps were isolated from 8 ‘control’ teeth for the purpose 
of optimising experimental protocols for sample storage, RNA isolation, RNA 
quantification, RNA integrity assessment, reverse-transcription and RT-qPCR assay 
efficiency. 
A further 10 contralateral pairs of ‘control’ and ‘treated’ teeth, 2 pulps per patient from 
10 patients, were isolated in order to identify a stable reference gene for use in  
RT-qPCR analysis of mRNA expression. 
In patients where orthodontic forces were applied to teeth prior to extraction, the oral 
cavity was divided along the mid-sagittal plane in order to assign a ‘control’ sample that 
would forego orthodontic force application; and a contralateral ‘treated’ sample which 
would experience a force in the range of 0.5 – 1 N for the duration of treatment. Fixed 
appliance straight wire orthodontic brackets (Roth 0.022 inch, 3M Unitek, California, 
USA) were direct bonded (Transbond, 3M Unitek, California, USA) to the upper and/or 
lower teeth from second premolar to second premolar, except the assigned ‘control’ 
teeth. Orthodontic bands were cemented (Ketac, 3M ESPE, Seefeld, Germany) onto all 
first permanent molar teeth. Test tooth position was carefully assessed and brackets 
were bonded in a position (offset if necessary) so that the archwires (0.016 inch nickel-
titanium, TP Orthodontics Inc., Leeds, UK) placed gave the required force of 0.5 – 1 N 
in a mesial and extrusive direction (Derringer et al. 1996). Following the required 
period of two weeks of force application, brackets were removed from the premolar 
teeth assigned as ‘treated’ teeth.  
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In all patients, the ‘control’ and contralateral ‘treated’ premolar teeth were extracted 
under local anaesthesia, placed in individual tubes containing 20 ml of cold sterile 
saline solution, and sectioned immediately with a high-speed water-cooled diamond bur 
through the buccolingual aspect. Dental pulps with a mean mass of ± 0.05 g (n = 5) 
were removed from the pulp chamber with sterile blunt instruments. Isolated pulps were 
then: (a) individually placed in a sterile 1.5 ml centrifuge tube and snap-frozen in liquid 
nitrogen before transferring to -70 °C for permanent storage; or (b) immersed separately 
in 500 µl RNALater™ (Cat. No. AM7021) (Ambion Inc., Warrington, UK), an RNA 
preservation solution, kept at 4 °C for 8 hr and transferred to -20 °C for permanent 
storage. 
All orthodontic procedures and dental pulp isolations, following tooth extraction, were 
performed by Dr K. A. Derringer, Dental Institute, King’s College London at Guy’s 
Hospital and King’s College Hospital. 
3.3.5 Pulp Homogenisation for RNA Isolation 
3.3.5.1 Mortar and Pestle 
Individual snap-frozen pulp samples were submerged in 15 ml TRI Reagent® (Cat. No. 
AM9738) (Ambion Inc., Warrington, UK), an RNA stabilisation solution, before being 
ground to a fine powder in a sterile ceramic mortar containing ± 20 ml liquid nitrogen. 
The powdered pulp was transferred to a sterile tube containing the RNA stabilising 
solution: (a) 2 ml TRI Reagent® or (b) 600 µl Buffer RLT (Cat. No. 74104 or 74106) 
(RNEasy Mini Kit, Qiagen Ltd., Crawley, UK) supplemented with 6 µl  
β-mercaptoethanol (Cat. No. M6250) (Sigma-Aldrich, Poole, UK).  
RNAtotal was subsequently isolated from the ground pulps using one of the techniques 
outlined in section 3.3.6 
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3.3.5.2 Passing Tissue through a Needle 
A snap-frozen pulp sample was immersed in: (a) 1 ml TRI Reagent® or (b) 600 µl 
Buffer RLT supplemented with 6 µl β-mercaptoethanol; and placed on ice to thaw. 
Once thawed the sample was passed repeatedly through a 21 gauge sterile needle (BDH, 
Dorset, UK) with a 1 ml sterile syringe (BDH, Dorset, UK) until entirely shredded.  
RNAtotal was isolated from the shredded pulps using one of the techniques outlined in 
section 3.3.6. 
3.3.5.3 FastPrep®-24 Instrument 
Individual snap-frozen pulp samples were transferred to a 2 ml impact resistant 
FastRNA® Pro Green tube (Cat. No. 116913050) (MPBiomedicals, London, UK) 
containing: (a) 600 µl TRI Reagent® or (b) 600 µl Buffer RLT supplemented with 6 µl 
β-mercaptoethanol. Tubes were sealed and positioned in the FastPrep®-24 Instrument 
(Cat. No. 116004500) (MPBiomedicals, London, UK) according to manufacturer’s 
instructions. Samples were homogenised at 6 ms-1 for 60 sec. Cell debris and ceramic 
beads were pelleted by centrifuging homogenates at 9,000 g for 5 min at 4 °C. 
Supernatants were removed and RNAtotal was isolated using one of the techniques 
outlined in section 3.3.6. 
3.3.5.4 Glass Dounce Tissue Homogeniser 
Individual snap-frozen pulp samples or individual pulp samples stored in RNALater™ 
(Ambion Inc., Warrington, UK) were ground in a 7 ml glass Dounce tissue homogeniser 
(Wheaton Science Products from VWR, Poole, UK) containing 600 µl of the RNA 
stabilisation solution RNA-Bee™ (Cat. No. CS-104B or CS-105B or  
CS-501B) (AMS Biotechnology, Abingdon, UK) and homogenates were transferred to 
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sterile centrifuge tubes. RNAtotal was isolated using one of the techniques outlined in 
section 3.3.6. 
3.3.6 RNA Isolation Techniques 
3.3.6.1 Phenol:Chloroform & DNAse Treatment  
400 µl chloroform (Cat. No. C7559) (Sigma-Aldrich, Poole, UK) was added to sample 
homogenates before vortexing for 15 sec and centrifuging at 9,000 g for 20 min at 4 °C. 
Supernatants were collected in fresh tubes and 500 µl isopropanol (Cat. No. W292907) 
(Sigma-Aldrich, Poole, UK) was added before inverting samples and leaving samples 
for 10 min at room temperature. Samples were centrifuged at 9,000 g for 15 min at 4 °C 
and supernatants were discarded. RNAtotal pellets were re-suspended in 700 µl of 70 % 
ethanol and centrifuged at 9,000 g for 5 min at 4 °C. Supernatants were discarded and 
pellets were left to dry until ethanol had completely evaporated. Ethanol-free pellets 
were re-suspended in 172 µl diethyl pyrocarbonate (DEPC)-treated nuclease-free water 
(Cat. No. AM9906) (Ambion Inc., Warrington, UK). 
20 µl of 10 × RQ1 RNAse-free DNAse reaction buffer (Cat. No. M198A-C) (Promega 
UK Ltd., Southampton, UK) and 8 µl RQ1 RNAse-free DNAse (Cat. No. M6101) 
(Promega UK Ltd., Southampton, UK) was added to the re-suspended RNAtotal and 
samples were incubated at 37 °C for 60 min. 200 µl phenol:chloroform:isoamyl alcohol 
[25:24:1] (Cat. No. P3803) (Sigma-Aldrich, Poole, UK) was added and samples were 
vortexed for 15 sec prior to centrifugation at 9,000 g for 5 min at 4 °C. Supernatants 
were transferred to new tubes and 200 µl chloroform:isoamyl alcohol [24:1] (Cat. No. 
C0549) (Sigma-Aldrich, Poole, UK) was added; samples were vortexed for 15 sec and 
centrifuged at 9,000 g for 5 min at 4 °C. Supernatants were measured and transferred to 
new tubes where 1/10 total sample volume 3 M sodium acetate (pH5.2) (Cat. No. 
S2889) (Sigma-Aldrich, Poole, UK) and 2 × total sample volume 100 % ethanol was 
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added. Samples were shaken thoroughly and transferred to – 20 °C for 72 hr. Samples 
were thawed on ice and centrifuged at 9,000 g for 45 min at 4 °C. Supernatants were 
discarded and the RNAtotal pellet re-suspended in 700 µl of 70 % ethanol and 
centrifuged at 9,000 g for 5 min at 4 °C. Supernatants were discarded; pellets were 
washed in 700 µl of 70 % ethanol and centrifuged at 9,000 g for 5 min at 4 °C. 
Supernatants were discarded and the pellet left to air-dry until the ethanol had 
evaporated completely. Ethanol-free RNAtotal pellets were re-suspended in 20 µl DEPC-
treated water (Cat. No. AM9906) (Ambion Inc., Warrington, UK) and transferred to  
– 70 °C for permanent storage. 
3.3.6.2 RNEasy Mini Kit & DNAse Treatment 
Pulp sample homogenates were transferred to spin columns of the RNEasy Mini Kit 
(Cat. No. 74104 or 74106) (Qiagen Ltd., Crawley, UK) and processed according to 
manufacturer’s instructions. RNAtotal was re-suspended in a final volume of 50 µl. 
20 µl of 10 × RQ1 RNAse-free DNAse reaction buffer (Cat. No. M198A-C) (Promega 
UK Ltd., Southampton, UK), 8 µl RQ1 RNAse-free DNAse (Cat. No. M6101) 
(Promega UK Ltd., Southampton, UK) and 90 µl DEPC-treated water (Cat. No. 
AM9906) (Ambion Inc., Warrington, UK) was added to the re-suspended RNAtotal and 
samples were incubated at 37 °C for 60 min. 200 µl phenol:chloroform:isoamyl alcohol 
[25:24:1] (Cat. No. P3803) (Sigma-Aldrich, Poole, UK) was added and samples were 
vortexed for 15 sec prior to centrifugation at 9,000 g for 5 min at 4 °C. Supernatants 
were transferred to new tubes and 200 µl chloroform:isoamyl alcohol [24:1] (Cat. No. 
C0549) (Sigma-Aldrich, Poole, UK) was added; samples were vortexed for 15 sec and 
centrifuged at 9,000 g for 5 min at 4 °C. Supernatants were measured and transferred to 
new tubes where 1/10 total sample volume 3 M sodium acetate (pH5.2) (Cat. No. 
S2889) (Sigma-Aldrich, Poole, UK) and 400 µl 100 % ethanol was added. Samples 
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were shaken thoroughly and transferred to – 20 °C for 72 hr. RNAtotal was pelleted by 
centrifugation at 9,000 g for 30 min at 4 °C. Supernatants were discarded; the RNAtotal 
pellet re-suspended in 800 µl of 70 % ethanol and centrifuged at 9,000 g for 5 min at  
4 °C. Supernatants were discarded and the pellet left to air-dry until the ethanol had 
evaporated completely. Ethanol-free RNAtotal pellets were re-suspended in 20 µl DEPC-
treated water (Cat. No. AM9906) (Ambion Inc., Warrington, UK) and stored 
permanently at – 70 °C. 
3.3.6.3 Phenol:Chloroform & RNEasy Mini Kit  
60 µl of chloroform (Cat. No. C7559) (Sigma-Aldrich, Poole, UK) was added to the 
pulp homogenate and samples centrifuged at 4 °C for 15 min at 9,000 g. Supernatants 
were collected in fresh tubes and a single volume of 70 % ethanol was added. Samples 
were inverted repeatedly and transferred to spin columns and RNAtotal extracted using 
the RNEasy Mini Kit (Cat. No. 74104 or 74106) (Qiagen Ltd., Crawley, UK) according 
to manufacturer’s instructions. Isolated RNAtotal was suspended in a final volume of 30 
µl nuclease-free water (Cat. No. AM9938) (Ambion Inc., Warrington, UK) and stored at 
-70 °C. 
3.3.6.4 RNA Isolation from MG-63 Osteosarcoma Cells 
RNAtotal was isolated from snap-frozen 1 ml aliquots of MG-63 osteosarcoma cells 
using the ‘Qiashredder lysis protocol’ (Cat. No. 79654 or 79656) (Qiagen Ltd., 
Crawley, UK) according to manufacturer’s instructions. RNAtotal was suspended in a 
final volume of 50 µl nuclease-free water (Cat. No. AM9938) (Ambion Inc., 
Warrington, UK) and stored permanently at – 70 °C. 
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3.3.7 RNA Quantification Techniques 
3.3.7.1 Spectrophotometry 
Isolated RNAtotal was diluted 1:100 with DEPC-treated nuclease-free water (Cat. No. 
AM9906) (Ambion Inc., Warrington, UK) and the absorbance at 260 nm (A260) and  
280 nm (A280) was measured in a 1 ml quartz cuvette in a standard spectrophotometer. 
Tare readings were created with 1 ml DEPC-treated water (Cat. No. AM9906) (Ambion 
Inc., Warrington, UK). 
RNA purity was calculated as the A260:A280 ratio, which correlates to the ratio of nucleic 
acids and proteins in the sample; and should lie in the range of 1.0 – 2.0, where 2.0 is 
the most pure. 
The RNAtotal concentration (ng/µl) was calculated as absorbance at 260 nm (A260) 
multiplied by 40, the RNA specific constant, multiplied by the dilution factor, i.e. 
RNAtotal(ng/µl) = A260 × 40 × (100/1). 
The mass (µg) of RNAtotal isolated from a single sample was calculated as the 
concentration of RNAtotal (ng/µl), multiplied by the total sample volume (µl) divided by 
1000, i.e. RNAtotal Mass (µg) = ((A260 × 40 × (100/1)) ng/µl × 20 µl) ÷ 1000. 
3.3.7.2 NanoDrop Spectrophotometry 
The purity and concentration (ng/µl) of RNAtotal for each sample was determined by 
calculating the A260:A280 and A260:A230 ratios using the NanoDrop™ 1000 
spectrophotometer (Now replaced by Cat. No. ND-2000, NanoDrop™ 2000 
spectrophotometer) (ThermoFisher Scientific, Nottingham, UK), according to 
manufacturer’s instructions. 
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3.3.7.3 Ribogreen® RNA Assay Kit 
RNAtotal was quantified by fluorescence with the Quant-iT™ Ribogreen® RNA Assay 
Kit (Cat. No. R11490) (Molecular Probes, Invitrogen Ltd., Paisley, UK), according to 
the manufacturer’s protocol. 
3.3.8 Assessment of RNA Integrity – Bioanalysis of RNA 
1 µl of fluorescently labelled RNAtotal was analysed electrophoretically with the Agilent 
2100 Bioanalyzer (Cat. No. G2939AA) (Agilent Technologies, Stockport, UK) on a 
6000 Series II Pico chip (Cat. No. 5067-1513) (Agilent Technologies, Stockport, UK) 
according to manufacturer’s instructions. RNA Integrity Numbers (RIN’s) were 
assigned based on the level of sample degradation and solvent contamination. 
Previously calculated from the ratio of the 18S and 28S rRNA bands, RNA integrity 
values are now calculated from the entire electrophoretic trace against a scale of 1 – 10. 
A RIN of 10 indicating that the sample is pure and a RIN of 1 indicating high level 
degradation (http://www.chem.agilent.com/rin/_rinsearch.aspx). 
3.3.9 Reverse-Transcription Techniques 
3.3.9.1 Moloney Murine Leukaemia Virus Reverse Transcriptase 
In addition to reverse transcribing RNA to cDNA, a reverse-transcription control  
(RT control) was created for each sample by replacing the amount of RNA input into a 
reaction with 1 µl DEPC-treated water (Cat. No. AM9906) (Ambion Inc., Warrington, 
UK). 
3.3.9.1.a Method A 
1 µg DNAse treated RNAtotal and 1 µl random primers (Cat. No. C1181) (Promega UK 
Ltd., Southampton, UK) were added to a sterile centrifuge tube and made up to a 
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volume of 14 µl with DEPC-treated water (Cat. No. AM9906) (Ambion Inc., 
Warrington, UK), before heating for 5 min at 70 °C and transferring to ice for 5 min.  
5 µl 5 × Moloney Murine Leukaemia Virus (MMLV) Buffer (Cat. No. M5313) 
(Promega UK Ltd., Southampton, UK), 1.25 µl deoxyribonucleotide triphosphates 
(dNTPs) (Cat. No, U1511 or U1515) (Promega UK Ltd., Southampton, UK), 1 µl 
MMLV reverse transcriptase (MMLV-RT) enzyme (Cat. No. M1701) (Promega UK 
Ltd., Southampton, UK) and 3.75 µl DEPC-treated water (Cat. No. AM9906) (Ambion 
Inc., Warrington, UK) were added to the sample. Samples were heated at 55 °C for  
55 min and 80 °C for 15 min; centrifuged at 9,000 g for 15 sec and stored permanently 
at – 20 °C. 
3.3.9.1.b Method B 
0.5 µg DNAse treated RNAtotal and 1 µl random primers (Cat. No. C1181) (Promega 
UK Ltd., Southampton, UK) were added to a sterile centrifuge tube and made up to a 
volume of 14 µl with DEPC-treated water (Cat. No. AM9906) (Ambion Inc., 
Warrington, UK), before heating for 5 min at 70 °C and transferring to ice for 5 min.  
5 µl of 5 × MMLV Buffer (Cat. No. M5313) (Promega UK Ltd., Southampton, UK), 
1.25 µl dNTPs (Cat. No, U1511 or U1515) (Promega UK Ltd., Southampton, UK),  
1 µl MMLV-RT enzyme (Cat. No. M1701) (Promega UK Ltd., Southampton, UK) and 
3.75 µl DEPC-treated water (Cat. No. AM9906) (Ambion Inc., Warrington, UK) were 
added to the sample. Samples were heated at 55 °C for 55 min and 80 °C for  
15 min; centrifuged at 9,000 g for 15 sec and stored permanently at – 20 °C. 
3.3.9.1.c Method C 
0.5 µg DNAse treated RNAtotal and 0.5 µl random primers were added to a sterile 
centrifuge tube and made up to a volume of 7 µl with DEPC-treated water (Cat. No. 
AM9906) (Ambion Inc., Warrington, UK), before heating for 5 min at 70 °C and 
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transferring to ice for 5 min. 2.5 µl of 5 × MMLV Buffer (Cat. No. M5313) (Promega 
UK Ltd., Southampton, UK), 0.625 µl dNTPs (Cat. No, U1511 or U1515) (Promega 
UK Ltd., Southampton, UK), 0.5 µl MMLV-RT enzyme (Cat. No. M1701) (Promega 
UK Ltd., Southampton, UK) and 1.875 µl DEPC-treated water (Cat. No. AM9906) 
(Ambion Inc., Warrington, UK) were added to the sample. Samples were heated at  
55 °C for 55 min and 80 °C for 15 min; centrifuged at 9,000 g for 15 sec and stored 
permanently at – 20 °C. 
3.3.9.2 iScript 
10 ng RNAtotal was incorporated into a 25 µl one-step RT-qPCR reaction made up from 
0.5 µl iScript™ reverse transcriptase for one-step RT-PCR (Cat. No. 172-5038) (Bio-
Rad Laboratories Ltd., Hemel Hempstead, UK), 0.75 µl forward primer (10 µM) 
(Eurofins MWG Operon, London, UK), 0.75 µl reverse primer (10 µM) (Eurofins 
MWG Operon, London, UK), 12.5 µl 2 × SYBR® Green RT-PCR Reaction Mix (Cat. 
No. 170-8880) (Bio-Rad Laboratories Ltd., UK) and nuclease-free water (Cat. No. 
AM9938) (Ambion Inc., Warrington, UK). 
Amplifications were performed with an initial reverse-transcription step at 50 °C for  
10 min, followed by template denaturation at 95 °C for 5 min and 45 cycles of 
denaturation at 95 °C for 10 sec; combined primer annealing/extension at 60 °C for  
30 sec and data acquisition. 
A dissociation protocol was performed from 72 °C – 95 °C at 1 °C increments in order 
to determine analytical specificity and identify primer-dimer or other spurious binding 
products. 
3.3.9.3 WT-Ovation™ Pico RNA Amplification 
50 ng RNAtotal was converted to cDNA using the WT-Ovation™ Pico RNA 
Amplification System (Now replaced by Cat. No. 3302, Ovation Pico WTA System V2) 
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(NuGen Technologies, Inc., California, USA) according to the manufacturer’s protocol. 
cDNA was then purified using the DNA Clean and Concentrator 25™ kit (Cat. No. 
D4033 or D4034) (Zymo Research Corporation, California, USA) according to 
manufacturer’s instructions; and quantified with the NanoDrop™ 1000 
spectrophotometer. Samples were stored permanently at – 20 °C. 
3.3.10 Selection of Candidate Reference Genes and Angiogenic Growth 
Factors for mRNA Expression Analysis 
A panel of reference genes was selected from three lists of known human reference 
genes (Eisenberg and Levanon et al. 2003, Hsiao et al. 2001, Warrington et al. 2000) 
and supplementary microarray data for gene expression in the human dental pulp 
(Paakkonen et al. 2005). Selected genes were representative of a number of cellular 
functions including metabolism and cell structure, minimising the occurrence of gene 
co-regulation (Table 1). 
Genes thought to play a role in the angiogenic response of the human dental pulp to 
orthodontic force application were selected from a study linking growth factor release in 
the pulp to orthodontic treatment (Derringer and Linden 2004) (Table 2). 
 
 
Table 1 Candidate reference genes 
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Table 2 Candidate angiogenic growth factors 
 
3.3.11 Primer Design 
Primers (Eurofins MWG Operon, London, UK) for RT-PCR (Table 3 – Table 7) and 
RT-qPCR (Table 8 – Table 18) were designed by inspection of the nucleotide sequence 
and with the Primer-BLAST tool (Basic Local Alignment Search Tool, National Centre 
for Biotechnology Information) in collaboration with Dr G. Bluteau, Institute of Oral 
Biology, University of Zurich; or with Primer Express® Software v 2.0 (Applied 
Biosystems, Warrington, UK) in collaboration with Dr N. Silver, Dental Institute, 
King’s College London.  
In order to increase primer specificity and minimise the occurrence of self-binding, 
primer-dimer or artefact formation; primers were designed across exon-exon boundaries 
with similar GC contents, lengths and annealing temperatures. 
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3.3.11.1 Primers for RT-PCR of Angiogenic Growth Factors and the Reference 
Gene GAPDH 
 
Table 3  Primer sequences for angiogenic growth factor FGF2 for RT-PCR 
Primer for FGF2 was designed by Dr N. Silver. 
 
 
Table 4 Primer sequences for angiogenic growth factor PDGFA for RT-PCR 
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Table 5 Primer sequences for angiogenic growth factor TGFB1 for RT-PCR 
 
 
Table 6 Primer sequences for angiogenic growth factor VEGFA for RT-PCR 
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Table 7 Primer sequences for reference gene GAPDH for RT-PCR 
Primer for GAPDH was designed by Dr G. Bluteau. 
 
3.3.11.2 Primers for RT-qPCR of Angiogenic Growth Factors 
 
Table 8 Primer sequences for angiogenic growth factor FGF2 for RT-qPCR 
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Table 9 Primer sequences for angiogenic growth factor PDGFA for RT-qPCR 
 
 
Table 10 Primer sequences for angiogenic growth factor TGFB1 for RT-qPCR 
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Table 11 Primer sequences for angiogenic growth factor VEGFA for RT-qPCR 
 
3.3.11.3 Primers for RT-qPCR of Reference Genes 
 
Table 12 Primer sequences for candidate reference gene ACTB for RT-qPCR 
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Table 13 Primer sequences for candidate reference gene GAPDH for RT-qPCR 
 
 
Table 14 Primer sequences for candidate reference gene HPRT1 for RT-qPCR 
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Table 15 Primer sequences for candidate reference gene PPIA for RT-qPCR 
 
 
Table 16 Primer sequences for candidate reference gene RPL13A for RT-qPCR 
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Table 17 Primer sequences for candidate reference gene UBC for RT-qPCR 
 
 
Table 18 Primer sequences for candidate reference gene YWHAZ for RT-qPCR 
 
3.3.12 Reverse-Transcription PCR (RT-PCR) 
All materials in this experiment were sourced from Promega UK Ltd., Southampton, 
UK with the exception of DEPC-treated water (Cat. No. AM9906) and the PCR oil 
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(Cat. No. M8662-5VL), which was sourced from Ambion Inc., Warrington, UK and 
Sigma-Aldrich, Poole, UK respectively.  
50 µl reactions were made up from 10 µl GoTaq™ Buffer (Cat. No. M8305), 3 µl 
MgCl2+ (1.5mM) (Cat. No. A3513), 1 µl dNTPs (Cat. No, U1511 or U1515), 1 µl 
forward primer (0.1 µg/µl) (Eurofins MWG Operon, London, UK), 1 µl reverse primer 
(0.1 µg/µl) (Eurofins MWG Operon, London, UK), 0.5 µl Taq polymerase enzyme 
(Cat. No. M891A), 32.5 µl DEPC-treated water (Cat. No. AM9906) and: (a) 1 µl 
cDNA, (b) 1 µl DEPC-treated water (Cat. No. AM9906) or (c) 1 µl RT control (section 
3.3.9.1). 50 µl PCR oil (Cat. No. M8662-5VL) was then added to the top of each 
reaction to ensure even heat distribution in a thermal cycler with no top heat block. 
The general procedure for RT-PCR was: Initial denaturation at 95 ºC for 2 min;  
35 cycles of 94 ºC for 40 sec (denaturation), 60 ºC for 40 sec (annealing), 72 ºC for  
30 sec (extension); followed by a final extension of 5 min at 72 ºC. 
3.3.13 Reverse-Transcription Quantitative Real-Time PCR (RT-qPCR) 
Analysis of mRNA Expression 
RT-qPCR was performed using the Corbett Rotor-Gene™ 6000 (Corbett Life Sciences, 
Qiagen Ltd., Crawley, UK) on 25 µl one-step reverse-transcription reactions using 
iScript™ reverse transcriptase with SYBR® Green (Cat. No. 172-5038) (Bio-Rad 
Laboratories Ltd., Hemel Hempstead, UK). 
Reactions were set up manually in 0.1 ml strip tubes (Cat. No. 981103) (Qiagen Ltd., 
Crawley, UK) and 10 ng RNAtotal was added to 0.5 µl iScript™ reverse transcriptase for 
one-step RT-PCR (Cat. No. 172-5038) (Bio-Rad Laboratories Ltd., Hemel Hempstead, 
UK), 0.75 µl forward primer (10 µM) (Eurofins MWG Operon, London, UK), 0.75 µl 
reverse primer (10 µM) (Eurofins MWG Operon, London, UK), 12.5 µl 2 × SYBR® 
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Green RT-PCR Reaction Mix (Cat. No. 170-8880) (Bio-Rad Laboratories Ltd., UK) and 
nuclease-free water (Cat. No. AM9938) (Ambion Inc., Warrington, UK). 
Amplifications were performed with an initial reverse-transcription step at 50 °C for  
10 min, followed by template denaturation at 95 °C for 5 min and 45 cycles of 
denaturation at 95 °C for 10 sec; combined primer annealing/extension at 60 °C for  
30 sec and data acquisition. A dissociation protocol was performed from 72 °C –  
95 °C at 1 °C increments in order to determine analytical specificity and identify 
primer-dimer or other spurious binding products. 
To verify RT-qPCR amplification product size, a dissociation protocol was omitted for 
each of the genes of interest (GOIs) and products were separated by gel electrophoresis. 
Standard curves were constructed from a 1:10 dilution series of MG-63 cDNA  
(20 ng/reaction – 0.0002 ng/reaction) in order to calculate RT-qPCR reaction 
efficiencies. 
Details of primers are given in Table 8 – Table 18. 
3.3.14 Gel Electrophoresis 
RT-PCR products and RT-qPCR products from the iScript protocol were separated 
according to molecular weight by gel electrophoresis. 
20 µl RT-PCR product and 2 µl gel-loading buffer (Cat. No. G2526-5ML) (Sigma-
Aldrich, Poole, UK) was loaded onto a 2 % agarose (Cat. No. BIO-41025) (Bioline 
Ltd., London, UK) gel made with 0.5 × TrisBorateEDTA (TBE) buffer (Cat. No. 
T4415) (Sigma-Aldrich, Poole, UK) and 2 µl ethidium bromide (Cat. No. E1385) 
(Sigma-Aldrich, Poole, UK). Samples were run in 0.5 × TBE buffer for 40 min at  
100 V alongside a 100 bp DNA ladder (Cat. No. G2101) (Promega UK Ltd., 
Southampton, UK) and gels were photographed using a UV transluminator linked to a 
printer. 
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5 µl RT-qPCR product and 0.83 µl 6 × blue/orange loading dye (Cat. No. G1881) 
(Promega UK Ltd., Southampton, UK) were loaded onto a 2 % agarose gel made with 
0.5 × TBE buffer and 2 µl GelRed™ Nucleic Acid Gel Stain (Cat. No. 41003) (Biotium 
Inc., Cambridge BioScience Ltd., Cambridge, UK). Samples were run in  
0.5 × TBE buffer for 15 min at 100 V alongside a 100 bp ladder and gels were 
photographed using a UV transluminator linked to a printer. 
3.3.15 Statistical Analysis of RT-qPCR Data 
3.3.15.1 Reference Gene Expression Stability Analysis 
Raw RT-qPCR data was analysed with Corbett Rotor-Gene™ 6000 Application 
Software, version 1.7 (Build 87) and expressed as quantification cycle (Cq) values. Gene 
stability was initially assessed by analysing gene expression distribution and 
normalising to RNAtotal by performing statistical analysis with the paired Student’s  
t-Test. Cq values were inserted into the Microsoft Excel-based tool, BestKeeper© 
version 1 (Pfaffl et al. 2004, http://normalisation.gene-quantification.info/) and GenEx 
software version 4.3.5 (MultiD Analyses AB, Göteborg, Sweden and TATAA 
Biocenter, Göteborg, Sweden) (http://normalisation.gene-quantification.info/) which 
includes, among other useful BioInformatic tools, the geNorm (Vandesompele et al. 
2002) and NormFinder (Andersen et al. 2004) algorithms. Statistical significance was 
given at p ≤ 0.05 
3.3.15.2 Gene Expression Analysis for Angiogenic Growth Factors 
Relative mRNA expression of angiogenic growth factors (Table 2) was compared 
between ‘control’ and contralateral ‘treated’ pulps using the Delta Ct method 
(Schmittgen and Livak 2008) which compares the fold-change in gene expression by 
analysing each sample as an individual, isolated data point; and the Delta-Delta Ct 
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(Livak and Schmittgen 2001, Schmittgen and Livak 2008) method which compares the 
fold-change in gene expression by pairing the contralateral ‘treated’ and ‘control’ pulps 
together. Cq values were also input into the REST-2009© software package (developed 
by Prof. M. Pfaffl, Technical University Munich, Germany and Qiagen Ltd., Crawley, 
UK; http://www.gene-quantification.com/rest-2009.html) for relative expression 
analysis with efficiency correction. Statistical significance was given at p ≤ 0.05. 
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3.4 Results 
3.4.1 Sample Storage and RNA Preservation 
Student’s t-Test assuming unequal variances (n = 5) showed that there was no 
statistically significant difference (p > 0.05) in the amount (ng) of RNAtotal isolated from 
human dental pulp samples preserved by snap-freezing, mean (± SEM) of 2,816.98  
± 1,208.81 ng, when compared with storage in an RNA preservative, mean (± SEM) of 
2,126.56 ± 833.42 ng. Values were obtained with the NanoDrop™ 1000 
spectrophotometer (section 3.3.7.2). 
Both preservation methods were assumed to result in similar yields (ng) of RNAtotal  
(p = 0.66), and so RNALater™ was utilised for sample collection for mRNA expression 
analysis due to its safety advantages in the dental clinical environment and in 
transportation between the dental clinics and the laboratory; while snap-freezing was 
utilised for protocol optimisation as samples had already been collected using this 
technique. 
3.4.2 RNA Isolation, Yield and Sample Purity 
3.4.2.1 Optimisation of Tissue Homogenisation and RNA Isolation Protocols 
RNAtotal isolated from snap-frozen dental pulp tissue, homogenised with a mortar and 
pestle (n = 2, section 3.3.5.1) and isolated by: (a) Phenol:Chloroform & DNAse 
Treatment (n = 1, section 3.3.6.1) or (b) RNEasy Mini Kit & DNAse Treatment (n = 1, 
section 3.3.6.2); or homogenised by passing the sample through a needle in RNA 
stabilisation solution (n = 2, section 3.3.5.2) and isolated by: (a) Phenol:Chloroform & 
DNAse Treatment (n = 1, section 3.3.6.1) (b) RNEasy Mini Kit & DNAse Treatment  
(n = 1, section 3.3.6.2) yielded RNAtotal amounts of ≥ 0.5 µg per pulp when quantified 
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by standard spectrophotometry (section 3.3.7.1). Spectrophotometry indicated that there 
was little difference in sample integrity (A260: A280 ratio). 
Snap-frozen samples homogenised: (a) with a mortar and pestle (n = 1, section 3.3.5.1) 
and suspended in supplemented Buffer RLT (section 3.3.6.2); (b) by passing the sample 
through a needle (n = 1, section 3.3.5.2) in supplemented Buffer RLT (section 3.3.6.2); 
(c) pulverised in supplemented Buffer RLT in the FastPrep®-24 instrument (n = 1, 
sections 3.3.5.3 and 3.3.6.2); or (d) in a glass homogeniser in combination with the 
modified phenol:chloroform RNA isolation protocol (n = 1, section 3.3.5.4 and 3.3.6.3) 
were processed according to manufacturer’s instructions for RNA isolation with the 
RNEasy Mini Kit. RNAtotal was quantified by NanoDrop Spectrophotometry (section 
3.3.7.2) and sample integrity was assessed with the Agilent 2100 Bioanalyzer (section 
3.3.8) (Table 19). 
 
 
Table 19 Bioanalyzer RIN values and gel electrophoretograms 
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Electrophoretic traces (Figure 2 – Figure 5) constructed by the 2100 Expert Software, 
from the gel electrophoretograms shown in Table 19, illustrate the level of sample 
degradation and the defined peaks assigned to the 18S and 28S ribosomal RNA 
subunits. In samples homogenised by mortar and pestle in liquid nitrogen (Figure 2) or 
passed through a needle (Figure 3), the peaks representative of the ribosomal subunits 
were small and indistinguishable; samples were shown to have high levels of 
degradation and despite being treated with DNAse, contained large concentrations of 
genomic DNA indicated as a continuous peak between the 18S and 28S ribosomal RNA 
subunits. When the pulp was homogenised by the FastPrep®-24 machine, peaks 
representative of the ribosomal subunits were well defined and the remainder of the 
sample showed little degradation (Figure 4). When homogenised with the glass Dounce 
tissue homogeniser and isolated by the modified phenol:chloroform protocol, subunit 
peaks were well defined, however the remainder of the sample showed a low level of 
degradation (Figure 5). 
 
 
Figure 2 Bioanalysis of RNA from pulp homogenised by mortar and pestle 
Electrophoretic trace illustrating sample degradation and RNA integrity. Sample shows a large undefined 
18S ribosomal peak at 42 followed by a wide peak of genomic DNA (43 – 46) and a small 28S ribosomal 
RNA peak at 49. 
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Figure 3 Bioanalysis of RNA from pulp homogenised by passing pulp through a needle 
Electrophoretic trace illustrating sample degradation and RNA integrity. Sample shows a large undefined 
18S ribosomal peak at 42 followed by a peak of genomic DNA (43 – 46) and a defined 28S ribosomal 
RNA peak at 49. 
 
 
Figure 4 Bioanalysis of RNA from pulp homogenised by FastPrep®-24 
Electrophoretic trace illustrating sample degradation and RNA integrity. Sample shows a large defined 18S 
ribosomal peak at 42 followed a small 28S ribosomal RNA peak at 49. This sample showed no genomic 
DNA contamination. 
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Figure 5 Bioanalysis of RNA from pulp homogenised in a glass Dounce tissue homogeniser 
Electrophoretic trace illustrating RNA degradation and sample integrity. Sample shows a large defined 18S 
ribosomal peak at 42 followed by minimal genomic DNA (43 – 46) and a large 28S ribosomal RNA peak 
at 49. 
 
RNAtotal isolated by the RNEasy Mini Kit subsequent to homogenisation in the 
FastPrep®-24 instrument yielded the highest concentration of RNAtotal (2.34 ng/µl) with 
the lowest level of degradation from all tested combinations although no RNA Integrity 
Number (RIN) could be assigned (Figure 4). RNAtotal isolated by the modified 
phenol:chloroform extraction method subsequent to homogenisation in the glass 
Dounce tissue homogeniser yielded a marginally lower concentration of RNAtotal  
(1.44 ng/µl) with similarly strong peaks to those of the FastPrep®-24 instrument and a 
RIN of 5.40. As the glass Dounce tissue homogenisers were readily available at no 
additional cost to the laboratory, this combination of homogenisation and RNA isolation 
was used from this point forward. 
3.4.2.2 Optimisation of RNA Quantification Protocols 
Standard spectrophotometry was discounted as an accurate method for RNA 
quantification as yields of  0.5 µg per pulp (n = 4) were below the limit of detection 
(LOD) for this assay (Bustin 2000, Fleige and Pfaffl 2006). 
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Table 20 RNAtotal yields from human dental pulps when quantified by NanoDrop spectrophotometry 
and fluorescence (Ribogreen assay) 
 
RNA yields ranged from 1,087.30 – 10,742.40 ng per sample with a mean (± SEM) 
yield of 2,885.86 ± 559.33 ng RNAtotal per pulp sample (n = 20, Table 20) when 
quantified with the NanoDrop™ 1000 spectrophotometer. However, this mean yield 
was determined to be 3.5-times lower when the same samples were quantified by 
fluorescence with the Ribogreen® RNA Assay Kit (464.70 – 1,035.60 ng per sample 
with a mean (± SEM) yield of 806.54 ± 33.37 ng RNAtotal per pulp sample (n = 20, 
Table 20). By paired Student’s t-Test it was identified that there was a statistically 
significant difference between the two quantification techniques (p < 0.0005), and a 
Pearson’s correlation coefficient of 0.559 was assigned, indicating that the 
methodologies are not tightly correlated. 
The mean (± SEM) A260:A280 (nucleic acid to protein) ratio was 1.94 ± 0.02 (ranging 
from 1.71 – 2.11) (n = 20, Table 20). The mean (± SEM) A260:A230 (nucleic acid to 
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organic compound contamination) ratio was 1.19 ± 0.10 (range from 0.34 – 2.03)  
(n = 20, Table 20). 
NanoDrop Spectrometry was used in conjunction with Ribogreen® quantification for 
the duration of the study as the fluorescence assay, despite being more appropriate for 
our experimental model, could not determine the sample quality by assessing the 
A260:A280 or A260:A230 ratios. Samples were found to be within the acceptable range of 
good quality RNAtotal as per Sambrook et al (1989) which states that an A260:A280 ratio 
greater than 1.8 is acceptable. 
3.4.3 Reverse-Transcription for RT-PCR and RT-qPCR 
3.4.3.1 Optimisation of Reverse-Transcription Protocols for RT-PCR 
RNAtotal extracted from 1 µl MG-63 osteosarcoma cell aliquots (section 3.3.6.4) and 
quantified by standard spectrophotometry (section 3.3.7.1) was reverse transcribed by 
the three Moloney Murine Leukaemia Virus Reverse Transcriptase methods outlined in 
section 3.3.9.1.a – 3.3.9.1.c. RT-PCR was performed with primers for GAPDH  
(Table 7) and RT-PCR products were separated by gel electrophoresis (section 3.3.14). 
The gel electrophoretogram (Figure 6) illustrates that by halving the original input 
amount of RNAtotal to 0.5 µg as per method 3.3.9.1.b (result shown in Lane 5,  
Figure 6), the cDNA yield from a single reverse-transcription reaction is relative to that 
obtained by reverse transcribing a full 1 µg RNAtotal as per method 3.3.9.1.a (result 
shown in Lane 2, Figure 6). By halving both the RNAtotal input and the reagent volumes 
as per method 3.3.9.1.c, the cDNA yield is reduced by more than half (result shown in 
Lane 8, Figure 6). For the purpose of RT-PCR, method 3.3.9.1.b was used for reverse 
transcribing RNAtotal from this point onward as it maximised the number of reactions 
that could be performed with a single pulp. These observations are purely qualitative. 
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Figure 6 Optimisation of reverse-transcription protocols for RT-PCR 
Gel electrophoretogram of GAPDH amplification in MG-63 osteosarcoma cells using three methods of 
reverse-transcription. Lane 2 shows the product from method 3.3.9.1.a, where 1 µg RNAtotal was reverse-
transcribed to cDNA using full volume reagents. Lane 5 shows the product from method 3.3.9.1.b where 
0.5 µg RNAtotal was reverse-transcribed to cDNA using full volume reagents. Lane 8 shows the product 
from method 3.3.9.1.c, where 0.5 µg RNAtotal was reverse-transcribed to cDNA using half the reagent 
volume as previous methods. Lanes 3, 6 and 9 contain a no template control where RNAtotal was replaced 
by nuclease-free water. 
 
3.4.3.2 Optimisation of Reverse-Transcription Protocols for RT-qPCR 
RNAtotal extracted from control and orthodontically treated pulp samples (n = 20) had a 
mean (± SEM) yield of 806.54 ± 33.37 ng RNAtotal per pulp sample when quantified by 
fluorescence (Table 20). Using an input amount of 10 ng RNAtotal per RT-qPCR 
reaction, the one-step RT-qPCR kit, iScript, was compared against the WT-Ovation™ 
Pico RNA Amplification System to identify the most suitable method of reverse-
transcribing RNAtotal for RT-qPCR. It was calculated that 40 one-step RT-qPCR 
reactions could be performed, in technical duplicate, from a single pulp tissue with the 
above mean (± SEM) yield (ng) of extracted RNAtotal using the iScript one-step kit. The 
WT-Ovation™ Pico RNA Amplification System was shown to convert 50 ng of 
RNAtotal to a mean (± SEM) yield of 7979.58 ± 442.32 ng cDNA in a single reverse-
transcription-amplification reaction.  
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Table 21 Comparison between the iScript one-step RT-qPCR kit and the WT-Ovation ™ Pico RNA 
Amplification System 
Using the known mean RNAtotal yield per pulp sample (n = 20) the experimental potential of a single pulp 
was determined for RT-qPCR analysis. The iScript one-step RT-qPCR kit reverse-transcribes RNAtotal to 
cDNA during RT-qPCR whilst the WT-Ovation™ Pico RNA Amplification System reverse transcribes 
RNAtotal to cDNA prior to RT-qPCR. The iScript one-step RT-qPCR kit requires 10ng of RNAtotal per 
reaction whilst the WT-Ovation™ Pico RNA Amplification System requires 10ng of cDNA per RT-qPCR 
reaction. The WT-Ovation™ Pico RNA Amplification System proved to maximise the experimental 
potential of a single human dental pulp by 161 – times (in technical duplicate). 
 
Using an input of 10 ng cDNA per RT-qPCR reaction, it was shown that 398 RT-qPCR 
reactions could be performed, in technical duplicate, from a single reverse-transcription-
amplification reaction. We further calculated that a total of 16 reverse-transcription-
amplification reactions could be performed from the above mean (± SEM) yield (ng) of 
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extracted pulp RNAtotal; expanding the experimental potential of a single pulp tissue 
from 40 RT-qPCR reactions using the iScript one-step RT-qPCR kit to a possible 6,441 
RT-qPCR reactions, when carried out in technical duplicate with the WT-Ovation™ 
Pico RNA Amplification System. 
The WT-Ovation™ Pico RNA Amplification System was discovered only after all RT-
qPCR had been performed for the reference gene stability analysis and the mRNA 
expression analysis of angiogenic growth factors in this experimental chapter. It was 
found to be the most appropriate method for reverse-transcribing human dental pulp 
RNAtotal to cDNA for the purpose of RT-qPCR analysis and the remaining volumes of 
RNAtotal isolated from the pulps treated with an orthodontic force for 2 weeks prior to 
tooth extraction were reverse-transcribed to cDNA in order to expand the study in 
Chapter 4. 
3.4.4 Normalising to total RNA and Distribution of Reference Gene 
Expression 
In order to examine the range of expression of the reference genes in our control and 
treated samples, RT-qPCR was performed in technical duplicate for each gene with the 
iScript one-step RT-qPCR kit, inputting an equal mass of RNAtotal (10 ng) per reaction; 
Cq values were compared directly. 
A paired Student’s t-Test was performed on Cq values to determine the stability of 
expression of each reference gene in the treated samples (n = 10) relative to the 
contralateral controls (n = 10); no statistically significant difference (p > 0.05) was 
identified (Table 22). 
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Table 22 Normalisation of candidate reference gene expression against total RNA 
To identify differences in candidate gene expression between the control (n = 10) and treated (n = 10) 
subgroups, a paired Student’s t-Test was implemented. There was no significant difference (p > 0.05) in 
expression of any of the candidate genes between the control and treated subgroups. 
 
Cq values were plotted on box-whisker plots to show the distribution of gene expression 
across the sample set (Figure 7). Cq values for HPRT1 and PPIA were higher than those 
for the remainder of the panel, indicating that there were lower amounts of template 
present for these genes in the pulp samples; as Cq values are inversely correlated to the 
amount of template present for the gene of interest (GOI) in the original sample (Heid et 
al. 1996). 
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Figure 7 Distribution of candidate reference gene expression in control and treated samples  
Box-Whisker plots showing distribution of gene expression according to Cq values for control (n = 10) and 
treated (n = 10) subgroups. Whiskers correspond to data range while boxes illustrate the 25th percentile, 
median value and 75th percentiles. A paired Student’s t-Test showed no significant difference (p > 0.05) in 
mRNA expression of candidate genes between control and treated subgroups. 
 
3.4.5 Analysis of Reference Gene Expression Stability – BestKeeper© 
Cq values (n = 20) were inserted into the BestKeeper© Microsoft Excel based tool and 
the geometric mean, arithmetic mean, minimal value, maximal value, standard deviation 
(SD) and coefficient of variation (CV) were calculated for each reference gene  
(Table 23). CV values for HPRT1 and PPIA were lower than those of the other 
reference genes, indicating that these genes are not directly comparable with the others 
(Pfaffl et al. 2004). HPRT1 and PPIA were excluded from further stability analyses. 
The remaining genes were ranked according to stability, indicated by SD values, from 
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most to least stable, with the most stable gene having the lowest variability: (1) UBC, 
(2) RPL13A, (3) GAPDH, (4) ACTB and YWHAZ. 
 
 
Table 23 Analysis of variance and stability of each candidate reference gene using the BestKeeper© 
tool 
Coefficient of variation (CV) and standard deviations (SD) as calculated by the BestKeeper© tool. HPRT1 
and PPIA were shown to have a different variance to the remaining candidate genes. Whilst a low variance 
is considered to be optimal, Cq values for these two genes were greater (Cq = 39 – < 45, Chapter 8, section 
8.1.8.1 Table 57 – 58) than the remaining candidate genes and the genes of interest, indicating that these 
genes are expressed in low abundance within human dental pulps. Therefore these two genes were 
excluded from further stability analysis. SD values were used to rank genes according to stability where the 
lowest variation corresponds with the most stable gene across the sample set (n = 20). 
 
By performing numerous pair-wise correlation analyses and combining highly 
correlated genes into an index against which all remaining genes were compared by 
regression analysis, BestKeeper© identified RPL13A, UBC and YWHAZ to be the 
most tightly correlated genes in the panel (Table 24). 
 
  - 111 - 
 
Table 24 Analysis of inter-reference gene relations using pair-wise correlation and regression 
analysis in the BestKeeper © Excel-based tool 
Repeated pair-wise correlation analysis as calculated by the BestKeeper© tool. Candidate genes were 
initially correlated with one another and then correlated against the BestKeeper Index. Coefficient of 
correlation (r), coefficient of determination (r2) and p-values were calculated. Significance was given at  
(p < 0.05). 
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3.4.6 Analysis of Reference Gene Expression Stability – geNorm and 
NormFinder 
Gene expression stability was assessed by the geNorm and NormFinder algorithms by 
inputting Cq values into GenEx software version 4.3.5. geNorm calculated average pair-
wise variations and used a step-wise exclusion process to identify a pair of 
constitutively expressed genes; genes were ranked by an assigned gene expression 
stability value (M) (Figure 8). ACTB was shown to be the least stable candidate while 




Figure 8 Analysis of expression stability of candidate reference genes using the geNorm algorithm 
Plot of gene expression stability (M) values, average pair-wise variation in mRNA expression of a single 
candidate gene relative to variation in mRNA expression of the remaining candidate genes, illustrates 
ACTB to be the least stable candidate gene and RPL13A and UBC to be the most stable pair of candidate 
genes across whole sample set (n = 20). 
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The NormFinder algorithm determined the stability of individual candidate genes in 
inter- and intra-group analyses; and genes were ranked according to decreasing 
variability. Inter-group analyses (n = 20) identified ACTB to be the least stable and 
UBC to be the most stable reference gene under this experimental system (Table 25).  
 
 
Table 25 Analysis of expression stability of candidate reference genes using the NormFinder 
algorithm – without groups 
Reference genes ranked according to NormFinder analysis with GenEx software version 4.3.5 when 
considering control and treated samples as one group (n = 20). UBC identified as the most stable gene 
among samples with the lowest variability. 
 
While inter- and intra-group analyses of control (n = 10) and treated (n = 10) subgroups 
indicated GAPDH to be the least stable and UBC to most stable gene from the panel 
(Figure 9). NormFinder further identified that the geometric mean of UBC and 
RPL13A demonstrated the lowest amount of variability overall and should be used as a 
normalisation factor in place of a single gene. Both analyses of the full data set (n = 20) 
and the subgroups (n = 10) identified UBC as the single most stable reference gene 
under our experimental system. 
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Figure 9 Analysis of expression stability of candidate reference genes using the NormFinder 
algorithm: Intra-group Variation 
Plot of candidate reference genes ranked according to stability when inter- and intra-group variation is 
considered by NormFinder in GenEx software version 4.3.5. UBC was found to be the most stable among 
the candidate genes, with the lowest variability in expression among control (n =10) and treated (n = 10) 
subgroups. When used in combination, the mean expression of UBC and RPL13A was shown to have the 
lowest overall variability. 
 
3.4.7 Expression of Angiogenic Growth Factors in Human Dental Pulps 
3.4.7.1 Confirming the Expression of Angiogenic Growth Factor mRNA in 
Human Dental Pulps and MG-63 Osteosarcoma Cells 
RT-PCR was performed using primers for the angiogenesis-specific growth factors 
FGF2, PDGFA, TGFB1 and VEGFA (Table 3 – Table 6), RNA from MG-63 
osteosarcoma cells and RNA previously isolated from a control pulp sample (n = 1, 
section 3.4.2.1). Gel electrophoresis was used to separate RT-PCR products  
(Figure 10). MG-63 osteosarcoma cells were found to express similar levels of 
angiogenic growth factor mRNA as the human dental pulp, relative to GAPDH. As 
qualitative analysis showed little difference between mRNA expression levels in an 
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aggressive cancer cell line and the human dental pulp, a quantitative method  
(RT-qPCR) was deemed more appropriate for the study. 
 
 
Figure 10 Gel electrophoretograms of RT-PCR products in the MG-63 osteosarcoma cell line and 
an untreated human dental pulp 
 
3.4.7.2 Determining the Relative Expression of Angiogenic Growth Factor 
mRNA in Human Dental Pulps 
RT-qPCR was performed in technical duplicate, using primers for the angiogenic 
growth factors FGF2, PDGFA, TGFB1 and VEGFA (Table 3 – Table 8) on pulp 
samples isolated from premolar teeth that had been treated with an orthodontic force for 
two weeks prior to extraction (n = 10) and on untreated contralateral ‘controls’ (n = 10).  
3.4.7.2.a Comparing mRNA Expression using the Livak Comparative Ct 
Method  
Cq values were input into Microsoft Excel® spreadsheet software in order to perform 
Delta Ct and Delta-Delta Ct analysis as outlined by Livak and Schmittgen et al. (2001) 
and clarified in 2008 (Schmittgen and Livak 2008).  
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Data was normalised against: (1) UBC (Table 26 – Table 29) or (2) the geometric mean 
of UBC and RPL13A (Table 30 – Table 33).  
 
 
Table 26 Delta Ct and Delta-Delta Ct analysis of angiogenic growth factor FGF2 normalised against 
the reference gene UBC 
 
 
Table 27 Delta Ct and Delta-Delta Ct analysis of angiogenic growth factor PDGFA normalised 
against the reference gene UBC 
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Table 28 Delta Ct and Delta-Delta Ct analysis of angiogenic growth factor TGFB1 normalised 
against the reference gene UBC 
 
 
Table 29 Delta Ct and Delta-Delta Ct analysis of angiogenic growth factor VEGFA normalised 
against the reference gene UBC 
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Table 30 Delta Ct and Delta-Delta Ct analysis of angiogenic growth factor FGF2 normalised against 
the geometric mean expression of the reference genes RPL13A and UBC 
 
 
Table 31 Delta Ct and Delta-Delta Ct analysis of angiogenic growth factor PDGFA normalised 
against the geometric mean expression of the reference genes RPL13A and UBC 
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Table 32 Delta Ct and Delta-Delta Ct analysis of angiogenic growth factor TGFB1 normalised 
against the geometric mean expression of the reference genes RPL13A and UBC 
 
 
Table 33 Delta Ct and Delta-Delta Ct analysis of angiogenic growth factor VEGFA normalised 
against the geometric mean expression of the reference genes RPL13A and UBC 
 
It was shown in all Delta Ct and Delta-Delta Ct analyses, using both normalisation 
approaches, that the mRNA expression of all angiogenic growth factors was reduced or 
down-regulated as a result of orthodontic treatment.  
A paired Student’s t-test was performed to assess the different analysis and 
normalisation methods. There was shown to be no significant difference in normalising 
against the single reference gene UBC when compared to normalising against the 
geometric mean of two reference genes, RPL13A and UBC (p = 0.56). There was 
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shown to be no significant difference in analysing samples as individuals by the Delta 
Ct method when compared to the Delta-Delta Ct method which analyses samples in their 
respective contralateral pairs (p = 0.83). 
3.4.7.2.b Comparing mRNA Expression using Pfaffl’s REST Method 
Cq values from the pulp samples and reaction efficiencies, determined from the MG-63 
osteosarcoma RNAtotal standard curves, were entered into the REST-2009© software 
and expression ratios were calculated normalising against: (1) UBC (Figure 11) or (2) 
the geometric mean of RPL13A and UBC (Figure 12). 
It was shown that there was no significant up- or down-regulation of mRNA expression 
of the growth factors FGF2, PDGFA, TGFB1 and VEGFA in human dental pulps 
treated with an orthodontic force for a period of two weeks when data was normalised 
against UBC only (Figure 11). When data was normalised against the geometric mean 
of RPL13A and UBC, FGF2 was found to be significantly up-regulated by a mean 
factor of 1.383 (Figure 12).  
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Figure 11 Differential expression analysis of angiogenic growth factor mRNA in two week treated 
samples relative to contralateral controls. Normalising against UBC. 
Plot shows expression ratios calculated by REST-2009© software. Box-Whisker plots illustrate the range 
of observations (whiskers), 25th and 75th percentiles (boxes) and sample medians (dashed line). Data was 
normalised against UBC, which has been identified as the most appropriate individual reference gene 
under our experimental conditions. There was no significant difference (p > 0.05) in mRNA expression of 
any of the growth factors in the two week treated samples (n = 10) relative to the contralateral controls  
(n = 10). 
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Figure 12 Differential expression analysis of angiogenic growth factor mRNA in two week treated 
samples relative to contralateral controls. Normalising against the geometric mean of RPL13A and 
UBC. 
Plot shows expression ratios calculated by REST-2009© software. Box-Whisker plots illustrate the range 
of observations (whiskers), 25th and 75th percentiles (boxes) and sample medians (dashed line). Data was 
normalised against the geometric mean of RPL13A and UBC, which has been identified as a suitable 
normalisation factor under our experimental conditions. There was a significant up-regulation of FGF2 
mRNA expression in the two week treated samples (n = 10) relative to the contralateral controls (n = 10)  
* indicates statistical significance (p < 0.05). 
 
Expression ratios were subsequently calculated by normalising against the full panel of 
candidate reference genes and it was identified that by normalising against generic 
reference genes, a number of erroneous interpretations could be made (Figure 13).  
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Figure 13 Normalisation of differential expression analysis data with multiple reference genes 
Box-Whisker plots illustrate the range of observations (whiskers), 25th and 75th percentiles (boxes) and 
sample medians (dashed line). FGF2, PDGFA and VEGFA mRNA expression was significantly up-
regulated in treated samples (n = 10) relative to contralateral controls (n = 10) when normalised against 
individual reference genes that had been identified as being unstable, demonstrating that identification of a 
stable reference gene is fundamental. * indicates statistical significance (p < 0.05).  
 
FGF2 was shown to be significantly up-regulated in treated samples relative to 
contralateral controls when data was normalised with GAPDH, HPRT1, PPIA or 
RPL13A (p < 0.05). PDGFA was significantly up-regulated when data was normalised 
with PPIA (p < 0.05). TGFB1 showed no significant difference between expression of 
mRNA in control and treated samples (p > 0.05). VEGFA was significantly up-
regulated when sample data was normalised against HPRT1, PPIA or RPL13A (p < 
0.05). 
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3.5 Discussion 
Previous studies on pulp-derived stem cells and pulp tissues, using RT-qPCR to analyse 
differential gene expression, have been carried out using generic reference genes for 
normalising data (Dissanayaka et al. 2015, Dong et al. 2013, Gronthos et al. 2002, Liu 
et al. 2007, McLachlan et al. 2005). As it is known that gene expression undergoes 
modification under changing experimental conditions and while reference genes are 
expressed constitutively among cell types, modification of their regulation cannot be 
ignored. 
Orthodontic treatment is known to be associated with a number of reversible and 
irreversible alterations to the tooth and dental pulp (Bauss et al. 2009, Hamersky et al. 
1980, Ramazanzadeh et al. 2009, Sano et al. 2002, Santamaria et al. 2006, Stenvik and 
Mjor 1970). As there is possible risk of damage to the pulp during routine patient 
treatment, characterisation of the pulp’s responses to these heavy forces is important; as 
this may provide an insight into the mechanisms involved and could lead to clinical 
interventions. 
In order to ensure that any changes in gene expression, as a result of experimental 
manipulation or physiological alteration, are measured accurately; it is essential that a 
stable reference gene is identified for unique experimental systems. This experimental 
chapter has focussed on the standardisation of experimental protocols from sample 
collection and RNAtotal quantification through to validation of reference gene stability 
and quantification of differential mRNA expression. 
3.5.1 Sample Storage and RNA Preservation 
While the use of snap- or flash-freezing tissue samples in liquid nitrogen is a recognised 
approach for ensuring sample integrity and RNA quality, safety hazards associated with 
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the technique make its use impractical in clinical environments and in transporting 
samples (http://stores.biochem.uiowa.edu/Pages/ln2msds.htm). Past work on human 
tumour cells lines, ocular tissues, urine cell pellets and other tissues used in clinical 
diagnostics have identified that samples stored in an RNA preservative such as 
RNALater™ will yield similar amounts (ng) of RNAtotal as samples of a similar weight 
that have been snap-frozen (Florell et al. 2001, Grotzer et al. 2000, Medeiros et al. 
2003, Wang et al. 2001). We have shown that there is no statistically significant 
difference in the amount (ng) of RNA attainable from human dental pulps stored in 
RNALater™, when compared with snap-frozen samples (p > 0.05). Our findings 
substantiate those of past studies (Florell et al. 2001, Grotzer et al. 2000, Medeiros et al. 
2003, Wang et al. 2001) in that RNA preservation solutions ensure minimal RNA 
degradation, are safe for use in clinical environments and make transportation of 
samples less onerous. 
3.5.2 RNA Isolation, Yield and Sample Purity 
3.5.2.1 RNA Isolation Protocols 
Considered selection of the tissue/cell homogenisation and RNA isolation protocols 
used in any experiment is critical as these two frequently overlooked stages determine 
the quality and quantity of RNAtotal isolated from a sample. In clinical studies where 
valuable samples are under investigation, any loss or degradation of RNAtotal could 
prevent accurate assessment of the state of the tissue and could lead to erroneous 
conclusions being made (Bartlett 2002). It was noted that homogenisation of the tissue 
by a mortar and pestle in liquid nitrogen resulted in a loss of sample. Fractions of the 
sample were projected out of the mortar as the liquid nitrogen reacted with the ambient 
temperature; or the homogenised tissue, now in powder form, stuck to the pestle and 
could not easily be transferred into an RNA stabilisation solution prior to defrosting 
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completely, thus compromising sample integrity. Although the amount of sample that 
was lost could not be quantified, it is fundamental that when working with valuable 
samples of small mass (± 0.05 g (n = 5)), restrictions are put in place to prevent sample 
loss and protect sample integrity. We therefore suggest that this method of 
homogenisation is discounted as an appropriate technique for use with the human dental 
pulp. Sample loss was also noted when tissue was passed through a needle in an RNA 
stabilisation solution. Initially the sample got stuck inside the needle’s shaft as it was 
too large to pass through unhindered; large amounts of pressure were then used to force 
the sample back out into the collection vessel. Due to the build up in pressure in the 
needle shaft, the sample was rapidly ejected, resulting in spillage. As the sample broke 
down and was able to pass through the needle with ease, collagenous fibres built up and 
obstructed the needle shaft, preventing complete homogenisation of the tissue. As 
samples cannot be homogenised completely with this technique, we propose that this is 
an unsuitable method for use with the human dental pulp. Although the  
Fast-Prep®-24 machine provided the greatest concentration of undegraded RNAtotal 
(ng/µl), the cost and availability of equipment were limiting factors in this study. 
RNAtotal with a similar concentration (ng/µl) and marginally higher level of degradation 
was obtained when tissue was homogenised in a glass Dounce tissue homogeniser on 
ice. Concentrations achieved with this method were thought to be lower compared to 
the Fast-Prep®-24 machine as the manual grinding of the tissue did not break up the 
sample as completely as the Fast-Prep®-24 machine, and collagenous fibres remained. 
Although resulting in a marginal loss of RNAtotal mass (ng), this method was chosen as 
the most appropriate method for human dental pulp homogenisation as the RNAtotal 
integrity remained in tact. 
Although three methods for RNA isolation were examined using MG-63 osteosarcoma 
cells as human dental pulps samples were unavailable at the time of experimentation 
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(data not shown); phenol:chloroform isolation, a biphasic liquid-liquid extraction 
protocol, in combination with DNAse treatment was discounted immediately as high 
levels of organic compound contamination were present and DNAse treatment was 
shown to reduce the extracted yield of RNAtotal (ng) when quantified by 
spectrophotometry. High levels of organic compound contamination were thought to be 
due to manual error occurring during the separation of the upper aqueous phase from the 
lower phase; or from inefficient ethanol precipitation which purifies and concentrates 
RNA from an aqueous solution.  
The RNEasy Mini Kit, a well-known commercial product limiting the incidence of 
manual error by using a filtered-column system, was used in combination with DNAse 
treatment and although the organic compound concentrations (ng/µl) were lower in 
comparison to the phenol:chloroform extraction protocol when quantified by 
spectrophotometry; RNAtotal yields (ng) remained lower than expected and this was 
thought to be due to the separate stage of DNAse treatment. This separate stage of 
DNAse treatment removes genomic DNA from RNAtotal samples, reducing the overall 
yield (ng) when samples are quantified by spectrophotometry. In contradiction to our 
hypothesis of DNAse treatment reducing overall RNAtotal yield (ng) by negative effect, 
the larger yields (ng) obtained from isolation of RNAtotal without DNAse treatment were 
in fact samples contaminated with genomic DNA that could not be detected due to the 
quantification protocol used at this point in the study. Following Bioanalysis, it was 
confirmed that DNAse treatment should be excluded from the study, as samples treated 
with DNAse contained higher levels of genomic DNA contamination than those that 
had not been treated (section 3.4.2.1). This was contrary to our expected hypothesis as 
DNAse treatment should remove genomic contamination and we have no reasonable 
proposal by which to substantiate this finding. 
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The RNEasy Mini Kit without DNAse treatment was compared against a modified 
phenol:chloroform protocol used in combination with the RNEasy Mini Kit, under the 
direction of Dr N. Silver, and this was found to produce greater yields (ng) of RNAtotal 
with low levels of organic compound degradation when assessed by Bioanalysis 
(section 3.4.2.1). As this method produced the largest yield (ng) of RNAtotal with the 
lowest level of degradation, this method is suggested as the most appropriate for 
isolating RNAtotal from the human dental pulp in our experimental system. 
3.5.2.2 Assessment of RNA Integrity 
Bioanalysis was performed on a combination of tissue homogenisation and RNA 
isolation approaches and each was assigned an RNA Integrity Number (RIN). RIN 
values range from 10 to 1 showing a scale of increased gradual degradation from fully 
intact RNA to totally degraded RNA, respectively. This is depicted in the 
electrophoretic traces as a shift from two clear tall peaks, representing the 18S and 28S 
ribosomal RNA subunits, to shorter, indistinct fragment sizes; and eventually a single 
peak next to the axes origin, representative of complete degradation (Schroeder et al. 
2006). Samples assessed from all combinations of tissue homogenisation and RNA 
isolation showed shorter peaks throughout the trace, indicating some level of sample 
degradation in each homogenisation-isolation approach. The most degraded sample, 
isolated in a mortar and pestle, was assigned an RIN of 2.9 and showed a large peak, 
representative of genomic DNA contamination (Caruana 2004) and low peak at the 28S 
subunit. The height of the 28S peak is an important indicator of RNA degradation, as 
during degradation this peak will disappear faster than the 18S peak (Schroeder et al. 
2006). A RIN was not assigned to the electrophoretic trace from the most intact sample, 
isolated in the Fast-Prep machine; despite there being a strong peak at the 18S subunit 
and very few shorter fragments between ribosomal subunit peaks and to the left of the 
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18S peak. Had the assessment been able to be performed in duplicate, it is the opinion 
of the researcher that a high RIN would have been assigned to this experimental 
approach. The approach utilising the modified phenol:chloroform isolation technique 
and the Dounce tissue homogeniser was selected for further use in this study as it was 
assigned a RIN of 5.4 and showed limited genomic DNA contamination in comparison 
to the approach used by isolating the RNA while passing the sample through a needle. 
According to the literature, there is no current level of sample degradation that would 
render a sample as unusable in RT-qPCR analysis, although it has been established that 
the optimal template for RT-qPCR will have an RIN of 8 or more; whilst partly 
degraded RNAtotal with an assigned RIN in the range of 8 – 5 may result in suboptimal 
RT-qPCR gene expression results (Fleige et al. 2006, Fleige and Pfaffl 2006, Gallego et 
al. 2014). In order to correct for RNA integrity, it has been suggested that primers for 
the GOIs are designed across an internal region of the gene and that the RT-qPCR 
product be no more than 200 bp in length (Fleige et al. 2006, Fleige and Pfaffl 2006). 
As our combined homogenisation and isolation approach produced RNAtotal of partly 
degraded integrity, we corrected for this during the primer design stage of the 
experiment. 
3.5.2.3 Optimisation of Protocols for Quantification of RNA Yields 
Conventional methods of sample assessment are often not sensitive or specific enough 
to identify variations in the quantity and quality of isolated RNAtotal (Bustin et al. 2005, 
Imbeaud et al. 2005). We have demonstrated that there is a statistically significant 
difference (p < 0.05) in the amount (ng) of RNAtotal considered to be attainable when 
quantified by the fluorescence-based ‘Quant-iT™ Ribogreen® RNA Assay Kit’ when 
compared with quantification by NanoDrop™ UV spectrophotometry. These 
differences may be attributed to the sensitivity levels of each assay. At concentrations 
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lower than 100 ng/µl, UV spectrophotometry has proven to be unreliable as proteins, 
genomic DNA and free nucleotide levels are measured at the 260 nm wavelength 
alongside RNA (Bustin 2000, Fleige and Pfaffl 2006). However, at concentrations of 
100 ng/µl or more, UV spectrophotometry presents similar yields to the Ribogreen® 
assay (Bustin 2002). As our samples produced a mean (± SEM) yield of 26.89  
± 1.11 ng/µl and the Ribogreen® assay is able to detect as little as 1 pg/µl RNA, we can 
conclude that the Ribogreen® assay is the most sensitive technique for quantifying 
RNAtotal isolated from human dental pulp samples (Fleige and Pfaffl 2006, Jones et al. 
1998). 
3.5.3 Optimisation of Protocols for RT-PCR and RT-qPCR 
3.5.3.1 Primer Design 
Following quantification, RT-qPCR protocols were optimised by reducing variability at 
the stages of primer design, standardising RNAtotal inputs (ng) and reverse-transcription. 
Poor RNA integrity has been shown to have significant effects on detected expression 
levels when amplicon lengths exceed 200 bp (Fleige and Pfaffl 2006). This is because 
longer amplicons are not well suited to endure the prolonged exposure to high 
temperatures in the RT-qPCR reactions, which may result in degradation of the 
amplicon. Shorter amplicons would separate efficiently in the denaturation stage of the 
PCR, primers would then compete more effectively for their binding sites during the 
annealing stage and the extension stage could be shortened to as little as 15 sec; which 
would also minimise the chances of amplifying genomic DNA (Bustin 2000, Jeffreys et 
al. 1988). By designing amplicons within the range of 73 bp – 203 bp, the influence of 
RNA integrity on the reaction was reduced.  
Whilst Primer-BLAST analysis was carried out for all primers, thus ensuring primer 
specificity to the target GOI; some of the primers designed for RT-PCR did not produce 
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gene-specific peaks in the dissociation/melt curve analysis in RT-qPCR (data not 
shown). Primers for RT-PCR were therefore not suitable for use with the highly specific 
RT-qPCR technique and new primers had to be designed using Primer-BLAST in 
conjunction with Primer Express® Software v 2.0. By performing RT-PCR, followed 
by gel electrophoresis, we were able to determine that the GOIs were expressed in both 
MG-63 osteosarcoma cells and in the human dental pulp. It is important to note that 
while RT-PCR is a good method for determining gene expression in target samples and 
potential experimental calibrators, and that this is a fundamental step to the inception of 
any experiment where gene expression has not been previously reported in the target 
sample; if RT-qPCR is to be the predominant method for gene expression analysis, it 
may be better to optimise the experimental conditions, primers and reagents using RT-
qPCR from the onset. Although RT-qPCR is more expensive, optimisation of 
experimental conditions within this protocol may save a lot of time and prevent the 
unnecessary purchase of reagents and primer sets which may be efficient in RT-PCR 
but are unsuitable for RT-qPCR analysis. 
3.5.3.2 Standardising Amount of RNA Input and Reaction Reagents 
Standardising the amount (ng) of RNA input into each reaction ensures that changes 
observed in gene expression are not artefacts of cell state, as RNA isolated from 
complex tissues is recognised to contain a wide range of cell types at varying stages of 
differentiation (Bustin et al. 2005, Vandesompele et al. 2002). RNAtotal input was 
standardised at 10 ng per reaction.  
Reverse-transcription yields can vary by up to 100-fold according to which reverse-
transcriptase is used and this variation is reflected in the genes that are subsequently 
analysed (Stahlberg et al. 2004). In the reverse-transcription of RNAtotal to cDNA in the 
MG-63 osteosarcoma cells for RT-PCR, an MMLV-reverse transcriptase enzyme was 
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used. This enzyme is considered to be the best enzyme to use when amplification of 
full-length cDNA molecules is required (Bustin 2000). The details of the reverse-
transcriptase enzymes used in the iScript one-step kit and in the RNA Amplification 
System were withheld by the manufacturers. Therefore, no conclusion could be made as 
to which reverse-transcriptase enzyme should be utilised with preference in this study.  
The primers for reverse-transcription are also known to have a significant effect on the 
cDNA produced and the subsequent down-stream gene expression analysis, as each 
priming technique offers advantages and disadvantages. The iScript one-step RT-qPCR 
kit utilises gene-specific primers. Whilst this method of reverse-transcription produces 
highly specific cDNA for the GOI, which is then amplified directly in PCR; the use of 
gene-specific primers only allows for a select number of genes to be analysed from the 
samples in relation to the amount of RNAtotal initially isolated (Bustin 2000, Bustin et 
al. 2005, Lekanne Deprez et al. 2002). This is an additional limiting factor that should 
be excluded when samples are of a rare, clinical origin. The MMLV-RT method for 
MG-63 osteosarcoma cells uses random primers, whilst the RNA Amplification System 
uses a combination of random and Oligo-dT primers. Random primers will anneal to the 
RNA at multiple points along the strand, resulting in a number of cDNA strands of 
varying lengths. The advantage of this method is that a large amount of cDNA is 
produced in the reverse-transcription reaction, thus allowing the quantification of a wide 
range of genes; however the sections of the RNA containing the GOIs may not be 
transcribed proportionately leading to an over- or under- estimate of mRNA copy 
number present in the sample (Bustin 2000, Bustin et al. 2005, Zhang and Byrne 1999). 
It is anticipated that any potential alteration of the real expression profile of mRNA, as a 
result of reverse-transcription with random primers, will occur for all genes expressed 
within the tissue. Thus, by normalising to an internal reference gene, thought to be 
expressed by all cell types, at a maintained level of expression; these over- or under-
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estimates of the mRNA copy are negated (Resuehr and Spiess 2003). Oligo-dT primers 
bind to the poly(A)-tail of 3′-end of the RNA strand and will prime only mRNA 
sequences unlike random primers which also transcribe rRNA. The disadvantage to this 
type of primer is that degraded RNA will be difficult to transcribe and if samples are 
reverse-transcribed, there is potential for biased reverse-transcription of the 3′-end 
(Bustin et al. 2005, Resuehr and Spiess 2003). By combining random priming with 
Oligo-dT priming, the RNA Amplification System maximises the experimental 
potential of a sample by producing large volumes of cDNA representative of the mRNA 
present in the original sample from both the 5′ to the 3′- ends of the RNA strands. As 
the mean yield of cDNA following amplification were in the magnitude of 8,000 ng per 
reaction, it is assumed that any potential degradation of the isolated sample RNAtotal, 
which would affect reverse-transcription with the Oligo-dT primers, was 
counterbalanced by the random primers in the reaction. 
By modifying the amount of reagents and RNAtotal input into the reverse-transcription of 
MG-63 osteosarcoma cells, we showed the importance of experimental optimisation in 
order to increase the experimental potential of our samples. 
3.5.3.3 One-Step RT-qPCR vs RNA Amplification : Getting the most out of 
samples with small RNAtotal yields 
The one-step RT-qPCR system was used for all samples in this chapter, reducing the 
risk of introducing manual error in separate reverse-transcription and RT-qPCR steps 
(Nolan et al. 2006). Although use of a one-step system is beneficial, these systems are 
limited by the amount (ng) of RNA isolated from the samples; i.e. the less RNA 
isolated, the fewer number of genes can be analysed. We have shown that reverse-
transcription using an RNA Amplification System eliminates the experimental 
limitations of RNAtotal yield, maximising the potential of individual pulp samples and 
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eradicating the need for sample pooling. In order to analyse a larger panel of genes in 
the same samples, the RNA Amplification System was used throughout the remaining 
chapters of this thesis and we are of the opinion that this system should be utilised by 
groups analysing gene expression in rare, clinical samples where tissue mass and 
isolated RNA is limited. It is critically important to note that RT-qPCR results are only 
directly comparable when the “same priming strategies and reaction conditions” are 
used (Bustin et al. 2005, Resuehr and Spiess 2003), therefore the GOIs analysed within 
this chapter were assessed again alongside the extended panel of target genes using the 
RNA Amplification System and a separate RT-qPCR step. 
3.5.4 Optimising Protocols for Normalising RT-qPCR Data  
In order to reduce sample-to-sample and run-to-run variability by removing sampling 
noise such as a difference in RNAtotal concentration or quality, RT-qPCR data is 
normalised against a stable internal control. It is known that variation in reference gene 
expression introduces error and obscures real changes in expression of target genes 
(Bustin 2000, Bustin 2002, Bustin et al. 2005, Toegel et al. 2007); and it is therefore 
fundamental that an appropriate gene, which is stably expressed and is not co-regulated 
under experimental conditions, is carefully selected for each experimental system. A 
panel of reference genes was selected for stability assessment from three published lists, 
compiled from a range of tissue types in the human (Eisenberg and Levanon 2003, 
Hsiao et al. 2001, Warrington et al. 2000), and an additional list of supplementary 
microarray data from the human dental pulp (Paakkonen et al. 2005). One-step RT-
qPCR was performed on RNAtotal isolated from samples treated with an orthodontic 
force for a period of two weeks and on contralateral intra-patient controls. 
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3.5.4.1 Normalising Against RNA Input Amount 
Initially, Cq values were compared directly to assess changes in mRNA expression 
between the control and treated pulps; and normalised against the amount (ng) of total 
cellular RNA, a mixture of microRNA, mRNA (~ 1 – 5 %), tRNA (~ 15 – 20 %) and 
rRNA (~ 80 – 85 %), input into each reaction. It is assumed that equal amounts (ng) of 
RNA contain the same mRNA and rRNA fractions; that the ratio of the fractions will 
not change under the experimental system; and that there is little variability in total 
RNA content within the same tissue between individuals (Bustin 2000, Bustin 2002). 
However, it has previously been shown that the mRNA:rRNA ratio has a tendency to 
fluctuate under some experimental systems and can become imbalanced under 
physiological conditions (Hansen et al. 2001, Schmittgen and Zakrajsek 2000, Solanas 
et al. 2001, Spanakis 1993, Tricarico et al. 2002). From Figure 7 we can see that 
changes in the mRNA and rRNA fractions under this experimental system are minimal 
as 5 of the candidate reference genes analysed appear to have similar expression 
distributions between the control and treated groups and between the genes themselves 
and that no significant differences have been found (p > 0.05) (Table 22). 
3.5.4.2 Assessing the Variance in Reference Gene Expression 
The variance of Cq values was then assessed by examining the mean and SD for each 
reference gene. According to Dheda et al. (2004) a suitable reference gene should 
display a standard deviation of less than 2-fold (based on a logarithmic scale) or less 
than 1 Cq value change relative to the mean, assuming 100% reaction efficiency. Our 
study identified that, according to the variance of Cq values (data not shown), candidate 
genes should be ranked as follows from most to least stable: (1) HPRT1; (2) UBC; (3) 
GAPDH; (4) RPL13A; (5) ACTB; (6) YWHAZ; (7) PPIA. As normalising against total 
RNA and analysing Cq variance does not take reaction efficiency or the relationships of 
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expression between each reference gene into consideration, further statistical analysis 
was performed to substantiate our findings. 
3.5.4.3 Identifying a Stable Reference Gene: BestKeeper Analysis 
The Excel-based tool, BestKeeper© assumes that Cq values are normally distributed in 
most cases and linearises data by a logarithmic transformation to the base of two  
(Pfaffl et al. 2004). Following linearisation, reaction efficiency is corrected for and a 
pair-wise correlation analysis is utilised, assuming samples have equal variance, to 
calculate the stability of each reference gene and assess how similarly each gene is 
expressed. HPRT1 and PPIA were shown to have different coefficients of variation in 
relation to the rest of the panel as they were expressed at much lower levels than the 
other GOIs (Table 23); and were subsequently excluded from further analysis as it is 
recommended that reference genes should be expressed at similar levels as other 
reference genes and the GOIs (Dheda et al. 2004, Toegel et al. 2007). The remaining 
genes were compared and the Pearson correlation coefficient was calculated along with 
the probability that correlation is significant (p-value). As all five genes were found to 
be significantly correlated (Table 24), the data was combined and the geometric mean 
was calculated to provide a normalisation factor referred to as the BestKeeper© index. 
Correlation between individual reference genes and the BestKeeper© index was 
assessed by regression analysis and all five genes were found to be significantly (p < 
0.05) correlated to the index (Table 24). As care was taken to minimise co-regulation of 
the candidates, by selecting genes from different functional groups, we can assume that 
results produced by BestKeeper© are an accurate evaluation of mRNA expression in 
these samples, and that these reference genes are similarly expressed under our 
experimental system. 
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3.5.4.4 Identifying a Stable Reference Gene: geNorm and NormFinder 
Analysis 
In contrast to BestKeeper©, which identifies correlation and therefore similarity in 
candidate gene expression, the geNorm and NormFinder algorithms, embedded in 
GenEx software version 4.3.5, were used to identify differences in candidate gene 
expression. In their original study, Vandesompele et al. (2002) identified that the 
Pearson and Spearman correlation coefficients were unsuitable for statistical analysis of 
a ratio created from raw Cq values, as the data range and outlying values were found to 
have a profound effect on the correlation coefficient. For this reason logarithmic 
transformation of raw data was carried out in order to symmetrically distribute the data 
around zero (Vandesompele et al. 2002). This finding highlights the error of 
normalising against total RNA input (ng) and assessing gene stability by analysing Cq 
variance; as in these two methods, logarithmic data is compared directly using 
parametric tests such as the paired Student’s t-Test where equal variances are assumed. 
This finding emphasises the importance of further statistical analyses by software such 
as BestKeeper©, geNorm and NormFinder, which correct for the assumption of data 
distribution and for reaction efficiency. Using the geNorm function, reference genes 
were compared pair-wise, one gene against all other genes, in order to calculate the 
standard deviation or M-value (gene expression stability) of each ratio. Genes were 
ranked by implementing a step-wise exclusion process, removing the gene with the 
highest M-value and the highest degree of instability (Figure 8). This study has shown 
RPL13A and UBC to be the most stable pair under this system and corroborates the 
BestKeeper© findings. 
Andersen et al. (2004) proposed that all genes, reference or otherwise, will show 
variation in expression to an extent under any experimental system; and suggested that 
in order to normalise accurately, it is fundamental to assess variation of the reference 
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genes in the experimental subgroups in addition to overall expression variation 
(Andersen et al. 2004). Using the NormFinder function to assess overall expression 
variation, genes were ranked from least to most stable (Table 25, Figure 9). Disparities 
seen between the geNorm and NormFinder analysis, amongst the least stable genes, can 
be accounted for by the differences between the model-based (Andersen 2004) and the 
pair-wise comparison (Vandesompele et al. 2002) approaches. While geNorm attempts 
to identify a pair of reference genes with similar expression profiles and low intra-group 
variation; NormFinder attempts to identify a single gene with the least variation 
between the overall expression variation and that occurring between the subgroups. 
3.5.4.5 Reference Genes: The More the Merrier 
Vandesompele et al. (2002) have further suggested that normalisation can only be 
performed accurately when using the geometric mean of multiple reference genes but 
have outlined a number of limitations to this method including the wasteful use of 
multiple reference genes when there are limited resources and amounts of RNA 
available (Dheda et al. 2004, Vandesompele et al. 2002, Vandesompele et al. 2009.). 
They conclude that normalising against a single gene, whose stability has been assessed 
and verified, is a reasonable alternative when limitations apply. As the one-step RT-
qPCR kit used in this chapter limited us to analysing only a small panel of genes in our 
samples, we compared normalising Cq values against UBC alone and against the 
geometric mean of the two most stable genes RPL13A and UBC. This was done in 
order to illustrate the importance of normalising gene expression data against a verified 
combination of reference genes and to show that despite the limitations of sample yield, 
using the appropriate reference gene combination is more important than analysing a 
wider panel of genes. 
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3.5.5 Relative Expression Analysis of RT-qPCR Data from 
Orthodontically Treated Pulps 
To assess the effects of orthodontic force application on pulp microvasculature, RT-
qPCR was performed with primers specific to four angiogenic growth factors and Cq 
values were input into Microsoft Excel ® spreadsheet software and the REST-2009© 
software package (Pfaffl et al. 2002).  
3.5.5.1 Delta Ct and Delta-Delta Ct 
It was shown that assessment by the Delta Ct and Delta-Delta Ct methods resulted in the 
down-regulation of mRNA expression of all target genes as a result of orthodontic force 
application. This result opposes the hypothesis that the application of an orthodontic 
force will initiate the increase of mRNA expression and therefore protein expression of 
angiogenic growth factors in the human dental pulp. While there was no significant 
difference between the two methods, it should be noted that the Delta Ct method 
compares all samples us unrelated, individual cases whilst the Delta-Delta Ct method 
considers the change in expression directly within pairs of treated and control samples 
(Livak and Schmittgen 2001, Schmittgen and Livak 2008). In the Delta Ct method, 
target gene expression is normalised against reference gene expression in the sample 
and this normalised value is log transformed. The mean normalised expression of the 
log transformed data is then calculated for the control and treated samples respectively. 
The treated samples are then compared against the control samples in order to determine 
the fold change between the samples, the negative reciprocal of this fold-change is then 
calculated to determine the fold-change between the samples due to treatment (Livak 
and Schmittgen 2001, Schmittgen and Livak 2008). A negative value indicates a down-
regulation of mRNA expression whilst a positive value would indicate that treatment 
induces an increase or up-regulation of mRNA expression. The Delta-Delta Ct method 
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does not compare samples individually but rather assumes that all changes in the control 
will be directly related to the treated group as control and treated samples are paired 
from the same individual. Initially, the mean Cq is determined for the GOI and the 
normaliser in both the control and treated groups. The mean target gene expression is 
then normalised against the mean reference gene expression in the control and treated 
groups, respectively. The treated group is then compared against the control group to 
determine the Delta-Delta Ct value. This is then log transformed and the negative 
reciprocal of the log-transformed value is considered to be the fold-change between the 
two groups due to treatment (Livak and Schmittgen 2001, Schmittgen and Livak 2008). 
As with the Delta Ct method, a negative value indicates down-regulation of mRNA 
expression and a positive value indicates up-regulation. The use of the Delta Ct method 
is of significance in samples isolated from a large population where no direct 
comparison can be made, e.g. in cancer studies where patients either do or do not have 
cancer; there is no case in which a non-biased control can be obtained from a patient 
that is expressing a cancerous phenotype and therefore an external control has to be 
used. This method was used in this study to determine whether or not there was a 
significant difference between the samples treated as individual data-points and those 
treated as control-treated contralateral pairs. There was no significant difference 
between the two methods, although it should be noted that in every gene with the 
exception of PDGFA, down-regulation of mRNA expression as a result of treatment 
was lower in samples compared as contralateral pairs. This is due to the assumption that 
any changes between the samples are directly comparable and are a result of treatment. 
By using the Delta-Delta Ct method we are able to see direct responses to treatment and 
are able to limit sample-to-sample variation and false interpretation of data. 
Although there was no significant difference observed when comparing gene expression 
by normalising against: (1) the single gene, UBC and (2) the geometric mean of 
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RPL13A and UBC, previously found to be the most stably expressed pair of reference 
genes; it was observed that there was less down-regulation of mRNA expression in 
those genes normalised against the geometric mean of the two reference genes. This 
observation is thought to be due to the additional correction made by incorporating 
another reference gene, restricting the error introduced by a loose normalisation 
approach and regulating for possible co-regulation of the reference genes and target 
genes under the experimental conditions. 
3.5.5.2 Correcting for Reaction Efficiency using the Relative Expression 
Software Tool 
Previously, it has been shown that amplification efficiency plays a fundamental role in 
the determination of the threshold levels and points of quantification in each reaction 
(Pfaffl et al. 2004, Vandesompele et al. 2009); and that a difference in RT-qPCR 
efficiency will produce false expression ratios (Freeman et al. 1999, Peirson et al. 2003, 
Pfaffl et al. 2002). It is therefore crucial that efficiency is corrected for prior to 
determination of relative gene expression. The Delta Ct and Delta-Delta Ct methods do 
not correct for reaction efficiency and this may be the reason that an expected up-
regulation of mRNA expression was determined to be a down-regulation in mRNA 
expression as a result of orthodontic treatment prior to extraction.  
REST-2009© software calculates relative gene expression using an equation derived 
from the Delta-Delta Ct equation outlined by Livak and Schmittgen (2001) and a 
modification of Pfaffl et al.’s (2001) efficiency corrected model: Relative Expression 
Ratio = [EGOI(Mean Control – Mean Treated)]/[EREFERENCE GENE(Mean Control – Mean Treated)]. 
Subsequent significance testing is carried out by the Pair-Wise Fixed Reallocation 
Randomisation Test© (Pfaffl et al. 2002) and by a hypothesis test using bootstrapping 
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techniques (http://rest-2008.gene-quantification.info/); and expression ratios are 
represented in box-whisker plots to show the distribution of the data. 
3.5.5.3 Normalising RT-qPCR Data against a Single Reference Gene 
Compared to a Pair of Reference Genes  
Our study showed that when normalising against UBC, there were no significant 
changes in the mRNA expression of FGF2, PDGFA, TGFB1 and VEGFA in dental 
pulps removed from teeth that had been treated with an orthodontic force for two weeks 
prior to extraction (Figure 11). However, when Cq values were normalised against the 
geometric mean of RPL13A and UBC, the results showed that FGF2 was significantly 
up-regulated in the treated samples relative to the controls. This finding highlights the 
argument raised by Vandesompele et al. (2002) where a normalisation factor created 
from the geometric mean of multiple reference genes is more appropriate for 
normalising gene expression levels than a single candidate gene (Vandesompele et al. 
2002). 
Although there was an expectation of identifying an up-regulation of mRNA for all four 
of the angiogenesis-associated growth factors, as the morphological phenotype of 
increased vasculature was seen after a few days in the co-culture system used by 
Derringer et al. (2003), it is important to note that angiogenesis like any other biological 
process is a complex mechanism (Folkman and Shing 1992) and there may be a delay 
between the transcription of mRNA and translation to protein. From this we predict that 
alterations in mRNA expression are more likely to occur in the initial response to force 
application. In order to assess the effects of orthodontic treatment on pulpal 
microvasculature at the transcriptional stage we propose that the expression patterns of a 
larger panel of angiogenesis-associated genes is evaluated at a number of earlier time-
points during orthodontic treatment. 
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3.5.5.4 Normalising RT-qPCR Data against Reference Genes Identified as 
Unstable under our Experimental Conditions 
The effect of normalising with individual generic reference genes was subsequently 
assessed (Figure 13). In this experiment it was shown that a number of genes can be 
interpreted to be significantly (p < 0.05) up-regulated according to the influence of a 
variable reference gene. These findings confirm our initial statement that normalising 
against a reference gene, which has not been verified for stability under a given 
experimental condition may result in erroneous interpretation of expression data. For 
the purpose of this study, all further gene expression data was normalised against the 
geometric mean expression of the reference genes RPL13A and UBC. 
As PCR efficiency has been demonstrated to be affected by the tissue type analysed and 
the tissue homogenisation and isolation of RNAtotal protocols used; and has also been 
shown to have a down-stream effect on the generation of false gene expression ratios, 
its correction cannot be ignored. (Booth et al. 2010, Fleige et al. 2006, Pfaffl 2001). We 
therefore propose that the Delta Ct and Delta-Delta Ct methods be avoided in future 
studies and that every measure be taken to increase experimental efficiency to 100 %. In 
order to minimise any additional error in the remaining experimental chapters, where 
the panel of target genes was expanded to obtain a better understanding of the 
angiogenic response in human dental pulps as a response to orthodontic force 
application at varying time-points of initial treatment; primers for RT-qPCR were 
designed by the company Primer Design Ltd., Southampton, UK which guaranteed a 
reaction efficiency of 100 % when used in conjunction with their Precision Mastermix 
with SYBR Green. 
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3.6 Conclusion 
The human dental pulp has previously been shown to demonstrate increased 
microvasculature, in co-culture, following orthodontic force application and is an 
interesting model for the study of angiogenic growth factors. Previous studies assessing 
gene expression in this tissue have used reference genes for normalisation that have not 
been validated for expression stability (Dissanayaka et al. 2015, Gronthos et al. 2002, 
Liu et al. 2007, McLachlan et al. 2005). In order to ensure that any small changes in 
gene expression were measured accurately, a number of techniques were evaluated and 
optimised to eliminate the introduction of manual and experimental error. We identified 
that:  
1. RNA stabilisation solutions are more appropriate for sample collection under 
clinical conditions than snap-freezing samples in liquid nitrogen. 
2. The most commonly used technique for RNA quantification, UV 
spectrophotometry, is not sensitive enough to accurately measure the small yields 
of RNA isolated from this tissue. 
3. Elimination of the experimental error, produced in an additional reverse-
transcription step, by using a one-step RT-qPCR kit introduces limitations 
derived from the amount (ng) of total RNA isolated from a sample.  
4. Under non-limiting conditions where an RNA amplification system is used to 
produce large volumes of cDNA, the geometric mean of RPL13A and UBC is the 
most appropriate normalising factor under our unique experimental conditions.  
5. Under limiting conditions, where an RNA amplification system is unavailable, 
UBC alone could be used for normalising gene expression data as it is the single 
most stable reference gene under our experimental conditions, although this is 
unadvisable as spurious results may be derived.  
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6. Reaction efficiency is critical to the accurate determination of relative mRNA 
expression.  
7. Protocols for determining fold-change such as the Livak methods (Livak and 
Schmittgen 2001, Schmittgen and Livak 2008), which do not account for 
efficiency correction, should only be used where efficiency is calculated to be 
100% through the use of internal standard curves.  
This experimental chapter outlines the call for optimisation of experimental protocols 
prior to data acquisition and highlights the specific nature of reference genes in 
relation to a particular experimental model; both must be evaluated thoroughly and 
methodically in order to prevent erroneous interpretations of relative gene expression 
ratios. 
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Effects of Orthodontic Force Application on 
mRNA and Protein Expression of Angiogenic 
Growth Factors in Human Dental Pulp 
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4.1 Introduction 
The human dental pulp is a highly innervated, loose, vasculature tissue enclosed within 
an unyielding case of dentine, cementum and enamel (Grando Mattuella et al. 2007, 
Ramazanzadeh et al. 2009); and is a known source of regulatory cytokines and growth 
factors (Artese et al. 2002, Paakkonen et al. 2005, Roberts-Clark and Smith 2000, 
Shimabukuro et al. 2009, Smith 2002, Tete et al. 2008, Tran-Hung et al. 2006, Zhong et 
al. 2012).  
It is recognised that alteration to the pulp’s unique and noncompliant environment by 
microbes; trauma or iatrogenic therapies induces dramatic and often irreversible 
changes in the tissue, such as pulpitis or necrosis (Bjorndal and Ricucci 2014, Heyeraas 
and Berggreen 1999, Nagata et al. 2014, Rodd et al. 2005, , Schmalz 2014, Vianna et al. 
2007, Yu et al. 2007) 
In particular, routine orthodontic treatment has been shown to be associated with a 
number of morphological and physiological changes of the pulp including a reduction in 
pulpal blood flow (Sano et al. 2002, Yamaguchi 2007) alteration of the 
microvasculature (Santamaria et al. 2006, Yamaguchi 2007), congestion of the 
vasculature (Lazzaretti et al. 2014, Mostafa et al. 1991) and increased secretion of 
diffusible angiogenic growth factors (Derringer et al. 1996, Derringer and Linden 2003, 
Derringer and Linden 2004, Derringer and Linden 2007). However, the full impact of 
orthodontic treatment on the human dental pulp has yet to be comprehensively 
characterised, particularly from the perspective of the angiogenic response to treatment.  
Angiogenesis is the process of new vessel formation from a pre-existing capillary 
plexus (Brown et al. 1992, Li J, Yano et al. 2003, Zhang et al. 2003) and is known to 
occur in the adult as a: (a) result of localised hypoxia, (b) reaction to tissue damage or 
(c) an imbalance of regulatory cytokines (Carmeliet 2000, Risau 1996, Risau 1997). 
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This complex signalling cascade has been shown to occur by one or two processes 
concurrently: sprouting angiogenesis (Carmeliet 2000, Folkman and D'Amore 1996) 
and intussusceptive microvascular growth (Burri et al. 2004, Djonov et al. 2000) and is 
tightly regulated by a large number of cytokines, chemokines and growth factors.  
Some of the growth factors, cytokines and chemokines known to be involved in the 
angiogenic signalling cascades include: ANGPT1 (Aplin et al. 2006, Brindle et al. 
2006); FGF2 (Li et al. 2003, Presta et al. 2005); HIF1A (Hirota and Semenza 2006,  
Ke and Costa 2006, Pugh and Ratcliffe 2003); interleukin 8 (IL8) (Li et al. 2003, Ning 
et al. 2011); ITGAV (Bader et al. 1998, Weis and Cheresh 2011); ITGB3 (Hodivala-
Dilke et al. 1999, Serini et al. 2006); KDR (Hicklin and Ellis 2005, Hoeben et al. 2004, 
Terman et al. 1992); MMP2 (Bellafiore et al. 2013, Rundhaug 2005); NOS2 (Kroll and 
Waltenberger 1998, Luo and Chen 2005); PDGFA (Palomero et al. 2014, Shikada et al. 
2005, Tran-Hung et al. 2008); platelet-derived growth factor beta polypeptide (simian 
sarcoma viral (v-sis) oncogene homolog) (PDGFB) (Li et al. 2010, Ohlsson et al. 1999, 
Tran-Hung et al. 2008); roundabout homolog 4, magic roundabout (Drosophila) 
(ROBO4) (Jones et al. 2008, Yadav and Narayan 2014); SELE (Koch et al. 1995, 
Nishiwaki et al. 2007); TEK tyrosine kinase, endothelial (TEK) (Lin et al. 1997, Singh 
et al. 2011); TGFB1 (Carmeliet 2000, Nakagawa et al. 2004); TGFBR1 (Nakagawa et 
al. 2004, Sankar et al. 1996) and VEGFA (Folkman and D'Amore 1996, Gerhardt et al. 
2003, Hicklin and Ellis 2005, Hoeben et al. 2004). 
Several of these cytokines and growth factors were previously shown to be released 
from the human dental pulp in response to orthodontic force application (Derringer et 
al. 1996, Derringer and Linden 2003, Derringer and Linden 2004) and their mRNA 
expression levels have been investigated in Chapter 3 following a period of two weeks 
of routine orthodontic treatment; however, the expression of more growth factors and 
cytokines involved in the angiogenic signalling cascades has not yet been considered. 
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Therefore, in order to gain a greater perspective of the angiogenic response of the 
human dental pulp to the early stages of routine orthodontic treatment, our initial 
experimental time-point was expanded from 2 weeks to three early time-points: 1 day, 3 
days and 14 days (2 weeks); and the panel of angiogenesis-specific genes was expanded 
from four angiogenic growth factors to a panel of seventeen GOIs. 
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4.2 Aims 
1. Expand the panel of angiogenic growth factors previously assessed in order to 
more fully comprehend the angiogenic response of the human dental pulp to 
orthodontic force application. 
2. Expand the treatment time-point of orthodontic force application previously 
investigated from 2 weeks to: 1 day, 3 days and 14 days, respectively; in order to 
characterise the human dental pulp’s angiogenic response to the early stages of 
routine orthodontic treatment.  
3. Identify whether proteins previously seen to be secreted by pulps in response to 
orthodontic force application are transcribed earlier than our original anticipated 
time-point of two weeks force application. 
4. Determine relative changes in mRNA and protein expression in orthodontically 
treated pulps compared with untreated controls; linking these changes with 
known patterns in the angiogenic signalling cascades. 
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4.3 Materials and Methods 
MATERIALS 
4.3.1 Human Dental Pulps 
Following informed parental and patient consent, human dental pulps were obtained 
from healthy first and second premolar teeth extracted from volunteers aged between  
12 – 16 years. All patients included in the study required extraction of a minimum of 2 
paired, contralateral premolar teeth in conjunction with fixed appliance orthodontic 
treatment. Ethical approval was granted by the Research Ethics Committee at Guy’s 
Hospital and King’s College Hospital.  
METHODS  
4.3.2 Orthodontic Force Application and Dental Pulp Isolation 
In this experimental chapter, pulps were isolated from 30 pairs of ‘control’ and 
contralateral ‘treated’ teeth, in order to analyse the relative mRNA expression of 
angiogenesis-specific genes in human dental pulps at three early time-points in routine 
orthodontic treatment: 1 day, 3 days and 14 days. 10 contralateral pairs, 2 pulps per 
patient, were randomly assigned to each treatment time-point group prior to orthodontic 
force application. 
A further 15 contralateral pairs of ‘control’ and ‘treated’ teeth, 2 pulps per patient, were 
collected in order to assess protein expression following orthodontic force application. 
For each of the three time-points analysed, 5 contralateral pairs were randomly assigned 
to a group prior to orthodontic force application. 
In every patient, the oral cavity was divided along the mid-sagittal plane in order to 
assign a ‘control’ sample that would forego orthodontic force application; and a 
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contralateral ‘treated’ sample which would experience a force in the range of 0.5 – 1 N 
for the duration of treatment. Fixed appliance straight wire orthodontic brackets (Roth 
0.022 inch, 3M Unitek, California, USA) were direct bonded (Transbond, 3M Unitek, 
California, USA) to the upper and/or lower teeth from second premolar to second 
premolar, except the assigned ‘control’ teeth. Orthodontic bands were cemented (Ketac, 
3M ESPE, Seefeld, Germany) onto all first permanent molar teeth. Test tooth position 
was carefully assessed and brackets were bonded in a position (offset if necessary) so 
that the archwires (0.016 inch nickel-titanium, TP Orthodontics Inc., Leeds, UK) placed 
gave the required force of 0.5 – 1 N in a mesial and extrusive direction (Derringer et al. 
1996). 
Following the required period of force application (1 day, 3 days or 14 days 
respectively), brackets were removed from the premolar teeth assigned as ‘treated’ 
teeth. The ‘control’ and contralateral ‘treated’ premolar teeth were extracted under local 
anaesthesia, placed in individual tubes containing 20 ml of cold sterile saline solution, 
and sectioned immediately with a high-speed water-cooled diamond bur through the 
buccolingual aspect. Dental pulps with a mean mass of ± 0.05 g (n = 5) were removed 
from the pulp chamber with sterile blunt instruments. Isolated pulps to be used for 
proteomic analysis were individually placed in a sterile 1.5 ml centrifuge tube and snap-
frozen in liquid nitrogen before transferring to -70 °C for permanent storage. Isolated 
pulps to be used for transcriptomic analysis were immersed separately in 500 µl 
RNALater™ (Cat. No. AM7021) (Ambion Inc., Warrington, UK), an RNA preservation 
solution, kept at 4 °C for 8 hr and transferred to -20 °C for permanent storage. 
All orthodontic procedures and dental pulp isolations, following tooth extraction, were 
performed by Dr K. A. Derringer, Dental Institute, King’s College London at Guy’s 
Hospital and King’s College Hospital. 
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4.3.3 RNA Isolation 
Pulp samples stored in 500 µl RNALater™ were removed from solution and ground 
individually in a sterile, autoclaved 7 ml glass Dounce tissue homogeniser (Wheaton 
Science Products from VWR, Poole, UK) containing 600 µl of the RNA stabilisation 
solution RNA-Bee™ (Cat. No. CS-104B or CS-105B or CS-501B) (AMS 
Biotechnology, Abingdon, UK) and homogenates were transferred to sterile centrifuge 
tubes. 60 µl of chloroform (Cat. No. C7559) (Sigma-Aldrich, Poole, UK) was added to 
the homogenate and samples centrifuged at 4 °C for 15 min at 9,000 g. Supernatants 
were collected in fresh tubes and a single volume of 70 % ethanol was added. Samples 
were inverted repeatedly and transferred to spin columns and RNAtotal extracted using 
the RNEasy Mini Kit (Cat. No. 74104 or 74106) (Qiagen Ltd., Crawley, UK) according 
to manufacturer’s instructions. Isolated RNAtotal was suspended in a final volume of 30 
µl nuclease-free water (Cat. No. AM9938) (Ambion Inc., Warrington, UK) and stored at 
-70 °C. 
4.3.4 RNA Quantification 
The purity and concentration (ng/µl) of RNAtotal for each sample was determined by 
calculating the A260:A280 and A260:A230 ratios using the NanoDrop™ 1000 
spectrophotometer (Now replaced by Cat. No. ND-2000, NanoDrop™ 2000 
spectrophotometer) (ThermoFisher Scientific, Nottingham, UK), according to 
manufacturer’s instructions. RNAtotal was then quantified by fluorescence with the 
Quant-iT™ Ribogreen® RNA Assay Kit (Cat. No. R11490) (Molecular Probes, 
Invitrogen Ltd., Paisley, UK), according to the manufacturer’s protocol. 
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4.3.5 Reverse-Transcription 
50 ng RNAtotal was converted to cDNA using the WT-Ovation™ Pico RNA 
Amplification System (Now replaced by Cat. No. 3302, Ovation Pico WTA System V2) 
(NuGen Technologies, Inc., California, USA) according to the manufacturer’s protocol. 
cDNA was then purified using the DNA Clean and Concentrator 25™ kit (Cat. No. 
D4033 or D4034) (Zymo Research Corporation, California, USA) according to 
manufacturer’s instructions; and quantified with the NanoDrop™ 1000 
spectrophotometer. Samples were stored permanently at -20 °C. 
4.3.6 Selection of Angiogenesis-Specific Genes for mRNA Expression 
Analysis 
The panel of genes thought to play a role in the angiogenic response of the human 
dental pulp to orthodontic force application was expanded from the panel used in 
Chapter 3 in order to link the changes in mRNA expression to known signalling 
cascades. The extended panel of angiogenesis-specific genes that we selected for 
investigation is outlined in Table 34. 
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Table 34 Expanded list of angiogenesis-specific genes for mRNA expression analysis 
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4.3.7 RT-qPCR Analysis of mRNA Expression 
RT-qPCR was performed on 20 µl reactions set up manually in 0.1 ml strip tubes (Cat. 
No. 981103) (Qiagen Ltd., Crawley, UK): 5 µl cDNA (2 ng/µl), 1 µl forward and 
reverse primer mix (6 µM) (designed and optimised by PrimerDesign Ltd., 
Southampton, UK; see Table 35 – Table 51), 10 µl Precision Mastermix with SYBR 
Green (Now replaced by Cat. No. PrecisionPlus-SY, PrecisionPlus™ Mastermix) 
(PrimerDesign Ltd., Southampton, UK) and 4 µl RNAse/DNAse-free water (delivered 
in conjunction with the primers, no individual Cat. No.) (PrimerDesign Ltd., 
Southampton, UK) with the Corbett Rotor-Gene™ 6000 (No Cat. No. available but item 
is still available from Qiagen) (Corbett Life Science, Qiagen Ltd., Crawley, UK). 
Amplifications were performed with an initial template denaturation step at 95 °C for  
10 min followed by 50 cycles of denaturation at 95 °C for 15 sec; combined primer 
annealing/extension at 60 °C for 60 sec; and data acquisition.  
A dissociation protocol was performed from 72 °C to 95 °C at 1 °C increments in order 
to determine the presence of primer-dimer formation or other spurious binding products. 
In order to determine the size of the amplification products, a single assay was 
performed for each angiogenesis-specific GOI without a dissociation protocol. 5 µl  
RT-qPCR product and 0.83 µl 6 × blue/orange loading dye (Cat. No. G1881) (Promega 
UK Ltd., UK) were loaded onto a 2 % agarose gel made with 0.5 × TBE buffer and  
2 µl GelRed™ Nucleic Acid Gel Stain (Cat. No. 41003) (Biotium Inc., Cambridge 
BioScience Ltd., Cambridge, UK). Samples were run in 0.5 × TBE buffer for 15 min at 
100 V alongside a 100 bp ladder and gels were photographed using a UV transluminator 
linked to a printer to confirm primer specificity. 
Primers for RPL13A and UBC, established as the most stable expressed reference genes 
in our experimental model (see Chapter 3), were designed, optimised by and 
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guaranteed a reaction efficiency of 100 % by Primer Design Ltd., Southampton, UK; 
primer sequences were not given. 
Primers for the angiogenesis-specific GOIs were designed, optimised by and guaranteed 
a reaction efficiency of 100 % by Primer Design Ltd., Southampton, UK The details for 
these primers are provided in Table 35 - Table 51. 
 
 




Table 36 PrimerDesign Ltd. UK primer sequences of the angiogenesis-specific gene FGF2 for RT-
qPCR 
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Table 38 PrimerDesign Ltd. UK primer sequences of the angiogenesis-specific gene IL8 for RT-
qPCR 
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Table 40 PrimerDesign Ltd. UK primer sequences of the angiogenesis-specific gene ITGB3 for RT-
qPCR 
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Table 42 PrimerDesign Ltd. UK primer sequences of the angiogenesis-specific gene MMP2 for RT-
qPCR 
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Table 44 PrimerDesign Ltd. UK primer sequences of the angiogenesis-specific gene PDGFA for RT-
qPCR 
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Table 46 PrimerDesign Ltd. UK primer sequences of the angiogenesis-specific gene ROBO4 for RT-
qPCR 
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Table 48 PrimerDesign Ltd. UK primer sequences of the angiogenesis-specific gene TEK for RT-
qPCR 
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Table 50 PrimerDesign Ltd. UK primer sequences of the angiogenesis-specific gene TGFBR1 for 
RT-qPCR 
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Table 51 PrimerDesign Ltd. UK primer sequences of the angiogenesis-specific gene VEGFA for RT-
qPCR 
 
4.3.8 Statistical Analysis of RT-qPCR Data 
Raw RT-qPCR data was analysed with Corbett Rotor-Gene™ 6000 Application 
Software, version 1.7 (Build 87) and expressed as quantification cycle (Cq) values. All 
Cq values of unknowns fell within the linear quantifiable range of the reaction. Relative 
mRNA expression of the GOIs was compared between ‘control’ and contralateral 
‘treated’ pulps using the REST-2009© software package (developed by Prof. M. Pfaffl, 
Technical University Munich, Germany and Qiagen Ltd., Crawley, UK; 
http://www.gene-quantification.com/rest-2009.html). Statistical significance was given 
at p ≤ 0.05. 
Data was normalised against the geometric mean expression of the reference genes 
RPL13A and UBC, previously established to be the most stably expressed pair of 
reference genes in our experimental system (see Chapter 3). 
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Reaction efficiencies were assumed to be 100 %, as guaranteed by PrimerDesign Ltd., 
Southampton, UK 
In order to eliminate the effect of individual variability on average expression values, Cq 
values were analysed by the statistical tests outlined in ‘Standardization of real-time 
PCR gene expression data from independent biological replicates’ by Willems et al 
(2008); namely log transformation, mean centring and autoscaling. Methodology was 
clarified by Dr Nora Donaldson, Statistical Advisor, Dental Institute, King’s College 
London. 
In order to identify patterns on an inter- and intra-patient basis and to determine whether 
patient age, ethnicity, gender or root morphology was linked to gene expression 
profiles, data was sent to Dr Nora Donaldson, Statistical Advisor, Dental Institute, 
King’s College London for analysis.  
Statistical significance was given at p ≤ 0.05. 
4.3.9 Pulp Tissue Homogenisation for Protein Analysis 
Individual snap-frozen pulp samples were homogenised in 2 ml sterile centrifuge tubes 
containing 250 µl lysis buffer (Cat. No. EL-lysis) (RayBiotech Inc., Georgia, USA) 
supplemented with 25 µl protease inhibitor cocktail (Cat. No. 539131) (Calbiochem®, 
Merck4Biosciences, Darmstadt, Germany) with an Ultra-Turrax® homogeniser (Cat. 
No. 3370100) (Rose Scientific Ltd., Alberta, Canada). Tissue lysates were centrifuged 
at 4 °C for 10 min at 5,000 g to separate tissue debris from supernatants; debris pellets 
were discarded and tissue lysate supernatants were stored on ice.  
The total protein concentration was determined with the Pierce Bicinchoninic Acid 
(BCA) Protein Assay Kit (Cat. No. 23250) (ThermoFisher Scientific, Essex, UK), 
according to manufacturer’s instructions. 
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Samples were diluted to a concentration of 2 µg/µl with lysis buffer supplemented with 
protease inhibitor cocktail (1:10 dilution) as per instruction from RayBiotech Inc., 
Georgia, USA before snap-freezing 1000 µl aliquots in liquid nitrogen and transferring 
to -70 °C for permanent storage. 
4.3.10 Quantification of Proteins Associated with Angiogenesis 
Frozen human dental pulp lysates (1000 µl at a concentration of 2 µg/µl) were delivered 
to RayBiotech Inc., Georgia, USA for Quantibody® Array Testing. 12.5 µl of the 
human dental pulp lysate was added to each well of a custom Quantibody® multiplex 
sandwich-based Enzyme-Linked ImmunoSorbent Assay (ELISA) array in addition to 
12.5 µl running buffer, making a total concentration of 1 µg/µl. Reactions were 
performed in technical quadruplicate. The custom Quantibody® ELISA array targeted 
the following angiogenesis associated proteins: ANGPT1; FGF2; KDR; MMP2; 
PDGFA; PDGFB; SELE; TEK; TGFB1; VEGFA. Analyte concentrations were 
determined and delivered in a service report. 
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4.4 Results 
4.4.1 Relative mRNA Expression Analysis of RT-qPCR Data 
RT-qPCR was performed in technical duplicate using primers for the angiogenesis-
specific genes: ANGPT1, FGF2, HIF1A, IL8, ITGAV, ITGB3, KDR, MMP2, NOS2, 
PDGFA, PDGFB, ROBO4, SELE, TEK, TGFB1, TGFBR1 and VEGFA. RT-qPCR 
was performed on cDNA from isolated pulp samples that had been treated with an 
orthodontic force for 1 day (n = 10), 3 days (n = 10) or 14 days (n = 10) prior to tooth 
extraction; and on the untreated, contralaterally paired intra-patient controls (n = 10 per 
treatment time-point). Cq values were input into REST-2009© software and expression 
ratios were calculated, normalising against the geometric mean expression of reference 
genes RPL13A and UBC. 
There was shown to be no significant change in the mRNA expression of any of the 
angiogenesis-specific GOIs in human dental pulps treated with an orthodontic force for 
a period of 1 day prior to extraction (Figure 14). 
Following 3 days of orthodontic force application, there was a significant down-
regulation, by a mean factor of 0.531, of the mRNA expression of TEK. There was no 
significant difference in the mRNA expression of any of the other GOIs in treated 
samples relative to the untreated controls (Figure 15). 
There was no significant up- or down-regulation of mRNA expression for any of the 
GOIs following 14 days of orthodontic force application prior to extraction (Figure 16). 
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Figure 14 Differential expression analysis of angiogenic growth factor mRNA in one day treated samples relative to contralateral control. Normalising against the 
geometric mean of RPL13A and UBC 
Plot shows expression ratios calculated by REST-2009© software. Box-Whisker plots illustrate the range of observations (whiskers), 25th and 75th percentiles (boxes) and sample 
medians (dashed line). Data was normalised against the geometric mean of RPL13A and UBC, which has been identified as a suitable normalisation factor under our experimental 
conditions. There was no significant difference (p > 0.05) in mRNA expression of any of the GOIs in the one day treated samples (n = 10) relative to their paired contralateral 
controls (n = 10). 
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Figure 15 Differential expression analysis of angiogenic growth factor mRNA expression in three day treated samples relative to contralateral controls. Normalising 
against the geometric mean of RPL13A and UBC 
Plot shows expression ratios calculated by REST-2009© software. Box-Whisker plots illustrate the range of observations (whiskers), 25th and 75th percentiles (boxes) and sample 
medians (dashed line). Data was normalised against the geometric mean of RPL13A and UBC, which has been identified as a suitable normalisation factor under our experimental 
conditions. There was a significant down-regulation of TEK mRNA expression in the three day treated samples (n = 10) relative to their paired contralateral controls (n = 10).  
* indicates statistical significance (p ≤ 0.05). 
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Figure 16 Differential expression analysis of angiogenic growth factor mRNA expression in fourteen day treated samples relative to contralateral controls. Normalising 
against the geometric mean of RPL13A and UBC 
Plot shows expression ratios calculated by REST-2009© software. Box-Whisker plots illustrate the range of observations (whiskers), 25th and 75th percentiles (boxes) and sample 
medians (dashed line). Data was normalised against the geometric mean of RPL13A and UBC, which has been identified as a suitable normalisation factor under our experimental 
conditions. There was no significant difference (p > 0.05) in mRNA expression of any of the GOIs in the fourteen day treated samples (n = 10) relative to their paired contralateral 
controls (n = 10). 
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4.4.2 Assessment of Biological Variability in RT-qPCR Data 
In order to assess the level of variability in gene expression amongst the untreated 
‘control’ pulps and therefore the inter-patient biological variability, raw Cq values were 
log-transformed and the mean, standard error of the mean, standard deviation and 
coefficient of variation were calculated for each angiogenesis-specific GOI. Results are 
shown in Table 52 – Table 57. 
Untreated ‘control’ pulp samples should demonstrate similar gene expression patterns as 
all samples were of approximately the same size, had a similar morphology and were 
extracted from patients within a small age range. All samples were isolated from teeth 
with sound dental history and were not exposed to orthodontic force prior to extraction. 
All genes showed a coefficient of variation (%) in the range of 41.14 % – 124.15 %. 
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Table 52 Variability of ANGPT1, FGF2 and HIF1A mRNA Expression in Control Samples 
Cq values were log transformed in order to represent the mean, the standard error of the mean, the standard 
deviation and the coefficient of variation for all control samples used in the orthodontic experiments. 
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Table 53 Variability of IL8, ITGAV and ITGB3 mRNA Expression in Control Samples 
Cq values were log transformed in order to represent the mean, the standard error of the mean, the standard 
deviation and the coefficient of variation for all control samples used in the orthodontic experiments. 
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Table 54 Variability of KDR, MMP2 and NOS2 mRNA Expression in Control Samples 
Cq values were log transformed in order to represent the mean, the standard error of the mean, the standard 
deviation and the coefficient of variation for all control samples used in the orthodontic experiments. 
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Table 55 Variability of PDGFA, PDGFB and ROBO4 mRNA Expression in Control Samples 
Cq values were log transformed in order to represent the mean, the standard error of the mean, the standard 
deviation and the coefficient of variation for all control samples used in the orthodontic experiments. 
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Table 56 Variability of SELE, TEK and TGFB1 mRNA Expression in Control Samples 
Cq values were log transformed in order to represent the mean, the standard error of the mean, the standard 
deviation and the coefficient of variation for all control samples used in the orthodontic experiments. 
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Table 57 Variability of TGFBR1 and VEGFA mRNA Expression in Control Samples 
Cq values were log transformed in order to represent the mean, the standard error of the mean, the standard 
deviation and the coefficient of variation for all control samples used in the orthodontic experiments. 
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4.4.3 Linking Trends in Biological Replicates to those in RT-qPCR 
Data 
In order to identify inter- and intra-patient trends in mRNA expression levels, Cq values 
for each gene in each patient were normalised according to the method for relative 
expression ratio calculation as outlined by Pfaffl et al. (2002). Data was then input into 
a true/false equation in Microsoft Office Excel® where parameters were set against the 
difference between the calculated relative expression ratio and the ratio at which there is 
no change in mRNA expression between treated and control samples (value given as 1). 
All differences found to be greater than zero were said to be due to an up-regulation in 
mRNA expression of the GOI in that patient, while all differences found to be less than 
zero were said to be due to a down-regulation of mRNA expression. Significance was 
not calculated and trends are shown as a purely qualitative assessment of the data. 
 
 
Table 58 Inter- and intra-patient trends in mRNA expression following 1 day orthodontic force 
application 
 
Following 1 day of orthodontic force application there appeared to be a trend in the 
down-regulation of PDGFB mRNA expression and the up-regulation of TEK mRNA 
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expression among the majority of the patients (n = 8) (Table 58). In the remaining 
GOIs, trends of either up- or down-regulation were weak and could not be attributed to 
the duration of force application due to the limitations of the sample size analysed. 
There appeared to be a stronger predisposition toward up- or down-regulation of all 
GOIs within a single patient. In Patient 2, Patient 5 and Patient 10 there was a strong 
trend (≥ 80 %) toward down-regulated mRNA expression of all GOIs (Table 58). In 
addition to mRNA expression being mutually down-regulated in patients, it was 
identified that in Patient 2 and Patient 10, a mutual up-regulation of ANGPT1 mRNA 
expression occurred; while in Patient 2 and Patient 5 a mutual up-regulation of SELE 
mRNA expression was observed. There were no genes mutually up-regulated in Patients 
5 and 10. Patient 3 exhibited up-regulated mRNA expression of all analysed GOIs, with 
the exception of IL8 (Table 58). 
 
 
Table 59 Inter- and intra-patient trends in mRNA expression following 3 days of orthodontic force 
application 
 
After 3 days of orthodontic force application, no distinct trends in up- or down-
regulation of mRNA expression could be identified for any of the GOIs (Table 59). 
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mRNA expression was shown to be up-regulated in approximately 50 % of the sample 
group, while the other 50 % of the sample group showed a down-regulation of mRNA 
expression for the same GOI. Upon investigating trends within individual patients, it 
was shown that Patient 4, Patient 5 and Patient 7 showed a strong trend (≥ 80 %) 
towards down-regulation of mRNA expression; while Patient 1 and Patient 3 exhibited 
strong trends (≥ 80 %) toward up-regulation of mRNA expression for the GOIs (Table 
59). While Patients 4, 5 and 7 exhibited a strong trend (≥ 80 %) toward down-regulated 
mRNA expression; it was observed that they shared a mutual up-regulation of PDGFA 
mRNA. The remaining genes found to be up-regulated in these patients were shown to 
be entirely disparate. Patient 1 and Patient 3 did not share mutual down-regulation of 
mRNA expression for any of the GOIs (Table 59).  
 
 
Table 60 Inter- and intra-patient trends in mRNA expression following 2 weeks (14 days) of 
orthodontic force application 
 
Following an application of orthodontic force for a period of 2 weeks, there were no 
distinct trends in up- or down-regulation of mRNA expression in any of the GOIs 
(Table 60). When individual patients were examined, a distinct trend of up-regulated 
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mRNA expression was observed in Patient 6, Patient 7 and Patient 9; however there 
were no genes for which a mutual down-regulation of mRNA expression was observed 
(Table 60). Patient 5 and Patient 8 exhibited a trend toward down-regulated mRNA 
expression, however only HIF1A mRNA was found to be mutually up-regulated in 
these patients (Table 60). 
4.4.3.1 The Effect of Phenotypic Factors on mRNA Expression Levels 
In order to determine whether a patient’s phenotypic characteristics (i.e. ethnicity, 
gender and apical/apex morphology of the tooth from which the pulp was extracted) 
played a specific role in mRNA expression patterning among the GOIs; patient details  
(Table 61) were compared directly to trends calculated in Table 58 – Table 60.  
In pulps isolated from teeth treated with an orthodontic force for 1 day prior to 
extraction, we previously showed a trend in down-regulation of mRNA expression in 
Patient 2, Patient 5 and Patient 10 (Table 58). When analysing the patients’ phenotypic 
characteristics we were able to link all three patients by gender, however this could not 
be described as the sole contributing factor to the trend in down-regulation as 7 of the 
10 patients analysed in this treatment group belonged to the same gender (Table 61). 
Patient 2 and Patient 10 showed a mutual up-regulation of ANGPT1 mRNA expression 
and shared similar tooth apex morphology in combination with being of the same 
gender (Table 61). Although Patient 2 and Patient 5 were shown to share a mutual up-
regulation of SELE mRNA expression, the only phenotype linking the patients was 
gender (Table 61). Patient 5 and Patient 10 shared no mutual up-regulation of any of the 
GOIs but did share the same ethnicity and gender (Table 61). 
In patients treated with an orthodontic force for 3 days prior to tooth extraction there 
was a trend of up-regulated mRNA expression in Patient 1 and Patient 3; and a trend of 
down-regulated mRNA expression in Patient 4, Patient 5 and Patient 7 (Table 59). 
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When phenotypic characteristics were investigated there was shown to be no linking 
phenotype between Patient 1 and Patient 3 despite the observed trend in up-regulated 
mRNA expression. In Patient 4, Patient 5 and Patient 7 it was previously identified that 
PDGFA mRNA expression was mutually up-regulated (Table 59), however there were 
no phenotypic factors linking all three of these patients. Patient 4 and Patient 5 shared 
both the same ethnicity and gender while Patient 5 and Patient 7 shared the same apex 
morphology (Table 61). 
In the two week treated group Patient 6, Patient 7 and Patient 9 showed a general trend 
of up-regulated mRNA expression, while Patient 5 and Patient 8 showed a general trend 
of down-regulated mRNA expression in the GOIs (Table 60). Upon analysing the 
phenotypic characteristics of each of these patients it was noted that Patient 6, Patient 7 
and Patient 9 were linked by apex morphology while Patient 5 and Patient 8 were linked 
only by gender (Table 61). 
 




Table 61 Details of patients’ age, gender, ethnicity and root morphology 
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In order to determine whether age, gender, ethnicity or apex morphology had any 
significant effect on mRNA expression levels across all time-points of orthodontic force 
application, Cq values were normalised and a multivariate mixed linear regression 
analysis was performed (Chapter 8, section 8.3.1). It was shown that patient age and 
gender had no significant effect (p > 0.05) on the mRNA expression of any of the GOIs 
(Table 62 & Chapter 8, section 8.3.1). Patient ethnicity had a significant effect  
(p ≤ 0.05) on the expression of HIF1A and NOS2 mRNA; and had a borderline 
significant effect (0.12 ≤ p < 0.05) on TGFBR1 mRNA expression (Table 62 & 
Chapter 8, section 8.3.1). Apex morphology was shown to have a borderline 
significant effect (0.12 ≤ p < 0.05) on IL8 mRNA expression across the three treatment 
time-points (Table 62 & Chapter 8, section 8.3.1). 
 
 
Table 62 Multivariate mixed linear regression analysis identifies the impact of patient phenotype on 
mRNA expression 
Details for multivariate mixed linear regression analyses for individual genes can be found in  
Chapter 8, section 8.3.1 
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4.4.3.2 The Effect of Orthodontic Force Duration on mRNA Expression 
Levels 
Concurrent to the multiple mixed linear regression analysis, a one-way ANOVA 
(analysis of variance) test was performed in order to determine whether or not the 
application of orthodontic force for any period of time had a significant effect on gene 
expression levels in the human dental pulp (Chapter 8, section 8.3.2). Subsequently, a 
pair-wise regression analysis was performed on the data to assess the differences in 
mRNA expression between each of the treatment groups. Due to the sample size 
significance was given at (p ≤ 0.05) and borderline significance was given at  
(0.12 ≤ p < 0.05). 
It was shown that the application of an orthodontic force for any period of time had a 
significant effect on the mRNA expression of ANGPT1, FGF2, HIF1A and NOS2; and 
a borderline significant effect on ITGAV, KDR, PDGFA and TGFBR1 mRNA 
expression (Table 63 & Chapter 8, section 8.3.2). 
There was a significant difference in the mRNA expression of ANGPT1 and HIF1A 
between 1 and 3 days of orthodontic force application; and a borderline significant 
difference in FGF2, ITGAV and NOS2 mRNA expression at these time-points of 
orthodontic treatment (Table 63 & Chapter 8, section 8.3.2). 
Between 1 day and 2 weeks (14 days) of orthodontic force application, there was shown 
to be a significant difference in the mRNA expression of NOS2; and a borderline 
significant difference in HIF1A, KDR and TGFBR1 mRNA expression between these 
treatment time-points (Table 63 & Chapter 8, section 8.3.2). 
It was shown that between 3 days and 2 weeks of orthodontic force application, there 
was a significant difference in the expression of ANGPT1, FGF2, HIF1A, ITGAV, 
KDR, PDGFA, TEK and TGFBR1. There was also a borderline significant difference in 
the mRNA expression of ITGB3 and MMP2 (Table 63 & Chapter 8, section 8.3.2). 
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Table 63 One-way ANOVA and pair-wise regression analysis of the effect of orthodontic force 
application and the duration of treatment on mRNA expression 
Details for ANOVA and pair-wise regression analyses for individual genes can be found in  
Chapter 8, section 8.3.2 
 
4.4.3.3 Identifying Trends in the Variability of mRNA Expression across all 
Treatment Time-Points 
A factor analysis was performed on normalised Cq values in order to identify 
commonalities in the variability of mRNA expression for the GOIs across all time-
points of orthodontic force application. It was identified that MMP2, TGFB1 and 
VEGFA mRNA expression was most tightly correlated and changed in the same 
direction (Table 64). mRNA expression of ANGPT1, FGF2, HIF1A, ITGAV, ITGB3, 
KDR, PDGFA, PDGFB, ROBO4, SELE, TEK and TGFBR1 was also found to be 
tightly correlated but to a lesser degree than MMP2, TGFB1 and VEGFA (Table 64). 
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Table 64 Commonality of variability in mRNA expression of angiogenesis-specific GOIs 
A factor greater than or equal to 0.55 was considered to be significant when considering the correlated 
expression of the GOIs. GOIs considered to be tightly correlated are highlighted in green. GOIs considered 
to be the most tightly correlated to each other in expression amongst all orthodontic treatment groups are 
highlighted in blue. 
 
4.4.4 Statistical Standardisation of Biological Variability in RT-qPCR 
Data 
In order to eliminate the effect of biological, inter-patient variation on the average 
mRNA expression levels as calculated by the REST-2009© software; Cq values were 
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log-transformed, mean centred and auto-scaled according to the methodology outlined 
by Willems et al. (2008). The methodology was clarified and validated by Dr Nora 
Donaldson, Statistical Advisor, Dental Institute, King’s College London. 
Following analysis of Cq values using the methodology described by Willems et al. 
(2008), it was shown that after 1 day of orthodontic force application TEK mRNA 
expression was significantly up-regulated (p = 0.01) and PDGFB mRNA expression 
was significantly down-regulated (p = 0.01) in treated samples relative to their paired, 
untreated, contralateral controls (Figure 17).  
Following 3 days of force application there was a statistically significant down-
regulation of ANGPT1 (p < 0.01), HIF1A (p < 0.01), KDR (p < 0.01), PDGFA  
(p < 0.01), PDGFB (p = 0.01), ROBO4 (p = 0.01), TEK (p < 0.01) and TGFBR1  
(p < 0.01) mRNA expression in the pulps of treated teeth relative to their paired, 
untreated, contralateral controls (Figure 18). 
There was a statistically significant up-regulation of HIF1A (p = 0.01), ITGAV  
(p < 0.01), KDR (p = 0.01) and TGFBR1 (p = 0.01) mRNA expression in teeth treated 
with an orthodontic force for a period of 14 days prior to extraction relative to their 
paired, untreated, contralateral controls (Figure 19).  
Statistical significance was given as p ≤ 0.05.  
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Figure 17 Fold-change expression 
analysis of angiogenic growth factor mRNA in 
one day treated samples relative to 
contralateral controls. Normalising against 
the geometric mean of RPL13A and UBC 
Plot shows the fold-change (log) of mRNA 
expression (columns); and the error of the mean 
(error bars) in one day treated samples (n = 10) 
relative to contralateral controls (n = 10). Data 
was normalised against the geometric mean of 
RPL13A and UBC. There was a significant up-
regulation of TEK mRNA expression and a 
significant down-regulation of PDGFB mRNA 
expression in treated samples relative to 
contralateral controls.  
* indicates statistical significance (p ≤ 0.05). 
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Figure 18 Fold-change expression 
analysis of angiogenic growth factor mRNA in 
three day treated samples relative to 
contralateral controls. Normalising against 
the geometric mean of RPL13A and UBC 
Plot shows the fold-change (log) of mRNA 
expression (columns); and the error of the mean 
(error bars) in three day treated samples (n = 10) 
relative to contralateral controls (n = 10). Data 
was normalised against the geometric mean of 
RPL13A and UBC. There was a significant 
down-regulation of ANGPT1, HIF1A, KDR, 
PDGFA, PDGFB, ROBO4, TEK and TGFBR1 
mRNA expression in treated samples relative to 
contralateral controls.  
* indicates statistical significance (p ≤ 0.05).
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Figure 19 Fold-change expression 
analysis of angiogenic growth factor mRNA 
in two week (14 day) treated samples relative 
to contralateral controls. Normalising against 
the geometric mean of RPL13A and UBC 
Plot shows the fold-change (log) of mRNA 
expression (columns); and the error of the mean 
(error bars) in two week treated samples (n = 10) 
relative to contralateral controls (n = 10). Data 
was normalised against the geometric mean of 
RPL13A and UBC. There was a significant up-
regulation of HIF1A, ITGAV, KDR and 
TGFBR1 mRNA expression in treated samples 
relative to contralateral controls.  
* indicates statistical significance (p ≤ 0.05).  
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4.4.5 Linking Trends in Protein Expression Profiles to Orthodontic 
Force Application  
In order to identify the effects of orthodontic force application on the protein expression 
profiles of human dental pulps, a custom multiplex ELISA (Quantibody® Array) was 
performed by RayBiotech Inc., Georgia, USA on aliquots of human dental pulp lysate at 
a final concentration of 1 µg/µl. 
It was shown that for most of the angiogenesis-specific GOIs analysed, the average 
level of analyte present in the pulp homogenates was below the assay’s lower LOD 
(Table 65 – Table 67). FGF2 was the only protein of interest in which the concentration 
of analyte present in the majority of samples under all experimental conditions was 
greater than the assay’s lower LOD (Table 65 – Table 67). 
 
 
Table 65 Analyte concentrations (pg/ml) of angiogenesis-specific GOIs in human dental pulp 
explants exposed to one day of orthodontic force application prior to tooth extraction 
Cells marked in blue represent the assay’s lower LOD (pg/ml). Cells marked in purple represent samples 
that expressed an analyte concentration greater than the assay’s lower LOD. Cells marked in white 
represent samples which were below the assay’s LOD. Cells marked in green represent samples which did 
not express any detectable concentration of the analyte of interest. 
 
Using values where analyte concentration was greater than the assay’s lower LOD in 
both the control and treated pulps, it was shown that following one day of orthodontic 
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force application FGF2 expression increased in 3 out of 5 patients. PDGFA was shown 
to decrease in 1 patient whilst SELE increased in 1 out of 2 patients. As all other results 
were below the assay’s level of detection no comment can be made as to the 




Table 66 Analyte concentrations (pg/ml) of angiogenesis-specific GOIs in human dental pulp 
explants exposed to three days of orthodontic force application prior to tooth extraction 
Cells marked in blue represent the assay’s lower LOD (pg/ml). Cells marked in purple represent samples 
that expressed an analyte concentration greater than the assay’s lower LOD. Cells marked in white 
represent samples which were below the assay’s LOD. Cells marked in green represent samples which did 
not express any detectable concentration of the analyte of interest. 
 
Using values where analyte concentration was greater than the assay’s lower LOD in 
both the control and treated pulps, it was shown that following three days of orthodontic 
force application FGF2 expression decreased in 3 out of 5 patients. PDGFB was shown 
to increase in 1 patient whilst SELE increased in 2 out of 4 patients. As all other results 
were below the assay’s level of detection no comment can be made as to the 
significance of these results in relation to change in protein expression as a response to 
force application. 
 
 - 196 - 
 
Table 67 Analyte concentrations (pg/ml) of angiogenesis-specific GOIs in human dental pulp 
explants exposed to two weeks of orthodontic force application prior to tooth extraction 
Cells marked in blue represent the assay’s lower LOD (pg/ml). Cells marked in purple represent samples 
that expressed an analyte concentration greater than the assay’s lower LOD. Cells marked in white 
represent samples which were below the assay’s LOD. Cells marked in green represent samples which did 
not express any detectable concentration of the analyte of interest. 
 
Using values where analyte concentration was greater than the assay’s lower LOD in 
both the control and treated pulps, it was shown that following two weeks of 
orthodontic force application FGF2 expression increased in 4 out of 5 patients. PDGFA 
and PDGFB were shown to decrease in 1 patient whilst SELE increased in 1 patient. As 
all other results were below the assay’s level of detection no comment can be made as to 
the significance of these results in relation to change in protein expression as a response 
to force application. 
4.4.6 Linking Trends in Biological Replicates to Protein Expression 
Profiles 
Further statistical evaluation could not be performed on data from the protein analysis, 
as calculated analyte concentrations were below the assay LOD and several samples 
gave a reading of 0 pg/ml. In order to calculate statistical significance, a minimum of 5 
pairs of samples from each treatment group is recommended and it was observed that 
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there were no cases, with the exception of FGF2, in which all 5 sample pairs had an 
analyte concentration greater than 0 pg/ml for all treatment time-points. 
Qualitative analysis was performed in order to identify inter- and intra-patient trends in 
protein expression profiles. Differences between analyte concentrations (pg/ml) in 
control and treated pulp explants were calculated and are shown in Table 68 –  
Table 70. Where one of the values in the pair was 0 pg/ml, this pair was excluded from 
the analysis. Increased or decreased expression patterns were then compared. 
 
 
Table 68 Inter- and intra-patient trends in protein expression following 1 day of orthodontic force 
application 
 
In pulps isolated from teeth treated with an orthodontic force for 1 day prior to 
extraction, there were no strong trends (≥ 80 %) toward increased or decreased protein 
expression for any of the angiogenesis-specific genes or for any of the patients. Weaker 
trends (60 % – 80 %) of increased protein expression were seen for FGF2, SELE and 
TEK; and for Patient 4 where there was an increase in protein expression of six of the 
ten genes analysed (Table 68). 
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Table 69 Inter- and intra-patients trends in protein expression following 3 days of orthodontic force 
application 
 
Following an application of orthodontic force for 3 days, there were no strong trends  
(≥ 80 %) in protein expression for any of the patients or for any of the angiogenesis-
specific genes analysed. There were weaker trends (60 % – 80 %) observed in two of 
the patients. Patient 2 showed a weaker trend toward decreased protein expression and 
Patient 3 showed a weaker trend toward increased protein expression in treated teeth 
relative to controls. Weaker trends (60 % – 80 %) could be seen for the individual 
proteins FGF2, KDR and SELE (Table 69). 
 
 
Table 70 Inter- and intra-patient trends in protein expression following 2 weeks of orthodontic force 
application 
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As a response to orthodontic force application for 2 weeks prior to extraction, strong 
trends (≥ 80 %) were observed in the expression of FGF2, SELE and PDGFA. FGF2 
and SELE expression was found to be increased in response to force application, while 
PDGFA expression was decreased. No weaker trends (60 % – 80 %) in expression were 
observed for any of the angiogenesis-specific GOIs or for any of the individual patients 
(Table 70). 
4.4.6.1 Linking Patient Phenotypes to Protein Expression Profiles 
In order to determine whether phenotypic factors such as ethnicity, gender and apex 
morphology played a specific role in the observed protein expression profiles; patient 
details (Table 71) were compared directly to trends identified in Table 68 – Table 70. 
 
 
Table 71 Details of patients’ age, gender, ethnicity and root morphology in samples for protein 
analysis 
 
We previously observed no strong trends (≥ 80 %) in protein expression in pulps 
extracted from teeth treated with orthodontic force application for 1 day prior to 
extraction but observed weaker trends (60 % – 80 %) in FGF2, SELE and TEK protein 
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expression (Table 68). A weaker trend (60 % – 80 %) of increased protein expression 
was also observed in Patient 4 (Table 68). Upon examination of patient phenotype it 
was noted that two patients shared the phenotype of closed apex morphology, asian 
ethnicity and female gender (Patient 3 and Patient 4) (Table 68 & Table 71); and 
another two patients shared the phenotype of closed apex morphology, black ethnicity 
and female gender (Patient 2 and Patient 5) (Table 68 &Table 71). In the group with 
asian ethnicity there was a shared increased expression of FGF2 and TEK protein 
expression, while in the group with black ethnicity there were no shared trends in 
protein expression (Table 68 & Table 71). The trends previously observed in FGF2, 
SELE and TEK were not attributable to either one of these phenotypic groups but 
shared commonalities across the three patient phenotypes. 
Following exposure to 3 days of orthodontic force application prior to pulp isolation, 
there were no strong trends (≥ 80 %) in protein expression relative to the internal 
controls. Weaker trends (60 % – 80 %) were observed in the expression of FGF2, KDR 
and SELE; and among Patient 2 and Patient 3 individually (Table 69). When patient 
phenotypes were observed Patient 2 and Patient 3 were found to share the phenotype of 
closed apex morphology, black ethnicity and female gender (Table 71). Although the 
patient phenotypes matched, it was previously identified that Patient 2 showed a weak 
trend (60 % – 80 %) towards decreased protein expression while Patient 3 showed a 
weak trend (60 % – 80 %) toward increased protein expression (Table 69). Trends in 
protein expression in FGF2, KDR and SELE could not be attributed to one form of 
ethnicity, gender or apex morphology as the trends were observed across a range of 
phenotypic groups (Table 69 & Table 71). 
Although it was shown that there were strong trends (≥ 80 %) in expression of FGF2, 
PDGFA and SELE following 2 weeks of orthodontic force application (Table 70); 
when patient phenotypes were examined there was shown to be no definite phenotypic 
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cause for these trends (Table 71). Patient 1 and Patient 3 shared the phenotype of open 
apex morphology, black ethnicity and female gender but only shared common trends in 
FGF2 and PDGFA protein expression (Table 70 & Table 71). 
4.4.7 Linking mRNA Expression to Protein Expression in Human 
Dental Pulps 
Where possible, experiments for mRNA expression analysis and protein expression 
analysis were performed on human dental pulps isolated from the same individuals in 
order to minimise inter-patient biological variability and allow for intra-patient 
comparisons.  
mRNA and protein expression was compared qualitatively as Cq values could only be 
represented as delta Cq values (as per the normalisation method outlined by Schmittgen 
et al. (2008) and a number of the protein results had to be excluded as both values in a 
contralateral-treated pair yielded a protein concentration of 0 pg/ml. No correction for 
biological variability could be performed on the mRNA data, as the methodology 
outlined in Willems et al. (2008) calls for the mean-centring of data and gives a mean 
expression ratio in treated samples relative to contralateral controls, thus eliminating the 
option of observing changes in individuals. 
In all treatment time-point groups it was observed that several genes were regulated in 
the same direction at both the transcriptomic and proteomic levels, although this was not 
the case for all observations (Table 72 – Table 74). Within a single treatment time-
point group, the transcriptomic and proteomic expression patterns were not identical 
amongst all individuals or all GOIs. 
In the one day treated group it was previously shown that TEK mRNA was significantly 
up-regulated whilst PDGFB was significantly down-regulated. The up-regulation of 
TEK mRNA was matched by an increase in TEK protein expression in 3 of the 5 
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patients examined at both the transcriptomic and proteomic levels. PDGFB expression 
was not matched at the transcriptomic and proteomic levels as although all 5 patients 
examined showed a down-regulation of PDGFB mRNA, only 1 of the 5 patients showed 
a decrease in PDGFB protein expression. The remaining 4 patients showed a marginal 
increase or were negative results. 
In the three day treated group, only one patient was examined at both the transcriptomic 
and proteomic levels due to the number of teeth available for extraction from each 
patient. In this patient the mRNA expression patterns match those previously identified 
in the biological variability correction where mRNA is significantly down-regulated for 
ANGPT1, KDR, PDGFA, PDGFB and TEK after 3 days of treatment. The proteomic 
expression patterns differ in comparison, with only ANGPT1 expression being 
decreased out of the significantly decreased mRNAs. A number of proteins were 
increased in this patient in response to treatment, with FGF2, PDGFB and SELE all 
being above the lower LOD for the assay. 
After two weeks of force application there was previously shown to be a statistically 
significant increase in KDR mRNA expression. This was true in 3 of the 5 patients 
analysed in the group and only correlated with the proteomic expression of 1 of the 3 
patients.  
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Table 72 Comparison of mRNA and protein expression profiles in patients treated with orthodontic force for 1 day prior to tooth extraction 
The top block represents the log transformed Cq values obtained from RT-qPCR. Data was normalised against the geometric mean expression of RPL13A and UBC. The bottom 
block shows data obtained from the custom Quantibody® ELISA array. Change in expression was calculated by subtracting control values from treated values to identify up- / 
down-regulation of mRNA or increased / decreased protein expression. Patient numbers are provided as per the samples used earlier in this chapter. Prior to protein analysis, 
patients were randomly assigned to the mRNA study as Patient 1 – 10 for each treatment group. Upon protein analysis, another contralateral pair of pulps was extracted from some 
patients from the alternate row of dentition (e.g. mRNA from pulps from maxilla, protein pulps from mandible and vice versa). Therefore, Patient 4 from the mRNA expression 
analysis is paired with Patient 3 from the protein expression analysis (and so forth), as these are pulps which were extracted from the same individual. Cells marked as pink show a 
common trend in mRNA and protein expression in individual patients  
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Table 73 Comparison of mRNA and protein expression profiles in patients treated with 
orthodontic force for 3 days prior to tooth extraction 
The top block represents the log transformed Cq values obtained from RT-qPCR. Data was normalised against 
the geometric mean expression of RPL13A and UBC. The bottom block shows data obtained from the custom 
Quantibody® ELISA array. Change in expression was calculated by subtracting control values from treated 
values to identify up- / down-regulation of mRNA or increased / decreased protein expression. Patient numbers 
are provided as per the samples used earlier in this chapter. Prior to protein analysis, patients were randomly 
assigned to the mRNA study as Patient 1 – 10 for each treatment group. Upon protein analysis, another 
contralateral pair of pulps was extracted from some patients from the alternate row of dentition (e.g. mRNA 
from pulps from maxilla, protein pulps from mandible and vice versa). Therefore, Patient 10 from the mRNA 
expression analysis is paired with Patient 3 from the protein expression analysis, as these are pulps which were 
extracted from the same individual. Cells marked as pink show a common trend in mRNA and protein 
expression in individual patients. 
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Table 74 Comparison of mRNA and protein expression profiles in patients treated with orthodontic force for 2 weeks prior to tooth extraction 
The top block represents the log transformed Cq values obtained from RT-qPCR. Data was normalised against the geometric mean expression of RPL13A and UBC. The bottom 
block shows data obtained from the custom Quantibody® ELISA array. Change in expression was calculated by subtracting control values from treated values to identify up- / 
down-regulation of mRNA or increased / decreased protein expression. Prior to protein analysis, patients were randomly assigned to the mRNA study as Patient 1 – 10 for each 
treatment group. Upon protein analysis, another contralateral pair of pulps was extracted from some patients from the alternate row of dentition (e.g. mRNA from pulps from 
maxilla, protein pulps from mandible and vice versa). Therefore, Patient 1 from the mRNA expression analysis is paired with Patient 1 from the protein expression analysis (and so 
forth), as these are pulps which were extracted from the same individual. Cells marked as pink show a common trend in mRNA and protein expression in individual patients. 
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4.5 Discussion 
Previous investigations considering the response of the human dental pulp to 
orthodontic force application have been carried out in order to determine the true effect 
of routine orthodontic treatment on the tightly encapsulated loose connective tissue 
(Abdul Wahab et al. 2012, Derringer et al. 1996, Hamersky et al. 1980, Javed et al. 
2015, Lazzaretti et al. 2014, Mostafa et al. 1991, Sano et al. 2002, Santamaria et al. 
2006, Stenvik and Mjor 1970, Subay et al. 2001, von Bohl et al. 2012, Yamaguchi 
2007). It has been determined that routine orthodontic treatment results in the pulp’s 
release of several angiogenic growth factors and cytokines (Derringer et al. 1996, 
Derringer and Linden 2003, Derringer and Linden 2004, Derringer and Linden 2007). 
The cause of this release of growth factors and the extent to which neovascularisation or 
possible reparative angiogenesis occurs remains undetermined.  
This experimental chapter has focussed on expanding previous assessments in the field 
by analysing the relative expression of seventeen genes thought to be associated with 
angiogenic signalling cascades. Analyses were performed on human dental pulps that 
had been exposed to three separate early time-points of orthodontic treatment prior to 
tooth extraction. mRNA and protein expression was analysed to determine changes in 
expression at each of the treatment time-points. As it was previously established that the 
maturity of the apical foramina plays a potentially significant role in the pulp’s response 
to treatment (Hamersky et al. 1980, Mostafa et al. 1991), patient phenotypes were 
examined and compared. Changes in mRNA expression as a response to treatment were 
then compared to differences in protein expression amongst the individuals, in order to 
determine if a true pattern of up- or down-regulation of the GOIs existed in treated 
teeth. 
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4.5.1 Validating the use of Commercially Purchased Primers 
The optimisation of experimental conditions, in order to ascertain the most realistic 
representation of the physiological response, is a critical step in any in vivo experiment. 
The fundamental importance of normalising experimental RT-qPCR data with an 
appropriate statistical method, by using the correct combination of reference genes, was 
previously considered (Chapter 3) in order to eliminate any spurious interpretations. 
Efficiency correction was highlighted as a critical step in this normalisation protocol, as 
it eliminates any under- or overestimation of gene expression in the samples of interest 
(Freeman et al. 1999, Peirson et al. 2003, Pfaffl et al. 2002). In this light, we purchased 
sets of primers from a commercial distributor that designed, optimised and guaranteed 
the reaction efficiency of all experiments at 100 % in order to eliminate our need for 
standard curve creation and additional experimental optimisation. This was considered 
to be the most appropriate course of action as we have expanded our investigation from 
a panel of four GOIs to seventeen. The financial and time limitations of designing and 
optimising thirteen additional primers were considered too great and were outweighed 
by the guarantee of 100 % reaction efficiency. 
4.5.2 Relative Expression Analysis Showed Minimal Differences in 
mRNA Expression at any Treatment Time-Point 
It was shown that by analysing raw Cq data using the REST-2009© software package 
(developed by Prof. M. Pfaffl, Technical University Munich, Germany and Qiagen Ltd., 
Crawley, UK; http://www.gene-quantification.com/rest-2009.html), despite optimising 
all normalisation protocols, that there were little to no statistically significant changes in 
the mRNA expression levels of these seventeen GOIs at any of the early time-points of 
orthodontic treatment investigated. These results were in contrast to studies that have 
investigated changes in the protein expression of angiogenic growth factors in human 
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dental pulps of teeth undergoing orthodontic treatment (Derringer et al. 1996, Derringer 
and Linden 1998, Derringer and Linden 2003, Derringer and Linden 2004, Derringer 
and Linden 2007).  
As the previous studies showed an increase in secreted proteins and this can only be 
attributed to an initial up-regulation of mRNA expression at some point between 1 day 
and 14 days of force application, it was hypothesised that there must be an underlying 
factor skewing the data and prohibiting the true changes in mRNA expression from 
being identified. In order to confirm primer specificity and rule out any alternate 
binding products, primer sequences were analysed using in silico BLAST analysis and 
several possible alternate genes were identified (Chapter 8, section 8.1.5.4). Melt 
curves (Chapter 8, section 8.1.6.3) and gel electrophoretograms (Chapter 8,  
section 8.1.7.3) were then analysed in order to determine the incidence of spurious 
binding products, primer-dimers or amplification of alternate transcripts which may 
mask true mRNA expression changes in response to treatment. It was established, that 
despite primer sequences being specific for several alternate genes, the amplicon sizes 
were specific to our GOIs and the absence of distinct, observable differences in gene 
expression between the control and treated pulps could not be attributed to non-specific 
binding of the primers. 
4.5.3 Biological Variability May Play a Significant Role in RT-qPCR 
mRNA Expression Data Analysis 
As alternate amplification products were eliminated as the possible cause of ambiguity 
in our results, control samples were investigated for variability by analysing the mean 
gene expression, the standard deviation and the coefficient of variance for each GOI. It 
was shown that amongst 30 untreated samples, using 10 control samples from each 
treatment time-point, there was a large amount of variation in the expression of each 
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GOI amongst the untreated sample group (Table 52 – Table 57). This difference in 
mRNA expression amongst the untreated samples was unexpected as it was 
hypothesised prior to investigation that a random selection of samples from a small 
range of ages, genders, ethnicities and root morphologies would drastically reduce or 
eliminate inter-patient variability. Inconsistencies in the mRNA expression of the GOIs 
within the untreated samples may possibly be attributable to the cellular composition of 
individual tissues or the maturity of each tooth; and the lack of homogeneity amongst 
samples has been noted to be a contributor to erroneous interpretation of RT-qPCR data 
(Freeman et al. 1999). As relative expression analysis calculates the mean mRNA 
expression of a gene in the control samples and compares the mean difference in treated 
samples against this baseline, it is critical to note that a large amount of variability 
between the control samples will radically alter the perceived response to treatment. We 
can conclude at this stage that biological variability has a substantial effect within our 
experimental model and must be corrected for prior to performing relative expression 
analysis. 
4.5.4 Investigating Changes within Individuals to Determine the Effect 
of Force Application on mRNA Expression of Angiogenesis-
Specific Genes 
At this stage of investigation, no further correction for biological variability was 
available to the author and qualitative assessment was performed on normalised, 
individual Cq values as per Pfaffl et al. (2002) in collaboration with Dr Nora Donaldson 
in order to determine whether or not there were trends in the expression of a particular 
GOI at any of the treatment time-points. The mRNA expression trends within individual 
patients were also compared. It was shown that following 1 day of orthodontic force 
application there was a trend toward down-regulation of mRNA amongst Patients 2, 5 
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and 10, although none of the individual GOIs were expressed in a similar manner 
amongst all three patients. In Patient 3 there was a trend towards up-regulation of 
mRNA for all GOIs with the exception of IL8. PDGFB was down-regulated in most 
patients in this treatment group whilst TEK was up-regulated. Following 3 days of force 
application there were no direct trends in up- or down-regulation for any of the GOIs. 
Patients 1 and 3 exhibited a trend towards up-regulation of mRNA expression although 
they had no gene expression in common. Patients 4, 5 and 7 showed a trend toward 
down-regulated mRNA expression, yet the only gene expressed in a similar manner 
amongst all three patients was PDGFA, which was up-regulated. After 2 weeks of 
orthodontic treatment there were no distinct trends in the mRNA expression of any of 
the individual GOIs. Patients 6, 7 and 9 showed a general trend toward up-regulation of 
mRNA expression yet they had no common genes expressed in a similar manner among 
them. Patients 5 and 8 showed a trend towards down-regulation of mRNA expression 
but the only gene commonly expressed between the two patients was HIF1A which was 
up-regulated. 
There was no evidence of a conclusive trend in gene expression for any of the GOIs at 
any experimental treatment time-point amongst the samples analysed. We had 
hypothesised that by analysing paired Cq values from individuals and identifying 
differences within each gene, we would be able to recognise any trends previously 
unobservable when analysing the samples as a group and calculating a mean expression 
change as per REST analysis. If any trends within the treatment time-points were 
present as a true response to orthodontic force application for a measured duration, we 
were unable to identify these changes at this time due to the wide range of variability 
amongst the untreated ‘control’ sample group. There was no baseline level against 
which neither comparisons nor patterns could be determined. 
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4.5.5 Linking Biological Variability in Control Samples to Phenotypic 
Factors 
In order to assess the data further and attempt to determine if the biological variability 
seen within the untreated ‘control’ group was attributable to phenotypic factors such as 
age, gender, ethnicity or root morphology; a qualitative assessment was performed on 
the normalised Cq values in collaboration with Dr Nora Donaldson. It was previously 
shown that following 1 day of orthodontic tooth movement, Patients 2, 5 and 10 
exhibited a similar trend towards the down-regulation of mRNA expression. Upon 
examination of patient phenotypes, the only phenotype linking all three patients was 
gender. Seven of the ten patients within this group were of the same gender as these 
patients; therefore we could find no phenotypic cause for the trend towards down-
regulation of mRNA within these patients. This was also true in the 3 day treated group 
where Patients 1 & 3 and Patients 4, 5 and 7 appeared to be linked in expression but no 
common phenotype could be identified. Following 2 weeks of orthodontic force 
application Patients 6, 7 and 9 which exhibited a trend towards up-regulation of mRNA 
expression were linked by apex morphology while Patients 5 and 8 which showed a 
trend of down-regulated mRNA expression were linked by gender.  
The only phenotypic factor which seems noteworthy amongst all treatment time-points 
is that of apex morphology which was shown to be a common factor in Patients 6, 7 and 
9 in the 2 week treated group. Apex morphology has previously been associated with 
differing responses of the pulp to orthodontic treatment; where teeth with open apices 
recover more quickly from any detrimental effects of treatment than those with closed 
apices (Hamersky et al. 1980, Mostafa et al. 1991). Patients were chosen in the age 
range where premolars were fully erupted and roots were completely formed (Mostafa 
et al. 1991) and when these patients were examined radiographically, as per routine 
clinical protocol prior to orthodontic treatment, we observed that the apical foramina of 
 - 212 - 
these teeth were closed. When all samples within the 2 week treatment group were 
compared and the apical morphology of all patients was assessed, it was observed that 
six of the ten patients within this treatment group had the same apex morphology. 
Therefore, while apex morphology has been shown to have a significant effect on the 
pulp’s recovery from orthodontic force application in previous studies, we cannot 
conclusively ascribe changes of mRNA expression in these samples to a response 
pattern due to tooth maturity. 
In order to substantiate our findings regarding the effect of patient phenotype on gene 
expression, a multivariate mixed linear regression analysis was performed on the 
normalised Cq data by Dr Nora Donaldson. Following analysis of all samples across all 
time-points there was shown to be no statistical significance of the patient’s age or 
gender on the mRNA expression of any of the GOIs. This finding was not expected as it 
has been highlighted by AlQahtani et al. (2010) that females will preceed males in tooth 
development, particularly amongst patients within the same age range as those used in 
our sample groups. We have no explanation for our findings and propose that the lack 
of significance observed within our sample group, in relation to gender, is due to the 
uneven sampling of patients from each gender; and the size of the group itself. We 
postulate that a large sample group containing an equal number of male and female 
patients may result in a significantly different mRNA expression pattern between 
patient genders, due to the maturity of the teeth in each group. 
As tooth morphology has previously been directly linked to the patient’s age (Mostafa 
et al. 1991, Ramazanzadeh et al. 2009), we had assumed that the findings of the 
statistical analyses of tooth apex morphology on mRNA expression would be 
corroborative, however this was not found to be true in this instance. This finding 
further highlights those established by AlQahtani et al. (2010) where patient age and 
tooth morphology have been shown to be linked to gender. As our patient groups were 
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comprised of a mix of male and female samples, where female pulps are considered to 
be more mature; the analyses of tooth morphology appears to be scewed by the addition 
of sample information from the opposing gender. We propose that in order to determine 
whether patient age or apex morphology holds statistical significance within our 
experimental group, that data from males and females should be analysed separately 
using a larger sample group. 
Apex morphology of the tooth was shown to have a borderline (5 % – 12 %) significant 
effect on the mRNA expression of the gene IL8 in the human dental pulp. IL8 is a pro-
inflammatory chemokine and has been shown to be present in the human dental pulp 
solely under inflammatory conditions (Hahn and Liewehr 2007, Huang et al. 1999, 
Silva et al. 2009). It has been localised in odontoblasts, lymphocytes, macrophages and 
endothelial cells by immuno-histochemistry (Hahn and Liewehr 2007) but has not been 
localised to a specific region within the pulp tissue. The effect of apex morphology on 
orthodontically treated teeth is an interesting point for consideration as it has already 
been noted that pulps within teeth with closed apices recover from trauma at a slower 
rate (Hamersky et al. 1980, Mostafa et al. 1991). Should orthodontic force application 
induce an inflammatory response, up-regulating the expression of IL8 and other pro-
inflammatory cytokines and chemokines, a tooth with a completed apical morphology 
would maintain the physiological response for a greater length of time. This could have 
a negative or potentially deleterious effect on the pulp and should be considered in 
further future studies. 
Surprisingly, patient ethnicity was shown to have a significant effect on the expression 
of the genes HIF1A and NOS2. It was also shown to have a borderline significant effect 
on the mRNA expression of the gene TGFBR1. Whilst there are no publications in the 
literature that focus on the differences in expression of these three specific genes 
between ethnicities, it is now recognised in the literature that gene expression levels do 
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differ amongst cell types within an individual, among individuals and between ethnic 
groups (Spielman et al. 2007). As HIF1A and NOS2 continue to hold the focus of 
researchers as potential biomarkers for high profile population-wide diseases such a 
Huntington’s, cancer, tuberculosis and cystic fibrosis (Anam et al. 2015, Borovecki et 
al. 2005, Grasemann et al. 2000, McCluskie et al. 2004), it is the opinion of the author 
that the findings identified within this study, that patients of differing ethnicities 
respond differently to treatment, will be verified and clarified in future research. 
4.5.6 The Effect of Force Application on mRNA Expression: A 
Regression Analysis 
Despite the inability to correct for biological variability amongst the untreated control 
samples, a multivariate mixed linear regression analysis was performed concurrently 
with a one-way ANOVA (analysis of variance) test in order to identify if any level of 
force application would have a significant effect on the mRNA expression of the GOIs. 
Pair-wise regression analyses were then performed on the data for each treatment time-
point in order to determine if force application between two specific time-points would 
result in a significant difference in mRNA expression. The analyses were performed by 
Dr Nora Donaldson on the normalised Cq values and statistical significance was given at 
5 % whilst borderline significance was given from 5 % to 12 %. It was shown that the 
application of any duration of orthodontic force has a significant effect on the mRNA 
expression of the genes ANGPT1, FGF2, HIF1A and NOS2. Orthodontic treatment also 
has a borderline significance on the expression of ITGAV, KDR, PDGFA and 
TGFBR1. 
Using STRING (www.string-db.org), an online database of predicted protein-protein 
interactions, and the Kyoto Encyclopaedia of Genes and Genomes (KEGG) 
(http://www.genome.jp/kegg/), we were able to determine any existing links in the 
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literature between these genes. ANGPT1, HIF1A and NOS2 were shown to be linked 
via the ‘HIF-1 signalling pathway’, which is the predominant signalling pathway in the 
cell’s regulation of hypoxia; this was supported in the literature by a single publication 
(Lavine et al. 2013). Multiple publications were present linking paired combinations of 
these genes (ANGPT1 & HIF1A, HIF1A & NOS2 or ANGPT1 & NOS2) but only one 
paper listed all three genes in combination. FGF2, HIF1A and NOS2 were linked via 
‘Pathways in cancer’ and this was supported in the literature (Dinarello et al. 2011, 
Lavine et al. 2013, Lehner et al. 2011) although as with the previous gene combination, 
there were more publications about pairs of these genes than the full combination. FGF2 
and ANGPT1 were shown to be linked by the ‘Rap1 signalling pathway’, the ‘Ras 
signalling pathway’ and the ‘PI3K-Akt signalling pathway’ with numerous publications 
supporting their linkage (De Leon et al. 2014, Neve et al. 2014, Stockmann et al. 2014, 
Talwar and Srivastava 2014). The ‘Rap1 signalling pathway’ is controlled by Rap1, an 
enzyme of the GTPase family which is responsible for the control of cell-cell and cell-
matrix interactions and has a specific role in cell adhesion, cell-cell junction formation 
and cell polarity. The ‘Ras signalling pathway’ is controlled by small GTPase enzymes 
which are predominantly involved in intracellular signal transduction. This pathway 
controls cellular outcomes such as cytoskeleton organisation, cell motility and migration 
or cell growth, cell survival and cell death. The ‘PI3K-Akt signalling pathways’ have 
been shown to link a number of fundamental cellular functions such as protein 
synthesis, cell survival, cell growth, cell proliferation, angiogenesis, cell metabolism 
and cell cycle progression. 
FGF2 and HIF1A were linked by the ‘Proteoglycans in cancer’ pathway and a number 
of publications (Chung et al. 2012, De Leon et al. 2014, Jiang et al. 2014, Riabov et al. 
2014, Stockmann et al. 2014, Talwar and Srivastava 2014, Wise et al. 2012), whilst 
HIF1A was linked to NOS2 via a curate pathway published in NCI-Nature Pathways 
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Interaction Database (http://www.ndexbio.org/), the ‘HIF-1 signalling pathway’, 
‘Pathways in cancer’ and in the literature by publication (Bao et al. 2012, Elks et al. 
2013, Lehner et al. 2011). ANGPT1, FGF2 and HIF1A were linked in numerous 
publications (De Leon et al. 2014, Hadjipanayi and Schilling 2013, Peplow and Baxter 
2012, Riabov et al. 2014, Stockmann et al. 2014, Talwar and Srivastava 2014) but were 
not linked by a known signalling pathway. There were no signalling pathways linking 
all four genes together and only a single publication in the literature (Lavine et al. 2013) 
that has examined all four of these genes together in one investigation and found a link 
between them. The link between these genes is angiogenesis induced by ischemia or 
lack of oxygen (which in a general tissue would be referred to as hypoxia). Although we 
are unable to determine whether there was an up- or down-regulation of expression in 
these genes, which would enable us to compare trends in gene expression with those 
outlined by Lavine et al. (2013) directly; we can hypothesise at this juncture that the 
application of an orthodontic force for any duration of time may result in hypoxia and 
induce an angiogenic response. 
STRING and KEGG were used to identify any pathways with which the borderline 
significant genes were associated. ITGAV, KDR and PDGFA were shown to be 
associated with the ‘PI3K-Akt signalling pathway’ and the ‘Focal adhesion’ pathway. 
KDR and PDGFA were shown to be associated with the ‘Rap1 signalling pathway’, the 
‘Ras signalling pathway’ and the ‘Cytokine-cytokine receptor interaction’ pathway. 
ITGAV and PDGFA were shown to be linked by the ‘Regulation of actin cytoskeleton’ 
pathway whilst ITGAV and KDR were linked by the ‘Proteoglycans in cancer’ pathway 
and the curate pathway ‘VEGFR2 (dimer)/ VEGFA (dimer)/ ITGAV-ITGB3/ 
Vitronectin’ published on the NCI-Nature Pathways Interaction Database 
(http://www.ndexbio.org/). ITGAV and TGFBR1 were linked via curate pathways 
‘Complex assembly’ and ‘Complex: ITGAV-ITGB8/TGFBR1’ published on the NCI-
 - 217 - 
Nature Pathways Interaction Database (http://www.ndexbio.org/). As evidenced from 
the data available from current literature, a number of the genes with borderline 
significance were linked to those with statistical significance through a variety of 
signalling pathways. The pathways that these genes are linked together by suggest that 
there is an alteration within the tissue directly associated with cellular adhesion, 
intracellular signalling, cell survival and angiogenesis in response to orthodontic force 
application. It is hypothesised that these genes would also be involved in the angiogenic 
response of the human dental pulp to hypoxia induced by orthodontic force application 
but may require a longer duration than two weeks of force application or perhaps a 
greater intensity of force in order to obtain a level of statistical significance. 
When comparing force application for 1 day with force application for 3 days, there was 
shown to be a statistically significant difference in the expression of ANGPT1 and 
HIF1A; and a borderline significant difference in the expression of FGF2, ITGAV and 
NOS2. Although the analysis does not indicate whether these genes are up- or down-
regulated in response to a longer duration of force, these findings are important as they 
provide an indication as to possible tissue responses of the pulp in reaction to routine 
orthodontic treatment. ANGPT1 and HIF1A are not linked by any known signalling 
pathways but are linked in the literature to angiogenesis (De Leon et al. 2014, Forget et 
al. 2014, Riabov et al. 2014, Stockmann et al. 2014) and hypoxia (Fan et al. 2014, 
Hadjipanayi and Schilling 2013). FGF2, ITGAV and NOS2 are all linked by the 
‘Pathways in cancer’ signalling pathway and in the literature to angiogenesis in HIV-
infected patients (Rasheed et al. 2009). 
Between the next duration of force, 3 days to 2 weeks, there was shown to be a 
significant difference in the mRNA expression of the genes ANGPT1, FGF2, HIF1A, 
ITGAV, KDR, PDGFA, TEK and TGFBR1. There was also a borderline significant 
difference in the mRNA expression of ITGB3 and MMP2. There was no signalling 
 - 218 - 
pathway or literature that linked all 8 of the significantly differentially expressed genes 
between these two experimental time-points; however, a number of genes were linked 
by specific signalling cascades and in the literature. ANGPT1, FGF2, ITGAV, KDR, 
PDGFA and TEK were all linked by the ‘PI3K-Akt pathway’ but a maximum of five of 
these genes were shown to be linked in a single publication at any one time. The genes 
were linked in the literature to hypoxia, vascular differentiation and angiogenesis (Burns 
et al. 2011, Carmeliet and Collen 1998, Deng et al. 2006a, Deng et al. 2006b, 
Paternostro et al. 2010, Rahbari et al. 2011, Tressel et al. 2007, Vacca et al. 2003). 
ANGPT1, FGF2, KDR, PDGFA and TEK were linked by the ‘Rap1 signalling 
pathway’ and the ‘Ras signalling pathway’ in addition to the ‘PI3K-Akt signalling 
pathway’ and were linked in the literature to angiogenesis (Rahbari et al. 2011, Tressel 
et al. 2007).  
ITGB3 and MMP2 although shown to be effected in a borderline significant manner as 
a response to orthodontic force application, are not linked to each other in the literature 
or by any known pathway. They were however linked to known signalling cascades and 
published works when considered with the other significantly differentially expressed 
genes at this time-point of force application. ITGB3 was shown to be linked to ITGAV 
and FGF2 in the ‘Syndecan interactions’ pathway and to ITGAV and KDR in the 
curated pathway ‘VEGFR2 (dimer)/ VEGFA (dimer)/ ITGAV-ITGB3/ Vitronectin’ 
published on the NCI-Nature Pathways Interaction Database (http://www.ndexbio.org/). 
ITGB3, linked with these other genes in the literature was shown to be directly related 
to angiogenesis (Bhuvaneswari et al. 2008, Carmeliet and Collen 1998, Hanjaya-Putra 
et al. 2011, Hayashi et al. 2008, Mottet et al. 2007, Niland and Eble 2012, Rivera and 
Brekken 2011, Yao et al. 2006). MMP2 was shown to be linked to the significantly 
different genes by the ‘Pathways in cancer’ and the ‘Proteoglycans in cancer’ signalling 
pathways. It has been shown in the literature to be associated with hypoxia and 
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angiogenesis (Deng et al. 2006a, Deng et al. 2006b, Glesne et al. 2006, Lewis and 
Pollard 2006, Paternostro et al. 2010, Vacca et al. 2003). 
Over the entire experiment, from 1 day of force application to 2 weeks of treatment, 
there was shown to be a statistically significant difference in the mRNA expression of 
NOS2. HIF1A, KDR and TGFBR1 mRNA expression were also affected by the 
application of orthodontic force for the full period of 2 weeks, although this was less 
significant statistically when compared to the changes in NOS2 mRNA expression. 
NOS2 is an inflammatory mediator and is known to be associated with several of the 
signalling pathways previously mentioned, i.e. ‘Proteoglycans in cancer’ and the ‘Rap1 
signalling pathway’. It has shown to be prevalent in the literature amongst studies of 
cellular stress (Verma et al. 2014, Zhang et al. 2014), hypoxia (Branco-Price et al. 
2013, Cowburn et al. 2013, Lehner et al. 2011), cell death (Iwashina et al. 1998) and 
angiogenesis (Breton-Romero and Lamas 2014, Singh et al. 1996). HIF1A, KDR and 
TGFBR1 were shown to be related in the literature but not by any known signalling 
pathways. These genes were shown to be associated with hypoxia (Ciuclan et al. 2011, 
Porter et al. 2014), angiogenesis (Albini et al. 2007, Ciuclan et al. 2011, Ozkan et al. 
2012, Porter et al. 2014, Tressel et al. 2007) and erythrocyte differentiation (Fraser 
2013). 
It is important to note at this point in time that whilst a number of genes have been 
shown to be responsive to various durations of force application, the links in the 
literature and signalling pathways are for protein-protein interactions and not for 
mRNA. We have hypothesised prior to investigation that an application of orthodontic 
force will induce an angiogenic response as previously demonstrated by Derringer et al. 
(Derringer et al. 1996, Derringer and Linden 1998, Derringer and Linden 2003, 
Derringer and Linden 2004, Derringer and Linden 2007) but it is important to consider 
that prior to the translation of proteins from up-regulated mRNA, multiple post-
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transcriptional regulatory processes occur which may eliminate or enhance the 
translation of a given protein. We maintain that the genes shown to be effected by an 
application of orthodontic force are linked to an angiogenic response within the pulp but 
cannot conclude at this juncture that an application of orthodontic force will result in 
increased angiogenic protein. 
4.5.7 Is the mRNA Expression of Angiogenesis-Specific Genes in the 
Human Dental Pulp Linked? 
A factor analysis was performed by Dr Nora Donaldson in order to determine whether 
any commonality in gene expression variability existed across all time-points of 
treatment. This was done despite there being an undeterminable baseline of expression 
for the GOIs due to the large amount of biological variability present. Significance was 
set at 5 % and analysis was performed on normalised Cq data. By performing this 
analysis we were able to determine that mRNA expression for the genes MMP2, 
TGFB1 and VEGFA was the most tightly correlated and that expression would change 
in the same direction, i.e. if MMP2 was up-regulated, TGBF1 and VEGFA would also 
be up-regulated. By STRING analysis (www.string-db.org) MMP2, TGFB1 and 
VEGFA were shown to be linked via the ‘Pathways in cancer’ and ‘Proteoglycans in 
cancer’ signalling pathways. They were also shown to be linked in the literature to 
angiogenesis (Riabov et al. 2014), inflammation (Landskron et al. 2014) and hypoxia 
(Angelini et al. 2013). As VEGFA is a mitogenic factor specific to endothelial cells; 
MMP2’s primary function is the degradation of proteins in the extracellular matrix to 
regulate neovascularization and TGFB1 is an anti-inflammatory cytokine; the finding 
that these genes are tightly correlated in response to orthodontic force application over a 
duration of 1 to 14 days suggests that the human dental pulp may undergo an amount of 
oxidative stress, inducing inflammation and an angiogenic response to regulate for these 
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changes; or perhaps an inflammatory response to orthodontic treatment leads to hypoxia 
in the pulp followed by a subsequent regulatory angiogenic response. 
ANGPT1, FGF2, HIF1A, ITGAV, ITGB3, KDR, PDGFA, PDGFB, ROBO4, SELE, 
TEK and TGFBR1 were all shown to be correlated and to change in the same direction. 
According to STRING analysis (www.string-db.org), where gene co-expression was 
assessed, there was no co-expression of these genes found amongst Homo sapiens. The 
only co-expression found was in the mouse model between TEK and ROBO4. Despite 
this finding, a number of these genes are known to be linked within the literature 
(Carmeliet and Collen 1998, Fan et al. 2014, Murakami 2012, Paternostro et al. 2010, 
Riabov et al. 2014, Stockmann et al. 2014, Talwar and Srivastava 2014). 
We have found evidence in the literature to contest the finding that ANGPT1, PDGFB 
and TEK are correlated and will be up- or down-regulated concurrently; all other genes 
were shown to increase or decrease in expression while linked to the similar response of 
the remaining genes in the panel, according to the literature. TEK and PDGFB are 
known to be linked through the Rap1, Ras and PI3K-Akt signalling pathways 
(www.string-db.org) and a down-regulation of PDGFB has previously been associated 
with a collaborative regulation by ANGPT1 and TGFB1 (Nishishita et al. 2004). 
PDGFB has also been shown to be down-regulated by increased TEK expression in 
Human Umbilical Vein Endothelial Cells (HUVEC) (Uebelhoer et al. 2013). Therefore 
as ANGPT1 increases, TEK is thought to increase and thus results in a decrease in 
PDGFB expression. 
It is interesting to note that should HIF1A be up-regulated in response to hypoxia, 
induced by an application of orthodontic force, the remaining genes which are known to 
be associated with inflammation and angiogenesis will also be up-regulated in a 
correlated fashion.  
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IL8 and NOS2 were the only genes found not to be correlated to any of the other GOIs 
under our experimental conditions and were independent of each other, i.e. as IL8 was 
up-regulated; there was neither up-regulation nor down-regulation of NOS2 mRNA. 
This was not expected as NOS2 has previously been shown to enhance the synthesis of 
IL8 (Vuolteenaho et al. 2009) and gene expression should not only have been linked but 
should have been expressed in a similar direction, according to this publication. IL8 is 
also a pro-inflammatory chemokine and there was an expected association with TGFB1 
as not only did TGFB1 show the potential to link inflammation to angiogenesis and 
hypoxia in the orthodontically treated pulps but IL8 has previously been shown to be 
regulated by TGFB1 in human prostate cancer cells (Lu and Dong 2006). The lack of 
correlation between these genes and those of the rest of the panel are not understood at 
this time and further investigation is required in order to fully understand the changes in 
mRNA expression in the human dental pulp during routine orthodontic treatment. 
4.5.8 Correcting for Biological Variability Allows for Statistically Valid 
Conclusions to be Drawn 
Following multiple, varied analyses of the normalised Cq data in order to determine the 
effects of orthodontic force duration or patient phenotypic factors on the mRNA 
expression of the GOIs, we came across a methodology in the literature which would 
eliminate the effects of biological variability on the mRNA expression data. The 
methodology outlined by Willems et al. (2008) had previously been used in microarray 
data transformation to identify a “robust and powerful method to standardise 
independent biological replicate experiments so as to draw out statistically sound 
conclusions from a dataset that otherwise was of limited value due to high inter-
experimental variation.”. A copy of the published literature (Willems et al. 2008) and 
our spreadsheet of formulae defining our understanding of the methodology was sent to 
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Dr Nora Donaldson for clarification prior to analysing raw Cq values as a number of 
steps within the method had not been included in the publication of Willem et al.’s 
(2008) paper. We have outlined the full methodology used in Chapter 8, section 8.2.1  
Following analysis with the variability correction method, we were able to observe 
statistically significant changes in mRNA expression at every time-point of orthodontic 
force application. These findings were in agreement with those outlined by the original 
authors (Willems et al. 2008) where initial analysis by Livak et al.’s (2001) method 
yielded no significant results but additional standardisation cancelled out high levels of 
inter-experimental variation and enabled the observation of statistically significant 
differences in the various treatment groups.  
By comparing the graphs for the REST analyses (Figure 14 – Figure 16) against those 
created following the correction for biological variability (Figure 17 – Figure 19) it 
was clear to see that the trends observed in the REST analyses were equivalent to those 
present in the variability-corrected samples. These findings further substantiated the 
relevance and accuracy of Willem et al.’s (2008) method and Dr Nora Donaldson’s 
clarification of their processes in order to obtain statistical significance. 
There was shown to be a statistically significant up-regulation of TEK mRNA and 
significant down-regulation of PDGFB mRNA following a period of 1 day’s 
orthodontic treatment (Figure 17). TEK and PDGFB are known to be linked through 
the Rap1, Ras and PI3K-Akt signalling pathways (www.string-db.org) and a down-
regulation of PDGFB has previously been associated with a collaborative regulation by 
ANGPT1 and TGFB1 (Nishishita and Lin 2004). PDGFB has also been shown to be 
down-regulated by increased TEK expression in HUVEC (Uebelhoer et al. 2013). It is 
thought that stimulation of TEK by ANGPT1 results in the downstream phosphorylation 
of Akt and that this process is necessary for the maintenance of the vasculature as 
PDGFB is a vascular smooth muscle cell (vSMC) attractant and would result in 
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numerous attachments of pericytes on the vessel outer walls, should this process not be 
regulated. In order to validate our findings according to the publication by Nishishita 
and Lin (2004), we would have to see an increase in expression of both ANGPT1 and 
TGFB1. This was not the case, as there was only an observed increase in ANGPT1 
expression. Therefore, we can justify our findings according to the publication by 
Uebelhoer et al. (2013) where TEK is stimulated by ANGPT1 resulting in downstream 
down-regulation of PDGFB. We had originally hypothesised that there would be a 
greater change in expression amongst a wide panel of genes following the application of 
an orthodontic force for 24 hr but here we see an almost homeostatic process being 
induced as a response to treatment. Cytokines and chemokines associated with the 
inflammatory response were all down-regulated at this time-point of force application 
and HIF1A expression was shown to marginally increase. Although the expression of 
HIF1A was not statistically significant, this trend may indicate the inception of hypoxia 
in the human dental pulp as an immediate response to orthodontic force application. 
After 3 days of orthodontic treatment, pulps exhibited a general trend of down-
regulation in mRNA expression, with a statistically significant down-regulation of 
ANGPT1, HIF1A, KDR, PDGFA, PDGFB, ROBO4, TEK and TGFBR1 mRNA 
(Figure 18). This result corroborates our previous findings from the factor analysis 
(Table 64), which showed that these genes are loosely correlated and will increase or 
decrease in a like manner.  
A down-regulation of ANGPT1 expression has been linked in the literature to hypoxia, 
and therefore to an increase in HIF1A expression (Tsuzuki et al. 2013). Our findings are 
contrary to this in that we have observed a decrease in both ANGPT1 and HIF1A in 
response to 3 days of routine orthodontic treatment. In another study, HIF1A was shown 
to be linked to the activation of angiogenic growth factors including ANGPT1, PDGFB 
and VEGFA (Manalo 2005), indicating that these genes are correlated and will 
 - 225 - 
increase/decrease in a linked manner as per our findings in the factor analysis. Not 
enough literature is available to make a conclusive statement as to either corroborate or 
invalidate our findings with respect to the behaviour of these two genes at this treatment 
time-point. 
It has been shown in the literature that an increase in phosphorylated KDR will occur 
simultaneously with an increase in HIF1A (Giatromanolaki et al. 2008), therefore our 
finding that these two genes are down-regulated together suggests that the angiogenic 
and hypoxic responses may be linked in the human dental pulp’s reaction to orthodontic 
treatment. 
PDGFA and PDGFB have been shown to be expressed at different rates but also have 
been shown to be expressed at the same rate in a similar direction; depending on the cell 
type (Barrett and Benditt 1988). The correlation seen amongst the panel of genes that 
have been investigated in our study may relate not only to function of the gene within 
the cell but also to cellular composition. 
PDGFB and ROBO4 were shown to be concurrently down-regulated in the literature in 
a state of hyperoxia (Ishikawa et al. 2010). Hyperoxia is an excess of oxygen or 
increased partial pressure of oxygen in a tissue and is an opposing condition to hypoxia. 
Should hyperoxia exist in the human dental pulp at 3 days of force application, we 
should expect a down-regulation of HIF1A, KDR and TGFBR1 mRNA expression 
according to the literature (Lin et al. 2005, Moen et al. 2009, Ozaki et al. 1999). Our 
findings corroborate the expected down-regulation of mRNA expression for these genes 
and suggest that a state of hyperoxia may exist in the human dental pulp at 3 days of 
orthodontic force application.  
It was surprising to note that following 3 days of treatment PDGFB and TEK were 
concurrently down-regulated. We have previously shown evidence from the literature to 
substantiate our findings at 1 day of force application that as TEK increases, PDGFB is 
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down-regulated (Uebelhoer et al. 2013). As ANGPT1 and TEK have been strongly 
linked in the literature (Augustin et al. 2009, Kuroda et al. 2001, Thomas and Augustin 
2009, Wehrle et al. 2009) and have been linked in both the factor analysis and the 
variability corrected relative expression analysis, we hypothesise that the mechanism by 
which PDGFB is regulated at 3 days of force application must be different to the 
homeostatic mechanism outlined by Uebelhoer et al. (2013) which supports our 
findings at 1 day of force application. 
There was an observed increase in the expression of IL8 at this stage of routine 
orthodontic treatment and although this increase in mRNA expression did not reach 
statistical significance, it is imperative to note that IL8 has only been isolated from 
dental pulps in a state of inflammation. IL8 has also been shown to be linked to 
hyperoxia (Hjort et al. 2003, Lee and Kim 2011) and we hypothesise that following the 
inception of orthodontic force application, there is a state of hypoxia which induces an 
inflammatory and angiogenic response in the pulp. Due to the morphology of the pulp, 
with closed apices, there may be an over compensatory affect of the angiogenic or 
inflammatory response which results in hyperoxia within the tightly encapsulated tissue. 
This hypothesis requires verification by light microscopy to investigate whether there is 
an observable increase in the vasculature of the treated pulps between 1 and 3 days of 
force application that could support our proposed reaction of the pulp to treatment. 
After 2 weeks of orthodontic treatment there was a general trend towards up-regulation 
of mRNA expression in the GOIs (Figure 19). There was shown to be a statistically 
significant difference in HIF1A, ITGAV, KDR and TGFBR1 mRNA expression. When 
analysed using STRING (www.string-db.org), only three of the four genes were shown 
to be linked by known signalling pathways whilst pairs of genes were shown to be 
associated via other known pathways. ITGAV, KDR and HIF1A were shown to be 
linked via the ‘Proteoglycans in cancer’ signalling pathway while ITGAV was paired 
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with HIF1A via both the ‘Thyroid hormone signalling pathway’ and ‘Pathways in 
cancer’. ITGAV was linked with KDR through the ‘Focal adhesion’ pathway, the 
‘PI3K-Akt signalling pathway’ and the curated pathways for ‘Complex: 
VEGFR2(dimer) /VEGFA(dimer)/ Hsp90/ ITGAV/ ITGB3/ Victronectin’ and 
‘Complex: ITGAV/ ITGB3/ VEGFR2/ VEGFA(dimer)’ published on the NCI-Nature 
Pathways Interaction Database (http://www.ndexbio.org/). ITGAV was paired with 
TGFBR1 through the curated pathways: ‘Complex Assembly’ and ‘Complex: 
ITGAV/ITGB8/TGFBR1’ published on the NCI-Nature Pathways Interaction Database 
(http://www.ndexbio.org/). There was no signalling pathway evidence to suggest that 
KDR or HIF1A were linked with TGFBR1. 
ITGAV, HIF1A and KDR were all shown in the literature to be up-regulated together in 
endometrial samples from patients with ovarian endometriosis, where eutropic 
endometrial tissue is hypothesised to have an abnormal angiogenic potential (Laudanski 
et al. 2014). Whilst HIF1B is constitutively expressed in the cell, HIF1A is only up-
regulated in response to hypoxia (Wang et al. 1995), suggesting that following two 
weeks of force application, the human dental pulp is in a state of oxidative stress and 
that an angiogenesis is being initiated as a response to this stress state. 
ITGAV and KDR increases were linked in the literature to angiogenesis (Avraamides et 
al. 2008) and to coagulation (D'Asti et al. 2014). As it has previously been observed 
that orthodontic force application has resulted in congested vasculature of the human 
dental pulp (Lazzaretti et al. 2014, Mostafa et al. 1991), this increase in mRNA 
expression associated with coagulation may confirm previous findings but has yet to be 
investigated at the proteomic level. 
At this time-point of treatment, there was also an increase in the mRNA expression of 
IL8 and NOS2; although neither of these reached a level of statistical significance it is 
important to note that these genes are only increased in cases of inflammation and we 
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hypothesise that in addition to a state of oxidative stress, the human dental pulp is in an 
inflammatory state at two weeks of routine orthodontic treatment. 
It is interesting to note that at two weeks of orthodontic force application, there was a 
decrease in the expression of VEGFA and TGFB1 mRNAs. These two genes are 
normally at the forefront of the angiogenic response and it may be the case that while 
hypoxia is present, the angiogenic response has only begun to be initiated. Further work 
will need to be carried out in a strict time-course from 14 days of treatment onward to 
be able to ascertain true response mechanisms in the pulp. 
4.5.9 Determining Changes in Protein Expression by ELISA 
Where possible, protein analysis was performed on samples obtained from patients 
previously assigned to the mRNA expression analyses in order to reduce the 
introduction of further biological variability to the sample data. It has been shown that 
maxillary and mandibular teeth respond in a similar manner to orthodontic force 
application, with respect to cellular respiration (Hamersky et al. 1980) and it was 
therefore assumed that protein and mRNA expression results within patients would be 
relatively comparable.  
A custom multiplex ELISA (Quantibody® Array) was created and performed by 
RayBiotech Inc., Georgia, USA for 10 of the 17 genes analysed at the transcriptomic 
level. These genes were selected based upon availability and relevance to the original 
protein studies performed by Derringer et al. (Derringer and Linden 2003, Derringer 
and Linden 2004). Due to the size of the assay plate, only 5 patients were selected for 
each treatment time-point.  
It was shown in all samples, across all treatment time-points that FGF2 was the only 
protein expressed in pulp samples above the lower LOD for the ELISA assay. This was 
not expected as despite our previous observations, where human dental pulps yield low 
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concentrations of mRNA (Chapter 3), we had supposed that due to the cellular nature 
of the tissue, protein concentrations would be greater and in particular, more abundant 
than the low concentrations at which the ELISA assay limits were set. It was confirmed 
by RayBiotech Inc., Georgia, USA that the 1 ml sample aliquots had been delivered to 
them on dry ice and had not thawed or denatured during transportation. The original 
BCA assay concentrations were verified and were compared to guidelines for assay 
sensitivity where the assay was shown to have a detection limit between 20 –  
2000 µg/ml (Johnson 2012). According to the BCA assay results, total protein 
concentrations extracted from the pulp samples were in the range of 71799.31 – 
527162.63 µg/ml. This was well above the BCA assay’s LOD and in contradiction to 
the low concentrations observed in the ELISA, which was performed on sample aliquots 
with a standardised concentration of 2 µg/µl. It should be stressed at this point that the 
BCA assay does not only measure the concentration of a limited selection of genes but 
rather, measures the concentration of total extracted protein from the tissue 
homogenates. Concentrations of the GOIs were found to be extremely low in the tissue 
homogenate by the ELISA and it is proposed that in order to adequately quantify 
changes between control and orthodontically treated pulp samples, so as to make 
conclusive statements regarding the tissue’s response to treatment, a high-sensitivity 
assay such as fluorescent amplification catalysed by T7 polymerase technique (FACTT) 
should be utilised instead (Zhang et al. 2006).  
A paired Student’s t-Test was performed on the FGF2 results and there was shown to be 
no statistically significant difference in the protein expression of this gene between the 
treated and the control groups at any of the experimental time-points of orthodontic 
treatment. Unlike high-sensitivity microarray or mass spectrometry experiments where 
normalisation for inter-sample and inter-experimental variation is considered (Kreil et 
al. 2004, Ting et al. 2009), no such correction is currently available for ELISA data. 
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Analyte data was normalised against the total input of analyte per reaction (µg/ml) and 
concentrations of analyte present in the sample (pg/ml) were calculated from a standard 
curve of positive control for the protein of interest. As no baseline of cellular activity in 
the control samples could be determined, each patient’s contralateral pair should be 
compared qualitatively and individually, so as not to make conclusive remarks with 
respect to the increased or decreased expression of proteins as a response to force 
application. 
When sample pairs that expressed analyte concentrations greater than the assay’s lower 
LOD were assessed qualitatively, it was observed that FGF2 abundance increased at  
1 day and 2 weeks of treatment but decreased at 3 days. This trend matches that which 
was observed in the mRNA expression data following the correction for biological 
variability. This suggests that an increase in FGF2 mRNA expression yields a direct 
increase in FGF2 protein abundance (Moffett et al. 1998) and that FGF2 is translated to 
protein in the human dental pulps with minimal post-transcriptional modification as 
there appears to be little time lapse between transcription and translation. 
FGF2 is a pleiotropic factor and acts in a paracrine, intracrine and autocrine manner 
(Delrieu 2000, Gomm et al. 1997, Kim and Ma 2013, Lefevre et al. 2009, Presta et al. 
2009, Stachowiak et al. 1997). It has been shown to be associated with inflammation, 
angiogenesis, neuronal growth, neurotransmitter synthesis and the response to 
neuropathic pain (Mocchetti et al. 1996, Presta et al. 2005, Presta et al. 2009, 
Yamanaka et al. 2007). With respect to angiogenesis and inflammation, FGF2 is known 
to regulate the expression of extracellular matrix components, induce 
neovascularisation, stabilise vasculature and recruit pericytes through the induced 
expression of PDGFB and TGFB1 (Andres et al. 2009, Presta et al. 2005, Presta et al. 
2009). We have previously suggested in our mRNA expression analyses that 
orthodontic force application may induce hypoxia, angiogenesis and inflammation 
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within the human dental pulp; although this has yet to be confirmed and the order in 
which these three responses occur are yet to be determined. The observed increase in 
FGF2 protein abundance in treated human dental pulps at the 1 and 14 day time-points 
may link to our hypotheses as it has been shown in the literature that “inflammatory 
mediators can activate the endothelium in order to synthesise and release FGF2 which 
will stimulate angiogenesis by an autocrine mechanism” and may lead to an increase in 
interstitial fluid and hypoxia (Kuwabara et al. 1995, Presta et al. 2009, Wang et al. 
2000). As the results from the ELISA are only able to be assessed qualitatively due to 
the lack of variability correction protocols and a number of samples falling below the 
LOD, no direct correlation can be drawn between our observations and our hypothesis. 
Yet, should inflammation occur and angiogenesis be induced, we would expect to see 
an increase in PDGFB and TGFB1 proteins which would correlate with pericyte 
recruitment and increased interstitial fluid pressure. We can make no comment as to the 
pulp’s response with respect to hypoxia as HIF1A was not available for analysis on the 
ELISA plate. We do however confirm the findings of Derringer et al. (Derringer and 
Linden 2003, Derringer and Linden 2004), where an application of orthodontic force for 
a period of 2 weeks will result in increased FGF2 protein abundance in the human 
dental pulp; and the findings of Tran-Hung et al. (2006) who have identified that FGF2 
increases in the human dental pulp following injury. 
With respect to the other angiogenic growth factors assessed by Derringer and Linden 
(2003, 2004), there were no distinguishable trends that we could observe from the 
TGFB1 or VEGFA ELISA data due to concentrations in the tissue homogenates being 
below the assay’s lower LOD and the majority of the sample pairs having a negative 
result from either one or both of the pulps. Our findings do not discredit those of 
Derringer and Linden (2003, 2004) however, as this group utilised neutralising 
antibodies to confirm the presence of secreted growth factors. Any amount of growth 
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factor present would have been neutralised by these antibodies to some extent and as we 
were unable to determine the concentrations with an ELISA, we cannot state 
conclusively that there is no increase in TGFB1 or VEGFA production or secretion but 
rather that the analytes present are well below our assay’s limits of detection. We 
propose that further work be carried out with high-sensitivity assays in order to 
determine concentrations and relative changes in abundance of these growth factors 
before a conclusive statement is made. 
There was no observable change in protein abundance of PDGFB following 1 day of 
force application between control and treated samples. Protein abundances increased at 
3 days of treatment and then decreased by 2 weeks of treatment. These findings are in 
contrast to our mRNA expression analyses which showed a decrease in PDGFB mRNA 
at treatment days 1 and 3 and no distinguishable change between the control and treated 
samples at 2 weeks of treatment. PDGFA protein abundance was shown to decrease at 
all three time-points of force application which also contradicts the mRNA expression 
findings. In the variability corrected mRNA expression analysis, it was seen that 
PDGFA is down-regulated at 1 and 3 days before being up-regulated at 2 weeks of force 
application. 
PDGF is a dimeric glycoprotein that can be expressed as either of the homodimers 
PDGF-AA or PDGF-BB; or as the heterodimeric PDGF-AB (Kaetzel 2003, Meyer-
Ingold and Eichner 1995, Shih and Holland 2006). All isoforms are known to bind to 
the receptor PDGFRB, while receptor PDGFRA binds only the PDGF-AA homodimer 
(Heldin et al. 1989, Heldin and Westermark 1999, Kaetzel 2003, Shih and Holland 
2006). In our ELISA analysis, we attempted to quantify the concentrations of the 
homodimers, PDGF-AA and PDGF-BB, while PDGF-AB was not considered due to 
unavailability from the supplier.  
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It is well established that PDGFB plays a significant role in angiogenesis, particularly in 
stabilisation of the neovasculature by pericyte recruitment (Abramsson et al. 2003, 
Andrae et al. 2008, Gianni-Barrera et al. 2014, Lindblom et al. 2003, Wang et al. 2012) 
It has also been shown to play a role in fibrotic diseases, such as atheroscleroris (Libby 
et al. 1988), pulmonary fibrosis (Abdollahi et al. 2005) and liver cirrhosis (Zhou et al. 
2014), which are resultant of inflammation in the tissues. In addition to its role in the 
inflammatory response, it has been documented that PDGFB plays a crucial role in the 
homeostasis of interstitual fluid pressure (Heuchel et al. 1999, Wiig et al. 2003) and is 
responsible for increasing pressure to a point that may result in interstitial hypertension 
(Pietras et al. 2001, Reed and Rubin 2010). 
We observed an abundance of this protein following 3 days of force application, a time-
point where we have previously hypothesised that the tissue is in a state of hyperoxia. 
According to the literature, PDGFB mRNA and proteins are suppressed by hyperoxia 
(Zhang et al. 2005). This suggests that hyperoxia appears to be a less likely cause of the 
transcriptomic and proteomic differences observed in treated pulps at this time-point of 
treatment. Should hyperoxia not occur at this experimental time-point, the additional 
differences observed in the mRNA and protein abundances indicate that pulps 
undergoing routine orthodontic treatment are in an inflammatory state at 3 days of 
treatment. The increased PDGFB abundance would compliment this hypothesis of an 
inflamed pulp and may substantiate our finding of increased HIF1A mRNA expression 
in the two week samples; should an increase in PDGFB protein at 3 days of treatment 
result in increased interstitial fluid pressure in the tightly encapsulated tissue and lead to 
oxidative stress and a possible hypoxic response. We have already identified an increase 
in FGF2 analyte abundance following 1 day of force application and have noted that 
increased FGF2 is responsible for the regulation of PDGFB, resulting in increased 
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interstitial fluid pressure (Presta et al. 2009). This compliments our finding of increased 
PDGFB analyte abundances at 3 days of force application. 
We propose that further investigation be carried out in order to determine the changes in 
interstitial fluid pressure, the incidence of inflammation and the possible hypoxic 
response to this inflammation in a time-course of force application in order to make any 
conclusive statement as to the pulp’s response to orthodontic treatment. We also 
propose that a larger group of patients be investigated in order to determine true 
changes; as five patients per treatment group, where known large-scale biological 
variabilty exists, is only representative of a preliminary screening of the true 
physiological response. 
The PDGFA and PDGFB protein chains are subject to different regulatory mechanisms 
and are produced by different cell types in differing ratios (Dirks and Bloemers 1995, 
Hoch et al. 2003, Kaetzel 2003, Meyer-Ingold and Eichner 1995, Shih and Holland 
2006). This has been demonstrated further by Rahmann et al. when investigating 
osteoclastogenesis, where all three isoforms of PDGF were analysed and found to be 
sectreted at distinct stages of bone generation (Rahman et al. 2015). PDGFA is required 
for epithelial cell proliferation and has been associated with increased proliferation of 
mesenchymal stem cells but is primarily active during embryogenesis (Landskron et al. 
2014, Mizuno et al. 2015, Sukhotnik et al. 2012). At all three experimental time-points, 
we observed a decrease in PDGFA analyte expression in treated samples compared with 
untreated controls. There is no evidence in the literature to suggest that inflammation, 
hyperoxia or hypoxia would result in decreased protein expression for this GOI. We 
therefore propose that in order to make a conclusive statement as to the effect of 
orthodontic force application on PDGFA protein expression, a larger group of patients 
needs to be examined. The differences between control and treated pulps in the protein 
abundance analysis appear to contradict the results obtained from the variability 
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corrected mRNA analysis, where there was an increase in mRNA expression following 
two weeks of force application.  
We have previously suggested that an increase in PDGFB protein, as a potential result 
of orthodontically induced inflammation, may alter the interstitial pressure of the tissue 
and induce hypoxia at the two week time-point. It has also been documented that an 
increase in PDGFB mRNA will precede an increase in PDGFA mRNA in hypoxic 
vascular remodelling (Katayose et al. 1993) and in wound healing (Pierce et al. 1995). 
This suggests that despite our observing a decrease in PDGFA analyte concentration at 
two weeks, the increase in PDGFA mRNA expression is linked to the increased PDGFB 
expression within our time-course; and that the changes observed in the pulpal response 
to force application correspond with published reactionary mechanisms of inflammation 
resulting in increased interstitial fluid pressure and possible hypoxia. 
As no conclusive statement can be made from our qualitative data analysis in order to 
corroborate or repudiate the findings of Derringer and Linden (2003, 2004), we propose 
that the activity of both receptors, PDGFRA and PDGFRB, be assessed; as Derringer 
and Linden’s studies utilised blocking antibodies for PDGF and did not specify whether 
PDGFA or PDGFB was being secreted by the pulps in response to routine orthodontic 
treatment. 
Our study also showed an increase in the protein abundance of SELE at all time-points 
of treatment; this was in contradiction to the changes observed in the variability 
corrected mRNA expression data where at 1 and 14 days there was no perceivable 
change relative to the control samples; and in the 3 day treated samples where mRNA 
expression was down-regulated in response to force application. SELE protein is 
synthesised when vascular endothelial cells are stimulated by pro-inflammatory 
cytokines (Kawase et al. 2009), in order to attract, bind and activate circulating 
leukocytes to the site of inflammation or injury (Kraiss et al. 2003, Winkler et al. 2012). 
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The increase in the expression of this analyte observed in the treated samples, relative to 
untreated controls suggests that orthodontic force application induces inflammation 
within the human dental pulp. In the mRNA expression analysis, we noted an increase 
in pro-inflammatory chemokine IL8 at days 3 and 14 of treatment, with an additional 
increase in NOS2 expression at 14 days of force application. These mRNA expression 
changes, confirm that inflammation may be occurring in the dental pulp as a response to 
routine orthodontic treatment. However, no clear conclusion can be made at this time as 
protein concentrations for these GOIs were not investigated due to the unavailability of 
these genes in the ELISA reaction. 
4.5.10 Investigating Changes within Individuals to Determine the Effect 
of Force Application on Protein Expression at Distinct Treatment 
Time-Points 
Further qualitative assessment was performed in collaboration with Dr Nora Donaldson 
in order to determine whether trends in expression at any of the time-points could be 
observed. Sample pairs where one of the two samples gave an undeterminable reading 
of 0 pg/ml were excluded but all other samples whether above or below the assay’s 
lower LOD were considered. 
Following 1 day of orthodontic treatment there was a weak trend towards increased 
FGF2, TEK and SELE protein abundance. This general trend was loosely correlated 
with the trend observed in the variability corrected mRNA expression data. While no 
change was observed for SELE mRNA and there was only a minor increase in the 
mRNA expression of FGF2, TEK mRNA showed a significant up-regulation at this 
time-point of treatment. We have previously discussed that an increase in TEK and 
ANGPT1 mRNA expression is associated with the homeostatic regulation of PDGFB 
for pericyte recruitment (Nishishita and Lin 2004, Uebelhoer et al. 2013). When re-
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examining the protein data, there was an observable but weak trend in increased 
ANGPT1 protein expression but no determinable trend in PDGFB expression (owing to 
negative results from the ELISA). As a result of the absence of observable protein 
trends for PDGFB, we cannot relate the changes in TEK protein abundance to the 
homeostatic mechanisms discussed in the literature. FGF2 and SELE have already been 
discussed previously in the context of inflammation and we have hypothesised that in a 
response to orthodontic force application, the pulp becomes inflamed. This hypothesis is 
supported by the published literature that claims ANGPT1 will induce anti-
inflammatory effects through TEK-mediated signalling (Huang et al. 2010). We 
therefore expand our hypothesis to state that upon application of an orthodontic force, 
the pulp will become inflamed and induce an anti-inflammatory response through the 
up-regulation of TEK mRNA in order to regulate for these changes. 
At 3 days of orthodontic force application there was a weak trend towards decreased 
FGF2, KDR and SELE protein abundances which matched those trends observed in the 
variability corrected mRNA data. The decrease in the abundance of SELE is linked in 
the literature to the anti-inflammatory response of TEK (Huang et al. 2010) but no anti-
inflammatory response has been linked to decreased FGF2 or KDR protein expression 
patterns. We previously hypothesised that at 3 days of orthodontic treatment, the pulps 
are in a hyperoxic state in order to recover from inflammation induced hypoxia; when 
examining the trends in protein abundance, we found supporting evidence for our 
hypothesis in the literature (Asikainen et al. 2005, Hosford and Olson 2003, Lange et al. 
2007, Sukhotnik et al. 2008, Valter et al. 1998) where hyperoxia was shown to decrease 
the abundance of FGF2, KDR and SELE analytes. It should be noted that the incidence 
of hyperoxia was thought to be repudiated due to the observed increase of PDGFB at 
this experimental time-point. We could find no evidence in the literature to link an 
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increase in PDGFB, and potentially increased interstitial fluid pressure, to a decreased 
abundance of FGF2, KDR and SELE. 
At 2 weeks of treatment there were strong trends towards increased expression of FGF2 
and SELE with a decreased expression of PDGFA. This trend did not match that of the 
mRNA expression analysis following correction for biological variability. It was 
observed at the mRNA level that FGF2 and PDGFA increased while there was no 
change between the control and treated states for SELE expression. When analysed by 
STRING (www.string-db.org) there was shown to be no link in signalling pathways or 
in the literature between FGF2 and SELE. FGF2 has been shown to up-regulate the cell 
adhesion molecules for SELE in inflamed tissues but no direct link has been found 
between increased FGF2 and SELE protein expression (Zittermann and Issekutz 2006). 
As the cell adhesion molecules had not been investigated in our study, we propose that 
further investigation be implemented in order to determine whether or not their 
expression is increased in our experimental model; thus indicating whether or not the 
pulps are in an inflammatory state at this time-point of orthodontic treatment. We also 
suggest that the occurrence of inflammation be examined across the full time-course of 
treatment to determine whether a cycle of inflammation and recovery is occurring in 
this tissue; and at what stage of tooth movement this inflammation is experienced by the 
tissue. The decrease in PDGFA protein abundance has been observed in hypoxia 
(Heinzman et al. 2008) alongside an increase in FGF2 (Heinzman et al. 2008, 
Silpanisong and Pearce 2013). A combination of both hypoxia and inflammation was 
shown to induce SELE expression (Zund G et al. 1996), suggesting that our hypothesis 
of hypoxia occurring at two weeks of force application, either as a response to or 
resulting in inflammation is supported by the literature. 
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4.5.11 Linking Protein Expression to Phenotypic Factors 
In order to determine whether patient phenotype had any effect on protein expression, 
despite this being ruled out at the transcriptomic level; a qualitative analysis was 
performed on the data in collaboration with Dr Nora Donaldson. As per our findings in 
the mRNA expression analysis, the trends observed in protein expression amongst the 
time-points and between patients could not be conclusively linked to a phenotypic 
factor. At 1 day of force application Patient 3 and Patient 4 were linked by asian 
ethnicity, female gender and a closed apex morphology. When genes among these two 
patients were assessed for correlation there was found to be an increase in FGF2 and 
TEK proteins. Patients 2 and 5 were shown to be linked by black ethnicity, female 
gender and closed apex morphology but when the analyte expression of each of these 
patients were compared, no common expression could be determined. There was a 
general trend towards increased expression of FGF2, SELE and TEK although this 
could not be linked to a single phenotype across all patients. 
At 3 days of force application Patient 2 and 3 in this group were shown to be linked by 
black ethnicity, female gender and a closed apex morphology although Patient 2 showed 
a general decrease in analyte expression relative to intra-patient controls and Patient 3 
showed an increase in analyte concentration. The analytes for FGF2, KDR and SELE 
were all shown to be decreased in concentration at this time-point of treatment but there 
was no common phenotype which provided a link between protein expression patterns 
in these patients. 
At 14 days of force application, Patients 1 and 3 from this group were linked by black 
ethnicity, female gender and open apex morphology. These two patients were linked to 
an increase in FGF2 protein expression and a decrease in PDGFA protein expression. 
When the rest of the patients in this group were compared, we observed an increase in 
FGF2 and SELE analyte concentrations and a decrease in PDGFA analyte 
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concentration; although no common phenotype could be found to link the protein 
expression patterns amongst these patients. 
Despite the lack of conclusive evidence available at the mRNA level, we had 
maintained the hypothesis that tooth morphology would have a significant and linking 
effect on protein expression. This was not found to be the case and we suggest that in 
order to make a conclusive remark as to the effect of apex morphology on the pulp’s 
response to routine orthodontic treatment; a substantially larger group of patients should 
be considered with both open and closed apices and the expression of genes should be 
determined at the transcriptomic and proteomic levels. 
4.5.12 Linking mRNA Expression to Protein Expression 
In order to determine whether the changes we observed as a response to orthodontic 
force application were consistent at both the transcriptomic and proteomic levels 
amongst the experimental time-points of treatment, normalised Cq values (Table 58 – 
Table 60) were compared to analyte concentrations (Table 68 – Table 70) from the 
multiplex ELISA and samples from the same patient were paired for comparison. Both 
sets of data were not corrected for biological variability due to the mRNA data 
correction step requiring the mean-centring of all data points and there being no 
methodology defined for ELISA data at this stage. Numerous genes were expressed in 
the same direction at both the transcriptomic and proteomic levels within a single 
patient, confirming that true changes in gene expression were occurring in the pulp as a 
response to routine orthodontic treatment. However, gene expression patterns and the 
direction of expression varied greatly amongst the samples within a single treatment 
time-point. It was anticipated that the observable differences in gene expression would 
be similar within a single treatment time-point but due to the inability to correct for 
biological variability and the inability to determine a baseline expression level for each 
 - 241 - 
GOI, our findings are unsurprising. The differences in the expression of the GOIs 
observed within each sample group cannot be discussed in detail at this time, as each 
patient appears to react to force application with an individualistic response. Had a 
baseline been determinable, we would assume that any trends present would be more 
clearly observable. 
For the genes which did not increase or decrease synchronically at the transcriptomic 
and proteomic levels, we can either attribute these differences to the lack of analyte 
abundance data available; or we can attribute them to a lack of correlation between 
mRNA expression and protein expression within the tissues themselves. As translation 
is the expected linking process between mRNA expression and protein abundance, we 
had expected a direct correlation between the two; this was not found to be true in our 
study as a number of the proteins of interest displayed an opposing or slightly varied 
mRNA expression pattern, suggesting that protein abundances are independent of 
mRNA expression. According to a publication by Yu et al. (2007) only a small number 
of studies have attempted to correlate mRNA expression levels with protein 
abundances; with a limited number of cases of correlation being reported. This suggests 
that complicated post-transcriptional and/or post-translational mechanisms are involved 
in gene regulation. According to a publication by Vogel and Marcotte (2012), 
approximately 40 % of the variation of protein concentration within cells is due to 
mRNA abundance whilst the remaining 60 % is ascribed to post-transcriptional 
regulation. Wang et al. substantiate this statement by commenting that processes such 
as mRNA degradation and stabilisation play a significant role in the protein abundance 
of the cell, as mRNA abundance is not only dependent upon the rate of transcription but 
also upon the rate of decay and degradation (Ing et al. 2005, Wang et al. 2002). 
In this chapter, we have attempted to correlate mRNA expression patterns with those of 
protein expression without taking into consideration the regulatory mechanisms of both 
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the transcriptome and the pre-proteome. We have not considered the half-lives of the 
transcripts or the enzymes required to stabilise them, nor have we considered the small 
interfering RNA’s (siRNA) or micro RNA’s (miRNA) which attract endonucleases for 
cleavage or repress translation of mRNA, respectively. In order to further substantiate 
our findings and to attempt to link these findings to those already published by groups 
such as Derringer et al., we propose that further work is carried out in order to 
determine the mechanisms by which stabilisation and translation of our GOIs occurs; 
specifically for those GOIs where we have seen significant changes in mRNA 
expression and clear trends amongst protein expression. However, particular caution 
should be taken when interpreting this data as these genes, enzymes, siRNA’s and 
miRNA’s are associated with multiple signalling cascades and making defined 
conclusions pertaining to cellular mechanisms of gene regulation is incredibly 
complicated. 
In addition to this proposed further investigation of regulatory mechanisms, Yu et al. 
has designed a statistical tool to enable the correlation of mRNA and protein 
abundances using RT-qPCR and mass spectrometry data (Yu et al. 2007). We propose 
that the GOIs be examined by mass spectrometry and that the Protein Abundance and 
mRNA Expression (PARE) tool is utilised to attempt to determine if true correlation 
exists between the mRNA and proteins expressed within our treated samples. 
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4.6 Conclusion 
In order to investigate the initial response of the human dental pulp to routine 
orthodontic treatment, in an attempt to determine the angiogenic response of the tissue 
to force application, we have increased the number of experimental time-points from a 
single investigation at 2 weeks to three separate time-points at 1, 3 and 14 days 
respectively and expanded our ‘GOIs’ panel from 4 to 17 genes. We have determined in 
this experimental chapter that:  
1. The purchasing of optimised primers from a manufacturer, with guaranteed 
reaction efficiencies per primer pair, is far superior to optimising each primer set 
individually. This is particularly true with respect to smaller projects with 
limited time and financial resources available; as optimising primers and 
ensuring equal reaction efficiency can become incredibly costly when a large 
panel of genes are to be investigated.  
2. Testing for primer specificity by using BLAST analysis and confirming the 
product sizes and binding efficiency by gel electrophoresis and dissociation or 
melt curve is essential to ensure that mRNA specific to the GOI is being 
amplified in the RT-qPCR reaction. Multiple genes may be amplified by a single 
primer set, and so the confirmation of the product size and the incidence of 
primer-dimer or spurious binding products should be assessed prior to 
performing RT-qPCR reactions on limited patient samples.  
3. Biological variability has been shown to have a substantial effect on our 
experimental model and must be corrected for prior to performing relative 
expression analysis. Without correcting for biological variability, no trends 
could be observed between patients or between treatment groups.  
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4. In order to determine the source of biological variability amongst our samples, 
patient phenotypic factors such as age, gender, ethnicity and apex morphology 
were assessed and hypothesised to have a significant effect on the pulp’s 
reaction to orthodontic force application. No statistically significant evidence 
could be determined from our sample group to support our hypothesis; however, 
the inflammatory response of the human dental pulp to orthodontic treatment 
needs to be considered further as apex morphology may have a potentially 
detrimental effect on this tissue under these conditions. Patient ethnicity was 
shown to have an effect on mRNA expression patterns but future work is 
required to elucidate the signalling cascades and translational mechanisms that 
differ between ethnicities.  
5. It was shown, by regression analysis, that an application of orthodontic force 
had a significant effect on the expression patterns of a number of genes over the 
entire time-course of treatment, while other genes were shown to differ in 
expression pattern between two distinct time-points of treatment. We 
hypothesise that an application of routine orthodontic treatment at any point up 
to two weeks will result in hypoxia and subsequent angiogenesis in the human 
dental pulp. Between 1 and 3 days of force application there was a significant 
difference in the expression of genes associated with hypoxia and angiogenesis, 
suggesting that an application of orthodontic force will induce hypoxia and a 
subsequent angiogenic response. Between 3 days and 14 days, there was a 
change in expression of genes linked to hypoxia, angiogenesis and vascular 
differentiation. This suggested that in response to the initial oxidative stress, the 
tissue may be responding through angiogenesis and vascular differentiation. 
Between 1 and 14 days of force application, NOS2 was significantly altered in 
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expression, suggesting that through the entire duration of treatment, the pulp is 
in an inflammatory state.  
6. By performing a factor analysis, MMP2, TGFB1 and VEGFA were shown to be 
the most tightly correlated genes under our experimental conditions which 
would suggest that pulps undergoing orthodontic force application undergo an 
amount of oxidative stress which results in inflammation and an angiogenic 
response to regulate for these changes. Tooth morphology may play a role at this 
stage and an inflammatory response may induce hypoxia and a subsequent 
corrective angiogenic response. Although, as the pro-inflammatory cytokines 
and chemokines IL8 and NOS2 were not shown to be correlated, perhaps this 
proposed hypothesis is irregular.  
7. Willem et al.’s (2008) publication is sufficient to allow the extraction of 
statistically significant data from an otherwise undecipherable dataset due to the 
amount of variability within the control group. Following clarification of the 
methodology, which we have outlined in detail, we were able to determine 
statistically significant differences in mRNA expression between the control and 
treated groups at each experimental treatment time-point. Following 1 day of 
routine treatment, we determined that there was a change in mRNA expression 
associated with homeostasis of the vessel walls and a potential initiation of 
hypoxia in response to force application. Following 3 days of force application 
we found a general trend towards down-regulation of angiogenesis-specific 
mRNA and hypothesise that following 3 days of treatment the human dental 
pulp is in a state of both inflammation and hyperoxia, as a response to the 
original oxidative stress state seen at day 1. We suggest that these changes are 
attributed to tooth morphology, where most of the pulps investigated were 
extracted from teeth with closed apices, although we do acknowledge that 
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without correction for biological variability the impact of apex morphology on 
gene expression was found to be statistically insignificant. At 2 weeks of routine 
treatment, there was a statistically significant increase in the mRNA of HIF1A 
which is normally up-regulated solely in hypoxic conditions. This finding in 
conjunction with increased mRNA expression of genes associated with the 
coagulation process and inflammation might suggest that after 2 weeks of force 
application the tooth has attempted to recover from the initial inflammatory and 
hypoxic state, inducing angiogenesis and coagulation which has resulted in 
further inflammation and hypoxia due to the morphology of the tooth. These 
changes have yet to be confirmed by proteomic analysis and a more in-depth 
study of the time-points between those assessed in this study (day 2 and  
days 4 – 14) need to be considered. We propose that a full time-course from 1 
day through to 21 days of treatment be considered as the studies by Derringer et 
al. (Derringer et al. 1996, Derringer and Linden 1998, Derringer and Linden 
2003, Derringer and Linden 2004, Derringer and Linden 2007) treated teeth with 
force application for 14 days but then transferred the tissue to co-culture for an 
additional length of time, allowing for changes in mRNA and protein expression 
to continue prior to analysis.  
8. The levels of sensitivity within the custom multiplex ELISA assay were too high 
to quantify the small analyte concentrations of the GOIs present in the human 
dental pulp samples. We propose that an alternate high-sensitivity assay for low-
abundance proteins be used in order to assess these samples and obtain data that 
can then be corrected for biological variability, prior to drawing conclusions as 
to the pulp’s response to orthodontic treatment.  
9. When qualitatively assessed, our protein abundance data indicated that in 
response to orthodontic force application human dental pulps experience 
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inflammation, possible hyperoxia, hypoxia and angiogenesis. However, this data 
needs to be corroborated by further analysis where techniques such as light 
microscopy, in situ hybridisation and FACTT are used in a strict time-course on 
a much larger sample set.  
10. The findings from our protein analyses do not negate the observations of 
Derringer et al. where an increase in secreted angiogenic growth factors was 
identified using blocking antibodies in co-culture of treated human dental pulps 
and rat aorta. Our findings either support Derringer et al.’s work, with specific 
reference to increased FGF2 and PDGFB abundances, or require further 
investigation in order to substantiate their experimental findings. As our 
quantification method had limited sensitivity and could not determine 
concentrations of low-level protein expression, we cannot dismiss their findings 
outright and propose that FACTT be used to quantify protein abundances in 
human dental pulp homogenates.  
11. When relative mRNA expression data and analyte abundances were compared, 
few of the GOIs demonstrated a correlated expression pattern. However, the 
majority of the genes did not demonstrate any correlation between mRNA and 
analyte abundances. It has been determined that regulatory mechanisms in post-
transcriptional and/or post-translational modification are crucial to the 
understanding of the conversion of increased mRNA to increased protein 
abundances; and that investigation of these regulatory mechanisms will elucidate 
the true changes within human dental pulps treated with an orthodontic force for 
a period of up to two weeks.  
This experimental chapter has highlighted the importance of identifying correct 
protocols for statistical analysis of RT-qPCR data and low abundance protein 
concentrations present in human dental pulp homogenates. In it we have identified an 
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increased mRNA and protein expression of several angiogenesis-specific genes; and 
have suggested that following the application of orthodontic force, the pulp will 
experience inflammation, hypoxia and undergo angiogenesis in order to regulate for 
these changes. These responses to force application need to be investigated further. 
 









 Chapter V  
 
Effects of Hypoxia on the Angiogenic Response in 
Human Dental Pulp Explants 
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5.1 Introduction 
Hypoxia has been defined as the state where oxygen concentrations within a tissue or 
cell have been reduced below physiological levels, despite the presence of adequate 
perfusion by blood (Dorland 2007). It can occur continuously or intermittently whilst 
ranging in severity from an acute to a chronic condition, depending on the physiological 
or pathological cause. Hypoxia is mediated by the stabilisation of the mRNA of the 
transcription factor HIF1A and is regulated homeostatically by oxygen dependent 
hydroxylation of the ODD domain of the protein by PHD enzymes (Ivan et al. 2001, 
Jaakkola et al. 2001); or polyubiquitylation of the von Hippel-Lindau tumour 
suppressor (pVHL) E3 ligase complex (Jaakkola et al. 2001, Maxwell et al. 1999, 
Semenza 2003). Should the HIF1A transcript become stabilised by: (a) decreased 
oxygen concentration and an absence of oxygen-dependent hydroxylation,  
(b) nitrosylation of the oxygen-dependent domain of the HIF1A subunit by free radicals 
(Li et al. 2007) or (3) up-regulation of growth factors which inhibit PHD enzymes 
necessary for hydroxylation (Dengler et al. 2014, McMahon et al. 2006); angiogenesis, 
and the concordant up-regulation of angiogenesis-specific growth factor mRNA and 
increased protein transcription occurs in order to regulate oxygen tension (Krock et al. 
2011, Pugh and Ratcliffe 2003, Semenza 2001).  
Angiogenesis is the process of new vessel formation from a pre-existing capillary 
plexus (Brown et al. 1992, Li et al. 2003, Yano et al. 2003); involves a complex 
modification of the existing endothelium and is tightly regulated by a large number of 
cytokines, chemokines and growth factors. 
Endothelial cells form the inner lining of all blood and lymph vessels within the body 
and are known to vary in phenotype between arterial and venous cells, and to vary 
throughout different portions of the vascular network (Sumpio et al. 2002).  
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Human dental pulp has been shown to be a highly vascular tissue, containing a dense 
capillary network which pervades the entire organ (Vongsavan and Matthews 1992, 
Yoshida and Ohshima 1996). Vasculature and lymph vessels enter the pulp through the 
apical foramina and from the trunk, the vessels begin to branch out toward the crown 
and the periphery; with the peripheral edge of the tooth containing the highest 
concentration of neovessels (Digka et al. 2006, Provenza 1958, Berggreen et al. 2009).  
It has been shown in an in vitro study of cultured endothelial cells, that varying 
intensities of hypoxic exposure, namely: (a) intermittent hypoxia, (b) repeated cycles of 
intermittent hypoxia and (c) chronic hypoxia, will result in distinct transcriptomic and 
proteomic expression patterns between each exposure (Toffoli et al. 2009). 
To date, hypoxia and the effects of various intensities of hypoxia have only been 
considered in the human dental pulp amongst in vitro cell lines in order to treat avulsed 
permanent teeth (Aranha et al. 2010), accelerate bone healing (Fujio et al. 2015.), 
increase the proliferation of stem cells (Sakdee et al. 2009.) and determine the 
mineralization response of the pulp during reparative dentinogenesis (Li et al. 2011). 
No previous studies have attempted to characterise the angiogenic response of the 
human dental pulp tissue treated with varying intensities of hypoxia, with respect to 
determining whether hypoxic intensity has a significant effect on neovessel 
development in this tissue. 
As we have previously identified that an orthodontic force applied to teeth for two 
weeks prior to extraction may induce hypoxia (Chapter 4) in the human dental pulp, we 
propose that characterisation of the pulp’s angiogenic response to varied intensities of 
hypoxia is critical for our elucidation of the true response to routine clinical orthodontic 
treatment. For this purpose, pulps from untreated teeth were exposed to a series of 
hypoxic exposures (chronic, intermittent and repeated cycles of intermittent hypoxia) as 
per Tofolli et al. (2009); and the transcriptomic and proteomic expression of 
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angiogenesis-specific growth factors was assessed. We propose an a priori hypothesis 
that pulps due to their dense vasculature, will respond to each intensity of hypoxia with 
a unique and distinct transcriptomic and proteomic expression pattern. 
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5.2 Aims 
1. Expose untreated human dental pulps to a series of hypoxic intensities in order 
to characterise the pulp’s angiogenic response to: 
(a) intermittent hypoxia 
(b) repeated cycles of intermittent hypoxia 
(c) chronic hypoxia 
2. Following exposure to hypoxia, incubate ex vivo human dental pulps under 
normoxic conditions in vitro for an extended period to determine the effect of a 
prolonged incubation period on the proteomic expression profile.  
3. Compare the prolonged incubation protein expression profile to that of pulps 
snap-frozen immediately following exposure to hypoxia. 
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5.3 Materials and Methods 
MATERIALS 
5.3.1 Human Dental Pulps 
Following informed parental and patient consent, human dental pulps were obtained 
from healthy first and second premolar teeth extracted from volunteers aged between  
12 – 16 years. All patients included in the study required extraction of a minimum of 4 
position-paired premolar teeth in conjunction with fixed appliance orthodontic 
treatment. Ethical approval was granted by the Research Ethics Committee at Guy’s 
Hospital and King’s College Hospital.  
METHODS 
5.3.2 Tooth Extraction and Dental Pulp Isolation 
In this experimental chapter, pulps were isolated from 20 ‘control’ teeth (four teeth from 
five patients) where no orthodontic forces had been applied to teeth prior to extraction, 
in order to analyse the effect of varying exposures to hypoxia on the relative mRNA and 
protein expression of angiogenesis-specific genes in human dental pulps. 
A further 8 ‘control’ pulps (two teeth from four patients) were isolated in order to 
analyse the expression of angiogenesis-specific proteins following 16 hr normoxic, in 
vitro recovery periods from hypoxic exposure. 
All premolar teeth were extracted under local anaesthesia; and each tooth was placed in 
an individual tube containing 20 ml of cold sterile saline solution. Teeth were sectioned 
immediately with a high-speed water-cooled diamond bur through the buccolingual 
aspect and dental pulps with a mean mass of ± 0.05 g (n = 5) were removed from the 
pulp chamber with sterile blunt instruments. Isolated pulps were then individually 
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placed in sterile 7 ml bijou tubes containing 5 ml Dulbecco’s MEM (Cat. No. D6046) 
(Sigma-Aldrich, Poole, UK) supplemented with 50 U/ml penicillin (Cat. No. P4333) 
(Sigma-Aldrich, Poole, UK) and 50 µg/ml streptomycin (Cat. No. P4333) (Sigma-
Aldrich, Poole, UK). Samples were placed on ice and transferred immediately to a 
laminar flow cabinet for sectioning under sterile conditions. 
No orthodontic procedures were performed on these teeth prior to extraction. All dental 
pulp isolations, following extraction, were performed by Dr K. A. Derringer, Dental 
Institute, King’s College London at Guy’s Hospital and King’s College Hospital. 
5.3.3 Exposure of Human Dental Pulps to Hypoxia 
Pulp samples were sectioned through the mid-sagittal plane with a sterile surgical 
scalpel and both pulp halves were transferred directly to an upright 25 cm2 BD Falcon™ 
cell culture flask (Cat. No. 734-0009) (canted neck, plug-seal lids; VWR International 
Ltd., West Sussex, UK) containing 5 ml Dulbecco’s MEM (Cat. No. D6046) (Sigma-
Aldrich, Poole, UK) supplemented with 50 U/ml penicillin (Cat. No. P4333) (Sigma-
Aldrich, Poole, UK) and 50 µg/ml streptomycin (Cat. No. P4333) (Sigma-Aldrich, 
Poole, UK). 
Caps were removed from the tissue culture flasks containing supplemented medium and 
mid-sagitally sectioned pulps (Cat. No. 734-0009) (VWR International Ltd., West 
Sussex, UK) and pierced with a sterile 21G needle. Punctured lids were placed back 
onto flasks loosely, without tightening completely and a fresh, sterile 21G needle was 
slid gently into the hole in the punctured lid (Figure 20). Tissue culture flasks were 
flushed for 2 min with a 1 % O2, 5 % CO2, 94 % N2 gas mix (BOC Special Gases, 
London, UK) at 5 psi, sealed tightly and needle ends were sealed with luer plugs. 
Culture flasks under hypoxia were incubated for differing lengths of time before 
releasing the seal and allowing tissue media to equilibrate with ambient oxygen and  
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5 % CO2 for 30 min (see Table 75 for details). Pulps from the same dental position in 
different patients were used for appointed hypoxic exposures. Pulp halves for protein 
analysis were recovered from flasks, placed in 1 ml cryotubes (Cat. No. 374503) 
(Nunc™, ThermoFisher Scientific, Nottingham, UK), snap-frozen in liquid nitrogen and 
transferred to – 70 ºC for permanent storage. Pulp halves for mRNA analysis were 
recovered from flasks, immersed separately in 500 µl RNALater™ (Cat. No. AM7021) 
(Ambion Inc., Warrington, UK), an RNA preservation solution, kept at 4 °C for 8 hr 
and transferred to -20 °C for permanent storage. 
Pulp halves for the in vitro recovery experiments were allowed to recover under 
normoxic conditions (ambient oxygen and 5 % CO2) for a further 16 hr following 
equilibration, prior to snap-freezing, to allow for protein production; according to a 
modification of the protocol outlined by Tofolli et al. (2009) (see Table 76 for details). 
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Figure 20 Inducing chronic and intermittent hypoxia in the human dental pulp 
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Table 75 Protocols for induction of hypoxia in the human dental pulp 
 
 
Table 76 Hypoxia protocols with long recovery periods for protein production  
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5.3.4 Validation of Hypoxic Exposure 
Once samples had completed the flush, incubate, equilibrate cycle; 5 ml sample media 
was collected and transferred to a sterile 7 ml bijou tube. Oxygen concentration (ppm 
and %) was measured for 5 min with the ELIT 9701a Aqualyser and Galvanic dissolved 
oxygen probe (NICO2000 Ltd., Middlesex, UK).  
Sample readings were adjusted according to readings taken from pulp-free hypoxic 
media with a Fibre Optic Oxygen (FOXY) Probe (Ocean Optics, Florida, USA) at 
University College London in the laboratory of Prof. T. Arnett in collaboration with Ms. 
S. Taylor. 
5.3.5 RNA Isolation 
Preserved pulp samples were ground individually in a sterile, autoclaved 7 ml glass 
Dounce tissue homogeniser (Wheaton Science Products from VWR, Poole, UK) 
containing 600 µl of the RNA stabilisation solution RNA-Bee™ (Cat. No. CS-104B or 
CS-105B or CS-501B) (AMS Biotechnology, Abingdon, UK) and homogenates were 
transferred to sterile centrifuge tubes. 60 µl of chloroform (Cat. No. C7559) (Sigma-
Aldrich, Poole, UK) was added to the homogenate and samples centrifuged at 4 °C for 
15 min at 9,000 g. Supernatants were collected in fresh tubes and a single volume of  
70 % ethanol was added. Samples were inverted repeatedly and transferred to spin 
columns and RNAtotal extracted using the RNEasy Mini Kit (Cat. No. 74104 or 74106) 
(Qiagen Ltd., Crawley, UK) according to manufacturer’s instructions. Isolated RNAtotal 
was suspended in a final volume of 30 µl nuclease-free water (Cat. No. AM9938) 
(Ambion Inc., Warrington, UK) and stored at -70 °C. 
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5.3.6 RNA Quantification 
The purity and concentration (ng/µl) of RNAtotal for each sample was determined by 
calculating the A260:A280 and A230:A260 ratios using the NanoDrop™ 1000 
spectrophotometer (Now replaced by Cat. No. ND-2000, NanoDrop™ 2000 
spectrophotometer) (ThermoFisher Scientific, Nottingham, UK), according to 
manufacturer’s instructions. RNAtotal was then quantified by fluorescence with the 
Quant-iT™ Ribogreen® RNA Assay Kit (Cat. No. R11490) (Molecular Probes, 
Invitrogen Ltd., Paisley, UK), according to the manufacturer’s protocol. 
5.3.7 Reverse-Transcription 
50 ng RNAtotal was converted to cDNA using the WT-Ovation™ Pico RNA 
Amplification System (Now replaced by Cat. No. 3302, Ovation Pico WTA System V2) 
(NuGen Technologies, Inc., California, USA) according to the manufacturer’s protocol. 
cDNA was then purified using the DNA Clean and Concentrator 25™ kit (Cat. No. 
D4033 or D4034) (Zymo Research Corporation, California, USA) according to 
manufacturer’s instructions; and quantified with the NanoDrop™ 1000 
spectrophotometer. Samples were stored permanently at – 20 °C. 
5.3.8 RT-qPCR Analysis of mRNA Expression 
RT-qPCR was performed on 20 µl reactions set up manually in 0.1 ml strip tubes (Cat. 
No. 981103) (Qiagen Ltd., Crawley, UK): 5 µl cDNA (2 ng/µl), 1 µl forward and 
reverse primer mix (6 µM) (designed and optimised by PrimerDesign Ltd., 
Southampton, UK), 10 µl Precision Mastermix with SYBR Green (Now replaced by 
Cat. No. PrecisionPlus-SY, PrecisionPlus™ Mastermix) (PrimerDesign Ltd., 
Southampton, UK) and 4 µl RNAse/DNAse-free water (delivered in conjunction with 
the primers, no individual Cat. No.) (PrimerDesign Ltd., Southampton, UK) with the 
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Corbett Rotor-Gene™ 6000 (No Cat. No. available but item is still available from 
Qiagen) (Corbett Life Science, Qiagen Ltd., Crawley, UK). Amplifications were 
performed with an initial template denaturation step at 95 °C for 10 min followed by  
50 cycles of denaturation at 95 °C for 15 sec; combined primer annealing/extension at 
60 °C for 60 sec; and data acquisition.  
A disassociation protocol was performed from 72 °C to 95 °C at 1 °C increments in 
order to determine the presence of primer-dimer formation or other spurious binding 
products. 
Details of primers are given in Chapter 4, section 4.3.7. 
5.3.9 Statistical Analysis of RT-qPCR Data 
Raw RT-qPCR data was analysed with Corbett Rotor-Gene™ 6000 Application 
Software, version 1.7 (Build 87) and expressed as quantification cycle (Cq) values. All 
Cq values of unknowns fell within the linear quantifiable range of the reaction. Reaction 
efficiencies were assumed to be 100%, as guaranteed by PrimerDesign Ltd., 
Southampton, UK 
In order to eliminate the effect of biological variability amongst individuals on the 
average mRNA expression values, Cq values were analysed by the statistical tests 
outlined in ‘Standardization of real-time PCR gene expression data from independent 
biological replicates’ (Willems et al. 2008); namely log transformation, mean centring 
and autoscaling; where methodology was previously clarified by Dr Nora Donaldson, 
Statistical Advisor, Dental Institute, King’s College London. Data was normalised 
against the geometric mean expression of the reference genes RPL13A and UBC, 
previously established to be the most stably expressed pair of reference genes in our 
experimental system. 
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In order to identify patterns to determine whether patient ethnicity, gender or root 
morphology was linked to gene expression profiles, data was sent to Dr Nora 
Donaldson, Statistical Advisor, Dental Institute, King’s College London for analysis.  
Statistical significance was given at p ≤ 0.05. 
5.3.10 Pulp Tissue Homogenisation for Protein Analysis 
Individual snap-frozen pulp samples were homogenised in 2 ml sterile centrifuge tubes 
containing 250 µl lysis buffer (Cat. No. EL-lysis) (RayBiotech Inc., Georgia, USA) 
supplemented with 25 µl protease inhibitor cocktail (Cat. No. 539131) (Calbiochem®, 
Merck4Biosciences, Darmstadt, Germany) with an Ultra-Turrax® homogeniser (Cat. 
No. 3370100) (Rose Scientific Ltd., Alberta, Canada). Tissue lysates were centrifuged 
at 4 °C for 10 min at 5,000 g to separate tissue debris from supernatants; debris pellets 
were discarded and tissue lysate supernatants were stored on ice.  
The total protein concentration was determined with the Pierce BCA Protein Assay Kit 
(Cat. No. 23250) (ThermoFisher Scientific, Essex, UK), according to manufacturer’s 
instructions. 
Samples were diluted to a concentration of 2 µg/µl with lysis buffer supplemented with 
protease inhibitor cocktail (1:10 dilution) as per instruction from RayBiotech Inc., 
Georgia, USA before snap-freezing 200 µl aliquots in liquid nitrogen and transferring to 
-70 °C for permanent storage.  
5.3.11 Quantification of Proteins Associated with Angiogenesis 
Frozen human dental pulp lysates (200 µl at a concentration of 2 µg/µl, with the 
exception of 1 sample of 150 µl at a concentration of 0.244 µg/µl) were delivered to 
RayBiotech Inc., Georgia, USA for Quantibody® Array Testing. 12.5 µl of the human 
dental pulp lysate was added to each well of a custom Quantibody® multiplex 
sandwich-based ELISA in addition to 12.5 µl running buffer, making a total 
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concentration of 1 µg/µl (with the exception of a single sample which held a final 
concentration of 0.122 µg/µl). Reactions were performed in technical quadruplicate. 
The custom Quantibody® ELISA array targeted the following angiogenesis associated 
proteins: ANGPT1; FGF2; KDR; MMP2; PDGFA; PDGFB; SELE; TEK; TGFB1; 
VEGFA. Analyte concentrations were determined and delivered in a service report. 
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5.4 Results 
5.4.1 Verification of Hypoxic Exposure by Measuring Oxygen Tension 
In order to determine the total percentage of oxygen to which the human dental pulp 
explants would be exposed during the hypoxia experiments; sterile culture media was 
analysed with an ELIT 9701a Aqualyser and a Galvanic dissolved oxygen probe 
following exposure to control, intermittent, repeated intermittent and chronic hypoxia 
conditions as outlined in Table 75 and Table 76. In order to verify the oxygen 
concentrations calculated by the ELIT 9701a Aqualyser and Galvanic dissolved oxygen 
probe, experiments were repeated and oxygen concentrations were measured with a 
FOXY probe.  
Due to the nature of the FOXY probe, the oxygen partial pressure, displayed as a total 
oxygen percentage, is measured in a photoluminescence-quenching reaction by a 
spectrometer based on a phase shift from a state of complete anoxia to 
hypoxia/normoxia/hyperoxia. Galvanic probes do not provide a direct reading; instead 
oxygen is measured in parts per million or percentages of atmospheric oxygen, which is 
taken to be 100 %. 
In order to align the Galvanic probe readings with those of the FOXY probe, data from 
both probes was plotted on straight line graphs following an adjustment of the Galvanic 
probe data to the estimated percentage of oxygen present ambiently; we assumed that 
atmospheric oxygen concentrations ranged from 5 – 25 %. There was shown to be no 
direct correlation between the FOXY and Galvanic probes at any of the hypoxic 
exposures when a single adjustment to atmospheric oxygen was made, e.g. adjustment 
to 21 % atmospheric oxygen shown in Figure 21.  
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Instead, in order to adjust the Galvanic probe’s readings to align with those observed 
with the FOXY probe, we had to assume that ambient oxygen concentration within 
control pulp media was 19 %. (Figure 21). After exposing the media to the hypoxia gas 
mix, for an intermittent period or to repeated intermittent hypoxia, the FOXY probe and 
Galvanic probe readings were the closest after an adjustment of the Galvanic probe data 
to an atmospheric oxygen concentration of 10% (Figure 21). When exposed to chronic 
hypoxia, similar readings between the FOXY probe and Galvanic probe were reached 
after an adjustment of the Galvanic probe data to 24 % atmospheric oxygen  
(Figure 21). For the purpose of verifying the hypoxic exposure of all human dental pulp 
explants, the Galvanic probe data was adjusted according to the line of best fit 
calculated based on data from the FOXY probe and the established ambient oxygen 
concentration (%) corrections. 
It was shown that following adjustment to the line of best fit from the FOXY probe, that 
there were still discrepancies between the data collected from FOXY and Galvanic 
probes (Table 77). These discrepancies can be attributed to the way in which the FOXY 
and Galvanic probe data was collected. Data from the Galvanic probe (Table 77) was 
collected from media in which human dental pulp explants were immersed; the media 
was exposed to hypoxia and then allowed to equilibrate in ambient oxygen 
supplemented with 5 % CO2 for 30 min prior to pulp isolation and measurement with 
the dissolved oxygen probe. Data from the FOXY probe was collected from pulp-free 
media without equilibration in supplemented ambient oxygen. 
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Figure 21 Comparison of Oxygen 
Probes for Validation of Hypoxia 
Exposure 
Graph illustrating oxygen percentage of 
pulp-free media exposed to hypoxia as 
calculated by the FOXY probe (red line) 
and the Galvanic probe (purple and green 
lines). The purple line illustrates Galvanic 
probe data following an adjustment to  
21 % atmospheric oxygen. The green line 
illustrates a line of best fit constructed by 
adjusting Galvanic probe data to 19 %,  
10 % 10 %, 10 % and 24 % atmospheric 
oxygen respectively. 
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Table 77 Average Oxygen Concentration (%) in Culture Media Following Hypoxic Exposure 
This table illustrates the discrepancies between FOXY and Galvanic probe readings following adjustment 
of Galvanic probe data to ambient oxygen percentages calculated by the line of best fit (Figure 21). Data 
from the FOXY probe was calculated from pulp-free media exposed to hypoxia without a recovery period 
of 30 min exposure to ambient oxygen supplemented with 5 % CO2 between intermittent cycles or after 
hypoxic exposure. Data from the Galvanic probe was calculated from media which had contained human 
dental pulp explants, was exposed to hypoxia and was then allowed to recover for 30 min in supplemented 
ambient oxygen. 
 
5.4.2 Statistical Standardisation of Biological Variability in RT-qPCR 
Data and Relative Expression Analysis 
RT-qPCR was performed in technical duplicate using primers for the angiogenesis-
specific growth factors: ANGPT1, FGF2, HIF1A, IL8, ITGAV, ITGB3, KDR, MMP2, 
NOS2, PDGFA, PDGFB, ROBO4, SELE, TEK, TGFB1, TGFBR1 and VEGFA on 
human dental pulp explants exposed to no hypoxia (control) (n = 5), intermittent (n = 5), 
repeated intermittent (n = 5) and chronic (n = 5) hypoxic conditions (as outlined in 
Table 75 & Table 76). Raw RT-qPCR data was analysed with Corbett Rotor-Gene™ 
6000 Application Software, version 1.7 (Build 87) and expressed as quantification cycle 
(Cq) values. 
In order to eliminate the effect of biological variations between the individuals Cq 
values were log-transformed, mean centred and auto-scaled according to the 
methodology outlined by Willems et al. (2008). It was shown that following exposure to 
intermittent hypoxia, there was a statistically significant up-regulation of ANGPT1, 
MMP2, ROBO4, TGFB1 and TGFBR1 mRNA expression and a significant down-
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regulation of IL8 and ITGB3 mRNA expression in treated samples relative to untreated 
controls (Figure 22). 
Following repeated exposures to intermittent hypoxia there were no statistically 
significant differences in the mRNA expression of any of the GOIs (Figure 23). 
There was a statistically significant up-regulation of HIF1A, IL8 and TGFBR1 mRNA 
expression in samples treated with chronic hypoxia compared with untreated controls 
(Figure 24). 
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Figure 22 Fold change expression analysis of 
angiogenic growth factor mRNA in pulp explants 
exposed to intermittent hypoxia relative to normoxic 
controls. Normalising against the geometric mean of 
RPL13A and UBC 
Plot shows the fold-change (log) of mRNA expression 
(columns); and the error of the mean (error bars) in 
hypoxically exposed pulp explants relative to normoxic 
controls. Data was normalised against the geometric 
mean of RPL13A and UBC. There was a significant up-
regulation of ANGPT1, MMP2, ROBO4, TGFB1 and 
TGFBR1 mRNA expression; and a significant down-
regulation of IL8 and ITGB3 mRNA expression in the 
explants exposed to intermittent hypoxia (n = 5) relative 
to normoxic control explants (n = 5).  
* indicates statistical significance (p < 0.05). 
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Figure 23 Fold change expression analysis of 
angiogenic growth factor mRNA in pulp explants 
exposed repeatedly to cycles of intermittent hypoxia 
relative to normoxic controls. Normalising against 
the geometric mean of RPL13A and UBC 
Plot shows the fold-change (log) of mRNA expression 
(columns); and the error of the mean (error bars) in 
hypoxically exposed pulp explants relative to normoxic 
controls. Data was normalised against the geometric 
mean of RPL13A and UBC. There was no significant 
difference (p > 0.05) in mRNA expression of any of the 
angiogenic growth factors in explants treated with 
consecutive exposures to intermittent hypoxia (n = 5) 
relative to normoxic controls (n = 5). 
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Figure 24 Fold change expression analysis of 
angiogenic growth factor mRNA in pulp explants 
exposed to chronic hypoxia relative to normoxic 
controls. Normalising against the geometric mean of 
RPL13A and UBC 
Plot shows the fold-change (log) of mRNA expression 
(columns); and the error of the mean (error bars) in 
hypoxically exposed pulp explants relative to normoxic 
controls. Data was normalised against the geometric 
mean of RPL13A and UBC. There was a significant up-
regulation of HIF1A, IL8 and TGFBR1 mRNA 
expression in the explants exposed to chronic hypoxia  
(n = 5) relative to normoxic control explants (n = 5).  
* indicates statistical significance (p < 0.05). 
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5.4.3 The Effect of Phenotypic Factors on mRNA Expression Levels 
In order to determine whether a patient’s phenotypic characteristics i.e. ethnicity, gender 
and apical/apex morphology of the tooth from which the pulp was extracted played a 
specific role in mRNA expression patterning among the GOIs; patient details (see 
Table 78) were compared directly to trends observed in an analysis of inter- and intra-
patient trends (Chapter 8, section 8.3.3).  
In pulp explants exposed to intermittent hypoxia, we observed a trend of up-regulated 
mRNA expression in Patient 2. As there were no other patients exhibiting strong trends 
in mRNA expression, we could make no comparison of patient phenotype in this 
treatment group (Chapter 8, section 8.3.3). 
As a response to repeated exposures to intermittent hypoxia, we found a common trend 
in down-regulation of mRNA expression amongst all patients (Chapter 8,  
section 8.3.3). When patient phenotype was analysed, we observed that 3/5 patients 
were white, 3/5 patients had a closed apex morphology and 3/5 patients were female. 
However, none of the patients shared the same combination of phenotypic traits and 
therefore, changes in mRNA expression could not be attributed to a specific phenotypic 
characteristic. 
There was a trend of down-regulation in Patient 1 and Patient 5 following exposure of 
the human dental pulp explants to chronic hypoxia (Chapter 8, section 8.3.3). 
Evaluation of the phenotypes of these two patients indicates similar apex morphology 
but does not show mutual gender or ethnicity between the patients (Table 78).  
As the patient size is small (n = 5), it would be inappropriate to make conclusive 
statements as to the effect of phenotype on gene expression in human dental pulp 
explants exposed to hypoxia. 
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Table 78 Details of hypoxia patients’ root morphology, ethnicity and gender 
 
In order to gain a better understanding of the effect of phenotypic characteristics on 
each of the GOIs across all exposures to hypoxia, Cq values were normalised and a 
univariate linear regression analysis was carried out for each of the phenotypic factors, 
i.e. age, gender, ethnicity and apex morphology (Chapter 8, section 8.3.4). A summary 
table of the results of this analysis is given as Table 79. Significance was given at  
p ≤ 0.05 whilst borderline significance was in the range of 0.12 ≤ p < 0.05. 
It was shown that patient age had a significant effect on the mRNA expression of 
ANGPT1 and a borderline significant effect on the mRNA expression of ROBO4 
(Table 79). Patient gender was shown to have a significant effect on the mRNA 
expression of MMP2 and TGFB1 (Table 79). ANGPT1, PDGFA and VEGFA mRNA 
expression was shown to be effected significantly by patient ethnicity. Patient ethnicity 
was also shown to have a borderline significant effect on FGF2 and TEK mRNA 
expression (Table 79). Apex morphology was shown to have no statistically significant 
effect on mRNA expression in any of the GOIs (Table 79). 
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Table 79 Univariate linear regression analysis of patient phenotypes in hypoxically treated human 
dental pulp explants 
 
5.4.4 The Effect of Hypoxic Intensity on mRNA Expression Levels 
A mixed linear regression analysis was then performed in order to construct a one-way 
ANOVA test and pair-wise regression analysis for each of the GOIs. These tests were 
carried out in order to determine whether or not exposure of human dental pulp explants 
to any level of hypoxia would have a significant effect on mRNA expression; and to 
ascertain as to whether or not there were differences in the expression levels for each 
gene between two intensities of hypoxic exposure (Chapter 8, section 8.3.5). A 
summary table of the results of this analysis is given as Table 80. Significance was 
given at p ≤ 0.05 whilst borderline significance was in the range of 0.12 ≤ p < 0.05.  
It was shown that exposure to any intensity or duration of hypoxia had a significant 
effect on ANGPT1, FGF2, HIF1A, IL8, ITGB3, MMP2, ROBO4, SELE, TGFB1, 
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TGFBR1 and VEGFA mRNA expression levels; and a borderline significant effect on 
ITGAV, KDR and PDGFB mRNA expression (Table 80). 
There was shown to be a significant difference in mRNA expression between control 
and intermittent hypoxia exposure in the following genes: ANGPT1, FGF2, IL8, 
ITGB3, MMP2, PDGFB, ROBO4, SELE, TGFB1, TGFBR1 and VEGFA; with a 
borderline significant difference in mRNA expression of KDR and PDGFA at the same 
level of exposure to hypoxia (Table 80). 
Between control and repeated exposures to intermittent hypoxia, there was a significant 
difference in the mRNA expression of ITGB3 (Table 80). 
It was shown that between control and chronic exposure to hypoxia, there was a 
significant difference in the expression of ANGPT1, HIF1A, IL8, ITGAV, MMP2 and 
TGFBR1 mRNA (Table 80). 
Pair-wise regression analysis indicated a significant difference in mRNA expression of 
ANGPT1, IL8, ITGB3, KDR, MMP2, PDGFB, SELE, TGFB1, TGFBR1 and VEGFA; 
and a borderline significant difference in ROBO4 mRNA expression in pulp explants 
treated with repeated intermittent hypoxia relative to those exposed to intermittent 
hypoxia (Table 80). 
There was a significant difference in mRNA expression of ANGPT1, FGF2, HIF1A, 
IL8, ITGAV, ITGB3, KDR, MMP2, PDGFB, ROBO4, SELE, TGFB1 and VEGFA in 
human dental pulp explants exposed to chronic hypoxia when compared to mRNA 
expression in pulp explants treated with intermittent hypoxia (Table 80). 
Between chronic and repeated exposures to intermittent hypoxia, there was shown to be 
a significant difference in mRNA expression of ANGPT1, FGF2, HIF1A, IL8, ITGAV, 
ITGB3, TGFBR1 and VEGFA; there was also a borderline significant difference in 
KDR mRNA expression (Table 80). 
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Table 80 One-way ANOVA and pair-wise regression analysis of the effect of hypoxic exposure and intensity on mRNA expression levels 
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5.4.5 Protein Expression Profiles as a Response to Hypoxia 
In order to identify the effects of different hypoxic exposures on the protein expression 
profiles of human dental pulp explants, a custom multiplex ELISA (Quantibody® 
Array) was performed by RayBiotech, Inc., USA 
It was shown that for most of the angiogenesis-specific growth factors analysed, the 
level of analyte present in the standardised concentration of 2 µg/µl total protein, 
recommended by RayBiotech, Inc., was below the assay’s lower LOD (Table 81 – 
Table 83). FGF2 was the only protein of interest analysed in which the concentration of 
analyte present in all samples under all experimental conditions was greater than the 
assay’s lower LOD (Table 81 – Table 83). 
Statistical analysis could not be performed on data from the protein assay, as calculated 
analyte concentrations were below the assay LOD and several samples gave a reading 
of 0 pg/ml. Upon qualitative examination of trends amongst individual patients in each 
hypoxia treatment group, by the exclusion of any patient pair where either the control or 
treated value was equal to 0 pg/ml, we noted that there were several differences in 
analyte abundance following hypoxic exposure. In human dental pulp explants exposed 
to intermittent hypoxia there was an increase in the abundances of MMP2, PDGFA, 
PDGFB, SELE and TEK. FGF2 analyte concentration was decreased in these explants, 
relative to control samples (Table 81). Following exposure to repeated intermittent 
hypoxia, there was trend towards increased FGF2 abundance and decreased PDGFB 
and TEK abundances (Table 82). After exposing pulp explants to chronic hypoxia there 
was a trend towards an increase in MMP2, PDGFA and SELE analyte concentration; 
with a decrease in FGF2, PDGFB and TEK (Table 83). 
We also qualitatively assessed the inter-treatment trends and found there to be an 
increase in FGF2 and SELE analyte concentration, with a decrease in PDGFB between 
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the intermittent and repeated exposures to intermittent hypoxia. Between the repeated 
intermittent hypoxia and chronic hypoxia groups we observed an increase in KDR, 
PDGFB and TEK analyte concentration; and a decrease in FGF2, MMP2, PDGFA, 
SELE and VEGFA abundances. When comparing samples exposed to intermittent and 
chronic hypoxia, we observed a trend towards increased analyte concentration of KDR 
and SELE, with decreased abundances of FGF2, MMP2 and PDGFB.  
 




Table 81 Analyte concentrations (pg/ml) of angiogenesis-specific GOIs in human dental pulp explants exposed to intermittent hypoxic conditions 
Cells marked in blue represent the assay’s lower LOD (pg/ml). Cells marked in purple represent samples that expressed an analyte concentration greater than the assay’s lower 
LOD. Cells marked in white represent samples which were below the assay’s LOD. Cells marked in green represent samples which did not express any detectable analyte 
concentration of the protein of interest. 
 




Table 82 Analyte concentrations (pg/ml) of angiogenesis-specific GOIs in human dental pulp explants exposed to repeated intermittent hypoxic conditions 
Cells marked in blue represent the assay’s lower LOD (pg/ml). Cells marked in purple represent samples that expressed an analyte concentration greater than the assay’s lower 
LOD. Cells marked in white represent samples which were below the assay’s LOD. Cells marked in green represent samples which did not express any detectable analyte 
concentration of the protein of interest. 
 




Table 83 Analyte concentrations (pg/ml) of angiogenesis-specific GOIs in human dental pulp explants exposed to chronic hypoxic conditions 
Cells marked in blue represent the assay’s lower LOD (pg/ml). Cells marked in purple represent samples that expressed an analyte concentration greater than the assay’s lower 
LOD. Cells marked in white represent samples which were below the assay’s LOD. Cells marked in green represent samples which did not express any detectable analyte 
concentration of the protein of interest. 
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5.4.6 Linking Patient Phenotypes to Protein Expression Profiles 
In order to determine whether phenotypic factors such as ethnicity, gender and apex 
morphology played a specific role in the observed protein expression profiles; patient 
details (see Section 5.4.3; Table 78) were compared directly to trends identified in 
Table 81 – Table 83. 
We previously observed no strong trends (≥ 80 %) in protein expression in explants 
treated with exposure to intermittent hypoxia (Table 81). Therefore we could not use 
patient phenotypes to explain any patterns in protein expression. 
Following exposure to repeated intermittent hypoxia we observed a strong trend  
(≥ 80 %) toward increased expression of the FGF2 protein in the majority of patients 
(Table 82). Upon examination of patient phenotype (Table 78), it was noted that 3 of 
the 4 patients exhibiting an increase in FGF2 protein expression had a closed apex 
morphology; 2 patients were white while the other 2 were black; and 3 of the 4 patients 
were female (Table 78; Table 82). There was no direct correlation between the 3 
patients with closed apex morphology and the 3 female patients. 
After exposure to chronic hypoxia there was a trend of decreased FGF2 protein 
expression in treated explants relative to normoxic controls (Table 83). When patient 
phenotypes were observed in order to identify determining factors for this trend it was 
noted that 2 of the 4 patients exhibiting this protein expression pattern had an open apex 
morphology while the remaining 2 had a closed apex morphology; 3 of the 4 patients 
were white; and 3 of the 4 patients were female (Table 78; Table 83). There was no 
direct correlation between the 3 white and the 3 female patients. 
5.4.7 The Effect of an Extended Recovery Period on Protein Expression 
In order to determine if an extended recovery period of 16 hr, in ambient oxygen 
supplemented with 5 % CO2, had any effect on the protein expression profile of human 
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dental pulp explants exposed to chronic hypoxia (n = 4) compared to that of untreated 
controls (n = 4), a qualitative assessment was performed on data produced by 
RayBiotech, Inc. It was shown that for most of the samples, analyte concentrations were 
calculated to be 0 pg/ml. FGF2 was the only protein of interest in which all samples  
(n = 8) produced analyte concentrations greater than the assay’s lower LOD (Table 84). 
There were no strong trends (≥ 80 %) observed in protein expression between the 
control state and chronic hypoxic exposure in pulps allowed to recover for 16 hr in 
supplemented ambient oxygen, with the exception of FGF2 which was increased in 3 of 
the 4 patients studied (Table 84). As no strong trends were observed among either the 
patients or the angiogenesis-specific proteins, phenotypic factors could not be 
considered as a cause for protein expression patterns.  
Data from the extended recovery was then compared to samples treated with chronic 
hypoxia exposure and snap-frozen immediately after the 30 minute equilibration  
(Table 83). A summary table of this comparison and the overall trends in expression are 
given as Table 85. It was shown that following a prolonged incubation, the protein 
expression patterns were different to those of samples snap-frozen directly after 
exposure. TEK protein was decreased in abundance in both the immediately frozen and 
the prolonged incubation sample groups. 
 
 




Table 84 Inter- and intra-patient trends in protein expression following exposure to chronic hypoxia and 16 hr recovery in supplemented ambient oxygen 
Cells marked in purple represent samples that expressed a protein concentration greater than the assay’s lower LOD. Cells marked in white represent samples which were below 
the assay’s LOD. Cells marked in green represent samples which did not express any detectable concentration of the protein of interest. 
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Table 85 Protein Trends following Exposure to Chronic Hypoxia: A Comparison of Snap-freezing 
Post Exposure and Prolonged Incubation 
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5.5 Discussion 
Angiogenesis or the growth of neovessels from a pre-existing vascular bed is known to 
be regulated by a number of mechanisms, including hypoxia (Pugh and Ratcliffe 2003). 
Hypoxia occurs when oxygen concentrations have fallen below the physiological 
requirements of the cell or tissue, despite an adequate flow of blood to the region 
(Dorland 2007). It has been a popular topic of investigation in pathological conditions 
such as tumour metastasis (Semenza 2010), pulmonary hypertension (Bonnet et al. 
2006) and diabetes linked to obstructive sleep apnoea (Polotsky et al. 2003); and is 
known to occur in a range of intensities from acute to chronic and for varied durations 
from intermittent to sustained hypoxia. The severity of hypoxia experienced in the cell 
or tissue has been shown to induce hypoxic activity by distinctly different mechanisms 
(Yuan et al. 2008). 
We have previously identified that an orthodontic force, applied to teeth for a period of 
two weeks prior to extraction, may induce hypoxia in conjunction with a potential 
angiogenic response within the human dental pulp (Chapter 4). The human dental pulp 
is a highly vascularised tissue (Vongsavan and Matthews 1992, Yoshida and Ohshima 
1996) and is a known source of pluripotent stem cells (d'Aquino et al. 2009, Pisciotta et 
al. 2015, Tatullo et al. 2015); this has brought this tissue to the forefront of many 
translational research investigations. 
To date, no investigations have been performed in order to determine the angiogenic 
response of human dental pulps to a range of hypoxic intensities or durations. The 
outcome of such an investigation would potentially enable researchers to more fully 
comprehend pathological changes observed within the tissue in the fields of reparative, 
restorative and clinical dentistry; and in stem cell research where pathological 
interventions outside the field of dentistry are considered. 
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For this purpose, untreated human dental pulps were isolated from the pulp chambers of 
healthy premolars and were exposed to intermittent, chronic and repeated cycles of 
intermittent hypoxia under in vitro culture conditions. Transcriptomic and proteomic 
differences in the pulps were then compared using primers and antibodies, respectively, 
for a small panel of angiogenesis-specific growth factors, cytokines and chemokines. 
5.5.1 Verification of the Intensity of Hypoxic Exposure Experienced by 
Human Dental Pulps by Measuring Oxygen Tension 
In order to verify the intensity of hypoxia at which the human dental pulp explants were 
exposed, we analysed the oxygen concentrations of the cell culture media in which these 
tissues were incubated. Analysis was performed using both a Galvanic dissolved 
oxygen probe and a FOXY probe; with the Galvanic probe being used on media 
collected from flasks which had contained hypoxically exposed pulp explants and the 
FOXY probe being used on pulp-free hypoxically exposed media (in order to verify our 
data). Both probes calculate the oxygen concentration in different manners and it was 
found that these methods are not corroborative.  
The Galvanic probe was zeroed by inserting the sensor into a diluted sodium sulfite 
(oxygen scavenging) solution and then calibrated by exposing the sensor to the ambient 
oxygen of the open cell culture cabinet and setting the corresponding reading to 21 % as 
per manufacturer’s instructions. The ambient oxygen concentration, hypothesised to be 
21 % by the manufacturer, was considered to be the maximal value of all further 
readings; and all readings taken from the hypoxic culture media was compared directly 
against this maximal value. 
The FOXY probe calibration was performed by Ms. S. Taylor in the laboratory of  
Prof. T. Arnett at University College London and oxygen percentage was measured in a 
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photoluminescence-quenching reaction based on a phase shift from a state of complete 
anoxia to hypoxia, normoxia or hyperoxia. 
When we attempted to align the oxygen concentrations in cell culture media measured 
with the Galvanic probe to oxygen concentrations measured with the FOXY probe, we 
found large disparities between the data. We have shown that correlating the Galvanic 
probe readings to an hypothesised 21 % of ambient oxygen gives vastly different results 
to those observed by the FOXY probe; and that in order to align the data, we had to 
assume that the ambient oxygen concentrations for the Galvanic probe were not only 
much lower than the recommended 21 % but differed greatly according to the exposure 
of hypoxia. This was both unexpected and unusual but in order to align our data and 
confirm the intensities of hypoxia to which the pulps were exposed, we created a line of 
best fit from the FOXY probe data which showed pulp-free cell culture media to have 
the following oxygen concentrations: (a) control 15.4 %, (b) intermittent hypoxia 6.6 %, 
(c) repeated cycles of intermittent hypoxia 4.24 %, (d) chronic hypoxia 6.54 %. 
Despite creating a line of best fit, based upon the more accurate FOXY probe readings, 
when our Galvanic probe data was corrected, a number of disparities still existed. We 
propose that these disparities are due to not only the nature of the Galvanic probe, 
which requires continual manipulation in the solution in order to quantify an oxygen 
concentration, but may be attributed to the inability to equilibrate the FOXY media for a 
period of 30 min after hypoxic exposure due to time limitations of Ms. S. Taylor at 
University College London. 
We confirm that all pulps exposed to any given hypoxic exposure fell within a small 
range (0 % – 0.5 %) of the other pulps in their treatment group and that all intensities of 
hypoxic exposure were independent of each other. We suggest that should any further 
work be performed where oxygen concentrations need to be determined from cell 
culture media, the FOXY probe should be utilised in place of the Galvanic probe as 
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readings are not only more accurate (requiring little to no manipulation of the raw data) 
but is both quicker and easier to use, requiring minimal manipulation of the sample. 
5.5.2 Relative Expression of Angiogenesis-Specific mRNA in Pulps 
Exposed to Hypoxia 
Following exposure to varying hypoxic intensities, the explanted pulp halves were 
homogenised and RNAtotal was isolated for the purpose of RT-qPCR. Data was 
corrected for biological variability within the samples, as this was previously 
established to be a fundamental technique for the analysis of this experimental tissue 
(Chapter 4). It was shown that each hypoxic exposure resulted in a unique 
transcriptomic expression pattern, this confirmed our a priori hypothesis and linked to 
the literature where it is has been described that hypoxic activity is induced by different 
mechanisms in cells exposed to chronic hypoxia as opposed to intermittent hypoxia 
(Yuan et al. 2008).  
5.5.2.1 Intermittent Hypoxia Group 
After exposing pulps to intermittent hypoxia and comparing the expression of 
angiogenesis-specific growth factor mRNA, relative to control explants which had not 
been exposed to the hypoxic gas mix, we identified a statistically significant increase in 
the expression of ANGPT1, MMP2, ROBO4, TGFB1 and TGFBR1. We also observed 
a statistically significant decrease in IL8 and ITGB3 mRNA. In addition to this we 
observed a decrease in the expression of HIF1A and NOS2 and an increase in PDGFB, 
although these differences did not reach a level of statistical significance. 
Using STRING (www.string-db.org), an online database of predicted protein-protein 
interactions, and KEGG (http://www.genome.jp/kegg/), we were able to determine any 
existing links in the literature between these genes. In the significant down-regulation of 
IL8 and ITGB3 mRNA expression, there were no determinable links between the genes 
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by cell signalling pathway or within the literature. ITGB3 is a cell-surface protein which 
participates in cell adhesion and cell-surface mediated signalling (Saalbach et al. 2005, 
Shattil and Newman 2004); and was not shown to be linked to any of the other GOIs 
which were down-regulated following exposure to this intensity of hypoxia.  
IL8 is a pro-inflammatory chemokine that has previously been shown to be enhanced by 
NOS2, another pro-inflammatory chemokine (Vuolteenaho et al. 2009). In the 
intermittent hypoxia group, both of these genes were down-regulated, suggesting that 
the expression of these genes is correlated and that pulps did not become inflamed 
following short-term exposure to low oxygen concentrations.  
The down-regulation of HIF1A expression also suggests that in addition to the absence 
of inflammation, the tissues are in a normoxic state following treatment. This may be 
considered to be irregular, as tissues have been exposed to a depleted source of oxygen 
for a period of time; but can be explained by the reoxygenation stage of the 
experimental protocol, where tissues are allowed to recover and revert back to a 
normoxic state. This reoxygenation stage is fundamental in our attempt to mimic the 
true physiological state of the tissue, as intermittent hypoxia has been defined as the 
“periodic exposure to hypoxia, interrupted by a return to normoxia or less hypoxic 
conditions” (Powell and Garcia 2000). Short-term exposure to hypoxia in the absence of 
reoxygenation might be mistaken for mild chronic hypoxia; therefore, this 
reoxygenation stage is critical in our replication of the physiological environment of 
intermittent hypoxia. 
By analysing the GOIs shown to be significantly up-regulated following intermittent 
hypoxia, several combinations of genes were shown to be linked by cell signalling 
pathways and within the literature; although no signalling pathway or publication linked 
all up-regulated genes together. ROBO4 was the only gene which was not shown to be 
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linked to the other up-regulated genes by pathway or within the literature; neither was it 
shown to be linked in expression to the non-significantly up-regulated gene, PDGFB.  
ROBO4 is an endothelial specific protein which plays a role in vascular permeability 
and the maintenance of vascular integrity (Ishikawa et al. 2010, Jones et al. 2008). The 
increase of ROBO4 mRNA suggests that the vasculature within tissues, having 
experienced intermittent hypoxia, becomes unstable and is prone to leakage. This 
finding was supported by the significant up-regulation of MMP2, a matrix 
metalloproteinase enzyme which is responsible for the degradation of extracellular 
matrix components. MMP2 has previously been shown to play a role in the degradation 
of endothelial basement membrane following hypoxic exposure (Ben-Yosef et al. 
2005); and we postulate that the extent of vascular permeability may be regulated by 
balancing the expression of MMP2 and ROBO4 proteins, although this has yet to be 
confirmed. Should our findings be attributed to the reoxygenation stage of the 
experimental protocol, we suggest that MMP2 expression is induced by hypoxia as part 
of the angiogenic response and that ROBO4 expression is induced during the 
reoxygenation stage as part of a recovery from hypoxia in order to stabilise the existing 
vasculature. 
According to STRING analysis, MMP2 was shown to be linked to angiogenesis and 
tumour development in combination with TGFB1 and TGFBR1 expression in the 
literature (Gilles et al. 1996, Landskron et al. 2014, Zarzynska 2014); there was no 
signalling pathway which linked all three genes directly.  
TGFB1 is an anti-inflammatory cytokine which is known to inhibit the expression of 
both IL8 and SELE (Smith et al. 1996), this was confirmed in the response of the tissue 
to intermittent hypoxia. Whilst TGFB1 is known to induce angiogenesis, it is 
concurrently known to inhibit endothelial cell proliferation, induce endothelial cell 
death, down-regulate KDR expression (Ferrari et al. 2009) and induce the up-regulation 
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of MMP2 (Kim et al. 2007). The concentration of extracellular TGFB1 seems to have a 
vital role on the activity of this protein in angiogenesis where low concentrations of 
extracellular TGFB1 appear to promote endothelial cell proliferation and migration, 
whilst high concentrations lead to cytostasis and synthesis of extracellular matrix 
proteins which are associated with mature and stable vessels (ten Dijke and Arthur 
2007). It is not evident from the increases in mRNA expression as to whether TGFB1 
protein concentrations are low or high in the extracellular space. Nor is it evident 
whether this gene is acting in collaboration with MMP2 to promote cell migration, or if 
it is assisting ROBO4, ANGPT1 and PDGFB in stabilising the existing vasculature; this 
has yet to be investigated at the proteomic level. 
We have described TGFB1 as having both a positive and negative effect on 
angiogenesis, inflammation and cell death; and these effects are dependent on 
extracellular concentration of this protein. In pulp explants treated with intermittent 
hypoxia, we observed an increase in the expression of TGFB1 and its receptor 
TGFBR1. TGFBR1 has been shown to have a negative regulatory effect in combination 
with TGFB1; where the activation of this cell signalling pathway leads to an inhibition 
of endothelial cell migration and proliferation (Lebrin et al. 2005). We can therefore 
postulate that following exposure to intermittent hypoxia, TGFB1 binds to TGFBR1 in 
order to regulate the angiogenic response and inhibit any further vessel growth; and that 
this gene combination will act in conjunction with that of ROBO4, ANGPT1 and 
PDGFB. Although, before any conclusive statement can be made, this should be 
verified at the proteomic level. 
In the pulp explants treated with intermittent hypoxia, we observed an increase in the 
expression of ANGPT1 and PDGFB. ANGPT1 has been shown to play a role in 
recruiting pericytes to maturing vasculature (Krock et al. 2011), as has PDGFB 
(Nishishita and Lin et al. 2004). This concurrent up-regulation of both ANGPT1 and 
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PDGFB is in contradiction to the literature where a collaborative increase of ANGPT1 
and TGFB1 is supposed to suppress the increase in PDGFB expression (Nishishita and 
Lin 2004). PDGFB has also been shown to be down-regulated by an increase of TEK 
expression in HUVEC cells but this down-regulation did not occur despite the non-
statistically significant increase in TEK expression within these tissues. (Uebelhoer et 
al. 2013). The mechanism by which PDGFB is up-regulated in these samples is not 
understood but it is postulated that it will differ from those outlined in Nishishita et al. 
and Uebelhoer et al.’s publications, as according to Nilsson et al. capillary cells will 
respond to hypoxia by increasing PDGFB mRNA expression (Nilsson et al. 2004). 
By STRING analysis of the intermittent hypoxia group, we observed that MMP2 was 
linked to ANGPT1 and TGFB1 expression in the literature (Goel et al. 2011, Riabov et 
al. 2014, Taube et al. 2012); and a number of signalling pathways linked these genes 
together as pairs. There was no single signalling pathway which linked all three genes. 
MMP2 was linked to TGFB1 in the ‘Pathways in cancer’ and the ‘Proteoglycans in 
cancer’ signalling pathways. TGFB1 was linked to ANGPT1 in the ‘Rheumatoid 
arthritis’ signalling pathway and MMP2 was linked to ANGPT1 via the ‘Control’ 
curated pathway published on the NCI-Nature Pathways Interaction Database 
(http://www.ndexbio.org/). ANGPT1 is required in order to promote stability of the 
vasculature by recruiting pericytes to the vessels and TGFB1 has been shown to have a 
positive effect on vessel stabilisation, when expressed in conjunction with its receptor 
TGFBR1. At this time, we cannot make any conclusive statements as to the interaction 
of these two genes in the angiogenic response of human dental pulps to intermittent 
hypoxia, as proteomic analysis needs to be performed.  
MMP2 and ANGPT1 were both shown to be linked in the literature (ElAli et al. 2014, 
Neve et al. 2014) and were significantly up-regulated in the intermittent hypoxia 
treatment group. The concurrent increase in both of these genes appears to be 
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contradictory in that MMP2 is responsible for destabilising the vasculature whilst 
ANGPT1 is responsible for attracting pericytes, stabilising vessels and ensuring that 
vessels do not leak. It is proposed that ANGPT1 mRNA expression is increased in the 
reoxygenation stage of the experimental protocol, however, this requires further 
investigation.  
5.5.2.2 Repeated Intermittent Hypoxia Group 
Following repeated cycles of exposure to intermittent hypoxia, we observed no 
statistically significant differences in the mRNA expression of any of the GOIs. This 
was not expected as repeated cycles of intermittent hypoxia have been shown to have a 
greater negative effect on the body, as they have been shown to trigger multiple 
pathologies (Dale et al. 2014). For this reason, repeated intermittent hypoxia is often 
referred to in the literature as ‘chronic intermittent hypoxia’ due to its sustained nature.  
Despite the changes not reaching a level of significance, we observed an increase in 
ANGPT1, HIF1A, ITGAV, MMP2, ROBO4, SELE, TEK, TGFB1, TGFBR1 and 
VEGFA mRNA. We also observed a decrease in the mRNA expression of FGF2, IL8, 
ITGB3, KDR, NOS2, PDGFA and PDGFB.  
When analysed by STRING, we could find no more than five of the ten up-regulated 
GOIs to be linked by a single cell signalling pathway. HIF1A, ITGAV, MMP2, TGFB1 
and VEGFA were shown to be linked via the ‘Pathways in cancer’ and ‘Proteoglycans 
in cancer’ signalling pathways. ANGPT1, HIF1A, TEK and VEGFA were shown to be 
linked via the ‘HIF1 signalling pathway’. ANGPT1, ITGAV, TEK and VEGFA were 
linked via the ‘PI3K-Akt signalling pathway’. ANGPT1, TEK, TGFB1 and VEGFA 
were linked via the ‘Rheumatoid arthritis signalling pathway’. ANGPT1, TEK and 
VEGFA were linked via the ‘Rap1 signalling pathway’ and ‘Ras signalling pathway’. 
HIF1A, TGFB1 and VEGFA were linked via the ‘Renal cell carcinoma’ pathway. 
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TGFB1 and TGFBR1 were linked via the curated ‘Biochemical Reaction: UCHL5 or 
USP15 deubiquitinates TGFBR1’ and ‘Biochemical Reaction: SMURFs/NEDD4L 
ubiquitinate phosphorylated TGFBR1 and SMAD7’ pathways which are published on 
the NCI-Nature Pathways Interaction Database (http://www.ndexbio.org/). 
The down-regulated GOIs were also assessed by STRING analysis and a maximum of 
five of the seven genes were shown to be linked via a single cell signalling pathway. 
FGF2, IL8, NOS2, PDGFA and PDGFB were shown to be linked via the ‘Pathways in 
cancer’ signalling pathway. FGF2, KDR, PDGFA and PDGFB were shown to be linked 
via the ‘Rap1 signalling pathway’, ‘Ras signalling pathway’ and ‘PI3K-Akt signalling 
pathway’. IL8, KDR, PDGFA and PDGFB were linked via the ‘Cytokine-cytokine 
receptor interaction’ pathway. FGF2, PDGFA and PDGFB were linked via the 
‘Melanoma’, ‘Regulation of actin cytoskeleton’ and ‘MAPK signalling pathway’. KDR 
was linked to PDGFA and PDGFB via the ‘Focal adhesion’ pathway. IL8 was linked to 
NOS2 via the ‘Amoebiasis’ pathway. 
We postulate that the increase in VEGFA, a mitogenic factor specific to endothelial 
cells, has been induced by the increase in HIF1A expression; and that in spite of the 
reoxygenation stage of the experimental protocol these cells are in a sustained state of 
cellular hypoxia. VEGFA is known to be hypoxia-inducible and the mRNA expression 
of this gene is moderated quickly in order to aid in the physiological response to low 
oxygen concentrations (Brogi et al. 1994, Pugh and Ratcliffe 2003, Shweiki et al. 
1992). As VEGFA expression levels will ordinarily return to normal following 
reoxygenation of the tissue, the finding that VEGFA mRNA remains up-regulated 
supports the statement that these pulps remain in a sustained state of hypoxia following 
the final reoxygenation stage of the experimental protocol.  
It is interesting to note that should these tissues be in a sustained state of cellular 
hypoxia, there appears to be no corresponding increase in inflammation in these tissues. 
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This is evident from the decrease in IL8 and NOS2, which are both pro-inflammatory 
chemokines; and from the decrease in FGF2 expression which is also known to be 
associated with inflammation (Andres et al. 2009, Presta et al. 2009).  
The absence of inflammation appears to contradict the finding that SELE is increased in 
these explants. SELE protein is synthesised when vascular endothelial cells are 
stimulated by pro-inflammatory cytokines (Kawase et al. 2009), in order to attract, bind 
and activate circulating leukocytes to the site of inflammation or injury (Kraiss et al. 
2003, Winkler et al. 2012). We propose that inflammation does occur within these 
tissues during the repetitive cycles of hypoxic exposure in order to up-regulate the 
expression of SELE; however, we postulate that the rexoygenation stage is sufficient to 
induce a down-regulation of these GOIs. The mechanisms surrounding this 
hypothesised response needs to be verified in future work. 
FGF2 is a pleiotropic factor which acts in a paracrine, intracrine and autocrine manner 
(Delrieu 2000, Gomm et al. 1997, Kim and Ma 2013, Lefevre et al. 2009, Presta et al. 
2009, Stachowiak et al. 1997); and is known to be associated with inflammation and 
angiogenesis (Presta et al. 2005, Presta et al. 2009). With respect to angiogenesis, FGF2 
is known to regulate the expression of extracellular matrix components, induce 
neovascularisation, stabilise vasculature and recruit pericytes through the induced 
expression of PDGFB (Andres et al. 2009, Presta et al. 2005, Presta et al. 2009). In pulp 
explants exposed to repeated cycles of intermittent hypoxia, we have observed a 
decrease in FGF2 and PDGFB expression. These findings are contrary to what was 
expected, as the induction of angiogenesis requires both the regulation of extracellular 
matrix components and stabilisation of neovessels. 
The decrease in PDGFB expression was accompanied by increased expression of 
ANGPT1, TGFB1 and TEK, suggesting that the recruitment of pericytes to vessels is 
being suppressed by homeostasis and that neovessel creation is occurring (Nishishita 
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and Lin 2004, Uebelhoer et al. 2013); however, the homeostatic regulation of PDGFB 
by ANGPT1, an alternate pericyte recruiting agent, seems contradictory. It has 
previously been observed that an increase in ANGPT1 expression can accompany a 
decrease in PDGFB expression in the pathology of tissue with polycystic ovary 
syndrome, where abnormalities in angiogenesis are reported to occur (Di Pietro et al. 
2015). Whether tissues being exposed to repeated cycles of intermittent hypoxia 
experience abnormal angiogenesis or whether the expression of PDGFB is regulated by 
increased ANGPT1 expression remains to be confirmed. 
The increase in ANGPT1 expression was supported by an increase in ROBO4 
expression, suggesting that during the repeated exposure to intermittent hypoxia, the 
vascular permeability of existing and possible neovessels is regulated in response to the 
vasculature becoming leaky and permeated. The incidence of leaky vessels is supported 
by the increased expression of MMP2 which is required for the degradation of 
endothelial cell basement membrane components and endothelial cell migration. 
In conjunction to the increase in ANGPT1 expression, we observed a corresponding 
increase in the expression of its receptor, TEK. TEK is an endothelial specific receptor 
which plays a functional role in the interaction between endothelial cells and smooth 
muscle cells, such as pericytes (Fukuhara et al. 2010, Martin et al. 2008). It has 
previously been shown to be stimulated by hypoxia, although the response to hypoxia 
was dependent on the source of the endothelial cells examined (Willam et al. 2000). 
This suggests that the responses seen in this tissue may be unique to the pulp and that 
the mechanisms regulating hypoxia may not only be specific to the intensity of hypoxia 
(Yuan et al. 2008) but may be unique to the complexity of each tissue and it’s 
surrounding environment; although this hypothesis has yet to be confirmed. 
PDGFA is required for epithelial cell proliferation and has been associated with 
increased proliferation of mesenchymal stem cells but is primarily active during 
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embryogenesis (Landskron et al. 2014, Mizuno et al. 2015, Sukhotnik et al. 2012). The 
down-regulation of the mRNA expression for this GOI was expected in our 
experimental model. 
Unlike VEGFA, its receptor KDR was decreased in pulp tissue explants that had been 
exposed to repeated cycles of intermittent hypoxia. This was not expected, as an 
increase in VEGFA should require an increase in receptor for adequate binding and 
initiation of angiogenesis. KDR mRNA expression has previously been shown to be 
regulated by hypoxia in an oxygen dose-dependent manner (Takagi et al. 1996); and it 
was postulated by the authors that the intitial decrease in KDR may be attributable to 
tight regulation of the angiogenic response. This can be better described as a lag-period 
between increased ligand and receptor expression, in order to ensure that an appropriate 
response is considered and acted upon by the cells. The lag-period allows for cellular 
oxygen to either return to a state of normoxia or maintain at the hypoxic state and for 
angiogenesis to be induced accordingly. This lag-period or decrease in KDR expression 
was not observed by the authors (Takagi et al. 1996) in chronic hypoxia and this has yet 
to be investigated in our study. 
TGFB1 has previously been described as having a negative effect on endothelial cell 
proliferation when it is expressed in conjunction with its receptor TGFBR1. In pulp 
explants treated with a repeated exposure to cycles of intermittent hypoxia, we observed 
an increase in both the ligand and the receptor. We can therefore postulate that 
following repeated exposure to intermittent hypoxia, TGFB1 binds to TGFBR1 in order 
to regulate the angiogenic response and inhibit any further vessel growth. The duration 
following inception of intermittent hypoxia, at which each of these genes is up-
regulated, has yet to be considered; as TGFB1 may play an initial role in inducing 
migration and proliferation of endothelial cells in conjunction with another receptor.  
 - 299 - 
5.5.2.3 Chronic Hypoxia Group 
By exposing pulp explants to chronic hypoxia, there was an up-regulation in the mRNA 
of all GOIs with the exception of NOS2 and PDGFA, which showed a down-regulation, 
and PDGFB, which showed no difference between the control and treated pulps. The 
increase in HIF1A, IL8 and TGFBR1 mRNA expression reached a level of statistical 
significance. 
The down-regulation of PDGFA mRNA expression was expected in this experimental 
model following the exposure to chronic hypoxia, as PDGFA plays a predominant role 
in prenatal vasculogenesis and the tissue used in this study was postnatal human dental 
pulp explants.  
NOS2 is an enzyme which produces nitric oxide in order to relax the smooth muscle 
cells attached to the walls of the vasculature (Aktan 2004, Krock et al. 2011); inducing 
a temporary vasodilation. In contrast to this, NOS2 has also been shown to produce free 
radicals which act as a cytotoxic agent (Aktan 2004, Jung et al. 2000). It was expected 
that following exposure to chronic hypoxia, there would be an increase in the 
expression of NOS2 mRNA which would coincide with the vasodilatory actions of this 
gene; however this was not the case as a down-regulation was determined. In the 
original study by Toffoli et al. (2009), investigators determined that chronic hypoxia 
induced the repression of genes associated with the inflammatory processes. As NOS2 
is considered to be a pro-inflammatory chemokine, we can state that our findings are in 
accordance with those of the original researchers. The down-regulation of mRNA 
expression of this gene can also be explained by Zulueta et al. (2002) where it was 
established that hypoxia alone is not sufficient for the induction of NOS2 expression in 
endothelial cells and that NOS2 can only be induced within an hypoxic state by the pre- 
and post-transcriptional modification of this gene by alternate cytokines. 
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The general up-regulation of all other non-significantly different genes confirms our 
assumption that chronic hypoxia will induce a strong angiogenic response in the human 
dental pulps. VEGFA and KDR are induced, suggesting that endothelial cell 
mitogenesis and proliferation is occurring. ANGPT1, TEK and ROBO4 are up-
regulated, which suggests that the vasculature is being stabilised following degradation 
of the extracellular matrix by MMP2 and formation of neovessels; or that leakage of the 
existing vascular, induced by MMP2 activity, is being regulated homeostatically. 
ITGAV and ITGB3 are up-regulated concurrently suggesting that they are active in the 
cell-adhesion of new vasculature. FGF2 and SELE are up-regulated suggesting that 
inflammation is occurring in the pulps.  
The incidence of inflammation was postulated to be suppressed in endothelial cells as a 
response to chronic hypoxic exposure (Toffoli et al. 2009); however, this was not found 
to be true in human dental pulps where in addition to the up-regulation of FGF2 and 
SELE, we observed a significant up-regulation of IL8 mRNA expression. This finding 
negates our previous statement about NOS2 expression and we postulate that in order 
for NOS2 to be up-regulated in the chronic hypoxic state, this enzyme needs to be 
modulated by alternate cytokine activity. 
STRING analysis was performed on the genes which were found to be significantly up-
regulated in response to chronic hypoxic exposure. IL8 was shown to be linked to 
HIF1A in the literature (Riabov et al. 2014, Stockmann et al. 2014), whereas TGFBR1 
was not shown to be linked to either of the other two genes. There were no signalling 
pathways that could link any of the genes found to be significantly up-regulated in 
response to chronic hypoxia. 
It is unsurprising that the expression of HIF1A mRNA remains up-regulated following 
exposure to chronic hypoxia. Prolonged exposure to a limited oxygen concentration is 
expected to have a greater negative effect than a continual cycle between hypoxia and 
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reoxygenation. Here we observed a much greater difference in the relative expression of 
this GOI than we have observed at any of the other treatment intensities. This was also 
true for the relative expression of the pro-inflammatory cytokine IL8 which had 
previously been shown to be down-regulated at the other treatment intensities.  
The relative expression of TGFBR1 differs in the case of chronic hypoxia as there is no 
increase in TGFB1 which matches the strength of the receptor’s expression, as in 
intermittent hypoxia. The presence of TGFBR1 without a corresponding expression of 
TGFB1 is not understood at this time and further investigation is required to determine 
the function of this gene in the absence of a ligand. 
5.5.3 The Effect of Phenotypic Factors and Hypoxic Exposure on 
mRNA Expression 
A qualitative analysis was performed on normalised RT-qPCR data in order to 
determine trends in mRNA expression within patients and within hypoxic exposure 
treatment groups. Statistical examination of these trends was not available as the 
method which corrects for the biological variability of the data requires a calculation of 
the mean expression of the gene amongst all patients within a treatment group (Willems 
et al. 2008). Established trends were then compared against the patients’ phenotypes in 
order to determine whether a particular phenotypic characteristic would have an effect 
on the expression patterns of any of the GOIs. It has previously been shown in the 
literature that the age of the patient is directly linked to the morphology of the tooth 
apex (Mostafa et al. 1991, Ramazanzadeh et al. 2009) and therefore the patients’ ages 
were not considered to be an independent phenotypic factor for investigation.  
The morphology of the tooth apices has been considered as a significant phenotypic 
factor, as it has been suggested that pulps with a closed apex morphology will react 
independently to those with open apices (Hamersky et al. 1980, Mostafa et al. 1991).  
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In the intermittent hypoxia treatment group, only a single patient exhibited a strong 
trend of expression where most of the GOIs were up-regulated following treatment 
(Chapter 8, section 8.3.3). As there were no other patients within this treatment group 
that exhibited a distinct transcriptomic trend, the phenotypic characteristics of this 
patient could not be compared or considered as a significant cause of the observed 
trend. Following repeated exposure to cycles of intermittent hypoxia, we observed a 
general trend of down-regulated mRNA for the GOIs (Chapter 8, section 8.3.3), with 
the exception of ANGPT1 which was up-regulated in three of the four patients. This 
result is contrary to that which was observed in the variability corrected relative 
expression analysis where both up- and down-regulation of mRNA expression was 
observed. These findings can be explained, as in the qualitative analysis, the baseline 
expression level of the entire group had not been considered or normalised; and control 
pulps were paired directly with treated pulps. Amongst this experimental treatment 
group, three of the five patients where white, three of the five patients were female and 
three of the five patients had a closed apex morphology. There were no two patients in 
which all three traits were present and therefore no remark can be made on the effect of 
phenotype on mRNA expression following repeated exposure of human dental pulps to 
intermittent hypoxia. Following the exposure of human dental pulps to chronic hypoxia, 
we observed a general trend towards the down-regulation of mRNA in two of the five 
patients (Chapter 8, section 8.3.3). When phenotypic factors were considered, both 
pulps were shown to have a closed apex morphology. The relevance of closed apical 
foramina of the tooth roots has been remarked upon previously, where there is an 
expected difference in the transcriptomic and proteomic trends of pulps with closed 
apices in comparison to those with an open apex. Although the pulps had been extracted 
from their constricting enamel shell for the purpose of these experiments and should 
have responded in a similar manner to treatment, we propose that histological changes 
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that occur during tooth maturation and apical closure had altered the cellular 
composition of the pulp (Andujar et al. 1985); and these teeth would behave differently 
to those with open root apices, whether they were still within the pulp chamber or had 
been explanted.  
When we compared the apex morphologies of all patients within the chronic hypoxia 
group, three of the five patients were shown to have closed root apices. Therefore, we 
cannot attribute the changes in mRNA expression to any phenotypic factor within the 
hypoxia experiments and suggest that in order to truly identify whether phenotypes play 
a role in gene expression, a larger panel of patients needs to be considered in further 
investigation. 
In an assessment of the effect of each phenotype on the expression of angiogenesis-
specific mRNA in hypoxically treated pulps (Chapter 8, section 8.3.4), it was shown 
that patient age had a significant effect on the expression of ANGPT1 and a borderline 
significant effect on ROBO4. It was previously postulated that transcriptomic 
differences attributed to a patient’s age would be corroborated by the patient’s root 
morphology, as there is a correlation between these two factors. We found that the 
patient’s root morphology had no significant effect on the pulp’s response to hypoxic 
exposure. We could find no other reason for the propensity towards increased mRNA 
expression of these genes that was related to patient age. Patient gender was shown to 
have a significant effect on the mRNA expression of MMP2 and TGFB1 although there 
is no supporting literature to justify or defend these findings. Patient ethnicity was 
shown to have a significant effect on the expression of ANGPT1, PDGFA and VEGFA; 
and was shown to have a borderline effect on the expression of FGF2 and TEK mRNA. 
Whilst there are no publications in the literature that focus on the differences in 
expression of these specific genes between individual ethnicities, it is now recognised 
that gene expression levels do differ amongst cell types within an individual, among 
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individuals and between ethnic groups (Spielman et al. 2007). We suggest that further 
work be carried out on a larger sample group in order to determine the relevance of our 
findings.  
5.5.4 The Effect of Hypoxic Intensity on mRNA Expression 
Following a regression analysis on the effect of exposing the human dental pulp 
explants to any intensity of hypoxia and an examination of the relative differences 
between each hypoxic exposure, we determined that a number of transcripts are affected 
by our experimental conditions (Chapter 8, section 8.3.5). We determined that 
exposure of the pulp explants to any intensity of hypoxia would result in a change in the 
expression of ANGPT1, FGF2, HIF1A, IL8, ITGB3, MMP2, ROBO4, SELE, TGFB1, 
TGFBR1 and VEGFA. Hypoxia was also shown to have a borderline significant effect 
on the mRNA expression of ITGAV, KDR and PDGFB. Exposing the pulps to any 
intensity of hypoxia had no significant effect on the expression of NOS2, PDGFA or 
TEK mRNA.  
As all of the genes which have been shown to change in expression, following exposure 
to hypoxia, are known to be associated with the angiogenic signalling cascades, we can 
conclude that exposing human dental pulps to hypoxia will induce an angiogenic 
response in this tissue. The extent to which the pulp responds will depend on the 
severity of the hypoxic exposure, as each hypoxic exposure has been shown to result in 
a unique and distinct transcriptomic reaction.  
We have observed in this regression analysis that hypoxia has no effect on the 
expression of PDGFA mRNA; this was expected as this gene is primarily active in 
prenatal vasculogenesis and the experimental model that we have investigated is that of 
postnatal angiogenesis in human dental pulp explants.  
 - 305 - 
TEK mRNA expression was shown not to be correlated with any intensity of hypoxic 
exposure, this was unexpected as hypoxic exposure was shown to have an effect on the 
expression of its ligand, ANGPT1. This finding may be due to the small sample of 
patients which were analysed and we suggest that prior to making conclusive statements 
regarding the relationship between TEK expression and hypoxic intensity, future work 
is carried out on a larger group of samples.  
NOS2, an inflammatory mediator, was shown to be independent of hypoxia in its 
mRNA expression. While we hypothesise that inflammation occurs within the tissue in 
response to hypoxia, we have found no evidence in the literature that claims that NOS2 
is regulated by hypoxia. As the sample group that was analysed was a small 
representative of the general population, we propose that further work be carried out 
before making a conclusive statement in this regard. 
As the results from this analysis did not include the correction for biological variability, 
unlike the mRNA expression analysis; we propose that the results from the comparisons 
between the control state and each hypoxic exposure are overlooked and that the data 
from mRNA expression analysis are considered to be significant for these treatment 
groups. When assessing the differences between the hypoxic exposures, no correction 
for biological variability could be considered but these results are of interest as they 
highlight the potential differences between the mRNA expression levels of the GOIs 
within two hypoxic intensities.  
When comparing the mRNA expression between the individual hypoxic intensities, we 
observed an increase in the mRNA expression of ANGPT1, IL8, ITGB3, KDR, MMP2, 
PDFGB, SELE, TGFB1, TGFBR1 and VEGFA in samples treated with repeated cycles 
of intermittent hypoxia relative to samples exposed to only a single cycle of intermittent 
hypoxia. In this same treatment group we showed a borderline significant increase in 
the expression of ROBO4 mRNA.  
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This finding suggests that following the onset of hypoxia, inflammation is induced in 
the tissue in response to repeated exposure to intermittent hypoxia. This is evidenced by 
the increased expression of IL8 mRNA. The increase in KDR and VEGFA suggests that 
endothelial cells are both migrating and proliferating, this is supported by the increase 
in MMP2 expression which is required for the degradation of basement membrane 
molecules in the endothelium. The increase in ANGPT1, PDGFB, TGFB1 and 
TGFBR1 and the borderline significant increase in ROBO4 mRNA expression 
contradict these findings as they are associated with vessel stabilisation and the 
inhibition of endothelial cell proliferation. They may however be attributed to the 
reoxygenation stage of the experimental protocol or to the homeostatic regulation of 
vascular permeability. 
By comparing intermittent hypoxia to chronic hypoxia, we observed an increase in the 
mRNA expression of ANGPT1, FGF2, HIF1A, IL8, ITGAV, ITGB3, KDR, MMP2, 
PDGFB, ROBO4, SELE, TGFB1 and VEGFA. 
This finding suggests that following a long exposure to sustained hypoxia, pulp tissues 
are in a state of oxygen deprivation; this is evidenced by the increased expression of 
HIF1A mRNA. These tissues are also inflamed as is evidenced by the increase in FGF2, 
IL8 and SELE mRNA’s. The increase in TGFB1 (in the absence of increased 
TGFBR1), VEGFA and KDR suggests that endothelial cells are both migrating and 
proliferating, this is supported by the increase in MMP2 expression which is required 
for the degradation of basement membrane molecules in the endothelium. The increase 
in ANGPT1, ITGAV, ITGB3, PDGFB and ROBO4 mRNA expression contradict these 
findings as they are associated with vessel stabilisation and the inhibition of endothelial 
cell proliferation. They may however be attributed to the reoxygenation stage of the 
experimental protocol or may be due a homeostatic regulation of vascular permeability. 
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Between the repeated exposures to intermittent hypoxia and the exposure to chronic 
hypoxia there was an increase in the expression of ANGPT1, FGF2, HIF1A, IL8, 
ITGAV, ITGB3, TGFBR1 and VEGFA. There was also a borderline increase in the 
expression of KDR in this treatment group. 
As hypoxia intensifies from repeated cycles of intermittent hypoxia to a more sustained 
exposure of hypoxia, pulp explants are negatively affected by oxygen deprivation; this 
is evidenced by the increase in HIF1A mRNA expression. These tissues are also 
inflamed as is evidenced by the increase in FGF2 and IL8 mRNA’s. The increase in 
VEGFA and KDR suggests that endothelial cells are both migrating and proliferating. 
The increase in ANGPT1, ITGAV and ITGB3 mRNA expression contradict these 
findings as they are associated with vessel stabilisation and the inhibition of endothelial 
cell proliferation. They may however be attributed to the reoxygenation stage of the 
experimental protocol or may be due a homeostatic regulation of vascular permeability. 
The increased expression of TGFBR1 appears to be a residual characteristic of the 
repeated intermittent hypoxic exposure. 
5.5.5 Protein Expression Profiles as a Response to Hypoxia 
In order to minimise the addition of biological variability to the sample data and to 
ensure that transcriptomic and proteomic data was directly correlated, four teeth from 
the same dental position were extracted from a single patient in order to perform our 
experiments; we used pulps from 5 randomly selected patients. Pulp samples were 
halved along the mid-sagittal plane and exposed to various intensities of hypoxia. Pulp 
halves were homogenised and proteins were isolated for analysis by a custom multiplex 
ELISA. These samples were sent for analysis alongside the orthodontically treated 
samples from Chapter 4. Prior to their delivery to RayBiotech Inc., Georgia, USA, 
samples were standardised at a concentration of 2 µg/µl following analysis with a BCA 
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assay. It was identified that in all patients under all experimental treatment conditions, 
FGF2 was the only protein of interest expressed by the pulps at an analyte concentration 
greater than the assay’s lower LOD. We have previously established in Chapter 4 that a 
number of samples returned a concentration of 0 pg/ml for the analytes of interest; 
however, the number of samples that returned a negative result was greater in the 
hypoxic exposure experiments. We propose that this was due to the use of half pulps in 
the hypoxic exposure experiments in comparison to the use of a full pulp explant in the 
orthodontically treated experiments. Despite the sample homogenates being 
standardised to a working concentration of 2 µg/µl of total protein, the distribution of 
the proteins of interest within the homogenates and the initial volume of each protein of 
interest present in the pulp halves would have a significant effect on the outcome of the 
ELISA analysis. 
The large number of null results may additionally be attributed to the poor specificity of 
this assay technique. We have previously commented in Chapter 4 that the use of 
ELISA in this tissue type is inappropriate as, whilst the tissues appear to have high 
concentrations of total proteins, there appears to be a very low abundance of the 
proteins of interest in the samples. We propose, as we have previously, that a high 
specificity assay that can be used in conjunction with a statistical correction for 
biological variability is used in future analyses. 
We also noted that homogenisation of the pulps and pulp halves with an Ultra-Turrax® 
homogeniser resulted in some loss of the tissue within the shearing mechanism. 
Although this had no effect on the analyte concentration of the proteins of interest or the 
sensitivity of the ELISA assay, we propose at this time that should future investigators 
wish to homogenise the human dental pulp sample effectively, with minimal sample 
loss, that an homogenisation technique such as the FastPrep®-24 Instrument or a glass 
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Dounce tissue homogeniser (previously identified within Chapter 3) be used in place of 
the Ultra-Turrax® homogeniser. 
Despite the large number of samples which returned a null or negative result in the 
ELISA analysis, a qualitative assessment was performed of the data. Analyte 
concentrations for the proteins of interest were compared between the three hypoxic 
intensities relative to the untreated controls. Abundances were then assessed between 
each treatment group to assess the inter-treatment trends. Where one of the samples in 
the comparison gave a null result, the data pair was excluded from the analysis. 
5.5.5.1 Intermittent Hypoxia 
We identified that following an exposure to intermittent hypoxia, there was an increased 
abundance of MMP2, PDGFA, PDGFB, SELE and TEK relative to the control samples. 
FGF2 was shown to decrease in samples as a response to being exposed to intermittent 
hypoxia.  
Although we have stated that MMP2 increases in abundance in response to intermittent 
hypoxia, there was only one sample that returned a result in both the control and treated 
samples. It should also be noted that only one of these values was above the assay’s 
lower LOD and can be considered a true result. MMP2 was previously established to be 
increased at the transcriptomic level and is thought to play a role in the angiogenic 
response of human dental pulps to intermittent hypoxia, where vascular permeability 
and migration is induced by degradation of the extracellular matrix of the existing 
endothelium. All other increases and decreases in protein abundance at this treatment 
intensity were not correlated to a significant change in the transcriptome. The only 
genes which were shown to be expressed in a similar pattern between the transcriptome 
and the proteome were FGF2, which was decreased in abundance in three of the five 
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patients investigated; and PDGFB, which increased in abundance in three of the four 
patients that returned a positive result.  
PDGF is a dimeric glycoprotein that can be expressed as either of the homodimers 
PDGF-AA or PDGF-BB; or as the heterodimeric PDGF-AB (Kaetzel 2003, Meyer-
Ingold and Eichner 1995, Shih and Holland 2006). In our ELISA analysis, we attempted 
to quantify the analyte concentrations of the homodimers, PDGF-AA and PDGF-BB, 
while PDGF-AB was not considered due to unavailability from the supplier.  
We observed an increase in the abundance of both PDGFA and PDGFB in three of the 
four patients which returned a positive result, although only one patient from the 
PDGFB group returned both a control and treated concentration value greater than the 
assay’s lower LOD and can be considered a true result. 
PDGFA is required for epithelial cell proliferation and has been associated with 
increased proliferation of mesenchymal stem cells but is primarily active during 
embryogenesis (Landskron et al. 2014, Mizuno et al. 2015, Sukhotnik 2012); therefore 
it was surprising to identify an increase in this protein abundance amongst our samples. 
It was even more surprising to identify a synergistic increase in the abundance of 
PDGFB, as the PDGFA and PDGFB protein chains are subject to different regulatory 
mechanisms and are produced by different cell types in differing ratios (Dirks and 
Bloemers 1995, Hoch and Soriano 2003, Kaetzel 2003, Meyer-Ingold and Eichner 
1995, Shih and Holland 2006). 
PDGFB plays a significant role in angiogenesis, particularly in stabilisation of the 
neovasculature by pericyte recruitment (Abramsson et al. 2003, Andrae et al. 2008, 
Gianni-Barrera 2014, Lindblom et al. 2003, Wang et al. 2012); and it was expected that 
there would be an increase in the abundance of this protein following exposure to 
intermittent hypoxia, as we have already observed an increase in the mRNA expression 
of this gene at this treatment intensity. 
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It was expected that an increase in PDGFB abundance would result from an increase in 
FGF2 expression (Presta et al.2009); however, at this treatment intensity we observed a 
decrease in FGF2. We therefore suggest that PDGFB is induced by an alternate 
cytokine, although which cytokine this is has yet to be determined as none of the other 
proteins of interest which were increased in abundance are known to have any effect on 
the regulation of PDGFB. 
SELE protein is synthesised when vascular endothelial cells are stimulated by pro-
inflammatory cytokines (Kawase et al. 2009), in order to attract, bind and activate 
circulating leukocytes to the site of inflammation or injury (Kraiss et al. 2003, Winkler 
et al. 2012). The observed increase in SELE abundance, in three of the four patients 
which returned a positive result, suggests that tissues exposed to intermittent hypoxia 
are in an inflammatory state during this exposure. This finding cannot be confirmed or 
denied as there was shown to be no significant increase in pro-inflammatory chemokine 
mRNA expression and pro-inflammatory chemokines were not assessed within the 
protein analysis. We propose that in order to substantiate our finding, further work is 
performed to investigate the proteomic response to hypoxia using specific techniques to 
identify inflammation. 
The abundance of TEK was shown to be increased in two of the three samples which 
returned a positive result in the protein analysis. This was surprising as an increase in 
TEK was expected to mediate a decrease in SELE abundance by an anti-inflammatory 
response (Huang et al. 2010). The mechanism by which SELE and TEK protein 
abundance was increased, in the absences of an increase in pro-inflammatory cytokines, 
is not understood at this time. 
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5.5.5.2 Repeated Intermittent Hypoxia 
When samples were exposed repeatedly to intermittent hypoxia, FGF2 protein 
abundances were increased whilst PDGFB and TEK was decreased.  
This observation was surprising as we had previously determined that there were no 
significant differences in the mRNA expression in any of the GOIs in treated samples 
compared to untreated controls. The only gene which exhibited a similar trend in both 
transcriptomic and proteomic expression amongst these three genes was PDGFB.  
PDGFB was found to be increased in mRNA expression and in the protein abundance 
of two patients which both returned a positive result. Of the patients which returned a 
positive result in both the control and treated pulp explants, only one of the four analyte 
concentrations was above the assay’s lower LOD. As stated previously, PDGFB is 
known to play a role in the recruitment of perictyes in order to stabilise the existing 
vasculature. The increased abundance of PDGFB was expected as during repeated 
cycles of intermittent hypoxia, we anticipate that a degradation of the extracellular 
matrix will occur to enable endothelial cells to migrate and proliferate. The degraded, 
permeated vessels will then require stabilisation in order to ensure they will not leak 
into the surrounding tissue.  
TEK abundance was shown to be increased following repeated exposures to intermittent 
hypoxia, however it should be noted that only one patient in all five patients evaluated 
returned a positive result in both the control and treated samples; and neither of these 
positive results were above the assay’s lower LOD. 
FGF2 abundance was shown to be increased in four of the five patients that returned a 
positive result in both the control and treated samples. The increased abundance of 
FGF2 was not expected as we had previously observed a decrease in the mRNA 
expression of this gene. We have previously shown that there is minimal post-
transcriptional and post-translation modification of this gene (Moffett 1998); therefore, 
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this finding is irregular and should be evaluated further in a larger sample group. 
However, as FGF2 is associated with inflammation and SELE mRNA expression was 
shown to be up-regulated in explants exposed to repeated cycles of intermittent hypoxia, 
this may be a true observation. Further work is required to validate these findings and to 
correlate these changes with those from the transcriptome. 
5.5.5.3 Chronic Hypoxia 
Following an exposure to chronic hypoxia, we observed an increased abundance of 
MMP2, PDGFA and SELE and a decreased abundance of FGF2, PDGFB and TEK. 
Previously we had observed the significant up-regulation of three genes at the 
transcriptomic level. Of these three genes, none were assessed for proteomic expression 
due to the limitations of the assay. When the proteins which were shown to change in 
abundance, following exposure to chronic hypoxia, were compared against their mRNA 
expression trends, we observed an increase in MMP2 and SELE at both the 
transcriptomic and proteomic levels.  
It should be noted that the change in protein abundance observed for MMP2 was only 
present in one of the five patients analysed, as only this single patient returned a 
positive result for both the control and treated sample. Of these two positive values 
which were returned, only one of these values was greater than the assay’s lower LOD. 
The validity of this finding has therefore yet to be confirmed in further investigation. 
We expect this observation to be true as chronic hypoxia has been shown to be linked to 
a strong angiogenic response at the transcriptomic level and this includes the 
degradation of the extracellular membrane for the proliferation and migration of 
endothelial cells, which is mediated by MMP2. 
The increase of SELE protein abundance was shown to occur in three of the four 
samples that returned a positive result. Of these four samples, only one patient had an 
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analyte concentration in both the control and treated samples which was above the 
assay’s lower LOD. The remaining three patients each returned a single analyte 
concentration which was greater than the assay’s lower LOD, suggesting that prior to 
making any conclusive remarks, future work is required to validate our findings. SELE 
has been shown to be stimulated in response to inflammatory conditions; and we 
previously observed the increase of FGF2 and IL8 in the chronic hypoxia explants. We 
propose that this finding is most likely to be true, although future work which considers 
the proteomic response to inflammation will be required in order to substantiate our 
hypothesis. 
PDGFA which is generally expressed in prenatal vasculogenesis was shown to be 
increased in both of the two patients which returned a positive result. This was 
unexpected as the experimental model was postnatal human dental pulps undergoing 
hypoxia and an anticipated angiogenic response. This is the second observation of this 
protein following the exposure of pulp explants to hypoxia and we propose that future 
work is carried out in order to determine the validity of this result. The increased 
abundance of a prenatal protein in a postnatal response to hypoxia is of interest as it has 
not been observed prior to this investigation. 
FGF2 abundance was shown to be decreased in four of the five patients which returned 
a positive result following exposure of the pulps to chronic hypoxia. As stated 
previously, it was expected that protein abundance would change in accordance with the 
mRNA expression trend, as we have previously identified that there is minimal post-
transcriptional and post-translational modification of this gene. Therefore, we propose 
that further work is carried out on a larger group of samples in order to determine the 
true changes in FGF2 mRNA and protein following exposure of human dental pulps to 
chronic hypoxia. 
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As PDGFB is known to stabilise the vasculature by recruiting pericytes to the walls of 
the vessels; and we had previously been unable to determine whether there was an 
increase or decrease in the mRNA expression of this gene, we postulate that our finding 
is accurate. During chronic hypoxia, there is a sustained low concentration of oxygen; 
and correcting for this lack of oxygen by establishing neovessels may be a lengthy 
process. Therefore the stabilisation of the neovasculature by an increase in PDGFB to 
recruit pericytes could occur at a later duration. We propose that in order to determine 
whether or not our observation is true, pulp explants are exposed to a longer duration of 
chronic hypoxia in a strict time-course and proteomic assessment for PDGFB is carried 
out until an increase in PDGFB abundance is determined.  
TEK was shown to decrease in abundance in all three of the patients which returned a 
positive result in both control and treated explants. TEK is an endothelial cell specific 
receptor molecule which is involved in the communication between endothelial cells 
and smooth muscle cells. Like PDGFB, ANGPT1, the ligand of TEK, is responsible for 
the recruitment of pericytes in order to stabilise vasculature and inhibit vascular 
leakage. We have already hypothesised that during chronic hypoxia, the need for 
vascular stabilisation is potentially delayed. We propose that like PDGFB, further work 
is carried out in order to determine the time-point at which this analyte concentration 
will increase. 
5.5.5.4 Inter-treatment Trends of Protein Expression 
Between each hypoxic exposure, we observed a change in the abundance of a number of 
the proteins of interest. This difference in protein abundance did not match the trends 
observed in the mRNA expression but did show a distinct/unique difference in protein 
expression between each treatment intensity. This was expected as the original study by 
Toffoli et al. (2009) outlined that endothelial cells will respond in a different manner 
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according to the intensity of hypoxia to which they are exposed. This finding was also 
supported in the literature by Yuan et al. (2008), who have stated that hypoxic activity 
is induced by different mechanisms in cells exposed to chronic hypoxia as opposed to 
intermittent hypoxia.  
Between intermittent hypoxic exposure and repeated cycles of exposure to intermittent 
hypoxia, we determined that there was an increase in the protein abundances of FGF2 
and SELE, with a decrease in PDGFB abundance. In the comparison of expression of 
mRNA between these two treatment exposures, we also observed an increase in SELE 
expression. This indicates that exposing the tissue to repeated cycles of intermittent 
hypoxia will induce an inflammatory state. This hypothesis is evidenced by the 
concurrent increase in FGF2 analyte concentration but has yet to be confirmed in a 
larger sample group. The decrease in PDGFB analyte concentration suggests that by 
exposing pulps to repeated cycles of intermittent hypoxia, there is less requirement for 
the recruitment of pericytes as vasculature is stable. This observation appears to be 
contradictory as exposing cells to repeated exposure has been shown to have a more 
negative effect on samples when compared to the control state. The mechanisms by 
which angiogenesis is regulated following repeated exposures to intermittent hypoxia 
needs to be investigated further in order to make any conclusive statements.  
When we compared the proteomic expression of pulps exposed to chronic hypoxia to 
the proteomic expression of pulps exposed to intermittent hypoxia; we observed an 
increase in KDR, PDGFB and TEK abundances. We also observed a decrease in the 
expression of FGF2, MMP2, PDGFA, SELE and VEGFA.  
The decreased abundances of proteins were not expected in response to a longer 
duration of hypoxic exposure. These findings appear to be completely contradictory to 
those discussed previously where an extended exposure has been shown to intensify the 
angiogenic response of the human dental pulp explants. We hypothesise that the 
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decreases in protein abundances are not true results but are rather due to a qualitative 
comparison of very few samples in which most values were below the assay’s lower 
LOD. We suggest that these findings not be considered and that further work is carried 
out on a larger sample group using a technique that is specific for the detection of low-
abundance proteins. 
Between pulps exposed to repeated cycles of intermittent exposure and those pulps 
exposed to chronic hypoxia, we observed an increase in the abundance of KDR and 
SELE, with a decreased abundance of FGF2, MMP2 and PDGFB. As stated previously, 
we had not anticipated observing a decrease in the abundance of proteins exposed to a 
longer duration of treatment. The decrease in abundance of proteins associated with 
inflammation, basement membrane degradation and vascular stability appears to be 
contrary to those observations already discussed where tissues move to a more intense 
state of distress. We propose that these findings are only reflective of the qualitative 
assessment of several genes where the majority of results returned were null results. We 
suggest that prior to making any conclusive remarks, further work is carried out using a 
larger sample group and a technique which is more specific for the detection of low 
abundance proteins.  
5.5.6 Linking Patient Phenotypes to Protein Expression Profiles 
We went on from comparing differences in protein abundances between the hypoxic 
exposures, to identifying trends within a single experimental group. We then examined 
these trends in order to determine whether or not the phenotypic traits of the patients 
had any effect on the expression of the proteins of interest. 
We could not identify any distinct trends in the expression of any of the proteins of 
interest within the intermittent hypoxia treatment group and could not therefore attribute 
any changes in proteomic expression to a single phenotypic characteristic.  
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When we analysed the protein abundances within the samples exposed to repeated 
cycles of intermittent hypoxia, we noted a general trend towards increased FGF2 
expression in four of the five patients. By investigating the phenotypes of these four 
patients we noted that two patients were white and the remaining two were black; whilst 
three were female and the remaining patient was male. Therefore neither patient 
ethnicity nor gender could be considered as having an effect on the protein expression 
of the GOIs in this sample group. Upon further analysis of the phenotypes of these 
patients, we identified that three of these four patients had a closed apex morphology. 
We have previously discussed our expectations of alternate or differing expression 
patterns between pulps with a closed apex morphology and those with an open apex 
morphology. Although three of the five patients that we examined had closed root 
apices, the remaining two patients did not behave equally to each other in their expected 
opposing response to treatment. Our sample size was very limited and in order to make 
a conclusive statement as to the true effect of apex morphology on the pulp’s reaction to 
a series of hypoxic intensities, a much larger sample set is required for further 
investigation.  
In the chronic hypoxia group we established a trend towards the decrease in FGF2 
protein abundance in four of the five patients. We observed that two of the four patients 
had an open apex morphology while the remaining two had closed root apices. Three of 
the four patients were white and three of the four patients were female. Due to the 
limitation of sample size, we are hesitant to make any comment as to the effect of 
ethnicity or gender on protein expression as a response to hypoxic exposure at this 
point. 
As per our study of the mRNA expression trends, we also analysed the effect of patient 
phenotypes on each of the proteins of interest and details of the full analyses were 
provided in Chapter 8, section 8.3.6 and section 8.3.7. We identified that in patients 
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with a closed apex morphology, there was an increase in FGF2 expression in both the 
‘control vs intermittent hypoxia’ group and the ‘intermittent hypoxia vs repeated 
intermittent hypoxia group’. This gene was decreased in expression in patients with an 
open apex morphology in the ‘control vs chronic hypoxia’ group, the ‘intermittent 
hypoxia vs repeated intermittent hypoxia’ group and the ‘intermittent hypoxia vs 
chronic hypoxia’ group. The only treatment group in which protein expression followed 
the expected hypothesis, of open apex morphology having an opposing trend to that of 
teeth with a closed apex morphology, was the ‘intermittent hypoxia vs repeated 
intermittent hypoxia’ group. Patient gender and ethnicity were shown to have neither a 
corroborative nor opposing expression trend for any of the GOIs at specific hypoxic 
exposures. As stated previously, we determined that apex morphology is the only 
phenotypic characteristic that may play a significant role in the pulp’s reaction to 
hypoxic exposure but in order to validate this finding, further work needs to be 
considered where a significantly larger panel of patients is considered. 
5.5.7 The Effect of an Extended Recovery Period of Protein Expression 
In order to determine the effects of a prolonged recovery period from exposure to 
chronic hypoxia, as per Toffoli et al. (2009), we compared the protein expression 
patterns of pulps that had been exposed to chronic hypoxia directly before snap-freezing 
to those of pulps which had been allowed to recover from hypoxic exposure for a period 
of 16 hr. Upon analysis with a custom multiplex ELISA, we determined that many of 
the GOIs gave an analyte concentration of 0 pg/ml. As discussed previously, this could 
be attributed to the use of half of the pulp explant in place of a complete pulp; or could 
be attributed to the level of sensitivity of the assay itself.  
FGF2 protein abundance was found to be increased in three of the four patients that had 
been allowed to recover for the 16 hr period, when compared to those pulps which were 
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snap-frozen directly after exposure. In the pulps which were snap-frozen directly after 
treatment, we observed a decrease in FGF2 abundance in four of the five patients 
examined. It should be noted that any comments on these trends should not be 
considered as conclusive, as the baseline level of expression in the control samples 
amongst all nine patients had not been determined. There were no other strong trends in 
the expression of any of the other proteins of interest but this was due to the large 
number of null results from the ELISA. 
By looking at the general trends of expression in each of the experimental groups, we 
could determine that the prolonged recovery period resulted in a different protein 
expression profile overall in all patients. In order to determine if this trend is a true 
result, we propose that a larger selection of patients be examined in each of the 
treatment groups and that full explants are analysed using a much more sensitive 
technique such as FACTT (Zhang et al.2006).  
We also propose that should future work be performed in order to determine the effect 
of prolonged recovery on the proteomic expression profile; the mRNA expression 
profiles within these samples should also be considered alongside changes in post-
transcriptional regulatory factors. We did not perform a comparison of mRNA 
expression differences in the extended recovery samples as we have previously 
described that an alteration in cellular mRNA does not always correspond with an 
increase in protein abundance (Chapter 4). 
5.5.8 Will Tissue Culture Provide a Representation of the True 
Physiological Response? 
Whilst we have attempted to elucidate the pulp’s response to varying intensities of 
hypoxic exposure, we have done so ex vivo; and a number of the regulatory mechanisms 
that would occur physiologically have been excluded from our experimental model. 
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Within the hypoxia model, the pulps are no longer encapsulated by dentine, cementum 
or enamel, nor are they influenced by a homeostatically regulated partial pressure. The 
pulps have been deprived of a continual supply of nutrients and oxygen, except for that 
which is present in the culture media; and they have been injured by a mid-sagittal 
dissection. In the process of flushing the cell culture flasks with the hypoxic gas mix, 
the pulps within the media are agitated and pulp halves collide against each other and 
the walls of the cell culture flask, which may induce injury. The pressure of the gas mix 
during the flushing of the culture flasks may even exfoliate cells from the tissue surface, 
inducing damage which could alter both the transcriptomic and proteomic responses of 
the tissue.  
We have attempted to minimise the addition of further experimental variability by 
culturing the pulp halves in medium which had not been supplemented with FCS, a 
known source of growth factors and cytokines required for cell maintenance and cellular 
proliferation (Antypas et al. 2014, Brunner et al. 2010, Gstraunthaler 2003). FCS was 
not added to our experimental system as any addition of growth factors, cytokines or 
chemokines could alter the pulp’s true response to treatment (Suchanek et al. 2013). As 
we had analysed the protein abundance of a number of these growth factors and 
cytokines from pulp homogenates, where media on both the tissue surface and within 
the microvasculature had not been flushed out prior to homogenisation, the exclusion of 
serum from our experimental model was crucial to determining true responses of the 
pulp tissue to hypoxic exposure. Pulps were incubated for a short duration of time (up to 
16 hr, as per Tofolli’s publication) as a more prolonged recovery period may affect the 
tissue and induce changes that could lead to cellular outgrowth from the explants; not as 
a response to treatment but as a cell survival mechanism and differentiation of pulp-
derived stem cells (Couble et al. 2000, Huang et al. 2006, Ruch et al.1989, Tawab et 
al.2009). 
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It is of import to consider the damage to the tissue by dissection through the mid-sagittal 
plane. While we gain the benefit of determining both the transcriptomic and proteomic 
response of a single tissue, isolated from a single patient and thus minimising the 
biological variability in the sample group; we have induced injury to the tissue and 
initiated a wound-healing or angiogenic response. Therefore, the changes observed in 
both the transcriptomic and proteomic analyses may not be solely attributed to the 
hypoxic response of the tissue. 
We propose that further work be carried out in order to optimise the hypoxic model, 
using whole pulp samples, prior to attempting to determine the true response of pulps to 
hypoxic exposure. We would recommend that an in vivo model is used but appreciate 
that ethical restrictions may limit this as a possibility. Should this ever become an 
approved experimental option, careful control and moderation of the cellular oxygen 
concentrations will be both complicated and problematic. 
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5.6 Conclusion 
In order to investigate the angiogenic response of the human dental pulp to a range of 
hypoxic intensities, we exposed untreated healthy premolar pulps to a series of 
intermittent, chronic and repeated cycles of intermittent hypoxia. We have determined 
in this experimental chapter that:  
1. Quantification of oxygen concentrations with a Galvanic probe is an inefficient 
technique in this experimental model. Not only does this method require 
manipulation of the sample during testing; but results require multiple stages of 
correction. In addition to this, data from the Galvanic probe does not correspond 
with that obtained by spectrophotometric analysis with a FOXY probe. We 
propose that in all future assessment of oxygen concentration, using this 
experimental model, that a FOXY probe is utilised.  
2. The a priori hypothesis that different hypoxic intensities will produce varied and 
unique transcriptomic and proteomic expression patterns has been confirmed; as 
each hypoxic intensity appeared to affect the human dental pulp in a distinct 
manner.  
3. The application of any hypoxic intensity to human dental pulp explants will 
induce an angiogenic response. The severity of the angiogenic response is 
dependent upon the intensity of the exposure.  
4. Transcriptomic analysis of the expression for the angiogenisis-specific GOIs 
was performed and each hypoxic intensity resulted in a unique expression 
pattern, relative to normoxic controls. Following exposure to intermittent 
hypoxia, the human dental explants exhibited a transcriptomic trend towards 
increased vascular permeability, increased vascular stability, inhibition of 
vascular proliferation, an absence of inflammation and an absence of hypoxia. 
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These trends appear to contradict each other but may be attributable to the onset 
of hypoxia and an angiogenic response, followed by recovery from hypoxia in 
the reoxygenation stage of the experimental protocol. Following exposure to 
repeated cycles of intermittent hypoxia we observed a trend towards increased 
oxygen deprivation, halted or repressed vascular proliferation, vascular 
stabilisation and an inflammatory response where no pro-inflammatory 
mediation was evident. We hypothesise that the repeated exposure to hypoxia 
will induce oxygen deprivation, inflammation and vascular proliferation but that 
the reoxygenation stages will allow for a small recovery within the tissue. 
Following exposure to chronic hypoxia, we observed an increase in oxygen 
deprivation, inflammation, vascular permeability, vascular proliferation and 
vascular stability. We propose that a prolonged exposure to hypoxia without 
multiple reoxygenation stages intensifies the negative effects of oxygen 
deprivation experienced by the pulps; and will concurrently induce a state of 
inflammation. These tissues will undergo an angiogenic response in order to 
recover from the negative effects of oxygen deprivation. Vascular permeability 
is either regulated homeostatically throughout this process or during the 
reoxygenation stage at the end of the experimental protocol, and is sufficient to 
allow for a small amount of recovery.  
5. It was shown by regression analysis that hypoxic intensity had no effect on the 
mRNA expression patterns of any particular gene but it did have a notable effect 
on the expression patterns of genes between two treatment intensities. We 
hypothesise that following the initial onset of hypoxia the pulp explants will 
exhibit an induction of inflammation, cell proliferation, cell migration, increased 
vascular permeability and stabilisation of neovasculature or existing vasculature; 
should they be exposed to several more hypoxia-reoxygenation cycles. Should 
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this then intensify to a sustained hypoxia, tissues are hypothesised to experience 
oxygen deprivation, inflammation, vascular mitogenesis and endothelial cell 
proliferation in accordance with a strong angiogenic response. Between 
intermittent hypoxia and sustained chronic hypoxia, we hypothesise that pulps 
will experience oxygen deprivation, inflammation, vascular mitogenesis and 
vascular proliferation.  
6. The use of an Ultra-Turrax® homogeniser is inappropriate for the 
homogenisation of human dental pulp explants, especially when samples are 
halved, as per this experimental protocol. Whilst we were able to recover high 
concentrations of total protein from our samples, some of the pulp tissue was 
lost to the homogeniser. We propose that all future work be carried out using a 
Dounce tissue homogeniser instead.  
7. Halving pulp samples had no effect on the mRNA analysis due to the use of the 
RNA amplification system. By halving pulp samples in the proteomic analysis, 
we further reduced the total concentration of the low-abundance proteins of 
interest present in the homogenate. We therefore propose that despite the 
advantages of minimising biological variability, that halving human dental pulp 
explants is inappropriate due to the low RNAtotal and low protein yields of this 
tissue.  
8. The custom multiplex ELISA is an inappropriate technique for the quantification 
of low abundance proteins in the human dental pulp. We propose that high-
specificity techniques, which can be used in conjunction with a statistical 
protocol for the correction of biological variability, should be used in its place.  
9. Following qualitative assessment of proteomic expression patterns, we noted 
that each hypoxic intensity will result in a distinct pattern. However, this has yet 
to be verified as a number of samples within the investigation returned a null 
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value. It was determined that following exposure to intermittent hypoxia protein 
abundance increased for genes associated with vascular permeability, vessel 
stabilisation and a response to inflammation. Following repeated exposure to 
intermittent hypoxia, we observed an increased protein expression trend of 
inflammation and vascular stabilisation. Following exposure to sustained 
chronic hypoxia we observed an increased proteomic trend towards genes 
associated with inflammation, vascular permeability and the expression of 
PDGFA which is normally active in prenatal vasculogenesis. Between hypoxic 
intensities we hypothesise that by applying repeated hypoxia-oxygenation cycles 
to a tissue which has already experienced intermittent hypoxia, there will be an 
increase in inflammation. We hypothesise that there is an increase in oxygen 
deprivation, inflammation and vascular proliferation between repeated exposures 
to intermittent hypoxia and sustained chronic hypoxia.  
10. We have established that culturing pulps, previously exposed to chronic 
hypoxia, under normoxic conditions for a period of up to 16 hr following 
exposure will result in a distinct and unique protein expression pattern. We 
hypothesise that a prolonged recovery will have an effect on both mRNA 
stability, protein translation and protein degradation. The extent to which 
prolonged recovery affects the pulp explants has yet to be determined as the 
ELISA analysed only a small number of potential target genes and returned a 
large number of null results.  
11. We have established that patient phenotypes have no significant effect on the 
mRNA or protein expression of the GOIs in human dental pulps exposed to 
hypoxia. Apex morphology and patient ethnicity have been highlighted as 
potential phenotypes which could have an effect on gene expression, although 
further work is required in order to substantiate this hypothesis.  
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12. The experimental model used in this investigation removed the pulp tissue from 
its niche environment where homeostasis is maintained by a number of 
physiological features. A number of steps within the protocol could agitate the 
tissue, causing inflammation or wound healing; therefore masking or 
manipulating true results. We propose that further work be carried out in order 
to determine a protocol that better replicates the environment of this unique 
tissue. 
In this experimental chapter we have determined that following the exposure to any 
intensity of hypoxia, an angiogenic response will initiate within the human dental pulp 
to correct for oxidative deprivation. Each exposure will result in a distinct and unique 
expression pattern of mRNA and protein which corresponds with the individual hypoxic 
intensities. The reoxygenation stage of the experimental protocol appears to have a 
significant effect on the pulp tissue, as a longer duration of hypoxia appears to result in 
a greater reperfusion injury as oxygen concentrations return to normal. 
 









 Chapter VI  
 
General Discussion 
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The objective of the work within this thesis was to contribute to the current knowledge 
of the angiogenic response of the human dental pulp to orthodontic force application. 
This was done with a view to confirming the presence of angiogenesis-specific growth 
factors, cytokines and chemokines at the transcriptomic and proteomic levels in the 
tissue and subsequently determining whether key signalling pathways were activated at 
distinct time-points of routine treatment. Previous studies have identified the presence 
of several angiogenesis-specific growth factors in cells and tissue explants from human 
dental pulp; although few have linked these factors to routine orthodontic treatment, 
thus highlighting the importance of this research. 
6.1.1 Experimental Model for Orthodontic Force Application 
The experimental model used throughout this thesis was chosen as it would allow for 
extrapolated data to be linked directly to the physical processes occurring within routine 
clinical treatment. Patient groups were composed from a mixed ethnical background, a 
mixed gender population and a narrow age range where tooth morphology was 
considered to be the most similar. This was performed in order to reduce the 
introduction of bias and inter-patient variability which could sway the interpretation of 
data during statistical analyses. Further measures were taken to reduce the introduction 
of bias or variability at the intra-patient stage by utilising dentally sound contralateral 
pairs of premolar teeth, sharing similar anatomical attributes. In the experimental 
chapter attempting to determine the effect of exposure to varying hypoxic intensities, 
four healthy paired premolar teeth were extracted from each patient from the same 
dental position. Patients were from a mixed gender and ethnical background and fell 
within the same age range as the orthodontically treated patients. This was done to 
ensure that data from all experimental groups could be directly related. 
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6.1.2 Orthodontic Force Intensity 
It is well known that in order to facilitate tooth movement, forces inducing remodelling 
of the PDL and alveolar bone must be applied without introducing degenerative side 
effects such as tissue necrosis or hyalinization. While we used what is considered to be 
a light uninterrupted force (0.5 – 1 N, the equivalent of 50.99 – 101.97 grams-force), it 
has previously been shown in the rat model that a force greater than 4 grams-force 
would result in degeneration of the PDL tissue due to the greater level of compression 
experienced (Noda et al. 2009). This has been contradicted in a human study where 
pulpal blood flow was measured during continuous orthodontic force application and 
subsequent to force removal; forces within the range of 40 – 50 grams-force were found 
to be appropriate, as the effects on pulpal blood flow were shown to be fully reversible 
(Sano et al. 2002). Although a number of studies have attempted to identify the ‘optimal 
force’ where PDL damage does not occur and where pulpal blood flow remains as close 
to that of an untreated tooth, the aim of our study was to maintain uniformity with that 
of routine clinical conditions and therefore this level of force (0.5 – 1 N) was selected. 
Investigators should note that force levels are compared in the literature among a 
number of experimental models where the physiology of the subject does not always 
correlate with that of another model. Care should always be taken to try and optimise 
experimental conditions within the experimental organism of choice. 
6.1.3 Optimisation of Experimental Protocols for mRNA Expression 
Analysis 
In the first experimental section we highlighted the necessity for optimisation of 
thorough working protocols prior to the commencement of gene expression analyses. 
By trial and error we were able to determine that standard procedures used globally by 
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investigators in this field could result in detrimental knock-on effects in data production 
and interpretation.  
6.1.3.1 Sample Storage and RNA Preservation 
We observed that similar RNAtotal yields can be obtained from samples stored in an 
RNA preservative compared to those snap-frozen in liquid nitrogen; however, we later 
learned that an RNA preservative would have a denaturing effect on proteins within the 
sample. We suggested that for ease of use in a clinical environment, an RNA 
preservative is used for samples to be analysed by RT-qPCR or microarray; and that 
snap-freezing be used where tissue needs to be analysed by Western Blot, ELISA or 
histological processing for protein analysis. The effects of RNA preservatives on a 
tissue to be processed for in situ analysis has not been determined in this study. 
6.1.3.2 Sample Homogenisation 
While a number of homogenisation protocols are used globally for RNAtotal isolation we 
found that sample volume was lost during homogenisation in a mortar and pestle in 
liquid nitrogen; and by passing the sample through a needle in an RNA stabilisation 
solution. We proposed that the optimal method of pulp homogenisation for independent 
laboratories, which do not have extensive budgets for equipment and reagents, was to 
immerse the tissue in an RNA stabilisation solution within a glass Dounce tissue 
homogeniser and to homogenise the tissue on ice. Should a greater financial budget be 
available, homogenisation of pulps with the FastPrep®-24 Instrument is recommended. 
6.1.3.3 RNA Isolation Protocols 
Phenol:chloroform RNA isolation was discounted as an appropriate protocol for 
RNAtotal isolation from the pulp, as high levels of organic compound contamination 
were shown to be present at the point of RNAtotal quantification. The RNEasy Mini Kit 
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(Qiagen Ltd., UK) without the recommended DNAse treatment step was then compared 
against the phenol:chloroform extraction protocol and found to be notably favourable in 
comparison. It was suggested that by combining aspects from both the 
phenol:chloroform and RNEasy Mini Kit RNA isolation protocols, we could increase 
the yield of RNAtotal and reduce the level of organic compound contamination. This was 
shown to be true and we suggest that this method be used in combination with the  
WT-Ovation™ Pico RNA Amplification System for reverse-transcription as the 
amplification kit includes a DNA clean-up phase which purifies cDNA and removes 
potential qPCR inhibitors from the samples. 
6.1.3.4 RNA Quantification Protocols 
In this section of the study we were able to highlight the large discrepancies between 
commonly used RNA quantification protocols. By comparing a standard bench-top UV 
spectrophotometer to the new-age technology of a purpose-built NanoDrop UV 
spectrophotometer, we were able to note the effects of technological progress on a 
routine protocol where the physics has not changed but the sensitivity of the assay has. 
By then comparing NanoDrop UV spectrophotometry to the fluorescence-based assay 
in the ‘Quant-iT™ Ribogreen® RNA Assay Kit’ we were able to further illustrate the 
significant differences in the amount of RNAtotal thought to be obtainable by the UV 
spectrophotometry method compared with the true mass of RNAtotal present in a single 
isolate. While it is noted that at concentrations of 100 ng/μl or more, UV 
spectrophotometry presents similar yields to the Ribogreen® assay (Bustin 2002), the 
concentrations obtainable from a single pulp isolate fall well below this level, yielding 
standard UV spectrophotometry an obsolete protocol in quantification of RNAtotal 
isolated from the human dental pulp. It should however be noted that in a survey of 
nearly 100 researchers from academia, industry and diagnostic laboratories; similar 
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results were achieved where no correlation was found between quantification methods 
and it was concluded that it was inadvisable to compare methods, yet prudent to 
measure all samples within an experiment using the same quantification approach. 
(Bustin 2005, Nolan et al. 2006). Therefore, we do not suggest any preference between 
analysis with the NanoDrop UV spectrophotometer or the Ribogreen® fluorescence-
based assay but have utilised both in this experimental system. We have used the 
Ribogreen® assay for quantification of our samples and we have used the NanoDrop 
UV spectrophotometer for verification of sample integrity. 
6.1.3.5 Reverse-Transcription Protocols 
By identifying the low-RNAtotal yielding nature of this tissue, we were able to modify 
our approach to reverse-transcription and subsequently RT-qPCR. We compared a well-
known one-step RT-qPCR kit with an RNA amplification system, which in turn resulted 
in a maximisation of the experimental potential of a single pulp to beyond our original 
expectations. By utilising the one-step system, we would limit the number of RT-qPCR 
reactions per pulp to 40 reactions performed in technical duplicate. This was compared 
against the RNA amplification system which would allow for up to 6,441 RT-qPCR 
reactions to be performed in technical duplicate, based on an isolated mass of 806.54  
± 33.37 ng RNAtotal per pulp sample. The identification of the RNA amplification 
system thus eliminates the need for pooling samples in gene expression studies of the 
human dental pulp altogether.  
It should be noted that the use of a one-step RT-qPCR kit holds the advantage of 
reducing the potential for introducing contaminants to the reaction. Multiple processes 
are combined into a single tube and this process does not require as many freeze-thaw 
cycles of the original sample, should the sample not have been divided into aliquots at 
the time of extraction (Nolan et al. 2006). It has also been noted in the literature that in 
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two-step RT-qPCR reactions, where RNAtotal is converted to cDNA prior to the 
amplification reaction; the presence of any residual reverse-transcriptase enzyme may 
inhibit the amplification assay (Nolan et al. 2006). This has been considered in the RNA 
amplification system as the technique includes a separate phase where the cDNA is 
desalted and cleaned of any residual enzyme, although the potential for contaminating 
the sample through many handling stages remains a concern. 
6.1.3.6 Normalisation of RT-qPCR Data: Reference Gene vs. Normalising 
Factor 
Our attention then turned towards the normalisation of RT-qPCR data. It has been 
shown in a number of studies that the choice of reference gene or normalising factor 
(composed from a ratio of reference gene expression levels) will have a knock-on effect 
on the interpretation of data. This appears to have gone unnoticed amongst researchers 
in this field who have automatically reverted to the use of popular reference genes and 
have not considered the stability of other equally important, less prevalent reference 
genes in their studies. By comparing the expression stability of several reference genes 
confirmed to be expressed in human dental pulp tissue, and using three recognised and 
highly respected software packages for expression stability analysis; we were able to 
determine that in the in vivo model of orthodontic force application to human teeth prior 
to extraction and dental pulp isolation, a normalising factor created from a mean of 
RPL13A and UBC gene expression was the most appropriate for data normalisation in 
our experimental system. We also identified that should an experimental group have 
limited funding, it would be acceptable, although ill-advised, to use the single most 
stable reference gene UBC as a normaliser. We state that this is ill-advised as we have 
determined that there will be a number of significant differences in the data obtained by 
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normalising against a single gene in comparison to a normalising factor; but we leave 
this decision to the discretion of future investigators. 
6.1.3.7 The Effect of Reaction Efficiency on mRNA Quantification 
In the second experimental section, we identified the effect of amplification efficiency 
on the under- or over-estimation of mRNA abundances. In the first experimental 
section, we had identified the statistically significant up-regulation of FGF2 mRNA in 
pulps which had been treated with orthodontic force application for a period of 2 weeks 
prior to tooth extraction. When we attempted to verify this result, using a different set of 
primers, we did not establish the same conclusion. Primers were then assessed for 
differences between transcript length and inclusion of splice variants; it was established 
that primers from Primer Design Ltd., UK did not span the same region of the transcript 
as the primers designed in collaboration with Dr Nick Silver, and did not include the 
splice variant FGF2-002.  
This was thought to be the cause of the discrepancy until the calibration curves for the 
initial reactions were re-assessed and the amplification efficiency was established as 
1.03.  
The REST-2009© software package allows for a maximal input value of 1.00 
(representative of 100 % or exact doubling of the template) for reaction efficiency, as it 
is impossible to do any more than perfectly double the original template in each reaction 
cycle. Therefore, the discrepancy between results from experimental sections one and 
two were due to the over-estimation of mRNA abundance for this GOI by improper 
consideration of the amplification efficiency; and not due to the absence of the 
amplification of the splice variant FGF2-002. 
While the REST-2009© software package incorporates a critical reaction efficiency-
correction step, the methodology for biological variability correction, which was 
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utilised later in the project for statistical analysis, does not. Therefore it is essential that 
before performing the variability correction step on RT-qPCR data, the reaction 
efficiencies are established to be as close to 100 % as possible and within a small range 
of each other in order to ensure that data is directly comparable. Correcting for 
biological variability was only considered to be appropriate in this thesis as efficiency 
levels were guaranteed by the primer distributor. Had the efficiencies of the reactions 
not been guaranteed and directly comparable, any variation in efficiency may add to the 
over- or underestimation of mRNA expression in our samples. 
The variability correction step could not be performed on mRNA expression data in the 
first experimental section, from reactions where we had designed and optimised the 
reaction primers ourselves; as calibration curves created for the GOIs showed 3 of the 4 
genes having a reaction efficiency greater than 100 %, with the reference gene 
efficiencies being widely varied but below 100 %. The reaction efficiencies of the 
reference genes were taken into account when assessing reference gene stability and as 
no efficiency was ranked over 100 %, the results of reference gene stability analysis 
remain applicable to our experimental conditions. 
It is generally considered that within an RT-qPCR reaction, there is an intensity of 
fluorescence proportional to the DNA concentration present; and this relationship is 
linear throughout the exponential phase (Ruijter et al. 2013). This assumption allows 
investigators to calculate reaction efficiencies from a straight line graph where known 
concentrations are input into the reaction and Cq values are related accordingly. This 
method of determining the reaction efficiency is called the ‘constant efficiency’ method 
and assumes that reaction efficiency is constant throughout the exponential phase of the 
reaction. Following the exponential phase, reaction efficiency is thought to diminish.  
An alternate method for calculating the reaction efficiency is to assume that over the 
course of the reaction there is a continual decrease in reagents and an accumulation of 
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product, with an increase in binding competition between the primer and the amplicon. 
Over each cycle, the efficiency is calculated and an average efficiency is calculated for 
the entire reaction. This method is called the ‘decrease per cycle’ method (Ruijter et al. 
2013). 
The Corbett Rotor-Gene™ 6000 Application Software, version 1.7 (Build 87) does not 
utilise the ‘decrease per cycle’ method but instead uses the ‘constant efficiency’ 
method. It is known that by assuming the reaction efficiency to be 100 % for all GOIs 
across the entire experiment, without evaluating individual target gene calibration 
curves, will lead to an over-estimation of the data; but in that light so would the use of 
the ‘constant efficiency’ model for calculating the efficiencies of individual reactions. 
Should there be a decrease in efficiency due to binding competition between primers 
and the amplicon; or perhaps the amplification of spurious binding products; the 
reaction efficiency would be altered without consideration. This is notably a significant 
factor for any future researcher in this field to reflect upon at the onset of investigation. 
The concept regarding the over-estimation of data in RT-qPCR was not considered past 
the point of having an efficiency value greater than the maximal value for the GOIs in 
our first experimental section and attempting to correct for that in statistical analyses. 
Prior to being informed of the ‘decrease per cycle’ theory, we had assumed that all 
which was required in order to obtain valid and statistically significant data, was to 
optimise each gene’s primers against a calibration curve created from a cDNA library. 
For this purpose, we had purchased optimised primers where the reaction efficiency was 
guaranteed to be 100 % and then determined our relative gene expression between 
control and treated samples accordingly. The suggestion that this method would still 
lead to an under- or over-estimation of the mRNA abundance of our samples outlines 
the continual growth in this experimentally young field and highlights the progress 
which still needs to be made in order to obtain true and conclusive results. 
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6.1.3.8 Correcting for Biological Variability in mRNA Expression Data 
Following our identification that all RT-qPCR reactions should have a similar reaction 
efficiency value, based on literature available at the time of experimentation; RT-qPCR 
was performed for all samples using primers for each GOI. Data was expressed as Cq 
values which were then normalised against the expression of the normalising factor, 
created from the mean expression of reference gene RPL13A and UBC. Data was input 
into the REST-2009© software package and we could determine no significant 
differences in the expression of the GOIs at any of the experimental time-points. This 
was unexpected as previous work carried out by other groups suggested that there was 
an increase in the protein abundance of our GOIs in our experimental model and this 
had to be attributed to an initial up-regulation of mRNA expression. When patient data 
from the control samples was analysed for variability, we determined that each patient 
had a varying baseline of expression for each GOI when compared to other patients 
within the sample group. It has been postulated that this is due to the cellular activity 
and composition of each tissue.  
We had previously attempted to minimise the amount of variability present in the 
sample group by restricting the ages of patients and therefore the correlated tissue 
morphology of each tooth but this did not limit the variability sufficiently for accurate 
analysis of the data to be performed.  
A statistical model created for microarray data was identified amongst the literature and 
was broken down into individual steps, our understanding of the methodology was then 
sent for correction and clarification by Dr N. A. Donaldson, a statistician. Upon 
clarification of the process for obtaining statistical significance from the data, we 
analysed all RT-qPCR data and were able to identify a number of statistically 
significant changes in mRNA expression in our experimental model. 
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Biological variability has been considered to be an issue in a number of previous studies 
(Nixon et al. 1997, Ricos et al. 2009, Smith et al. 1993) but the limitation it places on 
RT-qPCR data, particularly from human dental explants, has not been considered until 
now.  
We propose that following the correction for amplification efficiency, according to the 
‘decrease per cycle’ model; the correction for biological variability is the second most 
critical step for obtaining a significant and valid interpretation of transcriptomic changes 
occurring within an experimental system. Therefore, all future analysis of the 
transcriptomic changes in human dental pulp should utilise the statistical method that 
has been outlined within this thesis. 
6.1.4 Angiogenic Response of the Human Dental Pulp to Orthodontic 
Force Application 
Within the second experimental section of this thesis, after having identified all correct 
protocols for mRNA expression analysis in our experimental model; we quantified and 
compared the expression of mRNA and proteins specific to the angiogenic signalling 
cascades in pulps isolated from orthodontically treated teeth. This was done in order to 
confirm or reject the hypothesised angiogenic response of the human dental pulp, 
proposed by Derringer et al. (Derringer et al. 1996, Derringer and Linden 1998, 
Derringer and Linden 2003, Derringer and Linden 2004), to three stages of early routine 
orthodontic treatment.  
Following 24 hr of force application we observed a concerted increase and decrease in 
mRNAs associated with the homeostatic regulation of pericyte recruitment to the vessel 
walls. This was not supported by a corresponding decrease in protein abundance for 
PDGFB, as six of the ten readings returned from the ELISA analysis were null results. 
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Although it is indicated at the transcriptomic level, we cannot conclusively state at this 
stage that the pulpal vasculature is stable following 24 hr of routine clinical treatment. 
In addition to this, we observed an increase in the abundance of FGF2 protein. This 
complemented the non-significant increase of FGF2 mRNA at this time-point of 
treatment and is associated with inflammation. The suggested state of inflammation at 
this stage of treatment is substantiated by the increase in mRNA for IL8, a pro-
inflammatory cytokine present in pulpal tissue solely in inflammatory conditions; and 
the increase in SELE protein abundance, where SELE is synthesised by vascular 
endothelial cells which have been stimulated by pro-inflammatory cytokines. We also 
observed a non-statistically significant change in the up-regulation of HIF1A mRNA 
which accumulates at the transcriptomic level only in conditions of oxidative stress and 
is associated with cellular hypoxia.  
After 3 days of force application, we observed corroborative trends in mRNA 
expression which suggested that hyperoxia and / or inflammation were present in the 
pulpal tissues at this stage of treatment. These trends included a significant decrease in 
the expression of HIF1A mRNA, associated with hyperoxia; and a non-significant 
increase in IL8 mRNA, indicative of inflammation.  
There was shown to be a non-significant decrease in FGF2 mRNA which was matched 
by a decrease in FGF2 protein abundance. This was not expected as an inflammatory 
response is known to increase the FGF2 abundance. There was also a decrease in SELE 
protein abundance which would normally increase under inflammatory conditions.  
We hypothesised that SELE is under the control of pro-inflammatory cytokines other 
than IL8 as we maintained the hypothesis that following 3 days of force application, 
pulps are an in inflamed state.  
PDGFB protein abundance was shown to increase at this time of treatment indicating a 
need to recruit pericytes to vessels and a potential increase in the interstitial fluid 
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pressure. Due to the increase of PDGFB protein, we concluded that it was less likely 
that hyperoxia was occurring; as PDGFB is known to decrease in hyperoxia and we 
assumed that pulps were responding to the initial inflammatory stimulus at 24 hr of 
treatment. Given the morphology of the pulp tissue, any increase in the interstitial fluid 
pressure would prolong the inflammatory state of the organ.  
At the 14 day duration of routine clinical treatment there was a significant increase in 
the expression of HIF1A mRNA, indicating that at this time-point the pulps were once 
again under oxidative duress. Other genes associated with angiogenesis and coagulation 
were also shown to be significantly up-regulated at this orthodontic treatment time-
point; and this was substantiated by the non-significant increase of pro-inflammatory 
cytokines IL8 and NOS2. 
FGF2 protein abundance increased in accordance with the corresponding non-
significant increase of FGF2 mRNA. This increase is thought to be associated with the 
inflamed state of the pulp. Incidence of inflammation was supported by the increased 
abundance of SELE protein. The decrease in PDGFB protein at this treatment time-
point indicates that either the vasculature is stable or that tissues are attempting to 
regulate the inflammatory state, where a negative feedback loop is preventing the 
further increase of interstitial fluid pressure. Although, this requires further 
investigation in order to make any conclusive statements. 
From our findings we postulate that following the initial application of orthodontic 
force, the pulp experiences inflammation and that this inflammatory response is 
accompanied by oxidative stress. We propose that the pulpal morphology of mature 
teeth, with closed apical foramina, maintains the inflammatory state which is then 
intensified by an increase in interstitial fluid pressure. Although at this point, the initial 
oxidative stress is relieved. After two weeks of force application, pulps are once again 
under oxidative stress in conjunction with inflammation and the potential onset of 
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angiogenesis, however, there is no apparent alteration to pericyte recruitment but there 
is a potential regulation of interstitial fluid pressure.  
At the onset of this experimental section our intent was to verify the findings of 
Derringer et al. (2003, 2004) where angiogenic growth factors were hypothesised to be 
increased transcriptomically prior to being secreted by the tissue as proteins. We could 
not confirm or deny all findings of this group but have noted an increase in the 
transcriptome and proteome of most of these GOIs previously studied by Derringer et 
al. and in some of the GOIs in the extended panel for investigation. At no time in our 
study did we identify a statistically significant increase in the mRNA expression or 
protein abundance of VEGFA, one of the leading protagonists in the angiogenic 
signalling cascades. We suppose that the additional time in which Derringer et al. 
(2003, 2004) continued to co-culture the pulps following isolation, was sufficient to 
induce both transcriptomic and proteomic up-regulation of this gene; and we 
hypothesise that this would be in response to hypoxia and inflammation which is 
evident in our findings following 2 weeks of force application. 
Inflammation and hypoxia have been evidenced in the literature as a response of the 
dental pulp to orthodontic force application and this too substantiates our findings 
(Romer et al. 2014, Yamaguchi 2007). It is also of interest to note that the existing 
lymph vessels of the pulp tissue are only stimulated to grow under inflammatory 
conditions and may only be required in order to reduce the interstitial tissue fluid 
pressure of an inflamed tissue (Gerli et al. 2010). It would be of interest for further 
groups to assess the vasculature of untreated control and orthodontically treated pulps, 
confirming or denying the presence of hypoxia and inflammation in the tissues; and 
then to go on and investigate the potential increase of lymph vessels, in order to confirm 
or deny the initiation of lymph angiogenesis as a potential homeostatic regulator of 
interstitial fluid pressure in response to orthodontic treatment. 
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As inflammation has been shown to play a putative role in the response of the human 
dental pulp to routine clinical treatment, it should be noted that the true inflammatory 
response of this tissue may not be reflected within our data. During the consultations 
associated with the initiation orthodontic treatment, patients are made aware of a 
potential pain response which may result from treatment and were advised to take 
paracetamol if necessary. It is possible that patients within the one and three day treated 
groups could have consumed anti-inflammatory medication in order to alleviate pain 
symptoms experienced as a routine side effect of treatment. These anti-inflammatory 
medications would have a knock-on effect on the regulation of the transcriptomes and 
proteomes associated with the inflammatory response in the pulp and periodontal 
tissues. Patients within the two week treated group are more likely to exhibit true 
responses, with respect to inflammation; as it is postulated that by this time-point of 
treatment teeth will be within the lag phase of tooth movement and pain would be 
minimal. Whilst it is unethical to suggest that patients should refrain from consuming 
medication to alleviate pain during the initial stages of tooth movement, future 
researchers would need to take into consideration whether or not anti-inflammatories 
were consumed and attempt to identify the course of medication adhered to in order to 
attempt to better understand the role of inflammation in the pulp in response to routine 
clinical treatment. 
6.1.5 The Response of the Human Dental Pulp to Varied Intensities of 
Hypoxic Exposure 
Following on from our determination that during the initial (24 to 48 hr) and lag (up to 
20 days after force application) phases of routine orthodontic treatment, pulps 
experience oxygen deprivation; we attempted to characterise the response of the human 
dental pulp to varied intensities of hypoxia. We had hypothesised prior to investigation 
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that defined intensities of hypoxia would yield a response, unique to each corresponding 
hypoxic intensity; and this was established to be true.  
Following an exposure to intermittent hypoxia we observed a transcriptomic trend 
towards increased vascular permeability, increased vascular stability, inhibition of 
vascular proliferation, an absence of inflammation and an absence of hypoxia. This was 
supported in the assessment of protein abundances where we observed an increase in 
proteins associated with vascular permeability, vessel stabilisation and a response to 
inflammation. We could not determine corroborative protein abundances for genes 
associated with the inhibition of vascular proliferation or for genes associated with the 
inception of inflammation and hypoxia. This was due not only to the number of samples 
which returned a negative or null result; but was due to the limited number of analytes 
available in the custom multiplex ELISA. We have postulated that the contradictory 
protein expression associated with both vascular permeability and vascular stability is 
either present because of a homeostatic balance of degrading and stabilising 
mechanisms; or that degradation occurs during the initial hypoxic response and vascular 
stability occurs during the recovery from the onset of angiogenesis. Homeostatic or 
potentially reparative mechanisms need to be investigated further in order to make a 
conclusive statement on the pulp’s response to intermittent hypoxia. 
Following an exposure to repeated cycles of hypoxia we observed a transcriptomic trend 
towards increased oxygen deprivation, halted or repressed vascular proliferation, 
vascular stabilisation and an inflammatory response, where no pro-inflammatory 
stimulation was evident. In the proteomic analysis we observed an increased protein 
expression trend of inflammation and vascular stabilisation. We could not determine the 
proteomic difference in the abundances of other genes associated with hypoxia or 
inflammation as these analytes were not available for the custom multiplex ELISA. 
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Following an exposure to chronic hypoxia we observed a transcriptomic trend towards 
oxygen deprivation, inflammation, vascular permeability, vascular proliferation and 
vascular stability. We observed a corroborative increase in the proteomic trend towards 
genes associated with inflammation and vascular permeability, in conjunction with the 
expression of a prenatal protein specific to vasculogenesis. We were not able to confirm 
increased expression of genes associated with vascular proliferation, hypoxia or vessel 
stabilisation due to the number of null results returned and the lack of availability of 
analytes in the ELISA. 
PDGFA, a protein found to be expressed most significantly in the embryo during 
vasculogenesis and neurogenesis has been shown to be expressed at low levels 
throughout a number of tissues in the adult, where expression is variable, is regionally 
restricted and is locally regulated (Andrae et al. 2014). It has also been shown to be 
specifically up-regulated in adult tissues which are mesenchymal-derived (Fecteau et al. 
2006, Floege et al. 2008, Yeh et al. 1991) and the presence of its receptor, PDGFRA, 
has been shown to be a marker of mesenchymal stem cells (Farahani and Xaymardan 
2015, Kaetzel 2003). While there has been no evidence to support an increase in the 
activity of PDGFA in the pulp previously, we hypothesise that this increase in protein 
abundance is not attributed to differentiated adult cells but rather to active, 
differentiating mesenchymal-derived human dental pulp stem cells. However, this 
hypothesis has yet to be confirmed in future work. 
The reoxygenation stage of the experimental protocol, within the intermittent and 
repeated cycles of intermittent hypoxic exposure, has been considered to be a significant 
factor which will alter the transcriptomic and proteomic expression trends observed 
within our investigation. Previously, we had postulated that these periods of 
reoxygenation would allow the tissue a short period of time to recover from the negative 
effects of oxygen deprivation. We had not considered that the reoxygenation phase of 
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the hypoxia-reoxygenation or ischemia-reperfusion cycle is associated with reperfusion 
injury; or that this may be the cause for many of the increased trends which have been 
observed in the human dental pulp explants. 
During ischemia (hypoxia), the intracellular pH decreases, ATP production is impaired 
and intracellular calcium increases; this causes the cells to swell and cell death is 
initiated (Kalogeris et al. 2012, Saikumar et al. 1998.). Cells are rescued from cell death 
or necrosis by reperfusion, where oxygen concentrations, intracellular pH and 
consequently ATP production is restored (Eltzschig and Collard 2004, Kalogeris et al. 
2012). The influx of oxygen results in the enhanced production of reactive oxygen 
species and these then act as cytotoxic agents to induce oxidative stress (Eltzschig and 
Collard 2004, Kalogeris et al. 2012). The induction of oxidative stress in the 
endothelium results in leukocyte-endothelial cell adhesion and the initiation of an 
inflammatory response, which has been shown to lead to coagulation of the 
microvasculature (Carden and Granger 2000, Granger and Kvietys 2015). 
When transcriptomic and proteomic changes in the intermittent hypoxia group were 
reassessed, the only gene which could be considered to be correlated with reperfusion 
injury was the increase in the proteomic abundance of SELE. The expression of SELE 
in conjunction with other cell adhesion molecules is activated by reactive oxygen 
metabolites in order to sustain leukocyte-endothelial adhesion and maintain the 
inflammatory response in the tissue (Carden and Granger 2000). As these tissues did not 
appear to be in an inflammatory state, we cannot conclude that reperfusion injury occurs 
in the human dental pulp in our defined intensity of intermittent hypoxia. 
In our assessment of the pulp’s angiogenic response to repeated cycles of intermittent 
hypoxia, we observed a number of increases in both the transcriptomic and proteomic 
expression of genes which may correlate with a response to reperfusion/reoxygenation 
injury. We also observed a number of these changes in our chronic hypoxia group. We 
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were surprised to note that in the group where the hypoxia-reoxygenation cycles were 
prevalent, a strong inflammatory response was not induced within the tissues as 
expected. Inflammation was however observed in the chronic hypoxia group. We 
therefore propose that the intensity of hypoxia which is experienced in the tissue is 
directly correlated to the extent of the reperfusion injury which will occur in response to 
reoxygenation. 
By investigating reperfusion injury we had attempted to elucidate the response of the 
human dental pulp to intermittent hypoxia and the repeated exposure to intermittent 
hypoxia. Instead, we determined that reperfusion injury is most likely to occur within 
the chronic hypoxia group under our experimental conditions. In order to more fully 
comprehend the true angiogenic response of the human dental pulp to chronic hypoxia, 
where reperfusion injury plays no significant role, we propose that this intensity of 
hypoxia is reinvestigated in the absence of a reoxygenation stage.  
Further to our investigation into the effect of hypoxic intensity on the angiogenic 
response of the human dental pulp, we investigated the effect of a prolonged recovery 
period on protein production within the chronic hypoxia group. This was done in an 
attempt to allow for translation of proteins to occur and was performed in accordance to 
Toffoli et al.’s (2009) manuscript. What had not been considered by the investigators 
was the continual modification of mRNA and protein expression within the tissues in an 
attempt to maintain homeostasis. Mechanisms of post-transcriptional and post-
translational modification had also been omitted from consideration.  
The prolonged recovery period outlined in the experimental protocol was intended to 
enable the observation of previously undetermined increases in protein abundance 
following treatment. However, as tissues are likely to attempt a correction, during the 
recovery period, for the oxygen deprivation experienced during hypoxic exposure; the 
protein result observed directly after hypoxic exposure can never be directly compared 
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to those from an extended recovery period. It should also be noted that we have 
established a likely correlation with reperfusion injury in these samples and that 
differences in protein abundance following the extended recovery period may be 
attributable to oxidative stress and recovery from its effects on the pulp tissue.  
6.1.6 The Effect of Patient Phenotypes on mRNA and Protein 
Abundances 
Throughout experimental sections two and three we attempted to determine the effect of 
patient phenotypes on the changes in transcriptomic and proteomic expression of the 
GOIs. Within each of these sections we established that patient phenotypes may play a 
potential role in the regulation of expression for several of these GOIs; however, 
phenotype-associated changes never reached any level of statistical significance due to 
the low number of pulp samples analysed and the number of proteomic evaluations that 
returned a null result. Of the phenotypic traits analysed, we found that patient ethnicity 
and patient tooth morphology had the greatest effect on gene expression and protein 
abundances. It has been postulated in the literature that patients from varied ethnic 
backgrounds will respond differently to a number of stimuli but this theory has yet to be 
confirmed. Apex morphology conversely has been shown in several studies to have a 
potential effect on the mechanisms by which the pulp would respond and our findings 
appear to substantiate those already published. Although, as stated previously, we 
require a greater panel of samples in order to identify the significance of apex 
morphology on the pulpal response.  
When the genes which were affected by patient phenotype were considered and 
compared against their expression patterns in the other experimental sections, we could 
find no correlation in mRNA expression or protein abundances in the human dental pulp 
samples. This does not necessarily mean that there is no correlation between these 
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experimental groups but rather highlights once again the small scale of this project and 
the need for many more investigations in order to verify and substantiate our findings 
and confirm our hypotheses. 
6.1.7 Linking Responses of Orthodontically Treated Pulps to the 
Characterised Responses of Pulps Exposed to Varied Hypoxic 
Intensities 
Following the transcriptomic and proteomic analysis of human dental pulps isolated 
from teeth that had been treated with routine orthodontic treatment, we determined that 
there was a potential hypoxic response in teeth that had been treated for a period of two 
weeks prior to extraction. We then attempted to characterise the angiogenic response of 
human dental pulp explants exposed to various intensities of hypoxia, as it has been 
shown that a distinct and defined hypoxic intensity will result in a unique transcriptomic 
and proteomic response (Yuan et al. 2008). This was of interest as the highly vascular 
human dental pulp has been shown to be a rich source of pluripotent stem cells and has 
come to the forefront of translational research (d'Aquino et al. 2009, Pisciotta et al. 
2015, Tatullo et al. 2015). Characterising the response of this tissue to hypoxia may not 
only assist in expanding the fields of reparative, restorative and clinical dentistry; but 
may assist in determining an intervention for pathological disease in a clinical field 
beyond dentistry. 
We then attempted to correlate the angiogenic response of orthodontically treated teeth 
with the angiogenic response of human dental pulps exposed to: (a) intermittent 
hypoxia, (b) consecutive exposures to intermittent hypoxia and (c) chronic hypoxia. 
This was done in order to more fully comprehend and characterise the response of the 
human dental pulp to routine clinical treatment. 
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It was identified that the time-course of the orthodontic experiments spanned both the 
initial (24 to 48 hr) and lag phases (up to 20 days) of routine clinical treatment. It has 
been shown that during these phases of treatment there is a compression of the 
vasculature within the PDL which will result in localised ischemia, leakage of blood 
constituents into the surrounding tissue, tissue hyalanization and cell death (Kitase et al. 
2009, Miyagawa et al. 2009, Ren et al. 2008). It has further been postulated that the 
circulatory damage which occurs in the periodontal vasculature at the “pressure” side of 
the tooth not only results in localised hypoxia in the PDL, but that this has a knock-on 
effect on the highly sensitive tissue contained within the pulp chamber of the tooth 
(Romer et al. 2014, Sano et al. 2002). 
We had anticipated that an application of orthodontic force for a duration of one day 
would correlate with the transcriptomic and proteomic expression pattern from pulps 
exposed to intermittent hypoxia or repeated exposure to intermittent hypoxia; that a 
force duration of three days would correspond with repeated exposure to intermittent 
hypoxia or chronic hypoxia; and that two weeks of force application would correlate 
with the expression pattern exhibited by pulps exposed to sustained chronic hypoxia. 
These assumptions were based upon our knowledge from the current literature, which 
has outlined the physiological differences between each phase of orthodontic tooth 
movement. 
When mRNA expression patterns and protein abundances were compared, we could 
find no correlation between orthodontic force durations: (a) one day or (b) three days 
with any intensity of hypoxic exposure. This was unexpected as the initial phase of 
orthodontic tooth movement has been shown to involve the rapid displacement of the 
tooth within the PDL. This process of rapid displacement is thought to involve multiple 
compression and relief cycles of the periodontal vasculature, which is postulated to 
result in cycles of ischemia and reperfusion in both the periodontium and subsequently, 
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the human dental pulp; reperfusion was also expected to result in oxidative stress and 
reperfusion injury in these tissues.  
We had supposed that an orthodontic force applied to teeth for a duration of three days 
prior to extraction would correlate more closely with the expression trends of pulps 
exposed to repeated cycles of intermittent hypoxia exposure. We had assumed that this 
was the most likely association, as at this time-point the tooth is moving from the initial 
phase of tooth movement, where rapid displacement in the periodontium occurs, into 
the lag phase where the tooth begins to settle into a new position until provision is made 
for the tooth to move forward through the alveolar bone. This was not found to be true, 
as at three days of force application there was a general decrease in the mRNA 
expression of all of the GOIs, whilst repeated exposures to intermittent hypoxia induced 
a predominantly positive expression for most of the genes analysed transcriptomically.  
We had identified in the previous analysis of the orthodontic experimental data, that 
following an application of orthodontic force for a period of two weeks, there was an 
angiogenic response in pulps which included hypoxia/ischemia within the tissue. When 
the expression trends for both mRNA and protein abundances were compared to those 
of each distinct hypoxic intensity, we were able to match the trends in the two week 
orthodontically treated teeth to pulps which were exposed to sustained chronic hypoxia 
for up to 5 hr and allowed to recover for 30 min. 
Whilst we had expected that pulps exposed to an orthodontic force for a period of two 
weeks would exhibit a similar expression trend to pulps exposed to chronic hypoxia, 
due to our understanding of the physiology of the lag phase of tooth movement; we 
were surprised that a chronic hypoxic exposure for such a short duration of time 
appeared to replicate expression trends observed in tissues which had been treated 
clinically for a period of two weeks. 
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We attribute these findings to the nature of the experimental model which was used in 
order to investigate the effect of hypoxic intensity on the pulp’s angiogenic response. In 
this experimental model, pulps were removed from their tightly encapsulated, highly 
regulated niche environment, dissected in half and were transferred directly into cell 
culture medium in a cell culture flask which was then flushed with a gas mix containing 
1 % oxygen. Tissues were exposed at all sides to the depleted oxygen solution, 
including the pulp core as a result of the dissection of the tissue; and perfusion of the 
tissue by the oxygen depleted medium was far greater than that which would occur 
physiologically in the pulp’s natural environment. 
In spite of the irregularity of the experimental model, there appeared to be a direct 
correlation between the transcriptomic and proteomic expression trends in pulps treated 
orthodontically for a period of two weeks and pulps exposed to sustained chronic 
hypoxia. We observed an increase in genes associated with hypoxia and inflammation 
in both data sets at the transcriptomic level but could only identify the increased 
expression of VEGFA, one of the protagonists of the angiogenic response, in the 
chronic hypoxia group. As the perfusion of the tissue by the depleted oxygen solution 
was greater than expected, we hypothesise that increased VEGFA expression will occur 
at a later stage in orthodontic tooth movement and that orthodontically treated teeth will 
follow the same expression trends as those observed in the in vitro culture for chronic 
hypoxia. 
When proteomic expression trends were compared there were several homologous 
results between the chronic hypoxia and two week orthodontically treated datasets. 
PDGFB, SELE and TEK appeared to behave synonymously between the two 
experimental treatment types. We have previously discussed the correlation of 
expression of proteins for vascular stability and leukocyte recruitment with a 
reoxygenation stage and a potential causative reperfusion injury in the hypoxia 
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experiments. We assume that the orthodontically treated pulps have also been exposed 
to a reperfusion stage prior to protein abundance analysis, as pulps appear to have been 
affected by oxidative stress and the induction of inflammation. We propose that this 
may have occurred during the isolation of the pulp sample where pulps are removed 
from their dentine-enamel shell prior to being immersed in RNA preservation solution 
or being snap-frozen in liquid nitrogen. We cannot state conclusively that this 
reoxgyenation stage occurred physiologically within the lag phase of tooth movement, 
as the remodelling of the vasculature within the PDL has not yet been characterised 
according to defined time-points in treatment through time-course investigations; 
although this would not be an unreasonable cause for these observations. 
We have previously mentioned that the induction of inflammation, as a result of 
reperfusion injury, may lead to coagulation of the microvasculature (Carden and 
Granger 2000, Granger and Kvietys 2015). This is interesting to note as previous 
research into the effect of routine orthodontic treatment on the human dental pulp has 
shown that following an application of orthodontic force, there is an increase in the 
congestion of microvasculature (Lazzaretti et al. 2014, Mostafa et al. 1991) and a 
concurrent reduction in pulpal blood flow (Sano et al. 2002, Yamaguchi 2007). Our 
findings suggest that in response to routine orthodontic force application, for a period of 
up to two weeks, pulps will experience sustained chronic hypoxia followed by 
reoxygenation, which will result in a reperfusion injury. However, this has yet to be 
confirmed in vivo and future work is required to validate our hypothesis.  
Consideration of the vast number of post-transcriptional and post-translational 
regulators involved within this system; and further work to visualise protein expression 
and neovascularisation of the tissue would be needed to make conclusive statements.  





 Chapter VII  
 
Conclusions and Future Work 
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7.1 Conclusions 
This study has investigated the angiogenic response of the human dental pulp to 
orthodontic force application at both the transcriptomic and proteomic levels and has 
attempted to correlate varying intensities of hypoxia with the early stages of orthodontic 
tooth movement. The following conclusions can be drawn: 
 
1. Identification of appropriate protocols for sample collection, storage, RNAtotal 
isolation, quantification and amplification is imperative prior to gene expression 
analysis in any experimental model; as it is essential that the experimental 
potential for irreplaceable, low RNAtotal yielding clinical samples is maximised. 
2.  The most suitable normaliser (Bustin 2000, Bustin 2002, Bustin et al. 2005) for 
gene expression analysis of a human dental pulp treated in an in vivo system, 
where an orthodontic force is applied to the tooth for two weeks prior to 
extraction, is constructed from a mean ratio of RPL13A and UBC expression. 
3. In order to determine true differences in gene expression, the amplification 
efficiency for the RT-qPCR reaction of each GOI needs to be considered. Where 
possible, the reaction efficiency should be calculated based on the ‘decrease per 
cycle’ theory. Should this not be possible and the ‘constant efficiency’ theory is 
used, reaction efficiencies should be as close as possible to the maximal value; 
and must fall in close range of those reactions for the reference genes. By 
purchasing sets of optimised primers, designed and optimised for unique 
experimental systems, any over- or under-estimation of mRNA present in the 
sample may be excluded from further consideration. 
4. In addition to the correction for amplification efficiency, we have established 
that RT-qPCR data from human dental pulp explants requires correction for 
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biological variability as transcriptomic expression of both reference genes and 
GOIs fluctuates from patient to patient and between teeth from individual 
patients; therefore, a baseline needs to be established prior to relative expression 
analysis. We have identified and clarified the required methodology in order to 
correct for this biological variability in the RT-qPCR data and have outlined this 
method in detail in our appendices (Chapter 8, section 8.2.1).  
5. Orthodontic force application has been shown to have a significant effect on 
mRNA and protein expression in human dental pulps at 1, 3 and 14 days of 
treatment. We have established that at the onset of treatment, pulps experience 
oxidative stress accompanied by inflammation. We suggest that the morphology 
of mature teeth maintains the inflammatory state and that this is then intensified 
by an increase in interstitial fluid pressure. At the two week duration of force 
application, human dental pulps are in a hypoxic and inflammatory condition; 
and angiogenesis may be initiated in a regulatory response to the stressed 
condition of the tissue.  
6. The use of an Ultra-Turrax® homogeniser is inappropriate for the 
homogenisation of human dental pulp explants, especially when samples are 
halved, as per the hypoxia experimental protocol. Whilst we were able to 
recover high concentrations of total protein from samples, some of the pulp 
tissue was lost to the homogeniser. We propose that all future work for both 
RNAtotal and total protein isolation be carried out using a Dounce tissue 
homogeniser instead. 
7. Quantification of proteins, extracted from human dental pulp explants, by 
ELISA is not recommended as pulp tissues appear to contain low concentrations 
of our proteins of interest. Total protein yields from these tissues were high, 
according to BCA analysis; but in order to quantify low-abundance proteins a 
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high-sensitivity technique, where normalization for patient variability is 
available, is recommended. We propose that these analyses are supported by in 
situ hybridisation and microscopy in order to substantiate any findings.  
8. Halving pulp samples had no effect on mRNA analysis due to the established 
use of an RNA amplification system. However, by halving pulp samples in the 
proteomic analysis, within the hypoxia investigations, the total concentration of 
the low-abundance proteins present in the homogenate were further reduced. We 
therefore propose that despite the advantages of minimising biological 
variability, halving human dental pulp explants is inappropriate for this 
experimental tissue due to the low RNAtotal and low protein yields of this tissue. 
9. While we can state conclusively that there are changes in expression of the 
mRNAs of angiogenesis-specific growth factors following force application, we 
are currently unable to elucidate the mechanisms by which the protein 
abundances are altered. mRNA expression is not directly correlated to an 
increase or decrease in protein abundance, as a number of post-transcriptional 
and post-translational modifications must occur to stabilise mRNA and produce 
proteins which can be secreted and utilised in physiological and pathological 
processes; these remain to be considered in our experimental model. 
10. The Galvanic probe was shown to be an inefficient tool for the accurate 
measurement of oxygen concentrations of tissue culture media in the in vitro 
hypoxia experiments. All future work where oxygen concentration needs to be 
determined should be carried out using a FOXY probe. 
11. We have confirmed the a priori hypothesis that hypoxic activity will induce a 
varied response in this tissue, with respect to the intensity of the exposure. Each 
hypoxic intensity was shown to produce a distinct and unique transcriptomic and 
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proteomic expression pattern, relative to the other hypoxic intensities 
investigated. 
12. The exposure of human dental pulps to hypoxia, at any intensity, has resulted in 
an angiogenic response within the tissue. This has confirmed the hypothesis that 
human dental pulps under hypoxia will endeavour to regulate oxygen 
concentrations by inducing an angiogenic response. The severity of the 
angiogenic response appears to be correlated with both the duration and intensity 
of the hypoxic exposure. 
13. Exposure to defined intensities of hypoxia has been shown to have a significant 
effect on the mRNA and protein expression of angiogenesis-specific growth 
factors in human dental pulp explants. Following exposure over a time-course of 
increased hypoxic intensity, there appears to be an increase in inflammation and 
oxidative stress within the tissues in response to reperfusion injury. Reperfusion 
injury appears to have very little effect on pulp explants under our defined 
intensities of intermittent and repeated intermittent hypoxia. The inflammatory 
responses observed at these hypoxic exposures appear to be true artefacts of the 
angiogenic response of the pulp and are eased by the restoration of normal 
oxygen concentrations during the reoxygenation stages. Chronic hypoxia 
appears to result in the most severe angiogenic response and we attribute this to 
both the need to reverse oxygen deprivation in order to prevent cell death and 
tissue necrosis; and to the reperfusion injury which results from a sustained 
exposure of the tissue to depleted oxygen concentrations.  
14. The use of prolonged recovery periods, in order to allow for adequate 
transcription of the proteins of interest, does not consider the continual 
modification of mRNA and protein stabilities by homeostasis, post-
transcriptional modification or post-translational modification. Any attempt to 
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correlate protein abundance data from prolonged recoveries to protein 
abundances in direct response to treatment, must take these factors into 
consideration during their interpretation of the experimental data; or erroneous 
conclusions will be drawn. 
15. The application of routine orthodontic treatment for a period of two weeks 
appears to deprive the dental pulp tissue of oxygen in a manner that correlates 
with sustained chronic hypoxia; and results in a state of inflammation within this 
tissue We have yet to determine whether this inflammation is due to: (a) the 
modification of the interstitial fluid pressure in an unyielding environment in the 
absence of draining vasculature, (b) oxidative stress induced by reoxygenation 
injury of the tooth as it moves through the alveolar bone in routine clinical 
treatment or (c) an artefact from the experimental protocol where tissues could 
become reoxygenated as they are isolated from their dentine-enamel shells. 
16. The experimental model used within the in vitro hypoxia experiments appears to 
alter the true angiogenic response of the tissue to hypoxia, as homeostatic 
regulatory mechanisms are removed by extracting the pulp from its tightly 
encapsulated space. Tissues are also injured by dissection during sample 
preparation and by agitation during the flushing process; this could induce a 
wound healing and angiogenic response in the tissue. We recommend that 
investigators gain a greater homology with the physiological environment of the 
tissue in the experimental model prior to attempting to further characterise the 
pulp’s response to hypoxia. 
17. Phenotypic characteristics such as patient ethnicity and tooth apex morphology 
have been shown to have some effect on the mRNA and protein expression of 
angiogenesis-specific growth factors in the human dental pulp. These 
phenotypes need to be investigated further in a greater sample of the general 
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population in order to identify whether or not these factors play a significant role 
in the pulp’s angiogenic response to orthodontic force application or hypoxic 
exposure.  
18. In all experimental investigations within this thesis, samples were collected in 
order to satisfy the requirements for obtaining statistical significance of 
experimental data. We propose that the sample groups were too small in order to 
gain a comprehensive assessment of the human dental pulp’s response to both 
orthodontic force application and hypoxic exposure. We suggest that in order to 
more fully characterise the response of this tissue to routine clinical treatment 
and oxygen deprivation, larger sample groups are used in further investigation. 
19. While the majority of the work which was performed in the initial stages of this 
thesis was carried out in order to optimise the molecular analysis of gene 
expression within the human dental pulp, in order to characterise the angiogenic 
response to orthodontic force application; we have established that there is little 
correlation between mRNA expression and protein abundance in any tissue. This 
lack of correlation is attributed to the large amount of post-transcriptional and 
post-translation modification which occurs routinely in physiological and 
pathological processes. We therefore propose that in order to fully characterise 
the pulp’s response to orthodontic force application, molecular analysis of 
mRNA expression needs to be considered only after proteins have been 
investigated and localised in tissues, and molecular regulators such a micro 
RNA’s and small interfering RNA’s are considered. 
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7.2 Future Work 
The angiogenic response of the human dental pulp to orthodontic force application 
remains to be fully characterised. Despite having established thorough working 
protocols; maximising the experimental potential of a single sample; and confirming 
gene and protein expression of angiogenesis-specific GOIs in this unique tissue, the 
original questions posed at the onset of investigation have yet to be answered 
completely. 
While every effort has been made to limit the incidence of bias or variability in gene 
and protein expression profiles by ensuring that patients come from a mixed racial 
background, that patient groups were compiled from both genders, and that patient age 
lies within a narrow range where tooth morphology should be similar; the indisputable 
extent of variability exhibited at both the inter- and intra-patient levels remains a major 
cause for hindering the identification of any distinct proteomic expression profiles 
which may be present as a response to orthodontic treatment in this experimental model. 
In order to eliminate the effect of inter- and intra- patient variability on transcriptomic 
data and to identify true trends in gene expression profiles during the process of 
orthodontic tooth movement, we have clarified a statistical protocol for RT-qPCR data 
analysis. This has yet to be considered for proteomic studies where ELISA is the 
investigator’s technique of choice. We have determined that normalisation and 
correction for biological variability is available in conjunction with the use of high-
specificity mass spectrometry (Yu et al. 2007); however, the lower limits of detection 
for these assays are greater than those assessed in the present study (Boja and Rodriguez 
2012, Burgess et al. 2014). 
Recent studies using bead based multiplex immunoassays (Khan 2012) and intercalating 
fluorescence immunoassays (Zhang et al. 2006) suggest an increased sensitivity and 
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may allow detection of chemokines, cytokines and growth factors found in human 
dental pulp. 
A number of investigations have been performed using in vitro analysis of both pulp 
tissues and pulp cells. Despite the numerous experimental techniques that can be 
applied to cells extracted from a single pulp tissue in vitro, we do not advise that an in 
vitro model is used for the purpose of understanding our experimental question. By 
shifting to an in vitro model all histological information that could be gathered in an in 
vivo system is lost; and resultant outgrowth of stem cells would alter the cell population 
of the original tissue. Removing the pulp from its constraining homeostatically 
controlled niche environment, which is crucial to its response to treatment, requires 
manipulations of the original sample: (1) Explants are injured by dissection or collagen 
is digested in order to create cell populations. (2) Growth factors would have to be 
added to samples in order to sustain proliferation and prevent cell death. Therefore, we 
recommend that investigators persist in their use of complete human dental pulp tissues 
for characterising the response of the pulp to routine clinical treatment. While there are 
ethical limitations to these studies, investigators should maintain the use of human 
tissue as animal tissues have been shown to differ in their response (Gerli et al. 2010, 
Mostafa et al. 1991, Ramazanzadeh et al. 2009.). 
While we have established statistically significant differences in mRNA expression in 
both our orthodontic and hypoxia experiments, following the correction for biological 
variability; we propose that future work be carried out on a larger sample group in both 
the transcriptomic and proteomic investigations, as the sample group we investigated 
here was too small to gain a comprehensive understanding of the pulp’s response to 
force application in the general population. We have assessed only teenagers from a 
precise geographical location and this is not fully representative of the populous. We 
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suggest that prior to performing further experiments for transcriptomic analysis; a 
power analysis is performed in order to establish the sample size that will be required. 
Although expanding the sample group would be highly favourable in order to verify our 
findings, it is extremely costly from the perspective of transcriptomic and proteomic 
expression analyses. It is also unrealistic to expect a smaller independent study such as 
this one, where a single orthodontist has had to take on additional patients in order to 
obtain adequate sample numbers, to be able to collect the number of human dental pulps 
that would be required to verify these findings. As a single pulp is required for RNAtotal 
isolation and another pulp is required for homogenisation for proteomic analysis, we 
can consider that the human dental pulp is an experimentally limiting sample, as only 
one technique can be performed successfully per pulp tissue when tissues are to be 
homogenised. 
In order to verify our results, extend the scope of the work and expand the sample group 
without financially crippling smaller independent laboratories, we propose that a 
collaboration among a number of dental schools/universities is organised in which 
standardised protocols for orthodontic force application, sample collection and storage, 
RNA/protein isolation, RNA/protein quantification, RNA amplification, and 
RNA/protein expression and data analysis are issued and followed to the letter in order 
to limit the experimental variability. 
In expanding our investigation and the scope of work, we propose that future 
experiments are performed in a strict time-course from 1 day to 60 days of force 
application, as we have not been able to determine the pulp’s reaction to all phases of 
orthodontic tooth movement (initial, lag, acceleration and linear). These experiments 
would help to validate the findings of our hypoxia experiments and enable us to 
determine whether intermittent hypoxia, repeated exposure to intermittent hypoxia or 
chronic hypoxia truly occurs in the pulp’s response to routine orthodontic treatment; 
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and after which duration of force application this type of hypoxia occurs. We anticipate 
some complications with this time-course however, as in routine orthodontic treatment 
for patients with crowding; premolars are extracted in order for the remaining teeth to 
move into their place and this would not occur in a 60 day experiment.  
We would also like to highlight the use of techniques such as laser capture 
microdissection, in conjunction with blood endothelial cell markers such as CD34++, 
CD105++ or CD146++, which may be used to analyse the cellular response of a particular 
region of the pulp to force application. i.e. The apical portion of the root, which is 
known to experience hypoxia during tooth movement vs. the coronal portion of the pulp 
where we have yet to determine whether or not hypoxia infiltrates this tissue. 
Fluorescence-Activated Cell Sorting (FACS) analysis might also be of interest as 
varying cell types may respond to treatment in differing manners, e.g. fibroblasts vs. 
odontoblasts. We also propose that post-transcriptional and post-translational 
moderators be evaluated as these are known to have a fundamental role in the 
translation of proteins.  
It has also been suggested that lymph angiogenesis is increased during inflammation, in 
order to reduce the interstitial fluid pressure of the tissue (Gerli et al. 2010). While 
hypoxia is responsible for an increase in new blood vessels and these vessels appear to 
be present according to Derringer et al. (2003, 2004), there has been no consideration 
that the mRNA expression differences of the GOIs in this study are due to lymph 
angiogenesis for the homeostatic regulation of the interstitial fluid pressure in inflamed 
tissue. We propose that in conjunction to assessing the angiogenic changes in response 
to routine clinical orthodontic treatment, further work is performed to establish the 
responses of the lymphatic system in this experimental model. 
The hypoxia model used in the experiments within this thesis show little correlation 
with the true physiological environment of the human dental pulp. In order to 
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characterise the physiological and pathological response of the human dental pulp to 
any intensity of hypoxic exposure it is critical that researchers attempt to better replicate 
this niche environment prior to performing any future investigation. 
The angiogenic response of the human dental pulp to varied intensities of hypoxia has 
yet to be fully characterised. Whilst we have identified a number of significant changes 
in the mRNA expression of several GOIs in these samples, we have yet to gain a 
confirmation of these findings at the proteomic level. We have argued that by halving 
pulp samples, in order to prevent further introduction of biological variability, we have 
sacrificed the integrity of the samples and have altered true expression trends by 
inducing angiogenesis by wound healing through dissection. In addition to moderating 
the experimental model, we propose that future work be performed for protein analysis 
which includes techniques such as microscopy, in situ hybridisation and a high-
specificity quantification assay which can be used in conjunction with statistical 
correction methods. 
Despite the discrepancies introduced by our experimental model, we have identified that 
there appears to be a correlation with the duration and intensity of hypoxic exposure 
with the extent of the potential reperfusion injury which is experienced by these tissues. 
In order to verify the scale of the injury to the human dental pulp tissues we recommend 
that further work is carried out for the quantification and localisation of reactive oxygen 
species which are known to behave as cytotoxic agents within cells and tissues. 
Additionally, as we have not observed any significant increase in the transcriptomic or 
proteomic expression of the growth factor VEGFA (a protagonist of the sprouting 
angiogenesis signalling cascade) at any of the orthodontic treatment time-points, it may 
be beneficial for investigators to attempt to identify the mechanism by which this 
angiogenesis occurs. Intussusceptive angiogenesis has been shown to regulate a number 
of angiogenic growth factors in the absence of VEGFA and we propose that this be 
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investigated further by utilising techniques such as electron microscopy following a 
strict time-course of orthodontic treatment. 
Finally, we propose that in order to fully characterise the angiogenic response of the 
human dental pulp to orthodontic force application, a substantial amount of further work 
needs to be performed where pulpal blood flow, microvessel coagulation, reactive 
oxidative species, in situ localisation of protein expression for GOIs and inflammatory 
markers are considered, in conjunction with performing high-specificity quantification 
for proteins of interest and post-transcriptional and post-translational modifiers. We 
propose that this work be performed in parallel to the assessment of a time-course of 
changes to the physiology and vasculature of the PDL as the pulp is dependent on these 
tissues for physiological and pathological support.  
To date, little work has been carried out to determine the effect of the dentine-pulp 
interaction on the angiogenic response of human dental pulps to orthodontic force 
application. This could be of worth to investigate, although the experimental model will 
be difficult to define.  
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Due to the large volume of figures and tables enclosed within the appendix, we have 
included this volume on a compact disc, as per King’s College London’s publication 
requirements.  
 
For the purpose of satisfying the requirements outlined by the MIQE Guidelines 
(Minimum Information for Publication of Quantitative Real-Time PCR Experiments) 
we have enclosed all possible requirements in the enclosed Appendix as Section 1 
(Bustin et al. 2009).  
 
Appendix Section 2 outlines the protocol for biological variability correction as was 
previously published by Willems et al. (2008). This methodology highlights the 
protocols which have been omitted in the original publication, which have been clarified 
by Dr Nora Donaldson, King’s College London. 
 
Appendix Section 3 outlines the detailed investigation into mRNA and protein 
expression patterns performed by Dr Nora Donaldson, King’s College London. 
Summary tables have been compiled within the text and explained in great detail. These 
analyses are for your perusal should you require any further information. 
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